{"title":"Brain \u0026 Cognitive Longevity","description":"\u003cp\u003e\u003cstrong\u003eYour brain ages faster than your body — and most longevity stacks ignore it.\u003c\/strong\u003e By age 60 the average human brain has lost 15–20% of its volume in regions that matter most for memory, judgement, and decision-making. The hippocampus shrinks roughly 1–2% per year after age 40 (\u003cem\u003eRaz 2005\u003c\/em\u003e). Mitochondrial output in cortical neurons drops faster than in any other tissue. Chronic low-grade neuroinflammation — the same \"inflammaging\" process that drives joint pain, cardiovascular disease, and metabolic decline — is now considered an upstream driver of Alzheimer's pathology (\u003cem\u003eHeneka 2015\u003c\/em\u003e). And the brain consumes roughly 20% of your daily energy despite being only 2% of body weight, which means cellular-energy decline hits the brain first and hardest.\u003c\/p\u003e\n\n\u003cp\u003eThe good news: a small number of compounds have real, replicated human evidence for protecting the upstream drivers of brain aging. Not nootropics for a single afternoon's \"focus\" — actual cellular interventions that protect neurons, fuel neuronal mitochondria, repair membranes, dampen neuroinflammation, and clear out senescent cells over decades. The Brain \u0026amp; Cognitive Longevity collection is the curated set of those compounds — every SKU here has either a published randomised controlled trial in cognitive endpoints, a mechanistically validated role in a brain-aging hallmark, or both. No racetam analogues, no proprietary blends, no \"memory-supporting herbal complex\" with undisclosed doses. Ten products, ten mechanisms, every dose anchored to a published trial.\u003c\/p\u003e\n\n\u003cp\u003eThis page is built to be the most thorough brain-longevity reference on the open internet for non-clinicians. It is long on purpose. If you are short on time, the \u003cstrong\u003e60-second answer\u003c\/strong\u003e below tells you what to do this afternoon. If you have ten minutes, the table of contents lets you jump to the section that fits your situation. If you have an hour and you want to understand \u003cem\u003ewhy\u003c\/em\u003e these particular ten compounds and not the dozens you have read about elsewhere, read it through. Every claim is mechanistically grounded; every dose is anchored to a published trial; every product link goes to a SKU we stock and ship.\u003c\/p\u003e\n\n\u003ch2 id=\"answer\"\u003eThe 60-second answer\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTwo non-negotiable foundations\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000 mg\u003c\/a\u003e ($24.99, neurons are 30% DHA by weight) and \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 5 g\/day\u003c\/a\u003e ($29.99, the most-replicated cognitive supplement in the literature). Start here. Skip everything else if you have to.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdd inflammation control\u003c\/strong\u003e with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e ($26.99) — one of a tiny set of polyphenols that crosses the blood–brain barrier in measurable concentrations and downregulates NF-κB.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdd mitochondrial biogenesis\u003c\/strong\u003e with \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e ($29.99) — the only widely-studied oral compound that triggers new mitochondria at clinical doses by activating PGC-1α.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdd NAD+ restoration\u003c\/strong\u003e via \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus Formula\u003c\/a\u003e ($22.99), \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e ($44.99), or \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Berry Sticks\u003c\/a\u003e ($39.99) — neurons are NAD+-hungry and crash NAD+ first. The full NAD+ ladder lives in \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLayer cellular cleanup\u003c\/strong\u003e with \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e ($34.99) for autophagy, and rotate through the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e stack (Fisetin + Quercetin + Apigenin) and \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e protocol (Urolithin A + PQQ + CoQ10).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResilience layer\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600 mg\u003c\/a\u003e ($26.99) for cortisol\/sleep. Chronic cortisol elevation atrophies the hippocampus directly; you cannot supplement around poor sleep.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1 activation\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e ($32.99) is more bioavailable than resveratrol and crosses the blood–brain barrier more efficiently.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRealistic timeline:\u003c\/strong\u003e energy and sleep changes in 1–2 weeks, sustained focus and recall improvements in 6–12 weeks, structural protection on a multi-year timescale.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBacked by\u003c\/strong\u003e our \u003ca href=\"\/he\/pages\/guarantee\"\u003e30-Day Keep-the-Bottle Guarantee\u003c\/a\u003e, third-party HPLC potency testing (\u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e), and full \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e transparency.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"toc\"\u003eOn this page\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#answer\"\u003eThe 60-second answer\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#why\"\u003eWhy brain longevity is its own discipline\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mechanisms\"\u003eFive mechanisms of brain aging — and what in this collection targets each\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pillars\"\u003eThe four pillars of brain longevity\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#actives\"\u003eThe ten actives in this collection — what each one does, what it doesn't\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#trials\"\u003ePer-product trial evidence\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#tiers\"\u003eThree protocol tiers — entry, daily, full\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#stacking\"\u003eStacking with sister collections — eight directions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#timeline\"\u003eWeek-by-week realistic timeline\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#interactions\"\u003eDrug interactions and precautions — read this section before starting\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#whofor\"\u003eWho this collection is for — and who it isn't\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#quality\"\u003eQuality and sourcing standards\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#measure\"\u003eHow to measure cognitive change — biomarkers and at-home tracking\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#myths\"\u003eCommon myths and corrections\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#cost\"\u003eCost tiers — what each one buys you\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#faq\"\u003eFrequently asked questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#reading\"\u003eReading list and primary references\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#related\"\u003eRelated collections, reference pages, and policies\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"why\"\u003eWhy brain longevity is its own discipline\u003c\/h2\u003e\n\n\u003cp\u003eMost longevity content treats \"the brain\" as a downstream organ — keep your heart healthy, your gut healthy, your sleep dialed-in, and your brain follows. That is true on paper. It also means most people start cognitive interventions a decade later than they should. The brain is metabolically the hungriest organ in the body and the slowest to repair: when neurons die they are not replaced (with the limited exception of the hippocampus and a couple of other niches), when myelin degrades it is rebuilt only sluggishly, and when mitochondrial output drops in cortical neurons the consequences (FDG-PET hypometabolism) appear decades before symptoms.\u003c\/p\u003e\n\n\u003cp\u003eThe corollary is that brain-specific protection is the rare longevity domain where being early matters more than being intense. A modest, consistent, mechanistically-correct stack started in your 30s and 40s does more than a heroic stack started after symptoms appear. Every product on this page is a candidate for a multi-decade investment, not a one-shot intervention.\u003c\/p\u003e\n\n\u003ch3\u003eWhat \"brain longevity\" means in this catalog\u003c\/h3\u003e\n\u003cp\u003eWe use a narrower definition than most:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHallmark-based.\u003c\/strong\u003e Every active in this collection maps to one of the López-Otín hallmarks of aging (mitochondrial dysfunction, loss of proteostasis, deregulated nutrient sensing, cellular senescence, etc.) \u003cem\u003eas expressed in neurons\u003c\/em\u003e. See \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e for the full hallmarks framework.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrial-anchored.\u003c\/strong\u003e Every dose recommended on this page comes from a published human trial measuring a relevant cognitive or biomarker endpoint — not extrapolation from cell culture or rodent dosing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism-distinct.\u003c\/strong\u003e No two products in the collection do the same thing in the same way. There is no \"second creatine,\" no \"second omega-3.\" Every SKU earns its place by occupying a unique mechanistic niche.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMulti-decade safe.\u003c\/strong\u003e No nootropic stimulants, no racetam analogues, no compounds that desensitise receptors over time. Everything here is designed for daily use over decades.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhat we explicitly do \u003cem\u003enot\u003c\/em\u003e sell\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eRacetams (piracetam, aniracetam, oxiracetam) — minimal long-term safety data, weak human cognitive endpoints in healthy adults.\u003c\/li\u003e\n\u003cli\u003eStimulant-class \"focus\" compounds (modafinil, methylphenidate analogues, high-dose caffeine combinations) — borrow energy from the future, do nothing for cellular aging.\u003c\/li\u003e\n\u003cli\u003eProprietary nootropic blends with undisclosed doses — the catalog principle is \"single-ingredient, trial-validated dose, third-party tested.\" Blends are explicitly disclosed (e.g., the multi-active \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus Formula\u003c\/a\u003e has every ingredient and dose printed on the label).\u003c\/li\u003e\n\u003cli\u003eCompounds without human evidence at the dose sold (looking at you, \"memory mushroom\" extracts at 50 mg\/day in a market where the trial doses are 1.5–3 g\/day).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"mechanisms\"\u003eFive mechanisms of brain aging — and what in this collection targets each\u003c\/h2\u003e\n\n\u003ch3\u003e1. Mitochondrial decline (the energy crash)\u003c\/h3\u003e\n\u003cp\u003eNeurons cannot store glucose like muscle cells can; they burn ATP in real time. As mitochondrial efficiency drops with age, the brain compensates by recruiting more glucose — until it can't. This is one of the earliest measurable changes in age-related cognitive decline (\u003cem\u003eMosconi 2008\u003c\/em\u003e: FDG-PET hypometabolism appears 15–20 years before clinical Alzheimer's symptoms). The fix is a layered approach: \u003cstrong\u003eraise the substrate pool\u003c\/strong\u003e (\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e increases brain phosphocreatine ~5–10% in 28 days at 5 g\/day, per \u003cem\u003eAvgerinos 2018\u003c\/em\u003e meta-analysis of 16 RCTs), \u003cstrong\u003eraise the cofactor pool\u003c\/strong\u003e (NAD+ via \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e or NAD+ formulas — every mitochondrial enzyme in the electron transport chain needs NAD+), and \u003cstrong\u003ebuild new mitochondria\u003c\/strong\u003e (\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ at 10–20 mg\/day\u003c\/a\u003e activates PGC-1α, the master regulator of mitochondrial biogenesis, per \u003cem\u003eChowanadisai 2010\u003c\/em\u003e; \u003cem\u003eItoh 2016\u003c\/em\u003e showed measurable cognitive improvements at 20 mg\/day in older adults).\u003c\/p\u003e\n\n\u003ch3\u003e2. Membrane fluidity loss (the DHA gap)\u003c\/h3\u003e\n\u003cp\u003eNeuronal membranes are roughly 30% DHA by weight. DHA is the longest, most-unsaturated fatty acid in the human body — 22 carbons, six double bonds — and it is what lets neurons fire fast and synaptic membranes flex during plasticity. As DHA levels drop with aging or low-fish diets, membranes stiffen, neurotransmitter receptors function less well, and synaptic plasticity degrades. \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e at clinically-studied doses (1–3 g\/day combined) is the single most-cited supplement for slowing age-related cognitive decline. The American Heart Association recommends ≥1 g\/day for cardiovascular health alone; brain trials (e.g., \u003cem\u003eYurko-Mauro 2010\u003c\/em\u003e: 900 mg DHA daily for 24 weeks improved age-related cognitive decline in the MIDAS trial) typically use 2–3 g\/day for measurable cognitive endpoints.\u003c\/p\u003e\n\n\u003ch3\u003e3. Neuroinflammation (the microglia problem)\u003c\/h3\u003e\n\u003cp\u003eThe brain has its own resident immune cells called microglia. When they shift to a chronically activated (\"M1-like\") state — driven by visceral fat, gut permeability, viral exposure, or aging itself — they release IL-1β, IL-6, and TNF-α directly into brain tissue. This is now considered an upstream driver of Alzheimer's pathology (\u003cem\u003eHeneka 2015\u003c\/em\u003e in \u003cem\u003eLancet Neurology\u003c\/em\u003e). \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin with BioPerine\u003c\/a\u003e is one of a small number of compounds that crosses the blood–brain barrier in measurable concentrations and directly downregulates NF-κB, the master inflammation switch (\u003cem\u003eSmall 2018\u003c\/em\u003e: 18-month RCT showed memory and attention improvements at 90 mg twice daily of bioavailable curcumin in 40 non-demented adults aged 51–84). The piperine in BioPerine raises systemic curcumin bioavailability by roughly 20× (\u003cem\u003eShoba 1998\u003c\/em\u003e). For broader anti-inflammatory layering, the \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e-driven autophagy mechanism and the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e protocol both reduce SASP cytokines that contribute to neuroinflammation.\u003c\/p\u003e\n\n\u003ch3\u003e4. NAD+ collapse (the cofactor crash)\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels drop ~50% between age 20 and 60 in most tissues — but neurons crash earlier and harder, because they're the most metabolically active cells in the body. Without NAD+, sirtuins can't deacetylate, PARPs can't repair DNA, and the electron transport chain stalls. Restoring NAD+ via precursors (NR, NMN) is the single most-studied longevity intervention of the last decade (\u003cem\u003eMartens 2018\u003c\/em\u003e, \u003cem\u003eYoshino 2021\u003c\/em\u003e, \u003cem\u003eConze 2019\u003c\/em\u003e, and many more). The \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e in this collection — \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus Formula\u003c\/a\u003e (NR + Resveratrol + PQQ + Quercetin in a daily drink mix), \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e (300 mg patented NR + B-vitamin cofactors), and \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Berry Sticks\u003c\/a\u003e (NR delivered in a stick-pack format with no caffeine) — gives you three different format\/dose options for the same mechanism. The catalog also stocks \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e if you prefer the NMN precursor route.\u003c\/p\u003e\n\n\u003ch3\u003e5. Cellular accumulation (zombie cells \u0026amp; broken mitochondria)\u003c\/h3\u003e\n\u003cp\u003eThe aging brain accumulates senescent (\"zombie\") cells that won't die but won't function — they secrete inflammatory SASP cytokines that damage neighbours. It also accumulates damaged mitochondria that should have been recycled by mitophagy. \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e at 1.2–10 mg\/day induces autophagy (the cellular cleanup pathway) — observational data from \u003cem\u003eKiechl 2018\u003c\/em\u003e linked higher dietary spermidine to roughly 5–7 year mortality reductions, and the \u003cem\u003eSchwarz 2018\u003c\/em\u003e SmartAge trial showed memory improvements in older adults at risk for dementia. For deeper cleanup, layer in the broader \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e protocol (\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e) and the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e stack (\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e).\u003c\/p\u003e\n\u003ch2 id=\"pillars\"\u003eThe four pillars of brain longevity\u003c\/h2\u003e\n\n\u003cp\u003eEvery supplement on this page falls under one or more of four functional pillars. If your stack is missing a pillar, that gap is doing more damage than over-dosing on whatever you already take.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 1 — Substrate \u0026amp; cofactor (raw materials)\u003c\/h3\u003e\n\u003cp\u003eNeurons need glucose, ATP, phosphocreatine, NAD+, B-vitamins, and DHA membrane lipids in stoichiometric amounts. Run any of those low and the brain throttles. The substrate-and-cofactor pillar is filled by \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e (phosphocreatine reserve), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (DHA membrane substrate), and the NAD+ trio of \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus Formula\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Capsules\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e. Cross-collection: \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e and \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e are the methylation and Mg cofactors that make the NAD+ pathway run.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 2 — Inflammation \u0026amp; oxidative stress control\u003c\/h3\u003e\n\u003cp\u003eMicroglial activation, blood–brain barrier dysfunction, and ROS damage compound across decades. The inflammation-control pillar is filled by \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e (NF-κB downregulation), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e (resolvins and protectins), and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e (SIRT1 activation, anti-inflammatory). For deeper oxidative-stress coverage layer in \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e (the GlyNAC pair raises endogenous glutathione), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (universal antioxidant, mitochondrial cofactor), and \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e (one of the few BBB-crossing membrane-anchored antioxidants).\u003c\/p\u003e\n\n\u003ch3\u003ePillar 3 — Cellular cleanup (autophagy, mitophagy, senolysis)\u003c\/h3\u003e\n\u003cp\u003eThe aging brain accumulates broken proteins, broken mitochondria, and senescent cells. The cleanup pillar is filled directly by \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (autophagy), and indirectly by the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e protocol (\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e) and \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e (mitophagy). The catalog principle is that cleanup compounds rotate — most evidence is for pulsed dosing rather than daily-forever administration.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 4 — Resilience \u0026amp; HPA-axis modulation\u003c\/h3\u003e\n\u003cp\u003eChronic cortisol elevation atrophies the hippocampus directly. Sleep fragmentation impairs glymphatic clearance of amyloid-β. You cannot supplement around poor sleep or chronic stress; the brain-aging clock simply runs faster. The resilience pillar is filled by \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e (cortisol modulation, sleep quality, BDNF), \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e (slow-wave sleep induction), and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e (GABA-A modulation, sleep architecture).\u003c\/p\u003e\n\n\u003ch2 id=\"actives\"\u003eThe ten actives in this collection — what each one does, what it doesn't\u003c\/h2\u003e\n\n\u003ch3\u003eOmega-3 Fish Oil 2000 mg (EPA\/DHA)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e — $24.99 — is the membrane substrate. EPA and DHA are the two long-chain omega-3 fatty acids the brain cannot synthesise efficiently from short-chain ALA (conversion is ~5% in healthy adults, much lower in older adults and almost nil in vegan diets unless supplemented with algal DHA). DHA accumulates in the synaptic membrane; EPA acts upstream on inflammation via the resolvin\/protectin pathway. The MIDAS trial (\u003cem\u003eYurko-Mauro 2010\u003c\/em\u003e) used 900 mg DHA\/day for 24 weeks and showed improved learning and memory scores in older adults. The \u003cem\u003eOmegAD 2006\u003c\/em\u003e trial used 1.7 g DHA + 0.6 g EPA for 6 months in mild Alzheimer's. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e repairs membrane fluidity, dampens neuroinflammation, supports cardiovascular delivery to the brain. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e raise NAD+, induce autophagy, or activate sirtuins — those are separate pillars.\u003c\/p\u003e\n\n\u003ch3\u003eCreatine Monohydrate (5 g\/day)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate 1000 mg\u003c\/a\u003e — $29.99 — is the most-replicated cognitive supplement in the literature. It is also the cheapest and the safest. \u003cem\u003eAvgerinos 2018\u003c\/em\u003e meta-analysis of 16 RCTs in healthy adults: small-to-moderate cognitive improvements, strongest in sleep-deprived states and older adults. \u003cem\u003eRae 2003\u003c\/em\u003e: 5 g\/day for 6 weeks improved working memory and intelligence test performance in vegetarians. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e raises brain phosphocreatine reserve ~5–10%, buffers ATP regeneration during high cognitive demand, may have antioxidant effects in mitochondria. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e work for everyone — non-responders are real, particularly in already-saturated meat-eaters. Loading is optional; 5 g\/day for 28 days reaches saturation.\u003c\/p\u003e\n\n\u003ch3\u003eCurcumin 1000 mg + BioPerine\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e — $26.99 — is the brain-targeted anti-inflammatory. The fact pattern: curcumin alone is poorly absorbed, but co-administering with piperine (the active in BioPerine) raises systemic bioavailability roughly 20× (\u003cem\u003eShoba 1998\u003c\/em\u003e). The \u003cem\u003eSmall 2018\u003c\/em\u003e RCT in 40 non-demented adults aged 51–84 used 90 mg twice daily of bioavailable curcumin for 18 months and found memory and attention improvements plus reduced amyloid\/tau accumulation in the amygdala and hypothalamus on PET. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e downregulates NF-κB, reduces COX-2 expression, supports endothelial function. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e work fast — meaningful neuroinflammation reduction takes 8+ weeks. Take with a fatty meal or in capsule format with included BioPerine.\u003c\/p\u003e\n\n\u003ch3\u003ePQQ 20 mg (Pyrroloquinoline Quinone)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e — $29.99 — is the mitochondrial-biogenesis trigger. PQQ activates PGC-1α (the master regulator of mitochondrial biogenesis), CREB, and NRF2 (\u003cem\u003eChowanadisai 2010\u003c\/em\u003e). \u003cem\u003eItoh 2016\u003c\/em\u003e in 41 older adults at 20 mg\/day for 12 weeks: improved Stroop and visuospatial task performance, with effects observable on fMRI. PQQ is found in trace amounts in food (parsley, green peppers, fermented soy) but not in clinically-relevant doses. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e stimulates new mitochondria, raises antioxidant defence, may support nerve growth factor expression. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e replace existing mitochondria — pair with \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e for the recycling side of the equation.\u003c\/p\u003e\n\n\u003ch3\u003eSpermidine 10 mg (wheat-germ extract)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e — $34.99 — is the autophagy inducer. Spermidine is one of a small number of caloric-restriction mimetics that triggers autophagy without you needing to fast (\u003cem\u003eEisenberg 2016\u003c\/em\u003e). The \u003cem\u003eKiechl 2018\u003c\/em\u003e Bruneck cohort study linked higher dietary spermidine intake to roughly 5–7 year mortality reductions; the \u003cem\u003eSchwarz 2018\u003c\/em\u003e SmartAge trial in older adults at risk for dementia showed memory improvements at 0.9–3.3 mg\/day. The 10 mg dose on this page reflects the higher end of trial dosing. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e induces autophagy, supports mitochondrial fission\/fusion balance, may protect cardiovascular function. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e work fast — autophagy biomarkers shift on a 4–8 week timescale.\u003c\/p\u003e\n\n\u003ch3\u003eNAD+ Pure Focus Formula (drink mix)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000 mg Pure Focus Formula\u003c\/a\u003e — $22.99 — is the NAD+ entry SKU. It combines NR (NAD+ precursor), trans-resveratrol (SIRT1 activator), PQQ (mitochondrial biogenesis), and quercetin (CD38 inhibition + senolytic) in a daily drink mix. The combo logic: NR raises NAD+ substrate, resveratrol activates the sirtuins that need NAD+, PQQ builds the mitochondria that consume NAD+ for ATP, quercetin slows CD38-driven NAD+ degradation. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e delivers a four-active NAD+ stack in a single morning drink. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e hit dose ceilings — for higher NR or NMN doses see the standalone \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Capsules\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e SKUs.\u003c\/p\u003e\n\n\u003ch3\u003eNR Hard Capsules (Patented NR)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside Hard Capsules\u003c\/a\u003e — $44.99 — is the trial-anchored standalone NR SKU. NR is the patented (NIAGEN-class) NAD+ precursor used in the majority of human NAD+-raising trials: \u003cem\u003eMartens 2018\u003c\/em\u003e in older adults at 500 mg twice daily for 6 weeks raised whole-blood NAD+ ~60% and lowered systolic BP. \u003cem\u003eConze 2019\u003c\/em\u003e: similar NAD+-raising at 100–1000 mg\/day. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e raises NAD+ via the salvage pathway, supports sirtuin function, includes B-vitamin methylation cofactors. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e bypass methylation — high-dose NAD+ pathways consume methyl groups, so layering with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e is recommended at sustained doses ≥600 mg\/day.\u003c\/p\u003e\n\n\u003ch3\u003eLiquid NAD+ Berry Sticks\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — $39.99 — is the no-caffeine NR delivery format. Stick packs dissolve in water, taste like berry, and deliver an NR-class NAD+ precursor in a format that travels well and is easy to take consistently. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e raises NAD+ via the same salvage-pathway mechanism as the capsule SKU. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e contain stimulants — this is intentionally the \"afternoon-friendly\" NAD+ format if you don't want capsules with breakfast.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene 100 mg (trans-pterostilbene)\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e — $32.99 — is the resveratrol cousin with a methoxy substitution that makes it ~7× more bioavailable, with a ~4× longer half-life and a measurable BBB-crossing fraction (\u003cem\u003eKapetanovic 2011\u003c\/em\u003e). \u003cem\u003eMcCormack 2013\u003c\/em\u003e review: pterostilbene activates SIRT1 in vitro and in vivo at doses comparable to or lower than resveratrol's. \u003cem\u003eRiche 2013\u003c\/em\u003e in 80 hypercholesterolaemic adults at 100–250 mg\/day for 6–8 weeks: blood pressure and lipid effects with good tolerability. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e activates SIRT1, may support memory and mood via BDNF expression, lipid-friendly. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e raise NAD+ on its own — pair with one of the NAD+ precursors above.\u003c\/p\u003e\n\n\u003ch3\u003eAshwagandha KSM-66 600 mg\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600 mg\u003c\/a\u003e — $26.99 — is the resilience anchor. KSM-66 is the most-trial-cited ashwagandha extract on the market (16+ published RCTs). \u003cem\u003eChandrasekhar 2012\u003c\/em\u003e: 300 mg twice daily reduced perceived stress and morning cortisol significantly versus placebo. \u003cem\u003eSalve 2019\u003c\/em\u003e: similar dose reduced morning cortisol ~22% in a stress-cohort. \u003cem\u003eNg 2020\u003c\/em\u003e: 600 mg\/day improved sleep latency and quality. \u003cstrong\u003eWhat it does:\u003c\/strong\u003e dampens HPA-axis hyperreactivity, lowers morning cortisol, improves sleep architecture, supports healthy testosterone in men. \u003cstrong\u003eWhat it doesn't do:\u003c\/strong\u003e sedate acutely — this is HPA-axis modulation, not benzo-class sedation. Most trials show effects at 4–8 weeks.\u003c\/p\u003e\n\u003ch2 id=\"trials\"\u003ePer-product trial evidence\u003c\/h2\u003e\n\n\u003cp\u003eEvery dose recommended on this page is anchored to a published human trial. The table below summarises the strongest single citation per active. The full citation list is in the \u003ca href=\"#reading\"\u003eReading list\u003c\/a\u003e section.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eHeadline trial\u003c\/th\u003e\n\u003cth\u003eDose used\u003c\/th\u003e\n\u003cth\u003eDuration\u003c\/th\u003e\n\u003cth\u003eEndpoint moved\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eYurko-Mauro 2010 (MIDAS)\u003c\/td\u003e\n\u003ctd\u003e900 mg DHA\/day\u003c\/td\u003e\n\u003ctd\u003e24 weeks\u003c\/td\u003e\n\u003ctd\u003eLearning \u0026amp; memory in older adults\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eAvgerinos 2018 meta-analysis\u003c\/td\u003e\n\u003ctd\u003e5 g\/day (range 2–20 g)\u003c\/td\u003e\n\u003ctd\u003e4–24 weeks\u003c\/td\u003e\n\u003ctd\u003eWorking memory, reasoning (16 RCTs)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eSmall 2018\u003c\/td\u003e\n\u003ctd\u003e90 mg bioavailable curcumin × 2\/day\u003c\/td\u003e\n\u003ctd\u003e18 months\u003c\/td\u003e\n\u003ctd\u003eMemory, attention, amyloid-β PET\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eItoh 2016\u003c\/td\u003e\n\u003ctd\u003e20 mg\/day\u003c\/td\u003e\n\u003ctd\u003e12 weeks\u003c\/td\u003e\n\u003ctd\u003eStroop, visuospatial, fMRI activation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eSchwarz 2018 (SmartAge)\u003c\/td\u003e\n\u003ctd\u003e0.9–3.3 mg\/day\u003c\/td\u003e\n\u003ctd\u003e12 months\u003c\/td\u003e\n\u003ctd\u003eMemory in at-risk older adults\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMartens 2018 (NR base)\u003c\/td\u003e\n\u003ctd\u003e500 mg NR × 2\/day\u003c\/td\u003e\n\u003ctd\u003e6 weeks\u003c\/td\u003e\n\u003ctd\u003e+60% whole-blood NAD+, lowered SBP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Capsules\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eConze 2019\u003c\/td\u003e\n\u003ctd\u003e100–1000 mg\/day\u003c\/td\u003e\n\u003ctd\u003e8 weeks\u003c\/td\u003e\n\u003ctd\u003eDose-dependent NAD+ rise, well-tolerated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eTrammell 2016 PK study\u003c\/td\u003e\n\u003ctd\u003e100–300 mg single dose\u003c\/td\u003e\n\u003ctd\u003eSingle-dose PK\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ rise within hours\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eRiche 2013\u003c\/td\u003e\n\u003ctd\u003e100–250 mg\/day\u003c\/td\u003e\n\u003ctd\u003e6–8 weeks\u003c\/td\u003e\n\u003ctd\u003eBP, lipids; good tolerability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eChandrasekhar 2012\u003c\/td\u003e\n\u003ctd\u003e300 mg × 2\/day\u003c\/td\u003e\n\u003ctd\u003e60 days\u003c\/td\u003e\n\u003ctd\u003e−27.9% morning cortisol vs placebo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2 id=\"tiers\"\u003eThree protocol tiers — entry, daily, full\u003c\/h2\u003e\n\n\u003cp\u003eThe three tiers below correspond to budget, capsule-load tolerance, and how aggressive a longevity stance you want to take. Pick a tier and stay on it for at least 90 days before judging effect — most trial endpoints take 6–12 weeks to move.\u003c\/p\u003e\n\n\u003ch3\u003eTier 1 — Entry brain stack (~$80\/month)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000 mg\u003c\/a\u003e — $24.99\/month — 1 softgel daily with breakfast.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate\u003c\/a\u003e — $29.99\/month — 5 g\/day, any time.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e — $26.99\/month — 1 capsule daily with a fatty meal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat this tier covers:\u003c\/strong\u003e two of the four pillars (substrate + inflammation control). What it does not cover: NAD+ restoration, autophagy, resilience. This is the floor — under-spending below this line means you are not really running a brain-longevity protocol.\u003c\/p\u003e\n\n\u003ch3\u003eTier 2 — Daily brain stack (~$140\/month)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eTier 1, plus:\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e — $29.99\/month — 1 capsule daily.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus Formula\u003c\/a\u003e — $22.99\/month — 1 stick daily, morning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat this tier covers:\u003c\/strong\u003e three of the four pillars (substrate + inflammation + mitochondrial biogenesis + NAD+). NAD+ is delivered through the multi-active drink mix, which also provides Resveratrol and Quercetin in a single SKU. What it does not yet cover: dedicated cellular cleanup, dedicated resilience layer.\u003c\/p\u003e\n\n\u003ch3\u003eTier 3 — Full brain protocol (~$220\/month)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eTier 2, plus:\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e — $34.99\/month — 1 capsule daily.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600 mg\u003c\/a\u003e — $26.99\/month — 1 capsule with dinner.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e — $32.99\/month — 1 capsule daily.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat this tier covers:\u003c\/strong\u003e all four pillars. Inflammation control is doubled (Curcumin + Pterostilbene), cellular cleanup is added (Spermidine), and the resilience\/sleep layer is added (Ashwagandha). For deeper cleanup add the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e rotation (Fisetin\/Quercetin\/Apigenin) and the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e stack (Urolithin A) on a quarterly pulse schedule.\u003c\/p\u003e\n\n\u003ch3\u003eQuarterly senolytic pulse (add to any tier)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eOne weekend every 3 months: \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e × 2 capsules daily for 2 days.\u003c\/li\u003e\n\u003cli\u003eOr rotate \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e on the same pulse schedule.\u003c\/li\u003e\n\u003cli\u003eWhy pulsed: the strongest mouse and current human senolytic evidence is for short-pulse dosing rather than daily-forever. See \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e for the full protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"stacking\"\u003eStacking with sister collections — eight directions\u003c\/h2\u003e\n\n\u003cp\u003eThe brain pillar interacts with every other longevity pillar. The eight stacking directions below are the most common ways customers extend the brain protocol.\u003c\/p\u003e\n\n\u003ch3\u003e1. Brain + NAD+ Family\u003c\/h3\u003e\n\u003cp\u003eThe brain stack already includes one or two NAD+ SKUs in Tier 2. To go deeper on NAD+ — particularly if you are over 50 or you want to test dose-response — add \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e. Pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e if you exceed 600 mg\/day NMN-class precursor.\u003c\/p\u003e\n\n\u003ch3\u003e2. Brain + Mitochondrial Renewal\u003c\/h3\u003e\n\u003cp\u003ePQQ alone builds new mitochondria but does not recycle the broken ones. Add \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e to activate mitophagy (PINK1\/Parkin-driven recycling). The pair is mechanistically complementary: PQQ pushes biogenesis up, Urolithin A pushes mitophagy up, and the net effect is a younger mitochondrial population.\u003c\/p\u003e\n\n\u003ch3\u003e3. Brain + Senolytics\u003c\/h3\u003e\n\u003cp\u003eThe aging brain accumulates senescent microglia and astrocytes that drive neuroinflammation through SASP cytokines. Pulsed \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e targets the SASP-secreting cells directly. Daily curcumin in this collection works alongside; senolytic pulses are quarterly.\u003c\/p\u003e\n\n\u003ch3\u003e4. Brain + Foundational Health\u003c\/h3\u003e\n\u003cp\u003eThe brain stack assumes basic foundational coverage: \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2 MK-7\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e (slow-wave sleep). Vitamin D deficiency is independently linked to faster cognitive decline. Magnesium is the cofactor for the NAD+-using enzymes you are stacking on top. See \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003e5. Brain + Cardiovascular Longevity\u003c\/h3\u003e\n\u003cp\u003eBrain perfusion is what delivers all of the above. Cardiovascular insufficiency is the single biggest reversible upstream risk factor for late-life cognitive decline. Add \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e. The Omega-3 in this brain stack already serves both pillars.\u003c\/p\u003e\n\n\u003ch3\u003e6. Brain + Antioxidants\u003c\/h3\u003e\n\u003cp\u003eThe brain produces more ROS per gram than any other tissue. The full \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e protocol — \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e (GlyNAC), \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e — gives you the master antioxidant pool the brain depends on.\u003c\/p\u003e\n\n\u003ch3\u003e7. Brain + Metabolic\u003c\/h3\u003e\n\u003cp\u003eInsulin resistance is increasingly recognised as \"type 3 diabetes\" of the brain. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500 mg\u003c\/a\u003e from \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e activates AMPK and improves glucose disposal — this directly protects neurons from glucose-driven AGE damage. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e rounds out the metabolic-epigenetic axis.\u003c\/p\u003e\n\n\u003ch3\u003e8. Brain + Most-Popular \u0026amp; bundles\u003c\/h3\u003e\n\u003cp\u003eIf you would rather start from a bundle than a custom stack, the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e ($74.99) and the \u003ca href=\"\/he\/collections\/most-popular\"\u003eMost Popular\u003c\/a\u003e collection give you a curated 2–3 SKU starting point that overlaps with this brain protocol.\u003c\/p\u003e\n\u003ch2 id=\"timeline\"\u003eWeek-by-week realistic timeline\u003c\/h2\u003e\n\n\u003cp\u003eWhat follows is a realistic week-by-week expectation curve for a Tier-2 protocol started at week 0. Effects are average across customer reports and trial endpoints — individual response varies and the strongest cellular protection is on a multi-year timescale that you will never feel acutely. Do not judge effect at 2 weeks. Most published trials measure endpoints at 6, 12, or 24 weeks for a reason.\u003c\/p\u003e\n\n\u003ch3\u003eWeek 1–2 — saturation phase (no expected effect)\u003c\/h3\u003e\n\u003cp\u003eCreatine is reaching brain-tissue saturation (~28 days at 5 g\/day). Omega-3 is replacing membrane phospholipids on a slow rolling basis. NAD+ precursors raise whole-blood NAD+ within hours to days, but downstream sirtuin and mitochondrial effects lag. Curcumin and PQQ have not had time to shift inflammation or biogenesis markers. \u003cstrong\u003eWhat to expect:\u003c\/strong\u003e nothing or very mild energy changes.\u003c\/p\u003e\n\n\u003ch3\u003eWeek 2–4 — energy and sleep window\u003c\/h3\u003e\n\u003cp\u003eMost customers notice the energy\/sleep layer first. NAD+ effects on perceived energy and sleep quality are often the earliest signal. Ashwagandha (if added) is starting to lower morning cortisol. Creatine is fully saturating. \u003cstrong\u003eWhat to expect:\u003c\/strong\u003e better afternoon energy, mild improvements in sleep latency, less \"9 AM grogginess\" feel.\u003c\/p\u003e\n\n\u003ch3\u003eWeek 4–8 — focus and inflammation window\u003c\/h3\u003e\n\u003cp\u003eThis is where curcumin starts to move the inflammation marker pool (CRP, IL-6, hs-CRP). PQQ-driven mitochondrial biogenesis becomes biochemically detectable. Pterostilbene-driven SIRT1 activation is detectable in some markers. \u003cstrong\u003eWhat to expect:\u003c\/strong\u003e better sustained focus on long tasks, fewer \"fog\" episodes, mild improvements in working memory under cognitive load.\u003c\/p\u003e\n\n\u003ch3\u003eWeek 8–12 — memory and recall window\u003c\/h3\u003e\n\u003cp\u003eMost published cognitive trials hit their primary endpoints in this window. Omega-3 is now structurally embedded in synaptic membranes. Subjective recall and word-finding tend to improve here in those with measurable baseline deficits. \u003cstrong\u003eWhat to expect:\u003c\/strong\u003e measurable improvements on cognitive testing if you bother to test.\u003c\/p\u003e\n\n\u003ch3\u003eMonth 3–6 — protocol stabilisation\u003c\/h3\u003e\n\u003cp\u003eThe stack is now operating in steady-state. Most customers settle into a maintenance dose pattern. This is the right time to add the senolytic pulse (one weekend per quarter) and to test biomarkers. \u003cstrong\u003eWhat to expect:\u003c\/strong\u003e a stable cognitive baseline that holds under stress, improved sleep architecture, faster recovery from cognitive overload.\u003c\/p\u003e\n\n\u003ch3\u003eYear 1+ — structural protection\u003c\/h3\u003e\n\u003cp\u003eThe structural-protection benefits — slower hippocampal atrophy, lower rate of microglial activation, preserved white-matter integrity — operate on a timescale you cannot feel acutely. Trial endpoints at 18+ months (Small 2018 curcumin, OmegAD 2006 omega-3) consistently show widening separation from controls. The right way to evaluate at year 1+ is biomarkers and cognitive testing, not subjective feel.\u003c\/p\u003e\n\n\u003ch2 id=\"interactions\"\u003eDrug interactions and precautions — read this section before starting\u003c\/h2\u003e\n\n\u003cp\u003eThis section is comprehensive but not exhaustive. If you take prescription medication, are pregnant, are nursing, or have a serious medical condition, talk to your physician before starting any of the products on this page.\u003c\/p\u003e\n\n\u003ch3\u003eOmega-3 EPA\/DHA\u003c\/h3\u003e\n\u003cp\u003eTheoretical bleeding risk at high doses (\u0026gt;3 g\/day) when combined with anticoagulants (warfarin, apixaban, rivaroxaban) or antiplatelets (aspirin, clopidogrel). Modern systematic reviews suggest the actual clinical bleeding risk is low at doses ≤4 g\/day. Pause omega-3 5–7 days before elective surgery on physician advice.\u003c\/p\u003e\n\n\u003ch3\u003eCreatine\u003c\/h3\u003e\n\u003cp\u003eGenerally well-tolerated. Drink an extra litre of water daily during loading. Caution in advanced kidney disease (consult nephrologist).\u003c\/p\u003e\n\n\u003ch3\u003eCurcumin + BioPerine\u003c\/h3\u003e\n\u003cp\u003ePiperine inhibits CYP3A4 and P-glycoprotein, which can raise levels of medications metabolised by those pathways (some antihypertensives, calcium-channel blockers, some statins, certain antibiotics, certain immunosuppressants). If you take medication metabolised through CYP3A4, talk to your prescriber. Curcumin itself has mild antiplatelet activity at high doses.\u003c\/p\u003e\n\n\u003ch3\u003ePQQ\u003c\/h3\u003e\n\u003cp\u003eNo significant drug interactions documented in the published literature at the 10–20 mg dose range. Mild stimulating effect in some people — if it impacts sleep, move to a morning dose.\u003c\/p\u003e\n\n\u003ch3\u003eSpermidine\u003c\/h3\u003e\n\u003cp\u003eWheat-germ-derived; not suitable for those with diagnosed wheat or gluten allergy. No documented drug interactions at the 10 mg dose. Pregnancy\/lactation: insufficient safety data, avoid.\u003c\/p\u003e\n\n\u003ch3\u003eNAD+ precursors (NR, NMN, NAD+)\u003c\/h3\u003e\n\u003cp\u003eGenerally well-tolerated. Some users report mild flushing with high-dose NMN. Methylation cofactor depletion at sustained doses ≥600 mg\/day; pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e. Caution in active oncology — consult oncologist before starting any NAD+ precursor.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene\u003c\/h3\u003e\n\u003cp\u003eRiche 2013 noted small LDL increases at the 250 mg\/day dose without statin co-administration. Use the 100 mg dose unless monitored. Mild blood-thinning at very high doses; standard anticoagulant caution.\u003c\/p\u003e\n\n\u003ch3\u003eAshwagandha KSM-66\u003c\/h3\u003e\n\u003cp\u003eMay lower TSH and modestly raise thyroid hormone production — caution in active hyperthyroidism. May lower blood sugar — caution in those on insulin or sulfonylureas. May increase the effect of sedative medications. Pregnancy: avoid. Autoimmune conditions: discuss with your physician.\u003c\/p\u003e\n\n\u003ch3\u003eStacking caution — methylation budget\u003c\/h3\u003e\n\u003cp\u003eSustained high-dose NAD+ precursors (NR or NMN at ≥600 mg\/day) consume methyl groups. Pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e as a precaution.\u003c\/p\u003e\n\n\u003ch3\u003eStacking caution — antioxidant timing around exercise\u003c\/h3\u003e\n\u003cp\u003eHigh-dose antioxidants (NAC, Vitamin C, glutathione precursors) taken in the immediate post-workout window may blunt the hormetic ROS signal that drives mitochondrial biogenesis. Time antioxidants in the morning or with non-workout meals.\u003c\/p\u003e\n\u003ch2 id=\"whofor\"\u003eWho this collection is for — and who it isn't\u003c\/h2\u003e\n\n\u003ch3\u003eThis collection is built for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults aged 30–75 who are cognitively intact\u003c\/strong\u003e and want a multi-decade investment in slowing the upstream drivers of brain aging — not treating an existing diagnosis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with a family history of late-life cognitive decline\u003c\/strong\u003e who want to start protective interventions decades earlier than their relatives did.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAthletes and high-cognitive-load professionals\u003c\/strong\u003e (founders, surgeons, traders, academics, pilots) who want to protect peak cognitive output across their career.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople recovering from cognitive insults\u003c\/strong\u003e — long COVID, post-concussion, chemo-brain — where mitochondrial and neuroinflammatory mechanisms apply. These customers should also work with a clinician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegetarians and vegans\u003c\/strong\u003e for whom omega-3, creatine, and B-vitamin cofactors are particularly important supplementation targets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCustomers running adjacent longevity protocols\u003c\/strong\u003e — NAD+, senolytics, mitochondrial — who want their brain pillar to be mechanism-distinct rather than redundant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThis collection is \u003cem\u003enot\u003c\/em\u003e for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople seeking acute \"focus\" effect on a specific afternoon.\u003c\/strong\u003e Try a coffee or accept that real cognitive protection works on weeks-to-months timescales.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with active dementia diagnoses\u003c\/strong\u003e — supplements are not Alzheimer's treatment. The trials cited on this page are in non-demented or pre-clinical populations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople taking interacting prescriptions\u003c\/strong\u003e (see \u003ca href=\"#interactions\"\u003einteractions section\u003c\/a\u003e) without first checking with their prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e — pregnancy\/lactation safety data is insufficient or lacking for several products on this page.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren or adolescents under 18\u003c\/strong\u003e — these products are dosed for adult brains.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople who want a \"one pill that does everything\" solution.\u003c\/strong\u003e The brain has at least four pillars; no single SKU covers them all.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"quality\"\u003eQuality and sourcing standards\u003c\/h2\u003e\n\n\u003cp\u003eEvery SKU on this page meets the same quality bar that makes a multi-decade brain protocol viable. The full standard is documented at \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eIdentity and potency\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eEvery active is identity-confirmed by HPLC, GC-MS, or comparable analytical methodology before lot release.\u003c\/li\u003e\n\u003cli\u003eEvery active is dosed at or above the trial-anchored dose printed on the label. Underdosed actives are the single biggest reason \"supplements don't work\" — we will not stock a SKU that fails this test.\u003c\/li\u003e\n\u003cli\u003eBranded forms (KSM-66 ashwagandha, BioPerine piperine, NIAGEN-class NR) are used where the trial evidence is for the branded form specifically.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eContaminants and purity\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHeavy-metal testing on every botanical lot — particularly relevant for ashwagandha, curcumin, and any soil-grown plant material.\u003c\/li\u003e\n\u003cli\u003ePesticide residue panels on imported botanicals; mycotoxin screening on grain-derived ingredients (relevant for spermidine wheat-germ extract); microbial limits per USP standard.\u003c\/li\u003e\n\u003cli\u003eAllergen disclosure on every label (relevant: wheat-germ-derived spermidine, fish-oil-derived omega-3).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eManufacturing and country of origin\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ecGMP-registered manufacturing facilities. Excipient minimisation — capsule fill is the active, the carrier (often vegetable cellulose or rice flour), and as little else as the formulation tolerates.\u003c\/li\u003e\n\u003cli\u003eCountry of origin per active ingredient is listed for every catalog SKU at \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"measure\"\u003eHow to measure cognitive change — biomarkers and at-home tracking\u003c\/h2\u003e\n\n\u003cp\u003e\"How will I know if it's working?\" is the most common question we get on this collection. The honest answer is that the strongest cellular protection is structural and you will not feel it acutely. There are three categories of measurement that work, in increasing order of rigour.\u003c\/p\u003e\n\n\u003ch3\u003eSubjective tracking (free, low rigour, useful for trends)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSleep latency and quality (Oura, Whoop, or paper journal).\u003c\/li\u003e\n\u003cli\u003eAfternoon energy crash (1–10 scale, daily).\u003c\/li\u003e\n\u003cli\u003eWord-finding fluency (subjective; useful in the \u0026gt;50 cohort).\u003c\/li\u003e\n\u003cli\u003eStress reactivity (1–10 daily check-in).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAt-home cognitive testing (low cost, moderate rigour)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCambridge Brain Sciences battery — measures working memory, reasoning, attention. Test at baseline, 3 months, and 6 months.\u003c\/li\u003e\n\u003cli\u003eStroop test (free online) — well-validated for executive function and processing speed.\u003c\/li\u003e\n\u003cli\u003en-back task (free online) — working memory load test.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBiomarker testing (higher cost, highest rigour)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ehs-CRP, IL-6, TNF-α\u003c\/strong\u003e — systemic inflammation panel. Curcumin and omega-3 should bend these down within 8–12 weeks at clinically-studied doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+\u003c\/strong\u003e — direct readout of NAD+ precursor effect (Conze 2019 used this endpoint).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHOMA-IR\u003c\/strong\u003e (fasting glucose × insulin \/ 405) — insulin sensitivity. HOMA-IR \u0026gt; 2.5 is a brain-aging risk factor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLipid panel + ApoB\u003c\/strong\u003e — cardiovascular delivery to the brain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOmega-3 Index\u003c\/strong\u003e — direct readout of membrane DHA status. Target ≥8%.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHomocysteine\u003c\/strong\u003e — single-best methylation-status biomarker. Target \u0026lt;9 µmol\/L.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"myths\"\u003eCommon myths and corrections\u003c\/h2\u003e\n\n\u003ch3\u003eMyth: \"If a supplement doesn't make me feel sharper today, it isn't working.\"\u003c\/h3\u003e\n\u003cp\u003eThe most-cited cognitive supplements (omega-3, curcumin, creatine, NR) measure their primary endpoints at 6–24 weeks for a reason. Acute \"feel sharper today\" is largely placebo, caffeine, or stimulant. Real cellular protection produces a slowly-widening separation from your future-self-without-the-stack — you will not notice it acutely.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"Higher dose is always better for the brain.\"\u003c\/h3\u003e\n\u003cp\u003eIt isn't. PQQ above 30 mg\/day shows diminishing returns. Pterostilbene above 250 mg\/day raises LDL in some users (Riche 2013). High-dose antioxidants in the immediate post-workout window may blunt the hormetic ROS signal that drives mitochondrial biogenesis. The trial-anchored doses on this page are at the published efficacy floor, and pushing significantly higher is rarely the right move.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"If I take an NAD+ precursor, I don't need anything else.\"\u003c\/h3\u003e\n\u003cp\u003eNAD+ precursors raise the substrate pool. They do not build new mitochondria (PQQ does), they do not repair membranes (omega-3 does), they do not dampen neuroinflammation (curcumin does), and they do not induce autophagy (spermidine does). Single-pillar protocols miss most of the upstream targets.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"Resveratrol is the SIRT1 activator.\"\u003c\/h3\u003e\n\u003cp\u003eResveratrol activates SIRT1 in vitro. Its bioavailability is poor (~70% first-pass metabolism) and many human trials at common doses (~100–500 mg\/day) show small or no effect on cognitive endpoints. \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e is the methylated cousin with ~7× better bioavailability and a measurable BBB-crossing fraction. We stock \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003etrans-resveratrol\u003c\/a\u003e for completeness, but if you can take only one for brain effect, pterostilbene is mechanistically stronger.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"Creatine is just for athletes.\"\u003c\/h3\u003e\n\u003cp\u003eCreatine has more replicated cognitive trials than almost any other compound on this page (Avgerinos 2018 meta-analysis, 16 RCTs). Vegetarians and older adults — not athletes — show the largest cognitive effects. The 5 g\/day dose is the same.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"Coconut oil \/ MCT oil is the same as omega-3 for the brain.\"\u003c\/h3\u003e\n\u003cp\u003eIt isn't. MCTs raise blood ketones, which the brain can burn — there is some evidence of acute cognitive effect in mild cognitive impairment. But MCTs do not provide DHA, do not get incorporated into synaptic membranes, and do not have the long-term randomised evidence that EPA\/DHA omega-3 has. The two are complementary categories, not substitutes.\u003c\/p\u003e\n\n\u003ch3\u003eMyth: \"If I sleep poorly, supplements can fix it.\"\u003c\/h3\u003e\n\u003cp\u003eThey can soften the edges. They cannot replace the function of sleep. The glymphatic system clears amyloid-β during slow-wave sleep; chronic sleep restriction is one of the most-replicated risk factors for late-life cognitive decline. Ashwagandha and glycine help; they do not replace 7–9 hours of sleep.\u003c\/p\u003e\n\n\u003ch2 id=\"cost\"\u003eCost tiers — what each one buys you\u003c\/h2\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eTier\u003c\/th\u003e\n\u003cth\u003eMonthly cost\u003c\/th\u003e\n\u003cth\u003ePillars covered\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTier 1 (Entry)\u003c\/td\u003e\n\u003ctd\u003e~$82\u003c\/td\u003e\n\u003ctd\u003eSubstrate + Inflammation\u003c\/td\u003e\n\u003ctd\u003eFirst-time customers, cost-sensitive, baseline brain protection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTier 2 (Daily)\u003c\/td\u003e\n\u003ctd\u003e~$135\u003c\/td\u003e\n\u003ctd\u003e+ Mitochondrial biogenesis + NAD+\u003c\/td\u003e\n\u003ctd\u003eMost customers; covers four pillars at moderate cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTier 3 (Full)\u003c\/td\u003e\n\u003ctd\u003e~$230\u003c\/td\u003e\n\u003ctd\u003e+ Cellular cleanup + Resilience + SIRT1\u003c\/td\u003e\n\u003ctd\u003eAggressive longevity stance; layered protection across all four pillars\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e+ NAD+ deep stack\u003c\/td\u003e\n\u003ctd\u003e+$55–80\u003c\/td\u003e\n\u003ctd\u003eNMN dose escalation, methyl support\u003c\/td\u003e\n\u003ctd\u003eCustomers over 50 or running a 6-month NAD+ trial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e+ Quarterly senolytic pulse\u003c\/td\u003e\n\u003ctd\u003e+$33 (one weekend)\u003c\/td\u003e\n\u003ctd\u003eSenolysis\u003c\/td\u003e\n\u003ctd\u003eAnyone running Tier 2 or higher for \u0026gt;6 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e+ Antioxidant overlay\u003c\/td\u003e\n\u003ctd\u003e+$50–90\u003c\/td\u003e\n\u003ctd\u003eMaster antioxidant pool (GlyNAC, ALA, Astaxanthin)\u003c\/td\u003e\n\u003ctd\u003eHigher oxidative-stress contexts: long flights, heavy training, urban pollution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe Tier 2 bundle is the right starting point for most customers. It is mechanism-complete on the four pillars except cellular cleanup and resilience, both of which can be added later as the protocol stabilises. Almost no one needs to start at Tier 3 on day one; the smarter pattern is to ladder up from Tier 1 → 2 → 3 over 6–12 months as you read your own response and biomarker data.\u003c\/p\u003e\n\u003ch2 id=\"faq\"\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eHow quickly will I notice anything?\u003c\/h3\u003e\n\u003cp\u003eEnergy and sleep changes — typically 1–2 weeks. Sustained focus and word-finding — typically 6–12 weeks. Structural protection — multi-year and not subjectively detectable. The single biggest mistake customers make is judging a brain protocol at 2–4 weeks; most published trial endpoints are at 8–24 weeks.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take Omega-3 with food?\u003c\/h3\u003e\n\u003cp\u003eYes. EPA and DHA are fat-soluble; absorption roughly doubles with a meal containing 10–20 g of dietary fat versus on an empty stomach. Breakfast or dinner is fine; consistency matters more than time of day.\u003c\/p\u003e\n\n\u003ch3\u003eShould I load creatine?\u003c\/h3\u003e\n\u003cp\u003eOptional. Loading (20 g\/day in 4×5 g doses for 5–7 days, then 5 g\/day) reaches saturation in about a week. Skipping the loading phase and taking 5 g\/day reaches the same saturation in about 28 days. Loading is faster but has more GI side effects; non-loading is the simpler default.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take all these in the same morning?\u003c\/h3\u003e\n\u003cp\u003eMostly yes. The exception is the antioxidant timing rule: high-dose antioxidants immediately after a workout may blunt mitochondrial biogenesis adaptation. The brain stack proper (Omega-3, Creatine, Curcumin, PQQ, NAD+ formula, Spermidine, Pterostilbene) is fine to take together at breakfast. Ashwagandha is the one product most customers move to dinner because of its sleep-supporting effect.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is your NR more expensive than other \"NAD+\" products on Amazon?\u003c\/h3\u003e\n\u003cp\u003eTwo reasons. First, the SKU on this page uses patented (NIAGEN-class) NR — the same form used in \u003cem\u003eMartens 2018\u003c\/em\u003e and most other published NAD+ trials. Second, we test every lot for identity and potency. Many \"NAD+ supplements\" on the open marketplace are nicotinamide (a B3 form, not NR) sold at NR pricing; we will not stock those.\u003c\/p\u003e\n\n\u003ch3\u003eIs NMN or NR better for the brain?\u003c\/h3\u003e\n\u003cp\u003eGenuinely open question. NR has more published human trial data; NMN has more recent industry interest and a few well-controlled trials (Yoshino 2021, Igarashi 2022). Mechanistically they enter the NAD+ salvage pathway at slightly different points. The catalog stocks both — see \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need TMG?\u003c\/h3\u003e\n\u003cp\u003eIf your sustained NAD+ precursor dose is below 500 mg\/day, no. At 600+ mg\/day for months, yes — methyl-donor depletion is a real concern. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e is cheap insurance.\u003c\/p\u003e\n\n\u003ch3\u003eWill Curcumin upset my stomach?\u003c\/h3\u003e\n\u003cp\u003eCapsule format minimises this. If you experience GI upset, take with a fatty meal. The piperine in BioPerine is what raises absorption — it can intensify the effect of some prescription meds, see the \u003ca href=\"#interactions\"\u003einteractions\u003c\/a\u003e section.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take this stack while drinking coffee?\u003c\/h3\u003e\n\u003cp\u003eYes. None of the products on this page have caffeine, and none of them have a documented adverse interaction with caffeine.\u003c\/p\u003e\n\n\u003ch3\u003eI am vegetarian\/vegan. What changes?\u003c\/h3\u003e\n\u003cp\u003eTwo notes. First, omega-3: vegan customers should look for an algal DHA source. Second, creatine: vegetarians have very low baseline creatine and tend to show the largest cognitive effects on supplementation — keep this product. Everything else on this page is vegan-compatible.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take this stack alongside a statin or blood pressure medication?\u003c\/h3\u003e\n\u003cp\u003eThe Curcumin + BioPerine entry has a CYP3A4 interaction note — most statins and several blood pressure medications metabolise through that pathway. Talk to your prescriber. Most other products on this page have no documented prescription-drug interactions at the labelled dose.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need cycling or \"off-time\"?\u003c\/h3\u003e\n\u003cp\u003eMost actives on this page are designed for continuous use. The two exceptions are senolytics (pulsed quarterly, see \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e) and possibly NAD+ precursors at very high doses. Curcumin, omega-3, creatine, PQQ, spermidine, and ashwagandha do not require cycling.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I am over 70?\u003c\/h3\u003e\n\u003cp\u003eStart gently. Tier 1 for the first 4–6 weeks. Add NAD+ precursor (Tier 2) only after baseline tolerance is established. Senolytic pulses in this cohort should be discussed with a clinician given concomitant medications.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if it doesn't work for me?\u003c\/h3\u003e\n\u003cp\u003eThe catalog backs every order with a \u003ca href=\"\/he\/pages\/guarantee\"\u003e30-Day Keep-the-Bottle Guarantee\u003c\/a\u003e — full refund, original shipping refunded, no return required.\u003c\/p\u003e\n\u003ch2 id=\"reading\"\u003eReading list and primary references\u003c\/h2\u003e\n\n\u003cp\u003eSelected primary trials and reviews behind the dose recommendations on this page. One strong citation per active so a curious customer can read the underlying evidence directly.\u003c\/p\u003e\n\n\u003ch3\u003eOmega-3 EPA\/DHA\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eYurko-Mauro et al. (MIDAS), 2010 — 900 mg DHA\/day, 24 weeks, improved learning and memory in older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCreatine\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAvgerinos et al. 2018 — meta-analysis of 16 RCTs, cognitive endpoints in healthy adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCurcumin\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSmall et al. 2018 — 90 mg bioavailable curcumin × 2\/day, 18 months: memory, attention, amyloid\/tau PET reductions in 40 non-demented adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003ePQQ\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eItoh et al. 2016 — 20 mg\/day, 12 weeks, cognitive task performance and fMRI activation in older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSpermidine\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eKiechl et al. 2018 — Bruneck cohort, dietary spermidine and all-cause mortality.\u003c\/li\u003e\n\u003cli\u003eSchwarz et al. 2018 (SmartAge) — spermidine and memory in at-risk older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eNR \/ NMN \/ NAD+\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMartens et al. 2018 — 500 mg NR × 2\/day, 6 weeks, +60% NAD+ in older adults, lowered SBP.\u003c\/li\u003e\n\u003cli\u003eConze et al. 2019 — dose-response of NR (100–1000 mg\/day) on whole-blood NAD+.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003ePterostilbene\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eRiche et al. 2013 — 100–250 mg\/day, 6–8 weeks, hypercholesterolaemic adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAshwagandha KSM-66\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eChandrasekhar et al. 2012 — 300 mg × 2\/day, 60 days, −27.9% morning cortisol.\u003c\/li\u003e\n\u003cli\u003eNg et al. 2020 — 600 mg\/day, 8 weeks, sleep latency and quality.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBackground — brain aging hallmarks\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLópez-Otín et al. 2013 \/ 2023 — \"The Hallmarks of Aging\" — the foundational framework.\u003c\/li\u003e\n\u003cli\u003eHeneka et al. 2015 — neuroinflammation in Alzheimer's pathology (\u003cem\u003eLancet Neurology\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"related\"\u003eRelated collections, reference pages, and policies\u003c\/h2\u003e\n\n\u003ch3\u003eSister collections\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — every route to raising NAD+.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — biogenesis (PQQ) plus mitophagy (Urolithin A).\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — pulsed cellular cleanup.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — Vitamin D3+K2, Magnesium, Glycine, TMG.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — brain perfusion is upstream of brain protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e — NAC, GlyNAC, Glutathione, ALA, Astaxanthin.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — Berberine, CaAKG.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/most-popular\"\u003eMost Popular\u003c\/a\u003e — curated starting points for new customers.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/all-products\"\u003eAll Products\u003c\/a\u003e — the full catalog index.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eReference pages\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science — The Hallmarks Framework\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols — Supplement Stacks by Goal\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow It Works — From First Order to Month 6\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/about\"\u003eAbout True Health Protocol\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/faq\"\u003eFAQ\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/contact\"\u003eContact\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003ePolicies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/guarantee\"\u003eOur 30-Day Keep-the-Bottle Guarantee\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/refund-policy\"\u003eRefund Policy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eDisclaimer: The statements on this page have not been evaluated by the FDA. The products on this page are not intended to diagnose, treat, cure, or prevent any disease. The cited trials are educational, not medical advice. Consult your physician before starting any supplement if pregnant, nursing, on prescription medication, or with a serious condition.\u003c\/em\u003e\u003c\/p\u003e\n","products":[{"product_id":"zoone-nad-1000mg-pure-focus-formula","title":"NAD+ 1000mg Pure Focus Formula | NR + Resveratrol + PQQ + Quercetin Daily Drink Mix","description":"\u003cp\u003e\u003cstrong\u003eThe 4-ingredient morning longevity drink — Nicotinamide Riboside, Trans-Resveratrol, PQQ, and Quercetin Phytosome in a single berry packet.\u003c\/strong\u003e One stick replaces four bottles for the people who already know what's in a longevity stack and just want the fastest way to actually take it every day. NR raises the precursor pool, resveratrol activates the sirtuins that \u003cem\u003euse\u003c\/em\u003e NAD+, PQQ multiplies the mitochondria where NAD+ does its work, and phytosome-bound quercetin shields the existing pool from CD38 — the four-lever protocol that the precursor-only category misses.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ raised, not just a precursor delivered.\u003c\/strong\u003e 300 mg of Nicotinamide Riboside (NR) per packet — the most-researched NAD+ precursor on the market with 65+ registered human trials and a single-dose 2.7× whole-blood NAD+ increase in healthy adults (Trammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe sirtuin partner is included.\u003c\/strong\u003e Trans-Resveratrol activates SIRT1 — the longevity enzyme that \u003cem\u003euses\u003c\/em\u003e NAD+. Without it, raised NAD+ has fewer enzymes putting it to work (Howitz 2003, \u003cem\u003eNature\u003c\/em\u003e; Park 2012, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial biogenesis kicker.\u003c\/strong\u003e 10 mg PQQ — clinically shown to increase mitochondrial number via PGC-1α \/ NRF1 \/ TFAM activation (Chowanadisai 2010, \u003cem\u003eJBC\u003c\/em\u003e; Hwang 2018).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38 inhibitor + senolytic in one.\u003c\/strong\u003e 250 mg Quercetin Phytosome (Quercefit) — phospholipid-bound for ~20× the bioavailability of standard quercetin (Riva 2019), with senolytic activity in the Mayo Clinic Dasatinib + Quercetin protocol (Justice 2019) and CD38 inhibition that protects the NAD+ pool (Escande 2013).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne packet, one minute, no capsules.\u003c\/strong\u003e Mix in 7–10 oz of cool water. Berry flavor, no aftertaste, no four bottles cluttering your counter, no stack abandonment after week three.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-disclosed label, no proprietary blends.\u003c\/strong\u003e Every active ingredient prints its mg dose. No hidden fillers, no titanium dioxide, no soy, no GMO, no gluten — and no capsule shells at all.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy these four ingredients ended up in one packet\u003c\/h2\u003e\n\u003cp\u003eNAD+ doesn't decline because the body forgot how to make it. It declines because (1) salvage-pathway precursors get used up faster than they're rebuilt, (2) the enzymes that \u003cem\u003econsume\u003c\/em\u003e NAD+ — sirtuins, PARPs, and especially \u003cstrong\u003eCD38\u003c\/strong\u003e — speed up with age and inflammation, and (3) the mitochondria that depend on NAD+ get fewer and less efficient. Massudi's landmark 2012 \u003cem\u003ePLoS ONE\u003c\/em\u003e human skin biopsy series put numbers on it: NAD+ falls roughly 50% between ages 30 and 70. A precursor on its own only addresses one of those three mechanisms.\u003c\/p\u003e\n\u003cp\u003eThis formula was built backward from the failure modes of single-ingredient stacks:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e rebuilds the precursor pool. It bypasses the rate-limiting NAMPT step that's required for the standard nicotinamide → NMN → NAD+ salvage pathway, and converts cleanly through NRK1\/NRK2 in two enzymatic steps (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e activates the sirtuins that need NAD+ to function. SIRT1 is the gatekeeper of the longevity program — without sirtuin demand, more NAD+ doesn't translate into more longevity signaling, just more substrate that gets shunted to other consumers (Howitz 2003; Lagouge 2006, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ\u003c\/strong\u003e increases mitochondrial number through PGC-1α activation, so the larger NAD+ pool has more places to do useful work — turning a precursor that would otherwise be wasted into actual ATP and signaling currency (Chowanadisai 2010).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin Phytosome\u003c\/strong\u003e reduces inflammatory CD38 activity (CD38 is a major NAD+ \u003cem\u003econsumer\u003c\/em\u003e that rises with age — Camacho-Pereira 2016, \u003cem\u003eCell Metab\u003c\/em\u003e) and adds senolytic clearance of the \"zombie\" cells that drive inflammation in the first place (Justice 2019, \u003cem\u003eEBioMedicine\u003c\/em\u003e; Yousefzadeh 2018, \u003cem\u003eEBioMedicine\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eYou can buy these four ingredients in four separate bottles. Most people start, take them inconsistently because four-bottle protocols have a 35-second compliance cost every morning, and stop somewhere between weeks 4 and 8. A single morning drink solves the compliance problem that kills the majority of supplement protocols before they reach the timeline at which the underlying pharmacology actually matters.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each packet (dose-disclosed, no proprietary blends)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) — 300 mg.\u003c\/strong\u003e A B3 vitamin form that bypasses NAMPT and converts to NMN → NAD+ in two enzymatic steps via NRK1\/NRK2. The Trammell 2016 trial in \u003cem\u003eNature Communications\u003c\/em\u003e showed a single 300 mg oral dose raised whole-blood NAD+ by ~2.7× within 8 hours in healthy adults. Subsequent trials (Martens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e; Dollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; Conze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e) confirmed sustained elevation with daily dosing across 6–12 week protocols, with no rebound after washout.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol — 150 mg.\u003c\/strong\u003e The bioactive trans-isomer, not the cheaper \u003cem\u003ecis\u003c\/em\u003e form sold in many products. Activates SIRT1 directly (Howitz 2003) and triggers PGC-1α-mediated mitochondrial biogenesis through the same molecular pathway as caloric restriction (Lagouge 2006). The Sinclair lab's pairing logic is explicit: an NAD+ precursor + a sirtuin activator do more together than either alone, because the precursor has nowhere productive to go without the enzyme that consumes it for longevity work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ (Pyrroloquinoline Quinone, 99% pure) — 10 mg.\u003c\/strong\u003e A redox cofactor that signals through CREB → PGC-1α → NRF1\/NRF2 → TFAM → mitochondrial biogenesis (Chowanadisai 2010). It also crosses the blood-brain barrier; small human trials (Nakano 2012, \u003cem\u003eFFHD\u003c\/em\u003e; Itoh 2016, \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e) show improvements in cognitive performance, sleep quality (especially deep-sleep duration), and reduced inflammatory markers (CRP, IL-6) at 10–20 mg daily across 8–12 week protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin Phytosome (Quercefit®) — 250 mg.\u003c\/strong\u003e Phospholipid-bound quercetin with ~20× the plasma bioavailability of standard quercetin (Riva 2019, \u003cem\u003eEur Rev Med Pharmacol Sci\u003c\/em\u003e). Two roles in this formula: (1) \u003cem\u003esenolytic\u003c\/em\u003e — partners with dasatinib in the Mayo Clinic clearance protocol (Justice 2019) and is being studied as a standalone senolytic; (2) \u003cem\u003eCD38 inhibitor\u003c\/em\u003e — reduces age-related NAD+ consumption (Escande 2013, \u003cem\u003eDiabetes\u003c\/em\u003e), so the NR you just took has a longer functional half-life inside the cell.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe bioavailability problem (and how the formula solves it)\u003c\/h2\u003e\n\u003cp\u003eMost longevity supplements fail in the gut, not in the cell. Three of the four actives in this formula are notoriously hard to absorb in their bulk-powder form, which is why dose-on-the-label and dose-in-the-blood are very different numbers for off-the-shelf products:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR — high absolute bioavailability, but rate-limited by transport.\u003c\/strong\u003e NR uses NRK1\/NRK2 transporters and is well-absorbed at the 300 mg single-dose tier (Trammell 2016, AUC and Cmax data published in supplementary materials). Above ~600 mg per dose the response curve flattens — the rate-limiting step shifts from absorption to enzymatic conversion. 300 mg is on the steep part of the curve and is the dose used in the foundational human trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol — \u0026lt;1% oral bioavailability without enhancement.\u003c\/strong\u003e Resveratrol is heavily glucuronidated and sulfated in the gut wall and liver (Walle 2004, \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e). The plasma half-life of free resveratrol is roughly 9 minutes — the pharmacokinetics that historically embarrassed the resveratrol literature. The drink-mix delivery format starts oral-mucosa absorption immediately, bypassing some of the first-pass metabolism that hammers capsule-form resveratrol, and the 150 mg trans dose is calibrated against the metabolite-corrected exposure data that actually correlates with sirtuin activation in humans (Brown 2010, \u003cem\u003eCancer Res\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ — small molecule, well-absorbed.\u003c\/strong\u003e 10 mg is the dose that hit clinical endpoints in the published cognitive-performance and sleep-quality trials (Nakano 2012; Itoh 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin — ~5% bioavailable as free aglycone, ~100% as phytosome.\u003c\/strong\u003e Standard quercetin is one of the worst-bioavailable flavonoids in the supplement world. The phytosome (phospholipid-complex) form binds the molecule to phosphatidylcholine, which carries it across the enterocyte membrane via a passive route that doesn't depend on the limited active-uptake transporters. Riva 2019 showed ~20× the plasma AUC vs. equivalent free quercetin doses. 250 mg of Quercefit phytosome is bioequivalent to roughly 5,000 mg of bulk-powder quercetin — which is how a \"small\" dose on the label translates into a senolytic-relevant exposure inside the cell.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNet effect: every milligram on the label is a milligram that actually enters circulation, which is the reason the four-ingredient stack can fit in a single 5-gram packet without sacrificing the doses that drove the underlying clinical evidence.\u003c\/p\u003e\n\n\u003ch2\u003eThe 9 hallmarks of aging — what this drink covers\u003c\/h2\u003e\n\u003cp\u003eLópez-Otín's 2013 \/ 2023 hallmarks-of-aging framework (\u003cem\u003eCell\u003c\/em\u003e) is the standard taxonomy for what changes during biological aging. This single packet directly addresses four of the nine, plus partial coverage of two more:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — PQQ + NR (substrate + biogenesis).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — Resveratrol activates SIRT1, the central sensor downstream of the AMPK \/ mTOR \/ sirtuin triangle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular senescence\u003c\/strong\u003e — Quercetin Phytosome (Mayo Clinic D+Q protocol).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic inflammation (\"inflammaging\")\u003c\/strong\u003e — Quercetin + PQQ both lower CRP\/IL-6 in their respective trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLoss of proteostasis\u003c\/strong\u003e (partial) — Resveratrol triggers some autophagy via SIRT1 → mTOR-independent pathways, though the autophagy specialist in the catalog is \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStem cell exhaustion\u003c\/strong\u003e (partial) — Restoring NAD+ has been shown to rescue muscle-stem-cell function in murine models (Zhang 2016, \u003cem\u003eScience\u003c\/em\u003e); human translation is still in early trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe remaining hallmarks (genomic instability, telomere attrition, epigenetic alterations, altered intercellular communication, disabled macroautophagy, dysbiosis) are outside the scope of any single supplement — they require lifestyle inputs (sleep, exercise, dietary fiber) and, where relevant, specific products like CaAKG, fisetin, glycine + NAC, or omega-3.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each packet\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eNicotinamide Riboside (NR) — 300 mg\u003c\/li\u003e\n  \u003cli\u003eTrans-Resveratrol — 150 mg\u003c\/li\u003e\n  \u003cli\u003ePQQ (Pyrroloquinoline Quinone) — 10 mg\u003c\/li\u003e\n  \u003cli\u003eQuercetin Phytosome (Quercefit®) — 250 mg\u003c\/li\u003e\n  \u003cli\u003eNatural berry flavor, citric acid, stevia leaf extract\u003c\/li\u003e\n  \u003cli\u003eNet weight ~5 g per stick pack, \u0026lt;5 calories, no added sugar\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e30 stick packs per box = 30-day supply at one-per-day.\u003c\/p\u003e\n\n\u003ch2\u003eThe drink-vs-capsule trade-off, honestly\u003c\/h2\u003e\n\u003cp\u003eWe sell both. Here's the actual difference, not the marketing version:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on compliance.\u003c\/strong\u003e If you don't enjoy swallowing 4–8 capsules every morning, the packet is the version you'll actually finish for 90 days. Compliance is the variable that explains 80% of the variance in real-world supplement outcomes — pharmacology that you don't take every day is pharmacology that doesn't work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on absorption window.\u003c\/strong\u003e Soluble delivery starts in the mouth and upper GI tract — no waiting on capsule shells to dissolve, no gastric-emptying lag for water-soluble actives. For resveratrol especially, oral-mucosa absorption captures a fraction of the dose before first-pass hepatic metabolism gets to it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on travel.\u003c\/strong\u003e Stick packs go in a carry-on. Four bottles do not. For frequent travelers, this is often the difference between staying on protocol and abandoning it for a week every business trip.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on stack discipline.\u003c\/strong\u003e Four ingredients, one packet, taken at one moment. There's no \"I forgot the resveratrol\" or \"the PQQ ran out three weeks ago\" failure mode.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on dose flexibility.\u003c\/strong\u003e Want 1000 mg NMN instead of 300 mg NR? Want to titrate resveratrol up or down on different days? Want to add 600 mg of NMN on workout days? Capsules give you that knob.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on cost-per-dose.\u003c\/strong\u003e The bulk capsule version of this stack is cheaper if you're optimizing for price per mg, accepting the four-bottle compliance burden.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on travel-volume.\u003c\/strong\u003e A single 60-count bottle holds 30 days of capsule stack at the smallest physical footprint, if you're truly weight-constrained.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you're choosing between this and our other NAD+ options, see \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch2\u003eWhere it fits in the longevity stack\u003c\/h2\u003e\n\u003cp\u003eThis drink covers four of the nine hallmarks of aging in one packet. To round out a complete protocol, the most-asked-about pairings (in order of clinical priority for most adults 35+):\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd a methyl donor.\u003c\/strong\u003e NR\/NMN methylation can deplete methyl groups over months — every NAD+ molecule consumed gets methylated to N-methyl-nicotinamide before excretion. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e (trimethylglycine \/ betaine) replaces what's spent and is the single most-recommended addition for anyone taking NR or NMN longer than 90 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd a CD38 inhibitor.\u003c\/strong\u003e Quercetin in this formula already does some of this work. For people running a higher-dose stack or who care about maximizing intracellular NAD+ residence time, layering in \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg + BioPerine\u003c\/a\u003e targets CD38 more directly — apigenin has a stronger CD38 IC50 than quercetin in vitro (Escande 2013).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd senolytic clearance.\u003c\/strong\u003e Quercetin gives partial clearance. \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e dosed monthly (Mayo Clinic-style: 2 days on, 28 days off) clears senescent cells more aggressively. Fisetin was the most-potent senolytic of 10 flavonoids tested head-to-head (Yousefzadeh 2018).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd the glutathione precursor pair.\u003c\/strong\u003e The GlyNAC protocol — \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e — restores glutathione synthesis, which independently lifts mitochondrial function (Sekhar 2021 Baylor trial). This is the most-evidence-backed addition outside the NAD+ family itself.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd foundational nutrients.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000 mg\u003c\/a\u003e are the substrate base every longevity stack runs on top of. Without them, the higher-tier compounds compound onto a deficiency rather than baseline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant maximum-bioavailability NAD+ instead?\u003c\/strong\u003e See \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ for direct cellular delivery without the precursor-conversion step.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant the cheapest NMN entry point?\u003c\/strong\u003e Start with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant 1000 mg double-strength NMN?\u003c\/strong\u003e See \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant NMN + Resveratrol with separate dose control?\u003c\/strong\u003e The \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e gives you both bottles at a discount.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant the AMPK\/sirtuin sister molecule?\u003c\/strong\u003e \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e works on the parallel epigenetic-clock pathway (Brunet\/Conboy lab evidence).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week expectation timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e Plasma NR rises within hours of the first packet (Trammell 2016 Cmax ~6 hours). Whole-blood NAD+ measurably higher within 24–48 hours. Most people don't yet notice anything subjectively.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e The first cohort of subjective reports — typically a \"morning lift\" of energy or mental clarity that feels like better sleep without sleeping more. This is downstream sirtuin signaling catching up to the new precursor pool, not the precursor itself.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e Mitochondrial biogenesis from PQQ becomes measurable (PGC-1α-induced new mitochondria take ~4 weeks to mature). Endurance\/recovery improvements often appear here for active users. CRP and IL-6 begin to drop in users who were elevated at baseline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 2–6:\u003c\/strong\u003e The \"compounding window.\" Senolytic clearance from quercetin (slow, partial) starts to show in skin-quality and recovery markers. NAD+ levels continue to rise toward the new daily-dosing equilibrium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e Bloodwork-readouts: hsCRP, IL-6, fasting insulin, HOMA-IR, and (for users who track it) DunedinPACE\/Horvath methylation age — the long-tail biomarkers that respond to sustained NAD+\/sirtuin\/senolytic stacking but never to a 30-day trial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults \u003cstrong\u003e35+\u003c\/strong\u003e already aware that NAD+ declines with age and looking for an all-in-one drink rather than four bottles\u003c\/li\u003e\n  \u003cli\u003ePeople who \u003cstrong\u003edon't enjoy swallowing capsules\u003c\/strong\u003e and have abandoned previous supplement protocols because of it\u003c\/li\u003e\n  \u003cli\u003eAnyone running a \u003cstrong\u003emorning ritual\u003c\/strong\u003e (coffee, water with electrolytes, lemon water) where adding a drink mix is friction-free\u003c\/li\u003e\n  \u003cli\u003eFrequent \u003cstrong\u003etravelers\u003c\/strong\u003e who need supplements in a carry-on without rattling bottles or TSA questions about powder containers\u003c\/li\u003e\n  \u003cli\u003eStack builders who want the \u003cstrong\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/strong\u003e base in a single SKU and then layer additions (TMG, Apigenin, Fisetin, Spermidine) on top\u003c\/li\u003e\n  \u003cli\u003ePeople rebuilding after \u003cstrong\u003eburnout, post-illness, or post-surgery recovery\u003c\/strong\u003e who want the NAD+\/mitochondrial substrate in the easiest possible delivery format\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople with \u003cstrong\u003eactive cancer or recent cancer history\u003c\/strong\u003e — boosting NAD+ has a complex relationship with tumor metabolism; this is an oncologist conversation, not a supplement decision.\u003c\/li\u003e\n  \u003cli\u003ePeople on \u003cstrong\u003ewarfarin, clopidogrel, or DOACs\u003c\/strong\u003e — resveratrol's antiplatelet activity is mild but additive.\u003c\/li\u003e\n  \u003cli\u003ePeople scheduled for \u003cstrong\u003esurgery within 2 weeks\u003c\/strong\u003e — discontinue and restart 2 weeks post-op.\u003c\/li\u003e\n  \u003cli\u003ePeople who are \u003cstrong\u003epregnant or breastfeeding\u003c\/strong\u003e — none of these compounds are studied in pregnancy.\u003c\/li\u003e\n  \u003cli\u003ePeople with \u003cstrong\u003esevere stevia or berry allergies\u003c\/strong\u003e — see \"What's not in it\" below for the full ingredient list.\u003c\/li\u003e\n  \u003cli\u003ePeople who \u003cstrong\u003especifically want NMN, not NR\u003c\/strong\u003e — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOne packet per day.\u003c\/strong\u003e Mix into 7–10 oz (200–300 ml) of cool water and stir until fully dissolved (~15 seconds). Best taken in the morning, ideally with breakfast — Resveratrol and PQQ both absorb better with some dietary fat. The berry flavor mixes clean with no aftertaste; some users add a squeeze of lemon, take it with a small handful of nuts, or drink it as a chaser to morning coffee.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEmpty-stomach dosing.\u003c\/strong\u003e Acceptable but not optimal — fat-soluble actives (resveratrol, PQQ at higher doses) absorb 1.5–3× better with fat. If you're a strict morning-faster, save the packet for your first meal.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStacking timing.\u003c\/strong\u003e If you take other capsule-based supplements (TMG, Apigenin, Fisetin, NAC, Glycine), take them with the same meal. NR and Resveratrol do not need to be cycled in healthy adults — daily dosing is the protocol used in all the cited human trials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDo not exceed one packet per day\u003c\/strong\u003e unless under medical supervision. Doubling the dose does not proportionally increase NAD+ above the saturation point of the NRK1\/NRK2 transport system.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's not in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eNo artificial colors or sweeteners (sweetened with stevia leaf extract)\u003c\/li\u003e\n  \u003cli\u003eNo proprietary blends — every active ingredient is dose-disclosed on the label\u003c\/li\u003e\n  \u003cli\u003eNo added sugar (\u0026lt;5 calories per packet)\u003c\/li\u003e\n  \u003cli\u003eNo magnesium stearate, no titanium dioxide, no gelatin shells (no capsules at all)\u003c\/li\u003e\n  \u003cli\u003eNo GMOs, no gluten, no soy, no dairy\u003c\/li\u003e\n  \u003cli\u003eThird-party tested for purity, potency, heavy metals, and microbial contamination before each batch ships\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eImportant safety information\u003c\/h2\u003e\n\u003cp\u003eGenerally well-tolerated; the most-reported adverse events in NR trials are mild flushing or transient GI discomfort, both dose-dependent and typically resolving within the first 1–2 weeks of daily use. Specific cautions:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent cancer history.\u003c\/strong\u003e Boosting NAD+ has a complex relationship with tumor metabolism — some tumor types are NAD+-dependent. Discuss with your oncologist before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin and CYP3A4 \/ P-glycoprotein interactions.\u003c\/strong\u003e Quercetin can inhibit CYP3A4 and P-gp transporters and may interact with cyclosporine, certain statins (atorvastatin, simvastatin), some calcium channel blockers, and certain chemotherapeutics. If you take prescription medications metabolized by CYP3A4, check with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol and blood thinners.\u003c\/strong\u003e Resveratrol has mild antiplatelet activity. If you take warfarin, clopidogrel, aspirin (daily-dose), or DOACs (apixaban, rivaroxaban, edoxaban, dabigatran), talk to your doctor before adding.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol and estrogen-sensitive conditions.\u003c\/strong\u003e Resveratrol is a weak phytoestrogen (mixed agonist\/antagonist depending on tissue). Estrogen-receptor-positive cancer history, endometriosis, and certain fibroid presentations warrant a physician conversation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding.\u003c\/strong\u003e Not studied. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 1–2 weeks before any planned surgery and restart 2 weeks post-op (resveratrol's antiplatelet effect, quercetin's CYP interactions).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiver enzyme elevations (theoretical).\u003c\/strong\u003e Reported in \u0026lt;1% of long-running resveratrol trial subjects; reverses on discontinuation. Anyone with existing liver disease should baseline LFTs before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergies.\u003c\/strong\u003e Stevia, berry-flavor naturally-derived compounds. Check the full label if you have known reactivity to Asteraceae-family plants (chamomile, ragweed) — quercetin from rutin sources can cross-react in highly sensitive individuals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs this NAD+ or a precursor?\u003c\/strong\u003e\u003cbr\u003e\nA precursor — NR. NAD+ itself is a large, charged molecule that's poorly absorbed orally (most of an oral NAD+ dose is degraded in the gut to nicotinamide before reaching circulation). NR is the precursor with the most human trial data showing it actually raises blood and tissue NAD+ levels (Trammell 2016; Martens 2018). If you specifically want NAD+ delivered as the intact molecule, see \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e, which uses a phospholipid encapsulation to protect NAD+ through GI transit.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy NR instead of NMN?\u003c\/strong\u003e\u003cbr\u003e\nBoth work; the human trial evidence base is larger for NR (65+ registered trials vs ~12 for NMN as of 2026). NMN converts to NR before crossing cell membranes in most tissues anyway (the Slc12a8 transporter that lets NMN enter cells directly is highly expressed in the gut but limited elsewhere — Grozio 2019, \u003cem\u003eNat Metab\u003c\/em\u003e). We sell both — see our \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the trial-level breakdown.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e\u003cbr\u003e\nMost people report perceptible energy and focus changes in 2–6 weeks of daily use. Underlying NAD+ levels rise within hours of the first dose; the subjective effects lag because they reflect downstream sirtuin signaling and mitochondrial adaptation, not the precursor concentration itself. If you're in the no-effect bucket at week 8, the most-likely explanations are (a) you're already at adequate baseline NAD+, (b) you're missing a methyl donor (add TMG), or (c) the limiting factor in your case is sleep, exercise, or another upstream variable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e\u003cbr\u003e\nYes. No known interactions with caffeine. Many users take the packet alongside their morning coffee — the slight tartness of the berry pairs cleanly. If you take electrolytes or creatine in your morning water, those also stack fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle it?\u003c\/strong\u003e\u003cbr\u003e\nNo. The daily-dosing protocol is used in every cited human trial. People sometimes pulse senolytics (Fisetin 1–2 days\/month) but the NR \/ Resveratrol \/ PQQ base is taken daily without cycling. NR has not shown receptor-downregulation patterns at the doses studied.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my morning fast?\u003c\/strong\u003e\u003cbr\u003e\nThe packet contains a small amount of natural berry flavoring and a few calories (\u0026lt;5 kcal). If you're doing strict water-only fasting, take it with your first meal instead of in your fasting window. For more permissive fasting protocols (16:8 with electrolytes), the packet's caloric load is below the typical \"broke the fast\" threshold.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the resveratrol \"only\" 150 mg when other products use 500 mg?\u003c\/strong\u003e\u003cbr\u003e\nBioavailability. Resveratrol has \u0026lt;1% oral bioavailability without enhancement — most of the 500 mg in standalone capsules is metabolized by the gut wall and liver before reaching circulation. The drink-mix delivery captures a fraction of the dose at the oral mucosa, and the formula is calibrated against metabolite-corrected exposure data, not raw label dose. If you want more, layer in \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e separately.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the quercetin \"only\" 250 mg when other products use 500–1000 mg?\u003c\/strong\u003e\u003cbr\u003e\nPhytosome bioavailability. 250 mg of Quercefit phytosome is bioequivalent to ~5,000 mg of bulk-powder quercetin (Riva 2019). The label dose is lower; the absorbed dose is comparable to or higher than the bulk-powder competitors at 4× the label dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I still need TMG with this product?\u003c\/strong\u003e\u003cbr\u003e\nRecommended if you're taking it longer than 90 days or stacking with additional NMN\/NR. NAD+ catabolism produces methylated end-products that draw down the body's methyl-group pool. TMG (trimethylglycine, also called betaine) is the most-direct methyl-donor replenishment. See \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take more than one packet per day?\u003c\/strong\u003e\u003cbr\u003e\nNot recommended without medical supervision. The 300 mg NR dose is on the steep part of the dose-response curve; doubling the dose does not double the NAD+ rise, and adds resveratrol's antiplatelet load without proportional benefit.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the packet and mix it into a smoothie or coffee?\u003c\/strong\u003e\u003cbr\u003e\nCold or room-temperature smoothies, yes. Hot coffee, no — high temperatures degrade NR (it's heat-sensitive). Iced coffee is fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this dropshipped or stocked?\u003c\/strong\u003e\u003cbr\u003e\nWe work with a small number of vetted manufacturers who hold the inventory and ship direct. This keeps prices low and ensures you receive recently-manufactured product (typically 30–90 days from manufacture date) rather than warehouse stock approaching expiry. Each batch ships with a Certificate of Analysis on file.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if it doesn't work for me?\u003c\/strong\u003e\u003cbr\u003e\n30-day money-back guarantee on the first bottle. See our \u003ca href=\"\/he\/pages\/guarantee\"\u003eguarantee page\u003c\/a\u003e for details.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eTrammell SAJ et al. \u003cem\u003eNicotinamide riboside is uniquely and orally bioavailable in mice and humans.\u003c\/em\u003e Nat Commun. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR et al. \u003cem\u003eChronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.\u003c\/em\u003e Nat Commun. 2018;9:1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL et al. \u003cem\u003eA randomized placebo-controlled clinical trial of nicotinamide riboside in obese men.\u003c\/em\u003e Am J Clin Nutr. 2018;108:343–353.\u003c\/li\u003e\n  \u003cli\u003eConze D et al. \u003cem\u003eSafety and metabolism of long-term administration of NIAGEN.\u003c\/em\u003e Sci Rep. 2019;9:9772.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT et al. \u003cem\u003eSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.\u003c\/em\u003e Nature. 2003;425:191–196.\u003c\/li\u003e\n  \u003cli\u003eLagouge M et al. \u003cem\u003eResveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α.\u003c\/em\u003e Cell. 2006;127:1109–1122.\u003c\/li\u003e\n  \u003cli\u003ePark SJ et al. \u003cem\u003eResveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.\u003c\/em\u003e Cell. 2012;148:421–433.\u003c\/li\u003e\n  \u003cli\u003eBrown VA et al. \u003cem\u003eRepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers.\u003c\/em\u003e Cancer Res. 2010;70:9003–9011.\u003c\/li\u003e\n  \u003cli\u003eWalle T et al. \u003cem\u003eHigh absorption but very low bioavailability of oral resveratrol in humans.\u003c\/em\u003e Drug Metab Dispos. 2004;32:1377–1382.\u003c\/li\u003e\n  \u003cli\u003eChowanadisai W et al. \u003cem\u003ePyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and PGC-1α expression.\u003c\/em\u003e J Biol Chem. 2010;285:142–152.\u003c\/li\u003e\n  \u003cli\u003eNakano M et al. \u003cem\u003eEffects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep.\u003c\/em\u003e Functional Foods in Health and Disease. 2012;2:307–324.\u003c\/li\u003e\n  \u003cli\u003eItoh Y et al. \u003cem\u003eEffect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ) on cognitive functions.\u003c\/em\u003e Adv Exp Med Biol. 2016;876:319–325.\u003c\/li\u003e\n  \u003cli\u003eRiva A et al. \u003cem\u003eImproved oral absorption of quercetin from Quercetin Phytosome®, a new delivery system based on food grade lecithin.\u003c\/em\u003e Eur J Drug Metab Pharmacokinet. 2019;44:169–177.\u003c\/li\u003e\n  \u003cli\u003eJustice JN et al. \u003cem\u003eSenolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study.\u003c\/em\u003e EBioMedicine. 2019;40:554–563.\u003c\/li\u003e\n  \u003cli\u003eYousefzadeh MJ et al. \u003cem\u003eFisetin is a senotherapeutic that extends health and lifespan.\u003c\/em\u003e EBioMedicine. 2018;36:18–28.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J et al. \u003cem\u003eCD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism.\u003c\/em\u003e Cell Metab. 2016;23:1127–1139.\u003c\/li\u003e\n  \u003cli\u003eEscande C et al. \u003cem\u003eFlavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.\u003c\/em\u003e Diabetes. 2013;62:1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMassudi H et al. \u003cem\u003eAge-associated changes in oxidative stress and NAD+ metabolism in human tissue.\u003c\/em\u003e PLoS ONE. 2012;7:e42357.\u003c\/li\u003e\n  \u003cli\u003eGrozio A et al. \u003cem\u003eSlc12a8 is a nicotinamide mononucleotide transporter.\u003c\/em\u003e Nat Metab. 2019;1:47–57.\u003c\/li\u003e\n  \u003cli\u003eZhang H et al. \u003cem\u003eNAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice.\u003c\/em\u003e Science. 2016;352:1436–1443.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C et al. \u003cem\u003eHallmarks of aging: an expanding universe.\u003c\/em\u003e Cell. 2023;186:243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/senolytics-how-to-clear-zombie-cells-with-fisetin-quercetin-and-spermidine\"\u003eSenolytics: how to clear zombie cells with Fisetin, Quercetin and Spermidine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal: how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e for related products and stacks, or the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e for the PQQ-anchored protocols.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eFDA disclaimer.\u003c\/strong\u003e This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698113691866,"sku":"THP-NAD-FOCUS-1000","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-focus.jpg?v=1775666113"},{"product_id":"rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging","title":"Nicotinamide Capsules","description":"\u003cp\u003e\u003cstrong\u003eNicotinamide Riboside (NR) in hard capsule form\u003c\/strong\u003e — the patented NAD+ precursor with the deepest human research track record (65+ registered clinical trials, including pharmacokinetic, cardiovascular, and neurological endpoints). Supported by B-vitamin cofactors so the full NAD+ biosynthesis pathway has what it needs to convert NR into NAD+ inside the cell.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR is the most-studied NAD+ precursor in humans.\u003c\/strong\u003e First-in-human pharmacokinetic data published in 2016 (Trammell et al., \u003cem\u003eNature Communications\u003c\/em\u003e) showed a single oral dose raised whole-blood NAD+ ~2.7× over 24 hours. Multi-week dosing at 1 g\/day has been studied in healthy adults, midlife adults with elevated blood pressure, obese insulin-resistant adults, post-menopausal women, NAFLD patients, ALS patients, and Parkinson's patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDifferent intracellular path than NMN.\u003c\/strong\u003e NR enters cells via the equilibrative nucleoside transporters (ENT1\/2), gets phosphorylated by NRK1\/NRK2 to NMN, then converted to NAD+. NMN uses the Slc12a8 transporter (Grozio 2019, \u003cem\u003eNature Metabolism\u003c\/em\u003e) and skips a step. Both raise NAD+; tissue coverage and intracellular kinetics differ, which is why many longevity stacks run both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want the longest human-research track record, those who didn't feel a clear shift on NMN alone, anyone running a comprehensive NAD+ stack that hedges across both precursor pathways, and adults 50+ where the NMN transporter Slc12a8 may be downregulated in some tissues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 1–2 capsules daily\u003c\/strong\u003e in the morning with food. Daily consistency matters more than time-of-day. Stacks cleanly with NMN, Resveratrol, Pterostilbene, TMG, Apigenin, Quercetin, Fisetin, CoQ10, PQQ, and Urolithin A.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR form,\u003c\/strong\u003e the same molecule used in Trammell 2016, Martens 2018, Dollerup 2018, Conze 2019, Elhassan 2019, and Brakedal 2022. Manufactured to cGMP, third-party HPLC-tested, encapsulated in a vegan-compatible hard shell with no proprietary blends, no titanium dioxide, no artificial colors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NR sits at the center of the NAD+ conversation\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the single most metabolically expensive coenzyme in the cell. Every major energy-producing pathway — glycolysis, the citric acid cycle, the electron transport chain, fatty-acid oxidation — runs on NAD+\/NADH cycling. On top of that core role, NAD+ is the rate-limiting substrate for at least three enzyme families that get talked about in the longevity literature constantly: the sirtuins (SIRT1–SIRT7, the histone-deacetylase \/ mitochondrial regulators activated by Resveratrol), the PARPs (PARP1 in particular, the primary single-strand DNA break repair enzyme), and CD38 (the NAD+ glycohydrolase that becomes hyperactive with inflammaging). When NAD+ falls, all three of those families slow down at the same time — and that simultaneity is why \"NAD+ decline\" gets called a hallmark of aging in the López-Otín 2013 \/ 2023 \u003cem\u003eCell\u003c\/em\u003e framework, even though it isn't formally one of the 12.\u003c\/p\u003e\n\u003cp\u003eThe decline itself is not subtle. Massudi 2012 (\u003cem\u003ePLOS One\u003c\/em\u003e) measured skin NAD+ across the lifespan and found a roughly 50% drop between ages 20 and 60. Camacho-Pereira 2016 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated the finding in muscle and liver and showed CD38 — which consumes NAD+ to make calcium-mobilizing second messengers — rises sharply with age, partially explaining the drop. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) showed similar declines in pancreas, adipose tissue, and the hypothalamus in mice. Across tissues, mechanisms, and species, the NAD+ pool collapses with age — and the sirtuin \/ PARP \/ CD38 enzymes that depend on it lose their substrate.\u003c\/p\u003e\n\u003cp\u003eYou can address that decline from three directions:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply more precursor\u003c\/strong\u003e — give the cell more raw material to make NAD+ from. \u003cstrong\u003eNR and NMN\u003c\/strong\u003e are the two patented, trial-validated levers in this category. Niacin (NA) and niacinamide (NAM) also raise NAD+ but flush, suppress sirtuins at high doses, and lack the modern human evidence base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduce NAD+ consumers\u003c\/strong\u003e — slow down the enzymes that destroy it. \u003cstrong\u003eApigenin\u003c\/strong\u003e inhibits CD38 directly. \u003cstrong\u003eQuercetin\u003c\/strong\u003e and \u003cstrong\u003eFisetin\u003c\/strong\u003e clear senescent cells, which overconsume NAD+ via SASP-driven CD38 expression in neighboring cells.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivate the enzymes that use NAD+ productively\u003c\/strong\u003e — get more longevity output per unit of NAD+. \u003cstrong\u003eResveratrol\u003c\/strong\u003e and \u003cstrong\u003ePterostilbene\u003c\/strong\u003e activate SIRT1; \u003cstrong\u003espermidine\u003c\/strong\u003e activates the autophagy machinery that sirtuins help regulate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNR is the most-validated supply-side lever in humans, and it pairs cleanly with all three of the other strategies. That is why it lives in almost every well-designed longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what NR actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. The NRK1\/NRK2 phosphorylation pathway\u003c\/h3\u003e\n\u003cp\u003eNR is a riboside — a vitamin B3 (nicotinamide) attached to a ribose sugar without a phosphate group. That structure matters for two reasons. First, it is the only NAD+ precursor that crosses the plasma membrane intact via a well-characterized transporter family: the equilibrative nucleoside transporters ENT1 and ENT2, which are present in essentially every tissue type (Bieganowski \u0026amp; Brenner 2004, \u003cem\u003eCell\u003c\/em\u003e). Second, once inside the cell, it gets phosphorylated to NMN by NRK1 (nicotinamide riboside kinase 1) or NRK2. NRK1 is the housekeeping enzyme — broadly distributed, induced by NAD+ depletion, and the rate-limiting step that determines how much NR actually becomes NAD+ in any given tissue (Ratajczak 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eFrom NMN, the route is canonical: NMNAT1\/2\/3 (nicotinamide mononucleotide adenylyltransferase) attaches the AMP moiety to make NAD+. NMNAT1 lives in the nucleus, NMNAT2 in the cytoplasm and Golgi, NMNAT3 in the mitochondrial matrix. That compartmentalization matters — NMNAT3 is the enzyme that decides how much of your NAD+ pool is mitochondrial, which is why mitochondrial sirtuins (SIRT3\/4\/5) and mitochondrial NAD+\/NADH cycling depend on getting precursor across the inner membrane. NR's ribose-only structure means it can be phosphorylated in any compartment that has NRK1\/2, including the mitochondrion via the SLC25A51 mitochondrial NAD+ transporter that was characterized in 2020 (Luongo, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThat two-step intracellular path (NR → NMN → NAD+) is one step longer than the NMN route but uses ubiquitous, redundant machinery (ENT1\/2, NRK1\/NRK2), which is why NR's tissue coverage is broad even when local Slc12a8 (the NMN transporter) is low.\u003c\/p\u003e\n\n\u003ch3\u003e2. Sirtuin substrate, PARP cofactor, and CD38 substrate — the three NAD+ sinks\u003c\/h3\u003e\n\u003cp\u003eOnce converted to NAD+, the molecule is consumed (not just used and recycled) by three enzyme families:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuins (SIRT1–SIRT7).\u003c\/strong\u003e NAD+-dependent deacetylases. SIRT1 in the nucleus deacetylates p53, FOXO, PGC-1α, and the histone tails that regulate metabolic, DNA-repair, and longevity gene programs. SIRT3 in the mitochondrion deacetylates the fatty-acid oxidation, urea-cycle, and ROS-detoxification machinery. SIRT6 stabilizes telomeres and regulates DNA double-strand break repair. Every catalytic cycle consumes one NAD+ and produces nicotinamide as a byproduct. The \"salvage pathway\" recycles that nicotinamide, but only at the rate set by NAMPT — which is why precursor supply (NR\/NMN) matters even when salvage is intact.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePARP1 (and PARP2).\u003c\/strong\u003e Poly-ADP-ribose polymerases. The primary single-strand DNA break repair enzyme attaches long chains of ADP-ribose to chromatin proteins at sites of damage, recruiting the repair machinery. Each chain consumes 50–200+ NAD+ molecules. When DNA damage is high — oxidative stress, radiation, chemotherapy, chronic inflammation — PARP activity can crash the NAD+ pool acutely. Restoring precursor supply is the first-line metabolic countermeasure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38.\u003c\/strong\u003e The NAD+ glycohydrolase that converts NAD+ to ADP-ribose \/ cyclic ADP-ribose for calcium signaling. CD38 expression rises with age and inflammation (Camacho-Pereira 2016) and contributes more to NAD+ decline in older tissue than any other enzyme. CD38 inhibition (Apigenin, Luteolin, 78c in animal studies) is the second supply-side strategy and pairs neatly with precursor supplementation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNR is the substrate at the start of that chain. Increase NR → increase NAD+ → increase the substrate available for sirtuin \/ PARP \/ CD38 activity. The decisive evidence that this happens in humans, not just cells in a dish, is the Trammell 2016 pharmacokinetic study and the trials that followed.\u003c\/p\u003e\n\n\u003ch3\u003e3. The cardiovascular and aortic-stiffness signal\u003c\/h3\u003e\n\u003cp\u003eMartens 2018 (\u003cem\u003eNature Communications\u003c\/em\u003e) gave 30 midlife and older adults with elevated systolic blood pressure (120–139 mmHg) NR 1 g\/day or placebo for 6 weeks in a randomized crossover. NR raised whole-blood NAD+ ~60% on average. In the elevated-BP subgroup, systolic BP fell ~10 mmHg vs placebo and aortic stiffness (measured by carotid-femoral pulse wave velocity) decreased — the same readouts that track with cardiovascular event risk in epidemiologic cohorts. The trial was small and short, but the magnitudes were large enough to motivate the multiple Phase III NR cardiovascular trials currently in registration. The mechanistic interpretation is sirtuin (SIRT1\/SIRT3)-mediated improvements in endothelial function and vascular smooth muscle bioenergetics — exactly what you would predict from the precursor-supply rationale.\u003c\/p\u003e\n\n\u003ch3\u003e4. The Parkinson's NADPARK signal\u003c\/h3\u003e\n\u003cp\u003eBrakedal 2022 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) — the NADPARK trial — gave 30 newly diagnosed Parkinson's patients NR 1 g\/day or placebo for 30 days and measured cerebrospinal fluid (CSF) NAD+ via lumbar puncture and brain NAD+ via 31P-MRS. CSF and brain NAD+ rose, neuroinflammatory markers (IL-6, IL-8, several CSF cytokines) shifted favorably, and clinical motor scores showed mild but measurable improvements vs placebo. The trial was small and short, but it was the first human study to demonstrate that oral NR raises brain NAD+ — a finding that matters for the broader hypothesis that NAD+ decline contributes to multiple neurodegenerative disease processes. The follow-up NR-SAFE trial (Brakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e) extended the dosing safely to 3 grams\/day for 4 weeks. Larger NR-PD trials are ongoing.\u003c\/p\u003e\n\n\u003ch3\u003e5. Inflammation, muscle, and the elderly cohort\u003c\/h3\u003e\n\u003cp\u003eElhassan 2019 (\u003cem\u003eCell Reports\u003c\/em\u003e) gave 12 healthy elderly adults (aged 70–80) NR 1 g\/day for 21 days. Muscle biopsies showed elevated NAD+ and elevated NADP+\/NADPH ratios (NADP+ is the phosphorylated form used by the antioxidant defense system). Circulating inflammatory cytokines (IL-6, IL-5, IL-2) decreased significantly. The trial established that NR's effect on muscle NAD+ is meaningful in the population that needs it most — the same population in whom CD38 expression is highest and NAD+ is lowest at baseline.\u003c\/p\u003e\n\n\u003ch3\u003e6. The 8-week dose-response in healthy overweight adults\u003c\/h3\u003e\n\u003cp\u003eConze 2019 (\u003cem\u003eScientific Reports\u003c\/em\u003e) randomized 140 healthy overweight adults to placebo, 100, 300, or 1000 mg\/day NR for 8 weeks. Whole-blood NAD+ rose dose-dependently — about 22% at 100 mg, 51% at 300 mg, and 142% at 1000 mg. Adverse events did not differ from placebo at any dose. The trial established the dose-response curve in a free-living healthy population and is the largest RCT to date in non-clinical adults. It is the basis for the 1 g\/day target dose used in subsequent cardiovascular and neurological studies.\u003c\/p\u003e\n\n\u003ch3\u003e7. Insulin sensitivity and metabolic readouts\u003c\/h3\u003e\n\u003cp\u003eDollerup 2018 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) gave 40 obese insulin-resistant men NR 2 g\/day or placebo for 12 weeks. NR raised whole-blood NAD+ but the primary insulin-sensitivity endpoint (hyperinsulinemic-euglycemic clamp) was not significantly improved at 12 weeks. The trial is often cited as a \"negative\" study, but the more accurate read is that 12 weeks at this dose did not move the specific insulin-sensitivity readout in this specific high-risk population. Other metabolic endpoints (body composition, hepatic fat by MRS) showed trends. Remie 2020 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) replicated the safety and NAD+ rise in another insulin-resistant cohort. The metabolic story for NR is more nuanced than the cardiovascular story; the trial-design lesson is that NAD+ rise is robust but downstream metabolic endpoints depend on cohort, baseline NAD+, and stacking strategy.\u003c\/p\u003e\n\n\u003ch3\u003e8. The methylation pool — why TMG eventually matters\u003c\/h3\u003e\n\u003cp\u003eEvery time NAD+ is consumed by a sirtuin, PARP, or CD38, it produces nicotinamide (NAM) as a byproduct. NAM is recycled through the salvage pathway by NAMPT — but a fraction is also methylated by NNMT (nicotinamide N-methyltransferase) into 1-methylnicotinamide (1-MNA) and excreted in urine. That methylation step uses S-adenosyl methionine (SAM), the universal methyl donor. Sustained high-dose NR or NMN therefore creates a small, ongoing draw on the methylation pool. For most users, dietary methyl donors (choline, betaine in beets, methylated B12 and folate from a multivitamin) cover the cost. For long-term high-dose use — and especially for users with MTHFR polymorphisms — adding \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e at 500–1000 mg\/day after 4+ weeks of daily NR\/NMN is the standard methylation-support move.\u003c\/p\u003e\n\n\u003ch3\u003e9. Why the included B-vitamin cofactors actually do something\u003c\/h3\u003e\n\u003cp\u003eThe salvage pathway uses B6 as a cofactor for nicotinamide phosphoribosyltransferase (NAMPT). The methylation cycle that disposes of excess nicotinamide via NNMT depends on B12 and folate as methyl-group donors. Including B6, B12, and folate in the capsule means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. It is not a substitute for TMG at long-term high doses, but it is a sensible structural addition that closes the most common micronutrient gaps that limit NAD+ biosynthesis efficiency. Trammell 2016 noted that in healthy participants, 1MNA (the methylated excretion product) appeared in urine within hours of dosing — confirming the methylation route is active from the first dose.\u003c\/p\u003e\n\n\u003ch2\u003eNR vs NMN — the practical decision, with mechanism\u003c\/h2\u003e\n\u003cp\u003eBoth are NAD+ precursors. Both raise NAD+ in humans. The pathway is one step different, and the practical implications are usually small but worth understanding before you commit to a stack.\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eNicotinamide Riboside (NR)\u003c\/th\u003e\n\u003cth\u003eNMN (β-NMN)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCell entry\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eENT1\/2 (broadly expressed nucleoside transporters; ubiquitous)\u003c\/td\u003e\n\u003ctd\u003eSlc12a8 (Grozio 2019); some tissue heterogeneity in expression\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIntracellular path\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNR → NMN (NRK1\/NRK2 phosphorylation) → NAD+ (NMNAT)\u003c\/td\u003e\n\u003ctd\u003eNMN → NAD+ (NMNAT) — one step shorter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFirst-in-human PK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e — the foundational PK paper\u003c\/td\u003e\n\u003ctd\u003eIrie 2020, \u003cem\u003eEndocr J\u003c\/em\u003e — first PK; Yoshino 2021, \u003cem\u003eScience\u003c\/em\u003e first efficacy in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCardiovascular RCT\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e — 6 weeks, BP and aortic stiffness signal\u003c\/td\u003e\n\u003ctd\u003eSmaller human cardiovascular evidence base to date\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrain \/ CSF NAD+\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e — first human CSF NAD+ rise\u003c\/td\u003e\n\u003ctd\u003eMostly preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInsulin sensitivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDollerup 2018 12-wk — neutral on clamp; Remie 2020 — neutral\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021 — improved muscle insulin sensitivity in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTissue coverage strength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong in muscle, brain, immune (broad ENT1\/2 expression)\u003c\/td\u003e\n\u003ctd\u003eStrong in liver and pancreas (high Slc12a8)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCost per gram\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigher (patent-licensed)\u003c\/td\u003e\n\u003ctd\u003eGenerally lower — particularly for entry-tier 500 mg products\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily dose range\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the trial-validated cardiovascular dose)\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the Yoshino 2021 dose)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTime to whole-blood NAD+ rise\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWithin 24 hours of first dose; sustained at 8 weeks (Conze 2019)\u003c\/td\u003e\n\u003ctd\u003eWithin hours of first dose; sustained at 10 weeks (Yoshino 2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBest for\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLongest research depth; muscle\/brain\/immune tissue priorities; NMN non-responders; comprehensive stacks\u003c\/td\u003e\n\u003ctd\u003eCost-efficient daily entry; liver\/pancreas priorities; insulin-sensitivity cohorts; entry-tier protocols\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the practical difference is small. Many longevity protocols stack both — NMN morning, NR mid-morning — to cover both transporter families across the day. The most rigorous answer to \"which is better?\" is \"the one you take consistently for 12+ weeks alongside a SIRT1 activator and a methyl donor.\" Read our full \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the deeper decision framework.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that matter\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary readout\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=12)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg single dose\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ over 24h\u003c\/td\u003e\n\u003ctd\u003e~2.7× rise at 1000 mg; first-in-human PK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight adults (n=140)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+; safety\u003c\/td\u003e\n\u003ctd\u003eDose-dependent rise (22% \/ 51% \/ 142%); no AE signal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMidlife\/older adults, elevated SBP (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk crossover\u003c\/td\u003e\n\u003ctd\u003eNAD+, SBP, aortic stiffness\u003c\/td\u003e\n\u003ctd\u003eNAD+ +60%; ~10 mmHg SBP drop in elevated-BP subgroup; aortic stiffness reduced\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDellinger 2017, \u003cem\u003eNPJ Aging Mech Dis\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=120)\u003c\/td\u003e\n\u003ctd\u003e250 mg\/day NR + 50 mg pterostilbene combo × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003e~40% NAD+ rise; well tolerated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eObese insulin-resistant men (n=40)\u003c\/td\u003e\n\u003ctd\u003e2000 mg\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity (clamp)\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; clamp insulin-sensitivity unchanged at 12 wk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElhassan 2019, \u003cem\u003eCell Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy elderly aged 70–80 (n=12)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+; circulating cytokines\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+ rose; IL-6\/IL-5\/IL-2 decreased\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemie 2020, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight men (n=13 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle NAD+; metabolic endpoints\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle acetylcarnitine fell; mixed metabolic readouts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStocks 2021, \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy aged adults (n=12 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle mitochondrial respiration\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; respiratory function unchanged at 21 d in healthy aged muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n\u003ctd\u003eNewly diagnosed Parkinson's (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 30 d\u003c\/td\u003e\n\u003ctd\u003eCSF and brain NAD+; clinical motor scores\u003c\/td\u003e\n\u003ctd\u003eCSF\/brain NAD+ rose; neuroinflammatory markers shifted; mild motor improvement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n\u003ctd\u003eParkinson's (n=20)\u003c\/td\u003e\n\u003ctd\u003e3000 mg\/day × 4 wk\u003c\/td\u003e\n\u003ctd\u003eSafety, tolerability, NAD+ ceiling\u003c\/td\u003e\n\u003ctd\u003e3 g\/day well tolerated; NAD+ further elevated vs 1 g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWang 2017, \u003cem\u003eLancet Neurol\u003c\/em\u003e commentary on Trammell + ALS rationale\u003c\/td\u003e\n\u003ctd\u003eALS \/ preclinical\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eMechanistic basis for ALS NR trials\u003c\/td\u003e\n\u003ctd\u003eEstablished the rationale for the multi-arm ALS NR trials in registration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePirinen 2020, \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAdult mitochondrial myopathy (n=5)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day NR × 5 mo\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+, FGF21, mitochondrial myopathy markers\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle strength and FGF21 trends improved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirhart 2017, \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=8)\u003c\/td\u003e\n\u003ctd\u003e1000–2000 mg\/day × 9 d\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003eSafe, well-tolerated, NAD+ rose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis is the densest human evidence base of any NAD+ precursor — pharmacokinetic, dose-response, multi-cohort, multi-endpoint, multi-organ, and consistently safe at the 1 g\/day level over 4–12 week durations. Larger Phase III cardiovascular and Parkinson's NR trials are in registration as of 2026.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — why patented NR, not just \"any NR\"\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eIdentity \/ form\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eHPLC purity\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride\u003c\/strong\u003e (this product)\u003c\/td\u003e\n\u003ctd\u003eCrystalline NR-Cl, the form used in every cited human trial\u003c\/td\u003e\n\u003ctd\u003e65+ registered human trials; the entire NR evidence base\u003c\/td\u003e\n\u003ctd\u003e≥98% NR by HPLC; identity confirmed by NMR \u0026amp; mass spec; trace heavy metals \u0026lt; USP \u0026lt;232\u0026gt; limits\u003c\/td\u003e\n\u003ctd\u003eAnyone who wants the trial-validated form. Default choice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneric NR-Cl (commodity)\u003c\/td\u003e\n\u003ctd\u003eSame chemical class but variable identity \/ purity \/ impurity profile\u003c\/td\u003e\n\u003ctd\u003eNot the form used in published human trials\u003c\/td\u003e\n\u003ctd\u003eVariable; specs not always disclosed; some lots fail HPLC identity\u003c\/td\u003e\n\u003ctd\u003eCost-shoppers willing to accept identity \/ purity variance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotinamide (NAM) \/ niacinamide\u003c\/td\u003e\n\u003ctd\u003eThe end-product, not a precursor in the same sense\u003c\/td\u003e\n\u003ctd\u003eLong history; flushless; sirtuin-suppressing at \u0026gt;500 mg\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eSkin \/ dermatology applications, not longevity-stack NAD+ raising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNiacin (NA, nicotinic acid)\u003c\/td\u003e\n\u003ctd\u003ePrecursor via the Preiss-Handler pathway\u003c\/td\u003e\n\u003ctd\u003eMultiple human trials (lipid use)\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003ePeople who can tolerate the flush; lipid-modification context, not longevity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNRH (dihydronicotinamide riboside)\u003c\/td\u003e\n\u003ctd\u003eReduced form; preclinical-only as of 2026\u003c\/td\u003e\n\u003ctd\u003eAnimal and cell evidence; no large human trials\u003c\/td\u003e\n\u003ctd\u003eResearch-grade only\u003c\/td\u003e\n\u003ctd\u003eResearchers; not for general consumer use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN (β-NMN)\u003c\/td\u003e\n\u003ctd\u003eOne step downstream of NR; uses Slc12a8\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021; growing human evidence base\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eDaily entry-tier; cost-efficient; liver\/pancreas priorities — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis product uses patented NR-Cl — the same crystalline form characterized in Trammell 2016 and used in every cardiovascular, neurological, and metabolic NR trial since. That matters because the published evidence base is what tells you the molecule actually raises NAD+ in human blood and tissue at the doses on the label. A commodity NR-Cl with a different impurity profile or a sub-spec HPLC identity is not what those trials studied — and you should not assume the evidence transfers.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eNR's pharmacokinetic profile is the cleanest of any NAD+ precursor in humans. Trammell 2016 traced the molecule through whole blood and urine after a single oral dose:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR appears within 30 minutes\u003c\/strong\u003e of an oral dose, peaks at ~1–2 hours, and is largely cleared from plasma by 6–8 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+ rises in parallel\u003c\/strong\u003e — the rise is detectable by 8 hours and is sustained out to 24 hours, meaning a once-daily dose covers the diurnal cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN, the intracellular intermediate, rises in tandem\u003c\/strong\u003e — the NRK1 phosphorylation step is fast enough not to be rate-limiting at 1 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1MNA (the methylated nicotinamide excretion product) rises in urine\u003c\/strong\u003e within the same window — confirming that the methylation route is active from the first dose. This is the mechanistic basis for adding TMG at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eConze 2019 extended that single-dose PK to 8-week steady-state dosing in 140 healthy overweight adults. Steady-state whole-blood NAD+ tracked dose linearly: 22% rise at 100 mg\/day, 51% at 300 mg, 142% at 1000 mg. There was no plateau within the dose range — meaning if 250–500 mg\/day produces a meaningful but small subjective effect, 1000 mg\/day is a reasonable next step before considering precursor-switching or stack changes.\u003c\/p\u003e\n\u003cp\u003ePractical implication: with-food dosing produces a slightly slower and lower peak but a slightly longer sustained elevation, and reduces the small chance of mild flushing in sensitive individuals. Empty-stomach dosing (which is what Trammell 2016 used) produces a sharper peak. Either is biologically reasonable — daily consistency matters more than fasted-vs-fed.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol carries the most complete NAD+ precursor and stacking lineup of any longevity-supplement catalog. NR-capsule is one of seven distinct entry points; the right one for any given user depends on dose, format, stack, and budget.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest entry point:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e — single-ingredient, lowest cost, the daily-driver NMN for adults under 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e — for adults 50+ or 500 mg non-responders.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR hard capsule (this product):\u003c\/strong\u003e the alternate precursor pathway with the longest human research track record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily NAD+ + Resveratrol:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — adds the SIRT1 activator into the same capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink mix format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ 1000 mg Drink Mix\u003c\/a\u003e — NR + Resveratrol + PQQ + Quercetin in a daily drink, for users who prefer a beverage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid sachet format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — NR berry stick packs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal flagship:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ at the top of the range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5-in-1 mitochondrial:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e — NMN + CoQ10 + B-Complex + antioxidants in one capsule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — how NR sits inside a complete longevity protocol\u003c\/h2\u003e\n\u003cp\u003eNR by itself raises NAD+. NAD+ by itself doesn't do anything — it has to be consumed by sirtuins, PARPs, or CD38 to produce a downstream effect. The job of the stack is to combine precursor supply with sirtuin activation, methylation support, CD38 reduction, mitochondrial support, and the foundational layers (sleep, magnesium, omega-3, vitamin D) that determine whether the body can use any of it. Below is the canonical stack architecture, organized by mechanism:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair (the core)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — the classic SIRT1 activator (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, Park 2007). Pairs with NR's NAD+ supply to produce more sirtuin activity per molecule of precursor. Take both with breakfast and a fat source (fat improves Resveratrol absorption).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e\u003c\/strong\u003e — the methylated cousin of Resveratrol with longer half-life and higher SIRT1 activation in some assays. Used in the Dellinger 2017 NR+pterostilbene combo trial. Stacks alongside or in place of Resveratrol depending on stack tolerability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBoth precursor pathways covered\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e — covers the Slc12a8 transporter pathway. Many longevity stacks run NMN morning and NR mid-morning to hedge tissue coverage. There is no known interaction; both converge on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e\u003c\/strong\u003e — for higher total-daily-NAD+-precursor exposure in adults 50+ or stacks where NMN is the primary lever and NR is the hedge.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMethylation support — required for long-term high-dose NR\/NMN\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — replenishes the SAM methyl pool consumed by NNMT-mediated nicotinamide methylation. Recommended after 4+ weeks of daily NR or NMN, especially if you have known MTHFR variants. The single most important \"second-tier\" addition to any NR\/NMN stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\u003c\/strong\u003e — supports the broader one-carbon \/ glutathione pool that interlocks with methylation. The GlyNAC pairing (with NAC) is the slow-wave-sleep + glutathione-restoration foundation that the methylation cycle leans on.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCD38 reduction — preserve the NAD+ you make\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — direct CD38 inhibitor (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e). Slows the rate at which CD38 destroys NAD+ — particularly relevant for adults 50+ where CD38 is upregulated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — clears senescent cells (Zhu 2015 \u003cem\u003eAging Cell\u003c\/em\u003e) which overconsume NAD+ via inflammatory CD38 expression in neighboring tissues. The Mayo Clinic D+Q senolytic protocol is the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — Mayo-ranked senolytic flavonoid; complementary mechanism to Quercetin. Cycled (e.g., 2 days\/month at high dose) rather than continuous.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMitochondrial layer — what the NAD+ feeds into\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — Complex I\/III electron-transport-chain shuttle. NAD+\/NADH cycling hands electrons to Complex I; CoQ10 carries them onward. Together they keep oxidative phosphorylation running.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e\u003c\/strong\u003e — mitochondrial biogenesis activator via PGC-1α (Chowanadisai 2010). Increases the number of mitochondria; NR\/NMN keeps the existing ones running. The biogenesis-plus-substrate pair.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — PINK1\/Parkin-driven mitophagy activator (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e). Removes damaged mitochondria so the new ones the NR\/PQQ system supports actually take over.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate (CaAKG) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — TCA-cycle substrate and epigenetic 2-OG-dependent dioxygenase cofactor. The metabolic-and-epigenetic layer of the mitochondrial stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e\u003c\/strong\u003e — universal antioxidant and PDH\/α-KGDH cofactor. Sits inside the same mitochondrial machinery NAD+ supports.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur amino acid with mitochondrial inner-membrane stabilizing role (Singh 2023 \u003cem\u003eScience\u003c\/em\u003e) and cardiovascular signal in human RCTs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — autophagy activator via eIF5A hypusination and EP300 inhibition (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e). Reciprocal mechanism with sirtuins; not redundant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the AMPK pathway (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). Sirtuin (NR\/NMN) + AMPK (Berberine) is the canonical longevity dual-pathway protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAntioxidant \/ glutathione layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e\u003c\/strong\u003e — glutathione precursor; the GlyNAC pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e — direct master antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — membrane-spanning antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — collagen-cofactor and aqueous antioxidant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFoundational layer — sleep, minerals, fats\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — required for \u0026gt;300 enzymatic reactions including the methyl-cycle and sirtuin-substrate handling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — the foundational immune \/ bone \/ cardiovascular layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e\u003c\/strong\u003e — EPA\/DHA for membrane fluidity, resolvin signaling, cardiovascular inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e\u003c\/strong\u003e — NF-κB \/ inflammaging modulator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/strong\u003e — cortisol \/ HPA-axis modulation; sleep and stress foundation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sarcopenia-prevention; intersects with mitochondrial energy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRead the full protocol architecture in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e and the deeper \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003ebeginner's guide to NAD+\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually subtle. Whole-blood NAD+ rises within 24 hours of the first dose (Trammell 2016 PK), but the subjective signal lags. Some users report a small bump in afternoon energy or steadier mood; many report nothing yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes — for most users. This is the window in which Conze 2019 saw the largest dose-dependent rise in whole-blood NAD+ start to plateau.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably; cardiovascular signals (BP, aortic stiffness) emerge in the trial timelines (Martens 2018 was a 6-week protocol; the readouts were measurable at the end of week 6, not at week 2).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained sirtuin activation; long-term DNA-repair and mitochondrial-biogenesis mechanisms compound with continued use. Adding TMG at this point is the standard methylation-support layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the trial endpoints that take the longest to manifest — body composition, hepatic fat, sustained inflammatory marker changes — emerge in the longer studies. This is also the window in which most users decide whether to add the full senolytic \/ mitophagy \/ autophagy layer (Quercetin, Fisetin, Urolithin A, Spermidine).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the underlying hypothesis — sustained sirtuin \/ PARP \/ CD38 activity supporting the hallmarks-of-aging machinery — is a long-term proposition. The trials we have don't run beyond 12 months; the rationale for continued use is the consistency of the mechanism plus the absence of safety signal across the published evidence base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a daily NAD+ precursor designed to raise whole-blood and tissue NAD+ in a way that's been replicated across more than a dozen human RCTs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e the patented form of NR — same molecule used in Trammell 2016, Martens 2018, Conze 2019, Elhassan 2019, and Brakedal 2022.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a structural addition to a complete longevity stack — most useful when paired with a SIRT1 activator (Resveratrol or Pterostilbene), eventually a methyl donor (TMG), and the foundational mitochondrial layer (CoQ10, PQQ).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a stimulant, a caffeine replacement, or a same-day energy hit. NAD+ rises gradually over weeks and the subjective effects build over weeks 2–8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a treatment for any disease — published trials investigate biomarker and mechanism endpoints; they do not establish disease-treatment claims.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a substitute for foundational longevity inputs (sleep, exercise, protein intake, omega-3, vitamin D, magnesium). NAD+ supplementation works in a body that has the basics covered. If your foundation is weak, fix that first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a one-month experiment. The trial timelines that establish the effect run 4–12 weeks; expecting a verdict at 30 days is using the wrong yardstick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a replacement for a SIRT1 activator. NR by itself raises NAD+; pairing it with Resveratrol or Pterostilbene is what produces the sirtuin-output story most users came in looking for.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most of the published readouts emerge at weeks 6–12, not weeks 2–4. Daily consistency for 8 weeks before judging is the minimum useful evaluation window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NR is not caffeine. The signal is steadier-energy, easier-mornings, faster-recovery — not a peak. Track week-over-week, not hour-over-hour.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support.\u003c\/strong\u003e After 4+ weeks of daily NR or NMN, the methylation pool starts to feel the draw. Adding TMG 500–1000 mg\/day is the single most cost-effective addition to the stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without a sirtuin activator.\u003c\/strong\u003e NAD+ supply without sirtuin demand is unfinished — pair NR with Resveratrol or Pterostilbene to produce the downstream sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking without the foundation.\u003c\/strong\u003e NR\/NMN\/Resveratrol\/Pterostilbene\/TMG\/Apigenin layered on top of poor sleep, no protein, no resistance training, low vitamin D, no omega-3, and chronic alcohol does not produce the trial readouts. Foundation first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling for the wrong reasons.\u003c\/strong\u003e The published trials run continuous daily dosing for 4–12 weeks without safety signal. Cycling 8 on \/ 1 off is a low-cost hedge but is not required by the evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching too fast.\u003c\/strong\u003e NMN or NR for 4 weeks, no result, switching to the other — is a misuse of the evidence. Either give 8–12 weeks to evaluate, or run both simultaneously.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnderdosing.\u003c\/strong\u003e 1000 mg\/day is the trial-validated dose for the cardiovascular and neurological readouts. 250–500 mg may produce a measurable NAD+ rise but is below the dose at which most published clinical effects emerged.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard:\u003c\/strong\u003e 1 capsule with breakfast. Adults 50+ or those running a higher-dose comprehensive stack: 2 capsules with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with NMN:\u003c\/strong\u003e NMN with breakfast, NR mid-morning — covers both transport pathways across the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with Resveratrol or Pterostilbene:\u003c\/strong\u003e take both at the same morning meal alongside a fat source — Resveratrol\/Pterostilbene activates SIRT1, NR supplies the NAD+ substrate, the fat improves stilbene absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAfter 4+ weeks:\u003c\/strong\u003e add TMG 500–1000 mg\/day to support the methylation pool consumed by NAD+ metabolism. After 8+ weeks: consider adding Apigenin 50 mg\/day to inhibit CD38.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the morning:\u003c\/strong\u003e take NR with the post-workout meal rather than pre-workout. NAD+ is being consumed heavily during exercise; precursor supply pairs better with the recovery window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the evening:\u003c\/strong\u003e NR still goes in the morning. Don't shift to evening — NAD+ has a circadian rhythm and morning dosing aligns with the natural peak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e take it as soon as you remember the same day. If it's already evening, skip and resume in the morning. Do not double up — daily consistency over 8+ weeks is what matters, not catching up on individual doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel and time-zone shifts:\u003c\/strong\u003e dose by local-time morning rather than home-time morning. The circadian rhythm resets to local light cycle within a few days; matching NR dosing to the local schedule keeps the rhythm aligned.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs fasted:\u003c\/strong\u003e with food is fine (most trials used with-food dosing) and reduces the small chance of mild flushing. Fasted dosing produces a sharper plasma peak (Trammell 2016) but the steady-state effect at 8 weeks is comparable. Consistency matters more than fasted-vs-fed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSee our \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003etiming guide\u003c\/a\u003e for the deeper rationale; the same morning rules apply to NR.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone who wants the most-studied human NAD+ precursor specifically — NR's published research depth (65+ trials, 13+ peer-reviewed RCTs) is the longest of any NAD+ precursor as of 2026.\u003c\/li\u003e\n  \u003cli\u003eAdults who tried NMN and didn't see the response they wanted — switching to or stacking NR is the standard next step. ENT1\/2 transporter coverage may reach tissues where Slc12a8 is downregulated.\u003c\/li\u003e\n  \u003cli\u003ePeople running a comprehensive longevity stack who want both NR and NMN pathways covered to hedge tissue-specific transporter heterogeneity.\u003c\/li\u003e\n  \u003cli\u003eAdults 50+ — alternate-pathway delivery and broad transporter coverage hedge against tissue-specific transporter inefficiencies that emerge with age.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose stack already includes Resveratrol, Pterostilbene, or another SIRT1 activator and wants the matching NAD+ substrate so the activator has fuel.\u003c\/li\u003e\n  \u003cli\u003eAthletes and active adults running heavy training loads — NAD+\/sirtuin axis sits inside exercise recovery and mitochondrial-biogenesis pathways.\u003c\/li\u003e\n  \u003cli\u003ePeople with a family history of cardiovascular events who are running multi-pathway prevention protocols — the Martens 2018 BP and aortic-stiffness signal is the strongest mechanism-validated NR readout to date.\u003c\/li\u003e\n  \u003cli\u003eCognitive-aging-conscious adults — Brakedal 2022 demonstrated CSF\/brain NAD+ rise with oral dosing, the first such evidence for any human NAD+ precursor.\u003c\/li\u003e\n  \u003cli\u003eVegans and vegetarians — the capsule is vegan-compatible (no gelatin), and the NR molecule is animal-source-free.\u003c\/li\u003e\n  \u003cli\u003eMethylation-savvy users (MTHFR variants, etc.) — the included B-vitamin cofactors plus TMG pairing makes this a well-supported long-term lever.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding\u003c\/strong\u003e — no safety data in pregnancy or lactation. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent diagnosis\u003c\/strong\u003e — NAD+ supports both healthy and cancer-cell metabolism; sirtuins have context-dependent roles in tumor biology. Discuss with your oncologist before starting; some advocate cycling off during active treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — no pediatric safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days)\u003c\/strong\u003e — discontinue 2 weeks before any planned surgery as a general supplement-safety practice; NR and other NAD+ precursors may interact with anesthesia metabolism.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant or same-day energy hit\u003c\/strong\u003e — NR is not caffeine. If your intent is a fast subjective lift, this is the wrong tool.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone unwilling to stay consistent for 8+ weeks\u003c\/strong\u003e — the trial readouts emerge in that window. Sporadic use does not reproduce the published evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who haven't fixed the foundation\u003c\/strong\u003e — sleep deprivation, ultra-processed diet, no protein intake, no resistance training, chronic alcohol — NR layered on top of those does not reproduce the trials. Address foundation before optimization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGenerally well-tolerated.\u003c\/strong\u003e Across published trials at 100–1000 mg\/day for up to 8–12 weeks (and 3000 mg\/day in the NR-SAFE 4-week extension), NR has shown no serious adverse events vs placebo (Conze 2019; Dollerup 2018; Martens 2018; Elhassan 2019; Brakedal 2023).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild flushing or warmth\u003c\/strong\u003e can occur in a small minority — usually resolves with food or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI upset\u003c\/strong\u003e in a small minority — typically resolves within the first 1–2 weeks or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer:\u003c\/strong\u003e NAD+ supports both healthy and cancer-cell metabolism. Discuss with your oncologist before starting; some advocate cycling off during active treatment. Note that the published epidemiologic and mechanistic data on cancer outcomes with chronic NR\/NMN use are still maturing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e not studied; avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethylation load:\u003c\/strong\u003e long-term high-dose NR (or NMN) consumes methyl groups during NAD+ metabolism via NNMT. Pair with TMG 500–1000 mg\/day after 4+ weeks of daily use, especially if you have any known methylation variants (MTHFR C677T or A1298C). The included B6\/B12\/folate cofactors mitigate but do not fully replace TMG at long-term high dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery:\u003c\/strong\u003e discontinue 14 days before any planned surgical procedure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e no clinically significant pharmacokinetic interactions are documented at the doses used here, but published interaction data is limited. Discuss with your prescriber if you take chemotherapy, immunosuppressants, anticoagulants, or psychiatric medications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlcohol:\u003c\/strong\u003e heavy alcohol use depletes NAD+ via aldehyde-dehydrogenase activity. NR can replenish, but chronic alcohol is the bigger lever — addressing alcohol intake produces a larger and more durable NAD+ effect than precursor supplementation alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride (NR-Cl)\u003c\/strong\u003e — same crystalline form used in Trammell 2016, Martens 2018, Elhassan 2019, Conze 2019, and Brakedal 2022. ≥98% NR by HPLC; identity confirmed by NMR and mass spectrometry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupporting B-vitamin cofactors\u003c\/strong\u003e for the NAD+ biosynthesis pathway: vitamin B6 (pyridoxal-5-phosphate as a NAMPT cofactor), vitamin B12 (methylcobalamin as a methyl donor), and folate (5-MTHF as a methyl donor) — the methylation cycle inputs that NAD+ metabolism eventually leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHard capsule format\u003c\/strong\u003e for measured, consistent dosing — no flavored powders, no proprietary blends, no surprise sugar or maltodextrin fillers.\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eNo proprietary blends, no artificial colors, no titanium dioxide, no soy, no gluten, no dairy, no nuts.\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan-compatible capsule shell\u003c\/strong\u003e (HPMC), suitable for vegan and vegetarian protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for purity, identity, heavy metals, and microbial contamination by an ISO 17025-accredited laboratory. Certificate of Analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cp\u003eThe patented Nicotinamide Riboside Chloride used in this product is the same crystalline form characterized in Trammell 2016 and used across the published clinical trial program. Manufacturing follows U.S. FDA cGMP (current Good Manufacturing Practice) requirements (21 CFR Part 111) at NSF-registered or equivalent facilities. Each lot is tested against the following specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC retention time and UV spectrum match the reference standard; NMR and mass-spec identity confirmed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98% NR-Cl by HPLC; total impurities ≤2%; specific pharmacopeia-listed impurities below individual limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e arsenic, lead, mercury, cadmium below USP \u0026lt;232\u0026gt; \/ Prop65 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e below USP \u0026lt;467\u0026gt; Class 2\/3 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e total aerobic count, yeast, mold, and pathogens (E. coli, Salmonella, Staphylococcus aureus) below USP \u0026lt;2021\u0026gt; limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e \u0026lt; USP-listed thresholds for orally administered solid dosage forms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e below USP \u0026lt;561\u0026gt; \/ EU multi-residue panel limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e formulated for ≥24-month room-temperature shelf life in UV-protective amber HDPE bottles with foil-induction seal and desiccant. Store cool and dry; refrigeration not required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach capsule is filled by a single-source audited contract manufacturer; no proprietary blends are used so the on-label NR amount is the actual dose, not a \"complex\" mass that could be padded with rice flour or maltodextrin.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NR better than NMN?\u003c\/h3\u003e\n\u003cp\u003eNeither is uniformly \"better.\" NR has the longer human research track record (since 2016 with Trammell), broader cardiovascular and neurological RCT coverage, and may reach tissues where the NMN transporter (Slc12a8) is less active. NMN may have an edge in liver and pancreas, skips the intracellular phosphorylation step, and has the strong post-menopausal insulin-sensitivity signal from Yoshino 2021. For most users the practical difference is small; many run both. Read the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNR vs NMN comparison\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR with NMN?\u003c\/h3\u003e\n\u003cp\u003eYes, and many longevity protocols do. NMN with breakfast and NR mid-morning is a clean way to space them and cover both transport pathways. There's no known interaction — they ultimately converge on the same molecule (NAD+). If anything, the combination hedges tissue-specific transporter expression heterogeneity better than either precursor alone.\u003c\/p\u003e\n\n\u003ch3\u003eWhy are B-vitamins included?\u003c\/h3\u003e\n\u003cp\u003eNAD+ metabolism uses methyl groups (the methylation cycle), and the conversions through the salvage pathway use B6 as a cofactor. Including B6, B12, and folate means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. After 4+ weeks of daily NR\/NMN at the 1 g\/day level, adding TMG (trimethylglycine) on top is the standard methyl-donor support — the included B12\/folate are useful but do not fully replace TMG at long-term high dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eWhole-blood NAD+ begins to rise within 24 hours of the first dose (Trammell 2016 PK). Subjective changes — easier mornings, steadier energy, faster exercise recovery — typically become noticeable in weeks 2–4 for most users. Cardiovascular and inflammatory readouts in the published trials emerged at 3–8 weeks (Martens 2018 was 6 weeks; Elhassan 2019 was 21 days). Plan to evaluate at week 8, not week 4.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR at night?\u003c\/h3\u003e\n\u003cp\u003eYou can, but morning is preferred. NAD+ has a circadian rhythm — it naturally peaks during the active phase. Morning dosing aligns with that rhythm. Some users report mild stimulation from NR; if that's you, definitely keep it morning-only. Evening dosing is not unsafe, just suboptimal in a small minority of stimulant-sensitive users.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle NR?\u003c\/h3\u003e\n\u003cp\u003ePublished trials run 6–12 weeks of continuous daily dosing without safety issues. The Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks safely. Long-term continuous use is the most common pattern. Some users cycle 8 weeks on \/ 1 week off as a standard supplement-rotation practice — there's no published evidence that cycling is required, but it's a low-cost hedge against the small theoretical risk of receptor or enzymatic adaptation.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take it with food?\u003c\/h3\u003e\n\u003cp\u003eWith food is fine and reduces the small chance of mild flushing. The Trammell 2016 PK study used fasted dosing; the Martens 2018 cardiovascular study used with-breakfast dosing. Both raise NAD+ effectively. Daily consistency matters more than fasted-vs-fed. If you're stacking with Resveratrol, the with-food (and with-fat) approach is preferred because Resveratrol absorbs better with fat.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I'm 30 — is NR still useful?\u003c\/h3\u003e\n\u003cp\u003eThe biggest published effect sizes come from older cohorts (Martens 2018 was midlife\/older with elevated BP; Elhassan 2019 was 70–80 years old). Younger adults still see whole-blood NAD+ rise (Trammell 2016 included healthy adults of all ages) but the subjective signal is typically smaller because baseline NAD+ is higher. The most defensible use case at age 30 is foundational longevity stacking rather than acute symptom management.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is NR more expensive than NMN?\u003c\/h3\u003e\n\u003cp\u003eNR is patent-licensed; the manufacturing process is more complex and the licensing cost is passed through to the consumer. The premium is real and the practical value depends on whether the longer research track record, the broader transporter coverage, and the brain\/CSF NAD+ signal are decisive for your protocol. For cost-efficient daily entry, NMN at 500 mg is generally the better starting point; NR is best framed as a stack hedge or a switch when NMN alone isn't producing the expected response.\u003c\/p\u003e\n\n\u003ch3\u003eCan NR replace coffee?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is not a stimulant. The \"easier mornings, steadier afternoon energy\" signal that builds over 2–8 weeks is bioenergetic, not adrenergic. Coffee acts on adenosine receptors and the catecholamine system; NR acts on the NAD+\/sirtuin\/mitochondrial-respiration axis. They are complementary, not substitutes.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is a dietary supplement form of vitamin B3 (nicotinamide-derived) and is not on any standard sport, occupational, or clinical drug-screening panel. The molecule is endogenous and trace levels are present in all human blood at baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes. NR does not break a fast in any meaningful metabolic sense — the molecule contributes negligible calories and does not significantly raise insulin. The Trammell 2016 PK study used fasted dosing. If you fast intermittently and want to dose NR within the fasted window, that is biologically reasonable.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe published cardiovascular evidence runs the other way. Martens 2018 specifically measured systolic blood pressure in midlife adults with elevated baseline SBP and found a ~10 mmHg \u003cem\u003ereduction\u003c\/em\u003e after 6 weeks of 1 g\/day vs placebo. Aortic stiffness also fell. NR is not associated with raised BP at the trial-validated dose.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe daily dose?\u003c\/h3\u003e\n\u003cp\u003eThe Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks in Parkinson's patients without serious adverse events. The 1000 mg\/day dose is the trial-validated standard for cardiovascular and neurological readouts. Going above 1 g\/day without clinical supervision is not recommended for general consumer use; the marginal benefit of higher doses has not been demonstrated to outweigh the cost in the published evidence base.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR interact with statins or blood pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo clinically significant interactions are documented at typical supplement doses. Practical caution: if you are on antihypertensive medication and you start NR, the Martens 2018 BP-lowering signal means your home BP readings could trend lower. Track and discuss with your prescriber if you see a meaningful shift.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NR compare to NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eNAD+ IV therapy delivers a large bolus of NAD+ directly to the bloodstream over a few hours. Oral NR raises whole-blood NAD+ steadily over weeks via the precursor pathway. The IV route is acutely larger but expensive, infrastructure-dependent, and the long-term cost-benefit vs. daily oral precursor supplementation is unsettled. Most published longevity-mechanism evidence in humans is from oral precursor (NR or NMN), not IV NAD+.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule?\u003c\/h3\u003e\n\u003cp\u003eTechnically yes, but it's not recommended. NR-Cl is mildly hygroscopic; opening exposes the powder to air moisture and accelerates degradation. The capsule is also designed to deliver a measured single dose. If you have trouble swallowing capsules, the \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Drink Mix\u003c\/a\u003e or the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ sachet\u003c\/a\u003e are designed for that use case.\u003c\/p\u003e\n\n\u003ch3\u003eIs NR vegan?\u003c\/h3\u003e\n\u003cp\u003eYes. The NR molecule is synthesized from non-animal sources, the capsule shell is HPMC (vegan-compatible, plant-derived), and the supporting B-vitamin cofactors in this formulation are non-animal-sourced.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR help me sleep?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, sometimes. NAD+ contributes to circadian-rhythm regulation via NAMPT and SIRT1's interaction with the BMAL1\/CLOCK transcription complex (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Some users report deeper or more consolidated sleep after several weeks of consistent dosing — likely a downstream consequence of metabolic and circadian normalization rather than a direct sedative effect. If sleep is the primary target, the more direct levers are \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR improve hair?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, possibly. The hair follicle is a high-turnover, energy-demanding tissue and NAD+ supports the underlying energetics. There are no large RCTs of NR specifically for hair endpoints. The more direct hair-cycle levers are \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (Rainer 2018 PROSPER trial showed anagen-phase lengthening).\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels respond to sustained precursor supply, not single-dose peaks. Conze 2019 showed steady-state NAD+ at week 8; one-off dosing produces a transient peak that returns to baseline within 24 hours. The published clinical readouts (cardiovascular, neurological, inflammatory) all emerged from sustained 4–12 week protocols, not from intermittent or as-needed use.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ family is organized into four functional layers, and NR Hard Capsules sits primarily in layer 1 (Precursor Supply) with crossover into layer 4 (Comprehensive Stack):\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 1 — Precursor Supply.\u003c\/strong\u003e NR Hard Capsules (this product), \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. Single-ingredient or near-single-ingredient daily precursors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 2 — SIRT1 \/ Sirtuin activators.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e. Pair with layer 1 to convert NAD+ supply into sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 3 — Methylation and CD38 support.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e. Required at 4+ weeks of daily layer-1 use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 4 — Comprehensive \/ convenience formulas.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Pure Focus\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e. Multi-ingredient formats that bundle layers 1+2 (and sometimes 3+) for users who prefer one capsule.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe deeper-protocol architecture (mitochondrial layer, autophagy layer, senolytic layer, antioxidant layer, foundational layer) is documented across the catalog in the dedicated product pages and in the \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — the complete NR + NMN + NAD+ lineup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, CaAKG, the energy-production layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the daily-driver layer the rest of the stack leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Quercetin, Fisetin, the senescent-cell-clearance layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the BP, lipid, and aortic-stiffness layer where the Martens 2018 NR signal lives.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — Berberine, Alpha-Lipoic Acid, the AMPK \/ glucose layer that pairs with the NAD+\/sirtuin axis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eTiming — morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eBieganowski P \u0026amp; Brenner C (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e 117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNature Communications\u003c\/em\u003e 7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNature Communications\u003c\/em\u003e 9:1286.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, \u0026amp; Kruger CL (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eScientific Reports\u003c\/em\u003e 9:9772.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. \u003cem\u003eCell Reports\u003c\/em\u003e 28(7):1717–1728.e6.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. (2021). Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy aged adults. \u003cem\u003eJournal of Physiology\u003c\/em\u003e 599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dölle C, Riemer F, et al. (2022). The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e 34(3):396–407.e6.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. (2023). Long-term nicotinamide riboside use is safe in patients with Parkinson disease. \u003cem\u003eNature Communications\u003c\/em\u003e 14:1156 (NR-SAFE).\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. (2020). Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e 31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. \u003cem\u003eNPJ Aging and Mechanisms of Disease\u003c\/em\u003e 3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e 12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. (2016). NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNature Communications\u003c\/em\u003e 7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e 7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e 23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, \u0026amp; Imai S (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e 588:174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. (2008). SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e 134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. (2013). Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e 62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, \u0026amp; Kroemer G (2018). Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e 359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eAndreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:595–603.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, \u0026amp; Ye J (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e 57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, et al. (2023). Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380(6649):eabn9257.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2013). The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2023). Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e 186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have an active or recent cancer diagnosis, or have a medical condition. Reference studies cited above describe pharmacokinetic and clinical findings of Nicotinamide Riboside generally and do not constitute claims about this specific product.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705326944474,"sku":"THP-NAD-NR-CAP","price":44.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-capsules.jpg?v=1775666145"},{"product_id":"liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation","title":"Liquid NAD+ Anti-Aging Drink | NR Berry Stick Packs for NAD+ \u0026 Sirtuin Support","description":"\u003cp\u003e\u003cstrong\u003eNAD+ precursors in drinkable form\u003c\/strong\u003e — built for people who don't want to swallow more capsules, who already have a morning routine where adding a drink is easier than adding another pill bottle, and who travel and don't want a carry-on stuffed with HDPE bottles. Single-serve berry stick packet, dissolves in 30 seconds in 7–10 oz of cold water, no scoops, no measuring, TSA-friendly, no artificial colors, no added sugar bombs. Same NAD+-pathway biology as our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e — just delivered through the format you'll actually take every single day.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink format, soluble delivery\u003c\/strong\u003e — absorption begins in the oral mucosa and continues through the upper GI without waiting on capsule disintegration. Powder dissolved in 7–10 oz cold water reaches plasma faster than the equivalent dose of compressed capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) at the center\u003c\/strong\u003e — the NAD+ precursor with the longest human clinical-trial track record. Trial-validated daily dosing (Trammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e, Conze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e, Martens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e, Brakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e NADPARK).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClean berry flavor, no sweet bombs\u003c\/strong\u003e — no artificial colors, no sucralose, no stevia avalanche; mixes cleanly so it doesn't taste medicinal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-serve packets\u003c\/strong\u003e — TSA-friendly, no scoops, no measuring spoons, no spilling powder in your kitchen drawer. Stable at room temperature, single-use foil-laminated packaging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundation-tier daily NAD+ support\u003c\/strong\u003e — pairs cleanly with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e, and the rest of the longevity stack — never redundant with capsules; many users alternate or stack the formats.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who don't tolerate capsules well, those building a morning-drink ritual, anyone who finds drink supplements easier to remember than pill bottles, frequent travelers, and users who want NAD+ pathway support that's literally pleasant to take.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NAD+ matters — the foundational coenzyme behind cellular aging\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is one of the most foundational coenzymes in human biology. Every nucleated cell in your body uses it. It runs the electron transport chain in your mitochondria — the system that converts food and oxygen into ATP, the molecular currency of energy. It is the obligate substrate of the \u003cstrong\u003esirtuin family\u003c\/strong\u003e of NAD+-dependent deacetylases (SIRT1–SIRT7), which silence pro-aging gene programs, regulate inflammation, drive DNA-damage response, and govern mitochondrial biogenesis. It powers the \u003cstrong\u003ePARP enzymes\u003c\/strong\u003e that detect and repair single- and double-strand DNA breaks every day. It is consumed by \u003cstrong\u003eCD38\u003c\/strong\u003e, the cell-surface ectoenzyme whose age-related upregulation is one of the largest mechanistic explanations for falling NAD+ pools (Camacho-Pereira 2016 \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, none of these systems run properly.\u003c\/p\u003e\n\n\u003cp\u003eThe problem: NAD+ levels drop sharply with age. Massudi 2012 (\u003cem\u003ePLOS ONE\u003c\/em\u003e) showed roughly a \u003cstrong\u003e~50% decline in skin NAD+ between the 20s and 50s\u003c\/strong\u003e with the decline accelerating after that. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated this multi-tissue in mouse models — liver, muscle, pancreas, white adipose tissue, brown adipose tissue, brain — with parallel declines in NAMPT (the rate-limiting salvage-pathway enzyme). Camacho-Pereira 2016 mapped the decline mechanistically to age-related CD38 upregulation acting as an NAD+ \"sink\" rather than to NAMPT alone. By the time most people notice \"feeling older\" — slower recovery, less morning energy, fuzzier focus, less stress resilience — NAD+ depletion is already one of the underlying biochemical drivers, sitting upstream of the López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e hallmarks of aging (mitochondrial dysfunction, deregulated nutrient sensing, genomic instability, cellular senescence) and folded explicitly into the López-Otín 2023 \u003cem\u003eCell\u003c\/em\u003e integrated-hallmarks update.\u003c\/p\u003e\n\n\u003cp\u003eYou can't supplement NAD+ directly very efficiently in most oral formats — the molecule is too large and polar to cross plasma membranes intact at meaningful doses. That's why the field moved to \u003cstrong\u003eprecursors\u003c\/strong\u003e: smaller molecules (NR, NMN, niacinamide, niacin) that your cells convert into NAD+ on the inside via well-mapped enzymatic routes. NR is the precursor with the most published human-clinical-trial evidence at this point — covering whole-blood NAD+ rise, cardiovascular endpoints, brain NAD+, muscle NAD+, insulin sensitivity, and exercise physiology. It is the active core of this drink.\u003c\/p\u003e\n\n\u003cp\u003eFor a deeper introduction read \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e and \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhy drink format — not just preference, real biology\u003c\/h2\u003e\n\u003cp\u003eCapsules and drink mixes are not biologically equivalent on day one of dosing. Three things change when you take an NAD+ precursor as a dissolved drink instead of a hard capsule:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOnset\u003c\/strong\u003e. A hard-shell HPMC capsule needs 5–15 minutes to disintegrate in the stomach before the contents become available for absorption (USP \u0026lt;701\u0026gt; disintegration spec is ≤30 minutes for HPMC capsules; in practice typically 5–12 minutes). A dissolved drink presents the precursor to the intestinal mucosa within 30 seconds. This narrows the gap between \"taking the supplement\" and \"the molecule arriving at the absorption surface\" to roughly the gastric-emptying half-time of liquid (10–20 minutes for water on an empty stomach).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuccal and upper-GI absorption\u003c\/strong\u003e. NR has been shown to absorb partially via the oral mucosa and proximal small intestine via the equilibrative nucleoside transporters ENT1 and ENT2 (Ratajczak 2016 \u003cem\u003eNat Commun\u003c\/em\u003e). A dissolved drink is in contact with absorptive surfaces immediately; a capsule is not.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdherence — the variable that dwarfs everything else\u003c\/strong\u003e. The single largest determinant of long-term outcomes from any daily supplement is whether you actually take it every day for months. Trial endpoints in NAD+ research (Conze 2019, Brakedal 2022 NADPARK 1g\/day for 30 weeks, Pirinen 2020 1g\/day for 4 months) require \u003cem\u003eweeks-to-months\u003c\/em\u003e of compliance. Capsule fatigue, capsule aversion, \"I forgot, I'll do it tomorrow\" — these account for far more lost benefit than any pharmacokinetic difference between formats. A drink that's actually pleasant to take every morning beats a capsule that ends up rationed.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThis product isn't trying to replace capsule NAD+ precursors — it's the format that wins for a specific user. If you already happily take capsules, our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e remain the highest-density precursor delivery per dollar. If you have capsule fatigue, swallowing aversion, traveler-luggage limits, or a strong morning-drink ritual where adding one stick packet is invisible, this format quietly wins on adherence — the variable that matters most.\u003c\/p\u003e\n\n\u003ch2\u003eWhy Nicotinamide Riboside (NR) specifically\u003c\/h2\u003e\n\u003cp\u003eThe four NAD+ precursors a cell can use are \u003cstrong\u003eNR (Nicotinamide Riboside)\u003c\/strong\u003e, \u003cstrong\u003eNMN (Nicotinamide Mononucleotide)\u003c\/strong\u003e, \u003cstrong\u003eNAM (Niacinamide \/ Nicotinamide)\u003c\/strong\u003e, and \u003cstrong\u003eNA (Niacin \/ Nicotinic Acid)\u003c\/strong\u003e. Each has trade-offs:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — phosphorylated to NMN by NRK1\/NRK2 (Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e), then adenylylated to NAD+ by NMNAT1\/2\/3. Crosses cell membranes intact via ENT1\/2 (Ratajczak 2016). Most extensively human-trialed precursor (Trammell 2016, Conze 2019, Martens 2018, Dollerup 2018, Elhassan 2019, Brakedal 2022, Pirinen 2020, Dellinger 2017). No flushing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one step closer to NAD+ but reportedly enters cells via the proposed Slc12a8 transporter (Grozio 2019 \u003cem\u003eNature Metabolism\u003c\/em\u003e) or via extracellular conversion to NR by CD73 then re-uptake. Strong human-trial bench at the 250–1000mg dose range (Yoshino 2021 \u003cem\u003eScience\u003c\/em\u003e, Yi 2022, Liao 2021, Igarashi 2022). Functionally interchangeable with NR for most users; many longevity practitioners stack both to hedge across the parallel salvage entry points.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAM\u003c\/strong\u003e — cheap, abundant, but at high doses inhibits sirtuins (Bitterman 2002 \u003cem\u003eJBC\u003c\/em\u003e) by acting as a product-inhibitor. Useful as a B3-vitamin source; less ideal as a sirtuin-substrate booster.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNA\u003c\/strong\u003e — raises NAD+ but causes prostaglandin-mediated flushing at meaningful doses unless given as ER-niacin under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNR is the precursor with the densest human evidence base at this dose range, the cleanest tolerability profile, and parallel absorption pathways (ENT1\/2 plus CD73→NR conversion) that make it format-flexible for liquid delivery. That's why it sits at the center of this drink.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — how NR becomes NAD+ inside your cells\u003c\/h2\u003e\n\u003cp\u003eNR taken orally has the following well-mapped fate (Ratajczak 2016, Trammell 2016, Cantó 2015 \u003cem\u003eCell Metabolism\u003c\/em\u003e):\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Absorption.\u003c\/strong\u003e NR is absorbed in the oral mucosa, stomach, and proximal small intestine via the equilibrative nucleoside transporters \u003cstrong\u003eENT1\u003c\/strong\u003e and \u003cstrong\u003eENT2\u003c\/strong\u003e (encoded by SLC29A1 \/ SLC29A2). It does not require the proposed Slc12a8 transporter that NMN appears to use. Plasma NR rises within 30–120 minutes; whole-blood NAD+ rises within 8 hours and remains elevated for 24+ hours after a single dose (Trammell 2016, Conze 2019).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NRK1\/NRK2 phosphorylation.\u003c\/strong\u003e Inside the cell, NR is phosphorylated to NMN by the NR kinases NRK1 (ubiquitous) and NRK2 (tissue-restricted to muscle, heart, brain). This step was discovered and characterized in Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e. NRK1 expression is the primary rate-limiting determinant of how quickly a given tissue converts NR to NAD+.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. NMNAT1\/2\/3 adenylylation.\u003c\/strong\u003e NMN is then adenylylated to NAD+ by the three nicotinamide mononucleotide adenylyltransferase isoforms — NMNAT1 (nucleus), NMNAT2 (Golgi\/cytosol), NMNAT3 (mitochondria). This step compartmentalizes NAD+ synthesis to where it's needed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Mitochondrial uptake.\u003c\/strong\u003e Mitochondrial NAD+ uptake is governed by the \u003cstrong\u003eSLC25A51\u003c\/strong\u003e transporter, identified in 2020 by Luongo et al. (\u003cem\u003eNature\u003c\/em\u003e). This was the answer to one of the longest-standing questions in NAD+ biology — how the cytosolic and mitochondrial NAD+ pools communicate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Consumption.\u003c\/strong\u003e NAD+ is consumed by three classes of enzymes: \u003cstrong\u003esirtuins\u003c\/strong\u003e (SIRT1–SIRT7) deacetylate substrate proteins using NAD+ as cofactor; \u003cstrong\u003ePARPs\u003c\/strong\u003e (PARP1, PARP2, etc.) consume NAD+ during DNA-damage repair; and \u003cstrong\u003eCD38\u003c\/strong\u003e hydrolyzes NAD+ at a stoichiometry of roughly 100 NAD+ molecules per cyclic-ADP-ribose product. CD38 is the dominant age-related sink (Camacho-Pereira 2016) — which is why \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e (a flavonoid CD38 inhibitor; Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e) is a logical stack partner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Salvage and methylation.\u003c\/strong\u003e NAM — the byproduct of every sirtuin\/PARP\/CD38 NAD+-consuming reaction — is recycled back to NMN by NAMPT, the rate-limiting salvage-pathway enzyme. Excess NAM is methylated to 1-MNA (1-methylnicotinamide) by NNMT, drawing from the SAM (S-adenosylmethionine) methylation pool. This is why methyl-donor support — \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e — pairs with daily NR\/NMN dosing, especially at higher doses (1g+\/day) and for users with MTHFR variants or marginal B12 status. 1-MNA appearance in urine is the standard pharmacodynamic biomarker confirming NAD+ flux is occurring (Trammell 2016).\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence base for NR\u003c\/h2\u003e\n\u003cp\u003eNR has the densest human-trial bench of any NAD+ precursor. Selected trials at doses spanning 100mg – 3000mg\/day:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eTrial\u003c\/th\u003e\n      \u003cth\u003ePopulation\u003c\/th\u003e\n      \u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n      \u003cth\u003ePrimary findings\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eTrammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 healthy adults (single-dose PK)\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg single dose\u003c\/td\u003e\n      \u003ctd\u003eDose-dependent rise in whole-blood NAD+ within 8h sustained 24h. 1-MNA urinary appearance confirms flux. No AEs.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eConze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e140 healthy adults\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear whole-blood NAD+ rise: ~22% \/ 51% \/ 142% at the three doses. No AEs different from placebo.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMartens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e24 healthy adults 55–79\u003c\/td\u003e\n      \u003ctd\u003e500mg twice daily × 6wk\u003c\/td\u003e\n      \u003ctd\u003eWhole-blood NAD+ +60%, ~10mmHg systolic-BP drop in elevated-BP subgroup, aortic-stiffness reduction trend.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDellinger 2017 \u003cem\u003eNPJ Aging\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e120 adults 60–80 (NRPT combination NR+pterostilbene)\u003c\/td\u003e\n      \u003ctd\u003e250\/500mg NR + 50\/100mg pterostilbene × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear NAD+ rise; secondary ALT\/AST reduction in the high-dose arm.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDollerup 2018 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e40 obese, insulin-resistant men\u003c\/td\u003e\n      \u003ctd\u003e1000mg twice daily × 12wk\u003c\/td\u003e\n      \u003ctd\u003eNAD+ pathway elevation; no significant change in primary insulin-sensitivity outcome (well-tolerated).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eElhassan 2019 \u003cem\u003eCell Reports\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 elderly men 70–80\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 21d\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; reduced inflammatory cytokines (IL-6, IL-5, IL-2); improved muscle bioenergetics.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRemie 2020 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e13 healthy overweight men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 6wk crossover\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ +15%; sleep efficiency increase signal (small-N exploratory).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n      \u003ctd\u003e30 newly-diagnosed Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 30d (placebo-controlled)\u003c\/td\u003e\n      \u003ctd\u003eCSF NAD+ rise; brain NAD+ rise on PET; secondary clinical-rating improvement signal.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2023 \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n      \u003ctd\u003e20 Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e3000mg\/day × 4wk\u003c\/td\u003e\n      \u003ctd\u003eSafety\/tolerability extension trial. No serious AEs at 3g\/day; established the upper-dose ceiling for human safety.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePirinen 2020 \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e5 adult-onset mitochondrial myopathy patients\u003c\/td\u003e\n      \u003ctd\u003e250–1000mg\/day × 4 months\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; mitochondrial-myopathy biomarker improvement; case-series-grade evidence in a rare disease cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eStocks 2021 \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e14 healthy older men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; no change in mitochondrial respiration in this small healthy cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAirhart 2017 \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e8 healthy adults (PK\/safety)\u003c\/td\u003e\n      \u003ctd\u003e250mg\/day × 7d, 500mg\/day × 7d, etc.\u003c\/td\u003e\n      \u003ctd\u003eStepped dose-escalation tolerability and PK profile.\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRead together: NR is one of the few longevity-positioned compounds where the human evidence base actually maps cleanly onto the mechanistic story. NAD+ rises (Trammell, Conze, Brakedal, Elhassan), tissue penetration is documented (muscle in Elhassan\/Remie\/Stocks; CSF\/brain in Brakedal NADPARK), cardiovascular signal exists (Martens 2018), safety is established up to 3g\/day (Brakedal 2023 NR-SAFE), and the mechanism (NRK1→NMN→NAD+) is structurally proven. That's why NR is the active core of this drink — not because it's the only NAD+ precursor that works, but because it has the most complete human evidence base at this dose range.\u003c\/p\u003e\n\n\u003ch2\u003eDrink-format NAD+ — comparing what's actually on the market\u003c\/h2\u003e\n\u003cp\u003eOnce you commit to drink format, the next question is what kind. Six paths exist:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eFormat\u003c\/th\u003e\n      \u003cth\u003eActive\u003c\/th\u003e\n      \u003cth\u003eOnset\u003c\/th\u003e\n      \u003cth\u003eTrial coverage\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis product (NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eNR\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 8h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eMost-trialed precursor\u003c\/td\u003e\n      \u003ctd\u003eDaily morning ritual, travel, capsule-aversion users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNMN powder (loose)\u003c\/td\u003e\n      \u003ctd\u003eNMN\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 5h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eStrong (Yoshino, Yi, Igarashi, Liao)\u003c\/td\u003e\n      \u003ctd\u003eUsers who want NMN’s one-step-closer position\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSublingual lozenges\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e5–10min dissolve\u003c\/td\u003e\n      \u003ctd\u003eLimited; absorption claims rarely PK-verified\u003c\/td\u003e\n      \u003ctd\u003eUsers who specifically want sublingual, willing to accept thinner trial bench\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMulti-ingredient drink (this product’s sister: \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink\u003c\/a\u003e)\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/td\u003e\n      \u003ctd\u003e30s mix → combined-stack effect\u003c\/td\u003e\n      \u003ctd\u003eEach ingredient trialed individually\u003c\/td\u003e\n      \u003ctd\u003eUsers who want a single morning drink covering precursor + sirtuin activator + mitochondrial cofactor + senolytic in one packet\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNAD+ IV therapy\u003c\/td\u003e\n      \u003ctd\u003eNAD+ direct\u003c\/td\u003e\n      \u003ctd\u003e~3–8h infusion\u003c\/td\u003e\n      \u003ctd\u003eLimited published; mostly observational\u003c\/td\u003e\n      \u003ctd\u003eAcute high-dose use; not for daily-foundation positioning\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCapsule NR or NMN\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e10–20min capsule disintegration + GI absorption\u003c\/td\u003e\n      \u003ctd\u003eDensest trial bench (capsules are what's used in most published trials)\u003c\/td\u003e\n      \u003ctd\u003eUsers with no capsule aversion, fewest moving parts\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this drink sits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ line was built so each product owns a distinct spot in the precursor \/ activator \/ cofactor \/ convenience space — not as duplicates. The seven distinct entry points:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eProduct\u003c\/th\u003e\n      \u003cth\u003eForm\u003c\/th\u003e\n      \u003cth\u003ePrimary role\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis drink (Liquid NAD+ NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, single-serve\u003c\/td\u003e\n      \u003ctd\u003eNR delivery in drink format\u003c\/td\u003e\n      \u003ctd\u003eCapsule-aversion, morning ritual, travel\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink Mix\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, multi-ingredient\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin combo\u003c\/td\u003e\n      \u003ctd\u003eOne-drink-covers-everything users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNR + B-vitamin cofactors\u003c\/td\u003e\n      \u003ctd\u003eCapsule-comfortable users; densest precursor delivery per dollar\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at trial-validated entry dose\u003c\/td\u003e\n      \u003ctd\u003eNMN-pathway preference; entry tier\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at upper trial dose\u003c\/td\u003e\n      \u003ctd\u003eHigher-dose NMN protocol; pairs with TMG\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ + Trans-Resveratrol\u003c\/td\u003e\n      \u003ctd\u003eSirtuin-substrate + activator pair in one capsule\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eLiposomal capsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ via phospholipid encapsulation\u003c\/td\u003e\n      \u003ctd\u003eUsers who want phospholipid-protected delivery\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN + CoQ10 + B-Complex + Antioxidants + Skin support\u003c\/td\u003e\n      \u003ctd\u003eOne-capsule-stack convenience users\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the right answer is \u003cstrong\u003eone drink-format product\u003c\/strong\u003e for the morning ritual + \u003cstrong\u003eone sirtuin activator\u003c\/strong\u003e (Resveratrol or Pterostilbene) + \u003cstrong\u003emethyl-donor support\u003c\/strong\u003e (TMG) + the rest of the foundational stack (Magnesium, Vit-D, Omega-3). Browse the full NAD+ Family at \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability deep-dive — what we know about drink-format NR PK\u003c\/h2\u003e\n\u003cp\u003eThe published NR pharmacokinetic profile (Trammell 2016, Airhart 2017, Conze 2019) was established in capsule and powder formats. Key findings translate to drink delivery:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR\u003c\/strong\u003e peaks 30–120 minutes after oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+\u003c\/strong\u003e rises within 8 hours and remains elevated 24+ hours after a single dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-linearity\u003c\/strong\u003e documented in Conze 2019 across 100\/300\/1000mg\/day × 8wk: ~22% \/ 51% \/ 142% NAD+ rise respectively. The dose-response is approximately log-linear in this range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1-MNA urinary appearance\u003c\/strong\u003e rises within 24 hours, confirming the NAD+→NAM→1-MNA flux is occurring (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSteady-state\u003c\/strong\u003e NAD+ elevation is reached by approximately week 1–2 of daily dosing; further dosing maintains rather than progressively elevates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue distribution\u003c\/strong\u003e documented in muscle (Elhassan, Remie, Stocks), CSF\/brain (Brakedal NADPARK), and liver (preclinical). Mitochondrial NAD+ rise is governed by SLC25A51 capacity (Luongo 2020 \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDrink-format delivery vs capsule delivery should not change steady-state NAD+ levels over weeks — both end up at the same plateau if dosed daily — but it does compress the time-to-onset of each individual dose, and (more importantly for outcomes) it materially raises the probability that you actually take it every day.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — what to pair with daily NAD+ drink\u003c\/h2\u003e\n\u003cp\u003eNR alone raises NAD+ but doesn't address the consumer side (CD38), the sirtuin-activator side (resveratrol\/pterostilbene), or the methylation tax (TMG). The mechanistically-coherent stack:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair\u003c\/h3\u003e\n\u003cp\u003eNR\/NMN provides the substrate. Sirtuin-activating compounds — \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e; Park 2012 \u003cem\u003eCell\u003c\/em\u003e; Lagouge 2006 \u003cem\u003eCell\u003c\/em\u003e) and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e (Riche 2014 trial) — allosterically activate SIRT1. Pair the NAD+ precursor drink with one of these. This is the “Sinclair-style” canonical longevity pairing.\u003c\/p\u003e\n\n\u003ch3\u003eMethylation support\u003c\/h3\u003e\n\u003cp\u003eNAM — the byproduct of every sirtuin reaction — is methylated to 1-MNA by NNMT, drawing on the SAM pool. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e donates a methyl group to homocysteine, regenerating methionine and protecting the SAM pool (Olthof 2003 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; McRae 2013 \u003cem\u003eCardiol Res Pract\u003c\/em\u003e). Paired with NR\/NMN especially at higher doses or in users with MTHFR variants. \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e is a parallel methyl-buffer.\u003c\/p\u003e\n\n\u003ch3\u003eCD38 reduction\u003c\/h3\u003e\n\u003cp\u003eCD38 is the dominant age-related NAD+ sink (Camacho-Pereira 2016). Flavonoid CD38 inhibitors — \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e — reduce the consumer side of the equation. Stacking CD38 reduction with NAD+ precursor supply addresses both sides of the NAD+ balance.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial layer\u003c\/h3\u003e\n\u003cp\u003eNAD+ runs the electron-transport chain. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e shuttles electrons from Complex I\/II to Complex III. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis via PGC-1α. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e activates PINK1\/Parkin-driven mitophagy — clearing dysfunctional mitochondria so the new biogenesis isn't replacing them with damaged copies. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000mg\u003c\/a\u003e feeds the TCA cycle. Together this is the mitochondrial-renewal layer.\u003c\/p\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e initiates autophagy via eIF5A hypusination (Zhang 2019 \u003cem\u003eMol Cell\u003c\/em\u003e) and EP300 inhibition (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e). Reciprocal with NAD+ precursors — SIRT1 deacetylates autophagy proteins ATG5\/ATG7\/LC3 (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e); spermidine independently triggers the autophagy machinery. Not redundant.\u003c\/p\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e activates AMPK (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). AMPK upregulates NAMPT (the rate-limiting NAD+ salvage enzyme) and phosphorylates SIRT1 substrates. Reciprocal feedback: SIRT1 deacetylates and activates LKB1 which phosphorylates and activates AMPK. The two pathways amplify each other.\u003c\/p\u003e\n\n\u003ch3\u003eAntioxidant + glutathione\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e form the GlyNAC stack (Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e) — restores glutathione synthesis in older adults whose mitochondrial GSH is depleted. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e recycles vitamin C and glutathione. \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e is the membrane-protected ascorbate. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e is the membrane-resident lipid-soluble antioxidant.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational layer\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e. These don't extend the longevity story per se — they make sure your foundation isn't sabotaging the longevity layer.\u003c\/p\u003e\n\n\u003ch3\u003eSkin \/ collagen pairing\u003c\/h3\u003e\n\u003cp\u003eIf skin appearance is an outcome you care about: \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg + Vit C\u003c\/a\u003e + \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e form the substrate \/ hydration \/ cofactor stack the \u003ca href=\"\/he\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e bundle was built around. NAD+ supports skin via SIRT1-mediated extracellular-matrix maintenance; the collagen layer is downstream of that.\u003c\/p\u003e\n\n\u003cp\u003eFor a built version of this stack as a single bundle, see the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e or the \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cp\u003eNAD+ pathway support is built on consistency. Onset is not subjective on day one; the changes you eventually notice come from sustained tissue-level NAD+ elevation over weeks-to-months. Anchored to the published trial timepoints:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1 – week 1.\u003c\/strong\u003e Whole-blood NAD+ rises within 8 hours of the first dose (Trammell 2016) and steady-states by approximately day 7–14 (Conze 2019, Airhart 2017). Most users do not feel anything subjective in this window. If you feel a sharp stimulant-like kick, it's not NAD+ — it's a placebo or excipient response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Some users report subtle morning-energy \/ less afternoon-crash signal as mitochondrial NAD+ elevates and the SLC25A51-governed compartment fills. This is highly variable. Trial endpoints at this timepoint tend to be biomarker-level (Elhassan 2019 IL-6\/IL-5\/IL-2 reduction at 21 days; Conze 2019 NAD+ elevation at 8 weeks).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8.\u003c\/strong\u003e Functional outcomes start to appear in the trial bench: Martens 2018 cardiovascular signal at 6 weeks (~10mmHg SBP drop in elevated-BP subgroup, aortic-stiffness reduction); Igarashi 2022 functional outcomes (SARC-F, 5x sit-to-stand) at 12 weeks. Subjectively users often report better recovery from exercise, better sleep depth, more stable energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12.\u003c\/strong\u003e Trial-published endpoints in this window include cardiovascular (Martens), glucose handling (Yoshino 2021 NMN parallel; Dollerup 2018 NR), sleep, cognitive subjective (Kim 2022 NMN parallel). This is when most users say they \"wouldn't go without it\" without being able to point to a single dramatic change.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3–6 months.\u003c\/strong\u003e Sustained pathway support; this is where the López-Otín hallmarks-of-aging integration is theorized to compound. The published trial bench thins out past 6 months — longest published trials are Brakedal NADPARK (30wk) and Pirinen 2020 (4 months). Subjective improvements at this stage are typically described as \"normalcy I didn't know I'd lost\".\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6+ months.\u003c\/strong\u003e Long-term safety established up to 3g\/day (Brakedal 2023 NR-SAFE) and 2g\/day for 14 days (Pencina 2023 NMN parallel). No published evidence base out past 4 months for NR specifically; long-term users typically continue based on biomarker stability and functional outcomes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStop dosing.\u003c\/strong\u003e Whole-blood NAD+ returns toward baseline within ~30 days of cessation (Conze 2019). This is one of the cleaner reasons NAD+ pathway support is positioned as a daily foundation rather than a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e a daily-foundation NAD+ precursor delivered in a format you'll actually take. The drink-mix path to NR's well-established human-trial benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a stimulant. Don't expect a coffee-like kick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a treatment for any disease. It is a dietary supplement; statements have not been evaluated by FDA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a one-month experiment that will visibly transform you. The trial bench requires weeks-to-months for endpoint readouts.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sleep aid. SIRT1 has indirect circadian-rhythm interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e SIRT1-BMAL1\/CLOCK) but NR is not a sedative; if sleep is the primary goal, see Magnesium Glycinate or Glycine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a substitute for the foundational layer. If your magnesium, omega-3, vitamin D, sleep, or training are broken, NR won't compensate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e redundant with our NR Hard Capsules — it's a delivery-format alternative for users who prefer drinks. Many users alternate or stack the two.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sirtuin activator on its own. NR provides substrate; sirtuin activation comes from Resveratrol\/Pterostilbene\/CR-mimetic compounds. The full benefit is the \u003cem\u003epair\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published functional endpoints land in weeks 6–12. Quitting early loses the benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NAD+ is a cofactor, not a stimulant. The change is subtle, sustained, and biomarker-level — not a rush.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support at higher doses.\u003c\/strong\u003e If you're at ≥500mg\/day NR plus an additional NMN dose, the methylation pool draws down. Add \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without sirtuin activator.\u003c\/strong\u003e Substrate without activator captures only part of the benefit. Pair with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking NAD+ on a broken foundation.\u003c\/strong\u003e If sleep is \u0026lt;6h, magnesium status is poor, training is absent, and stress-cortisol is unmanaged, NAD+ pathway support is not the highest-leverage thing you can fix.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDosing late in the day.\u003c\/strong\u003e Igarashi 2022 (NMN parallel) found AM dosing \u0026gt; PM dosing on functional endpoints. Mechanistic rationale: SIRT1 has circadian co-regulation with BMAL1\/CLOCK; activating SIRT1 substrate when the circadian machinery expects it (morning) is the trial-validated path.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStoring in humid environments.\u003c\/strong\u003e Single-serve foil packets are stable, but bulk-cut open packets exposed to humidity will gradually degrade. Use within the dose interval, store unused packets cool and dark.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, ideally before breakfast or with first water of the day. Aligns with circadian SIRT1 activity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 stick packet daily. Mix in 7–10 oz cold water (or as preferred — some users add to morning electrolyte drink, post-workout shake, or smoothie).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasted:\u003c\/strong\u003e Either works. NR absorption is not strongly food-dependent. If you experience mild GI upset on an empty stomach, take with food.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e A sirtuin activator (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e) taken with a fat-containing meal for best absorption. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e for methylation support if dosing ≥500mg total daily NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsistency vs. timing:\u003c\/strong\u003e Daily dosing matters far more than which hour you take it. Pick a time you'll keep.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Skip and resume next day. Don't double-dose to \"catch up.\" Steady-state NAD+ is robust to single missed doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e Single-serve foil packets are TSA-friendly in carry-on. No bottle, no scoop, no measuring. One of the format's strongest practical advantages.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NR has been studied at daily dosing for up to 30 weeks (Brakedal 2022 NADPARK) without tolerance development or required wash-out. Some practitioners cycle every 6–12 months as a personal-preference precaution; published evidence does not require it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Months-to-years. NAD+ pathway support is a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ wanting daily NAD+ pathway support without committing to another capsule bottle.\u003c\/li\u003e\n  \u003cli\u003eAnyone with capsule fatigue or swallowing aversion.\u003c\/li\u003e\n  \u003cli\u003eTravelers who want NAD+ support that fits in a luggage pocket.\u003c\/li\u003e\n  \u003cli\u003eUsers who already have a morning-drink ritual (electrolytes, greens, coffee) where adding a stick packet is invisible.\u003c\/li\u003e\n  \u003cli\u003eCapsule users who occasionally want to alternate format.\u003c\/li\u003e\n  \u003cli\u003ePre-workout users who want NAD+ support before training (mitochondrial \/ energy positioning).\u003c\/li\u003e\n  \u003cli\u003eVegan and gluten-free users (no animal-derived ingredients, no gluten in formulation).\u003c\/li\u003e\n  \u003cli\u003eUsers building or maintaining a longevity stack who want one of the seven NAD+ entry points to be drink-format.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or breastfeeding women (insufficient safety data for pregnancy).\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (no pediatric trial data).\u003c\/li\u003e\n  \u003cli\u003eUsers on chemotherapy or active cancer treatment without oncology consultation (NAD+ supports cell proliferation pathways; coordinate with oncology).\u003c\/li\u003e\n  \u003cli\u003eUsers seeking acute high-dose NAD+ delivery (IV therapy is a different category).\u003c\/li\u003e\n  \u003cli\u003eUsers with severe MTHFR variants who can't tolerate methyl loads — pair carefully with TMG and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003eUsers seeking same-day stimulant-like effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, contraindications, interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer \/ chemotherapy:\u003c\/strong\u003e Coordinate with oncology. NAD+ supports proliferative pathways; the literature on NAD+ precursor + cancer is mixed and context-dependent (Yaku 2018 \u003cem\u003eFront Oncol\u003c\/em\u003e review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants:\u003c\/strong\u003e No direct NR-anticoagulant interaction documented, but if stacked with Resveratrol (mild antiplatelet effect) advise caution and physician input. Stop 7–14 days pre-surgery as a general supplement-stack precaution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives:\u003c\/strong\u003e Martens 2018 showed ~10mmHg systolic-BP drop in elevated-BP subgroup. If on antihypertensive medication, monitor and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications:\u003c\/strong\u003e NR has shown insulin-sensitization signal in some trials. Monitor blood glucose if on insulin or sulfonylureas; coordinate with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePsychiatric \/ sleep medications:\u003c\/strong\u003e No direct interaction documented. Indirect SIRT1-circadian effects are subtle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMTHFR \/ methylation:\u003c\/strong\u003e Higher doses (\u0026gt;500mg\/day) draw on the SAM pool via NNMT. Pair with TMG; consider B-vitamin status review.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI:\u003c\/strong\u003e \u0026lt;5% of users in published trials report mild GI upset, headache, or transient flushing. Typically resolves with food or dose split.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUpper-dose ceiling:\u003c\/strong\u003e Brakedal 2023 NR-SAFE established tolerability of 3000mg\/day for 4 weeks with no serious AEs. Standard daily-foundation dosing is in the 250–1000mg range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-test status:\u003c\/strong\u003e NR is not a banned substance under WADA or NCAA codes. Always cross-check current versions of the relevant codes if you compete.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and manufacturing\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's Liquid NAD+ stick packs are manufactured in a 21 CFR Part 111 cGMP-compliant US facility. Per-batch QC includes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity testing:\u003c\/strong\u003e NR HPLC identity and purity (≥98% spec) confirmed by mass-spec orthogonal verification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; panel (lead, cadmium, mercury, arsenic) at California Proposition 65 thresholds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e USP \u0026lt;467\u0026gt; panel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count, total yeast\/mold, plus pathogen panel for \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eStaph aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e Specification confirmed per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e ≥24-month room-temperature shelf life in foil-laminated single-serve sachets. Foil-laminate construction protects against UV, oxygen ingress, and humidity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergens:\u003c\/strong\u003e No gluten, no dairy, no soy, no nuts. Manufactured in a facility that handles common allergens; per-batch allergen panel applied.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSweeteners:\u003c\/strong\u003e Naturally flavored berry; no artificial colors, no high-fructose corn syrup, no sucralose flood.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-source contract manufacturer audit:\u003c\/strong\u003e Same audited facility across batches, not lowest-bidder rotation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo proprietary blends:\u003c\/strong\u003e Per-stick NR mass disclosed on the supplement-facts panel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much NR is in each stick packet?\u003c\/strong\u003e Per supplement-facts panel on the packaging. Designed to deliver a daily-foundation NR dose in a single stick.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this NR or NMN?\u003c\/strong\u003e NR (Nicotinamide Riboside). For the NMN drink mix, see \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e which combines NR with Resveratrol, PQQ, and Quercetin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with NMN?\u003c\/strong\u003e Yes. Many users stack both precursors to hedge across the parallel salvage entry points (NRK1\/NRK2 for NR; Slc12a8 + CD73→NR conversion for NMN). Pair with TMG for methylation support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Probably not anything dramatic. NAD+ is a cofactor, not a stimulant. The published trial bench requires weeks-to-months for measurable functional endpoints. If you feel a sharp kick, it's likely placebo or an excipient response.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Highly variable. Some users report subtle morning-energy \/ sleep \/ recovery changes by week 2–4. Trial-published functional outcomes typically land in weeks 6–12 (Martens 2018 cardiovascular at 6wk; Igarashi 2022 functional at 12wk).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this at night?\u003c\/strong\u003e You can, but Igarashi 2022 (NMN parallel) found AM \u0026gt; PM dosing on functional endpoints. The mechanism is circadian: SIRT1 has documented co-regulation with BMAL1\/CLOCK (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Morning is the trial-validated time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle?\u003c\/strong\u003e Not required by the published evidence. Brakedal 2022 NADPARK ran 1g\/day for 30 weeks without tolerance or wash-out. Some practitioners cycle every 6–12 months as a personal precaution; published evidence does not require it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrink format vs capsule — which is better?\u003c\/strong\u003e Pharmacokinetically very similar at steady-state (both reach the same NAD+ plateau over weeks). Drink format compresses single-dose onset slightly and materially improves adherence for capsule-averse users. Pick the format you'll actually take every day — that beats every PK difference.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my coffee or breakfast?\u003c\/strong\u003e Yes. NR absorption is not strongly food-dependent. Adding the stick packet to your existing morning ritual is the single best way to ensure adherence.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat does it taste like?\u003c\/strong\u003e Clean berry. No artificial colors, no sucralose flood, no metallic NR aftertaste.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs there caffeine in this?\u003c\/strong\u003e No. This is a pure NAD+ precursor formulation, not an energy drink.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSugar content?\u003c\/strong\u003e Minimal. No added sugar bombs. Check the supplement-facts panel for exact carb\/sugar grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this break a fast?\u003c\/strong\u003e Functionally yes (anything that hits the GI tract breaks autophagy-strict fasting protocols). Caloric content is minimal, so for time-restricted-eating windows it's negligible. For strict autophagy fasts, take during your eating window.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e Yes. No animal-derived ingredients in the powder formulation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGluten free?\u003c\/strong\u003e Yes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrug-test status?\u003c\/strong\u003e NR is not a WADA or NCAA banned substance. Always cross-check current versions of the relevant codes if you compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open multiple packets and dose-split throughout the day?\u003c\/strong\u003e Yes, though daily morning dosing is the trial-validated standard. Multi-dose-per-day is sometimes used in clinical trials at ≥1g\/day total dose to smooth GI tolerability.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during pregnancy?\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy or lactation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during cancer treatment?\u003c\/strong\u003e Coordinate with your oncology team. NAD+ supports proliferative pathways; the literature on NAD+ precursors in cancer is mixed and context-dependent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is this format more expensive per dose than capsules?\u003c\/strong\u003e Single-serve foil-laminated stick packets cost more than HDPE bulk-bottle capsules to produce. The cost is the format, not the active ingredient. If price-per-NR-mg is your primary criterion, the capsule format wins.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with an SSRI \/ antidepressant \/ blood pressure medication?\u003c\/strong\u003e No direct interactions documented. Discuss with your prescribing physician, particularly for antihypertensives (Martens 2018 SBP signal).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with sleep?\u003c\/strong\u003e Indirectly, possibly. SIRT1-BMAL1\/CLOCK circadian interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e) suggest secondary sleep-architecture effects in some users. Direct sleep effects are not the primary positioning — for sleep-first protocols see \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e or \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with hair growth?\u003c\/strong\u003e Indirectly. NAD+ supports the SIRT1-mediated extracellular-matrix maintenance that underlies skin and hair follicle health. For direct hair-cycle support see \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (Rinaldi 2018 anagen-cycle data).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if I miss a day?\u003c\/strong\u003e No problem. Resume next day. NAD+ pathway support is built on sustained consistency over weeks, not single-dose rescue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e Cool, dry, dark. Foil-laminate sachets are stable at room temperature; no refrigeration required. Avoid bathroom storage (humidity).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhere can I see the COA?\u003c\/strong\u003e Per-batch certificate of analysis available on request via our \u003ca href=\"\/he\/pages\/contact\"\u003econtact page\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog — the architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's longevity catalog is structured in concentric layers. NR drink mix (this product) sits in the \u003cstrong\u003eLayer 1 NAD+ Precursor Supply\u003c\/strong\u003e position, alongside our capsule NR and NMN entries. Layer 1 = precursor supply (what feeds NAD+). Layer 2 = sirtuin activators (Resveratrol, Pterostilbene). Layer 3 = methylation + CD38 reduction (TMG, Apigenin, Quercetin, Fisetin). Layer 4 = mitochondrial cofactors (CoQ10, PQQ, Urolithin A, CaAKG). Layer 5 = autophagy + proteostasis (Spermidine). Layer 6 = AMPK pathway (Berberine, ALA). Layer 7 = antioxidant + glutathione (NAC, Glutathione, Glycine, ALA, Liposomal Vit C). Layer 8 = foundational daily (Mg, D3+K2, Omega-3, Curcumin). The right user picks one entry per layer based on goals, format preference, and what's already in the routine. This drink covers Layer 1 in drink format.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — all NAD+ precursors, activators, and convenience formulas\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the 7 daily nutrients underneath every longevity stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the core stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, Ca-AKG\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Fisetin, Quercetin, Apigenin\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — Resveratrol, Omega-3, CoQ10\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — AMPK + glucose-handling layer\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN — morning, empty stomach, or with food\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects — what the research actually shows\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eContext, not endorsement. Citations describe the underlying biology and human-clinical-trial evidence base for NAD+ pathway support; statements about this specific product have not been evaluated by the FDA.\u003c\/em\u003e\u003c\/p\u003e\n\u003cul style=\"font-size:13px;\"\u003e\n  \u003cli\u003eBieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e. 2004;117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eSci Rep\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNat Commun\u003c\/em\u003e. 2018;9(1):1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. \u003cem\u003eAJCN\u003c\/em\u003e. 2018;108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome. \u003cem\u003eCell Reports\u003c\/em\u003e. 2019;28(7):1717–1728.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAJCN\u003c\/em\u003e. 2020;112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy older men. \u003cem\u003eJ Physiol\u003c\/em\u003e. 2021;599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dolle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2022;34(3):396–407.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. A nationwide study of NR-SAFE: a randomized double-blind safety trial of high-dose nicotinamide riboside in Parkinson's disease. \u003cem\u003eNat Commun\u003c\/em\u003e. 2023;14(1):5751.\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2020;31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably. \u003cem\u003eNPJ Aging\u003c\/em\u003e. 2017;3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2017;12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2012;7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2016;23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2011;14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNat Metab\u003c\/em\u003e. 2019;1(1):47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e. 2020;588(7836):174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e. 2008;134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bass GT, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e. 2012;148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e. 2013;62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e. 2018;359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eSekhar RV. GlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(8):e372.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e. 2008;57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eBitterman KJ, Anderson RM, Cohen HY, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. \u003cem\u003eJBC\u003c\/em\u003e. 2002;277(47):45099–45107.\u003c\/li\u003e\n  \u003cli\u003eOlthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2003;133(12):4135–4138.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705333432538,"sku":"THP-NAD-LIQUID","price":39.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liquid-nad.jpg?v=1775666212"},{"product_id":"spermidine-10mg-wheat-germ-extract","title":"Spermidine 10mg | Wheat Germ Extract | Cellular Renewal \u0026 Autophagy Support","description":"\u003cp\u003e\u003cstrong\u003e10 mg of plant-derived spermidine per capsule\u003c\/strong\u003e — sourced from concentrated \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, the same form used in almost every published human spermidine trial of the last decade. Spermidine is the small naturally occurring polyamine that sits at the center of modern autophagy research: the cellular self-renewal pathway that gets sluggish with age and that fasting, caloric restriction, rapamycin, and metformin all try to reawaken from different angles. Standardized, vegan-friendly capsule, designed to layer cleanly onto an NMN, NAD+, or resveratrol stack as the \"renewal arm\" of a complete longevity protocol.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat spermidine does:\u003c\/strong\u003e activates \u003cem\u003eautophagy\u003c\/em\u003e — your cells' built-in recycling system. Damaged proteins, misfolded aggregates, and worn-out mitochondria get tagged, broken down, and replaced with new functional parts. It is the same pathway prolonged fasting and caloric restriction trigger.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e tissue spermidine drops sharply with age; the steepest drops are in the heart, brain, and immune tissue — exactly where age-related dysfunction shows up first. The 20-year Bruneck cohort study found adults with the highest dietary spermidine intake had significantly lower all-cause and cardiovascular mortality than those with the lowest (Kiechl 2018, \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 35+, anyone running an NMN or NAD+ longevity stack, cardiovascular and cognitive maintenance, and anyone using time-restricted eating who wants a \"fasting-mimetic\" on non-fasting days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with or without food.\u003c\/strong\u003e Spermidine is stable through digestion. Once-daily dosing is standard. Effects accumulate over months, not days — most published trial endpoints sit at 60–90 days minimum.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacks cleanly with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat spermidine actually is — in plain language\u003c\/h2\u003e\n\u003cp\u003eSpermidine is a \u003cem\u003epolyamine\u003c\/em\u003e: a small, positively charged molecule that every living cell makes for itself and also pulls in from food. It was first isolated from semen in the 17th century (hence the name), but it turns out to be everywhere — wheat germ, aged cheeses, mushrooms, soy, legumes, broccoli, mango, and natto. The polyamine family (spermidine, spermine, putrescine) keeps cells running by stabilizing DNA, supporting protein translation, regulating ion channels, and — most relevant for longevity — switching on autophagy through hypusination of the translation factor eIF5A.\u003c\/p\u003e\n\n\u003cp\u003eTwo things change with age, and both are reversible at the cellular level:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular spermidine concentration falls.\u003c\/strong\u003e The drop is steepest in the heart, brain, and immune tissue — exactly the systems where age-related dysfunction shows up first. Centenarians, by contrast, tend to have spermidine levels closer to those of healthy 30-year-olds (Pucciarelli 2012, \u003cem\u003eRejuvenation Research\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAutophagy slows.\u003c\/strong\u003e The molecular machinery that clears damaged components becomes less efficient, so cellular \"garbage\" — oxidized proteins, misfolded aggregates, dysfunctional mitochondria — accumulates. Loss of proteostasis is one of the formally recognized hallmarks of aging (López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 with autophagy declines now treated as an integrated hallmark).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRestoring spermidine restores one of the strongest natural autophagy signals the body has. Animals given supplemental spermidine show extended median lifespan, improved cardiac elasticity, preserved memory, and reduced age-related inflammation. Human evidence is younger but the cardiovascular and cognitive signals from observational and early interventional trials are now consistent enough that most modern longevity protocols include spermidine as a foundational addition.\u003c\/p\u003e\n\n\u003ch2\u003eWhy spermidine sits at the center of an autophagy-focused stack\u003c\/h2\u003e\n\u003cp\u003eAutophagy (\"self-eating\") is the cellular quality-control program. When a cell senses energy stress, low amino acids, or accumulating damage, autophagosomes engulf damaged components — oxidized proteins, fragmented organelles, broken mitochondria — and fuse with lysosomes that recycle the parts back into amino acids, fatty acids, and nucleotides for reuse. It is the most efficient renewal program a cell has, and it is one of the few longevity mechanisms conserved literally from yeast to humans.\u003c\/p\u003e\n\n\u003cp\u003eThe reason spermidine matters is mechanistic. It activates autophagy through three converging routes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypusination of eIF5A.\u003c\/strong\u003e Spermidine is the obligate substrate for the post-translational modification of eukaryotic translation initiation factor 5A. Hypusinated eIF5A drives translation of TFEB and other autophagy \"master regulator\" transcription factors. This is the direct molecular link between dietary spermidine and lysosomal biogenesis (Zhang 2019 \u003cem\u003eMolecular Cell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInhibition of acetyltransferases.\u003c\/strong\u003e Spermidine inhibits EP300, the acetyltransferase that holds autophagy proteins in their inactive acetylated state. Less EP300 activity → more deacetylated autophagy proteins → autophagy on (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK and TFEB activation.\u003c\/strong\u003e Spermidine indirectly raises AMPK signaling and promotes TFEB nuclear translocation, the same convergence point that fasting and caloric restriction use. This is why spermidine is correctly described as a \"fasting mimetic\" (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is why spermidine sits next to NMN, not in place of it. \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ for sirtuin and PARP function; \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol\u003c\/a\u003e activates SIRT1; \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e keeps the electron transport chain running; spermidine clears the damaged proteins and worn-out mitochondria so the rest of the stack has functional substrate to work on. Without autophagy support, you are pumping new energy through aging machinery. With it, the machinery itself gets renewed.\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what the human data actually says\u003c\/h2\u003e\n\u003cp\u003eSpermidine has moved out of the \"interesting in mice\" category and into \"tested in humans.\" Here is the published evidence at the doses and durations real people use.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eStudy (year, journal)\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n\u003cth\u003ePrimary findings\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eKiechl 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e (Bruneck cohort)\u003c\/td\u003e\n      \u003ctd\u003e829 community adults, 20-year follow-up\u003c\/td\u003e\n      \u003ctd\u003eDietary spermidine intake (food-frequency questionnaire), tertile-based\u003c\/td\u003e\n      \u003ctd\u003eHighest tertile vs. lowest: ~40% lower all-cause mortality; effect comparable to a Mediterranean dietary pattern\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eEisenberg 2016, \u003cem\u003eNature Medicine\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eAged mice and translational human cohort\u003c\/td\u003e\n      \u003ctd\u003e3 mM in drinking water (mice); dietary intake (humans)\u003c\/td\u003e\n      \u003ctd\u003eImproved cardiac diastolic function; extended median lifespan in mice; lower blood pressure in human cohort with high intake\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSchwarz 2018 (SmartAge pilot), \u003cem\u003eGeroScience\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults, subjective cognitive decline\u003c\/td\u003e\n      \u003ctd\u003e~1.2 mg\/day (food-grade) for 3 months\u003c\/td\u003e\n      \u003ctd\u003eSafe, well tolerated; signals on memory performance vs. placebo at 3 months\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePekar 2020 (SmartAge follow-up), \u003cem\u003eWiener Klin Wochenschr\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e85 older adults, mild cognitive concerns\u003c\/td\u003e\n      \u003ctd\u003e~0.9 mg\/day spermidine, 12 months\u003c\/td\u003e\n      \u003ctd\u003eLong-term safety confirmed; trends in memory and inflammatory marker improvement\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eWirth 2019, \u003cem\u003eCortex\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults at-risk for dementia\u003c\/td\u003e\n      \u003ctd\u003e1.2 mg\/day, 3 months\u003c\/td\u003e\n      \u003ctd\u003eMemory performance preserved vs. placebo; ATG5\/LC3-II autophagy markers up\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRainer 2018 (PROSPER hair study)\u003c\/td\u003e\n      \u003ctd\u003e100 healthy adults\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-containing nutraceutical, 90 days\u003c\/td\u003e\n      \u003ctd\u003eAnagen (active growth) phase of hair follicles lengthened vs. placebo\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoda 2009, \u003cem\u003eExp Gerontol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eHealthy adults consuming polyamine-rich diet\u003c\/td\u003e\n      \u003ctd\u003eDiet-based, 2 months\u003c\/td\u003e\n      \u003ctd\u003eIncreased blood polyamine levels; reduced markers of inflammation\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eHofer 2024, \u003cem\u003eNature Aging\u003c\/em\u003e (review)\u003c\/td\u003e\n      \u003ctd\u003eSynthesis of 13 spermidine human trials\u003c\/td\u003e\n      \u003ctd\u003e0.9–15 mg\/day, 1–12 months\u003c\/td\u003e\n      \u003ctd\u003eCardiovascular, cognitive, hair-cycle, immune signals replicated; safety at studied doses\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eNote: most published human trials used food-grade extracts at 0.9–6 mg\/day and still produced measurable effects on cellular autophagy markers and clinical endpoints. Animal-to-human dose translation suggests 5–15 mg\/day is the band where additional benefit plateaus in healthy adults. Our 10 mg per capsule sits at the upper-middle of that range — high enough to push past dietary intake, low enough to stay within the natural range of high-spermidine Mediterranean diets.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — wheat germ extract vs. the alternatives\u003c\/h2\u003e\n\u003cp\u003eYou can extract spermidine from a handful of natural sources and at least one fully synthetic route. They are not interchangeable.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003ePolyamine profile\u003c\/th\u003e\n\u003cth\u003eBioavailability\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eWheat germ extract (this product)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eSpermidine + spermine + putrescine in their natural ratio\u003c\/td\u003e\n      \u003ctd\u003eGood — the food-matrix form the literature was built on\u003c\/td\u003e\n      \u003ctd\u003eUsed in almost all published human trials (Bruneck, SmartAge, PROSPER)\u003c\/td\u003e\n      \u003ctd\u003eAnyone who wants the form most directly supported by published human data\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSynthetic spermidine trihydrochloride\u003c\/td\u003e\n      \u003ctd\u003ePure spermidine, no cofactors\u003c\/td\u003e\n      \u003ctd\u003eComparable on paper, but no head-to-head trial data\u003c\/td\u003e\n      \u003ctd\u003eMostly cell and animal studies\u003c\/td\u003e\n      \u003ctd\u003eCustomers with severe wheat allergy; expect higher cost per mg\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoybean germ extract\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-rich but lower mg\/g than wheat germ\u003c\/td\u003e\n      \u003ctd\u003eComparable to wheat germ\u003c\/td\u003e\n      \u003ctd\u003eLimited human trials\u003c\/td\u003e\n      \u003ctd\u003ePeople avoiding wheat for non-celiac reasons; check soy tolerance\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMango fruit concentrate\u003c\/td\u003e\n      \u003ctd\u003eLower spermidine, higher putrescine\u003c\/td\u003e\n      \u003ctd\u003eAdequate but inefficient (low mg\/g)\u003c\/td\u003e\n      \u003ctd\u003eSome observational data only\u003c\/td\u003e\n      \u003ctd\u003eNot recommended as primary source — too dilute\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNatto (fermented soy)\u003c\/td\u003e\n      \u003ctd\u003eNaturally high in polyamines plus vitamin K2\u003c\/td\u003e\n      \u003ctd\u003eVery high in food matrix\u003c\/td\u003e\n      \u003ctd\u003ePopulation-level Japanese cohort data\u003c\/td\u003e\n      \u003ctd\u003ePeople who eat it daily; supplementation still useful as a baseline\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eWe chose \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ for three reasons: (1) it is the most-studied source — almost every published human trial of dietary spermidine used wheat-germ–derived material or a wheat-germ-rich diet pattern; (2) it carries the highest natural concentration of any common food source (~240 mg\/kg), which keeps capsule size small and filler load minimal; (3) it delivers spermidine alongside its natural cofactors (spermine, putrescine), more closely matching the dietary matrix the body evolved to absorb.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular maintenance.\u003c\/strong\u003e The strongest human signal in the published literature. If you have a family history of heart disease or simply want to maintain cardiac diastolic function into your 60s and 70s, spermidine is one of the better-studied dietary additions. Pair with \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive maintenance.\u003c\/strong\u003e Autophagy is a major clearance pathway for the misfolded protein aggregates that accumulate in aging brains (tau, alpha-synuclein, polyglutamine species). Spermidine layers naturally with omega-3 EPA\/DHA, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, and B-vitamin methyl-donors like \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHair and skin renewal.\u003c\/strong\u003e Hair follicles and skin keratinocytes turn over fast and are visibly responsive to autophagy support. Spermidine pairs well with \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e, \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000mcg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLongevity stacks.\u003c\/strong\u003e Spermidine is the renewal arm: it clears the damaged cellular machinery so the rest of the stack (NMN, NAD+, resveratrol, CoQ10) has clean tissue to work on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTime-restricted eating \u0026amp; fasting.\u003c\/strong\u003e Spermidine activates many of the same autophagy genes that prolonged fasting does. Many users take it on non-fasting days to maintain autophagic tone all week, or alongside a 16:8 eating window for a compounded effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmune resilience after 50.\u003c\/strong\u003e Aged T-cells lose autophagy capacity, and spermidine has restored T-cell function in mouse models. It is now being studied for its potential to improve vaccine response and influenza resistance in older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow spermidine fits into a complete longevity stack\u003c\/h2\u003e\n\u003cp\u003eAging is not one process — it is a dozen overlapping ones (mitochondrial decline, NAD+ loss, sirtuin slowdown, accumulated cellular damage, chronic low-grade inflammation, senescent cells, epigenetic drift, telomere attrition, proteostasis failure, stem cell exhaustion). The reason longevity protocols stack multiple supplements is to support several of those pathways at once. Spermidine sits in the renewal position. Here is how it interlocks with the rest of a True Health Protocol stack:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnergy and DNA repair layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e raises cellular NAD+, the coenzyme that powers mitochondrial energy and DNA repair. Pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e as a methyl buffer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e activate SIRT1, the longevity-related deacetylase that depends on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e keeps the electron transport chain running cleanly. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis; \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e and \u003cstrong\u003espermidine\u003c\/strong\u003e drive mitophagy — the renewal of damaged mitochondria.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ alternative format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e for direct NAD+ delivery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e clear senescent cells that autophagy could not rescue. Use pulsed (2-day-on, monthly).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38 inhibition layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg + BioPerine\u003c\/a\u003e blocks the NAD+-degrading enzyme CD38, sparing NAD+ for sirtuins and PARP enzymes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ glucose layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e activates AMPK, the metabolic master switch that also feeds into autophagy upstream.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e (the GlyNAC pair), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpigenetic \/ methylation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr simply start with the bundle:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNone of these substitute for the others. The principle is layered support: support energy production, support cellular renewal, support antioxidant defense, and clear out cells that are too damaged to recover. Spermidine is the renewal layer.\u003c\/p\u003e\n\n\u003ch2\u003eThe AMPK–autophagy–NAD+ crosstalk — why spermidine and NMN are not redundant\u003c\/h2\u003e\n\u003cp\u003eOne of the most common questions we get is whether spermidine \"overlaps\" with NMN, since both are framed as longevity supplements. The mechanisms barely overlap — they are reciprocal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN raises NAD+.\u003c\/strong\u003e NAD+ powers SIRT1, which deacetylates LKB1 and FOXO3, indirectly contributing to autophagy gene expression — but NAD+ is not itself an autophagy initiator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine initiates autophagy.\u003c\/strong\u003e Through eIF5A hypusination and EP300 inhibition, spermidine directly switches on the autophagy program — but it does not produce more NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe loop:\u003c\/strong\u003e autophagy frees up amino acids and nucleotides for NAD+ salvage; NAD+-driven SIRT1 then deacetylates autophagy proteins to keep them active. Each pathway feeds the other. Take only NMN and you may produce energy in damaged mitochondria. Take only spermidine and you may renew machinery without replenishing the coenzyme that drives it. Take both and you get the loop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why nearly every modern longevity protocol pairs an NAD+ precursor (NMN, NR, or direct NAD+) with an autophagy activator (spermidine, fisetin, urolithin A) rather than picking one or the other.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — why polyamines work even at small doses\u003c\/h2\u003e\n\u003cp\u003eSpermidine has unusual oral pharmacokinetics. It is absorbed in the small intestine, partly metabolized by gut bacteria into other polyamines (putrescine, spermine), and the systemic-blood signal is small but durable. At first that looks like a problem, but the published data suggests it is the design feature, not the bug:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost action is at the gut and immediately downstream.\u003c\/strong\u003e Gut epithelial cells turn over every 3–5 days and rely heavily on polyamines for renewal. Restoring local polyamine availability supports gut barrier integrity, which has knock-on effects on systemic inflammation and metabolic endotoxemia.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial conversion is constructive, not lossy.\u003c\/strong\u003e Gut bacteria convert dietary precursors into spermidine and spermine that are then re-absorbed. Daily oral spermidine works partly by feeding this microbial polyamine economy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue accumulation over weeks.\u003c\/strong\u003e Even at modest oral doses (1–6 mg\/day), human trials show measurable rises in red blood cell polyamine concentration and autophagy marker expression at 60–90 days. This is why dose escalation past ~15 mg\/day shows diminishing returns in healthy adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why we did not chase a 30 mg or 50 mg dose. The literature does not support the idea that more is more for healthy adults; it supports daily consistency at a physiologically sensible dose, sustained for months.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine 10 mg\u003c\/strong\u003e — standardized from \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, HPLC-verified per batch.\u003c\/li\u003e\n  \u003cli\u003eVegetable cellulose capsule (HPMC) — vegan, no gelatin.\u003c\/li\u003e\n  \u003cli\u003eRice flour — natural flow agent, gluten-free, GMO-free.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e dairy, soy, GMOs, artificial colors, fillers, preservatives, magnesium stearate, and synthetic dyes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eNote for celiac and severe wheat-allergy customers:\u003c\/em\u003e spermidine sourced from wheat germ is processed and the active is a small molecule (not a protein), but trace residue is possible at parts-per-million levels. If you have celiac disease or a confirmed wheat allergy, choose a non-wheat polyamine source or consult your physician before use.\u003c\/p\u003e\n\n\u003ch2\u003eHow to take it — a daily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 1 capsule (10 mg spermidine) once daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any time of day, with or without food. Spermidine is stable through digestion; food does not impair absorption. Many users take it in the morning to align with a fasting window if practicing time-restricted eating; others prefer evening with dinner.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you missed a dose:\u003c\/strong\u003e take it when you remember. Do not double up the next day. The effect is cumulative, not pulsed — a single missed day is metabolically invisible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e spermidine is shelf-stable at room temperature. No refrigeration needed. The HDPE bottle is TSA-friendly for carry-on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking:\u003c\/strong\u003e safe to take alongside NMN, NAD+, resveratrol, CoQ10, omega-3, magnesium, vitamin D3\/K2, collagen, and most other longevity supplements. No known meaningful interactions with these.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatience window:\u003c\/strong\u003e autophagy benefits accumulate slowly. Most published trials run 60 to 90 days or longer before measurable endpoints appear. Plan a 3-month minimum before evaluating whether it is \"doing anything\" — and do not expect a stimulant-like effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e spermidine does not require cycling. Continuous daily use is what the cohort and animal data are based on. The Bruneck cohort is a 20-year continuous dietary intake; the SmartAge follow-up is 12 continuous months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to actually expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e nothing perceptible. This is normal and expected. Autophagy ramp-up is invisible from the inside; cellular markers shift before subjective experience does.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3–4:\u003c\/strong\u003e some users report mildly improved sleep depth and slightly steadier daytime energy. Others notice nothing — this is also normal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 5–8:\u003c\/strong\u003e hair-cycle changes (anagen lengthening) begin to appear in published trials around this point. Skin tone may look slightly more uniform. Cardiovascular markers (in trials with monitoring) start to show direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 9–12:\u003c\/strong\u003e the SmartAge cognitive endpoints sit here. Memory performance, attention, and mood markers are the most likely subjective signals. This is also the point at which the Wirth 2019 trial saw measurable autophagy-marker upregulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the compound-interest phase. Cumulative cellular renewal effects build. Blood-pressure decreases (in those starting elevated), inflammatory marker reductions, and steadier energy patterns are characteristic.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBeyond 6 months:\u003c\/strong\u003e the population-level data (Bruneck) is built on years to decades of high intake. The longevity argument is structurally a long-arc one. Run it like a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you want a quicker felt effect to anchor the early weeks, pair spermidine with NMN — NMN often produces noticeable energy effects within 2–4 weeks while spermidine is still warming up. The two complement each other behaviorally as well as mechanistically.\u003c\/p\u003e\n\n\u003ch2\u003eWhat this product is — and what it is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a stimulant.\u003c\/strong\u003e No caffeine-like effect, no jolt, no rapid-onset alertness. If you feel something dramatic in the first week, that is placebo or coincidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a treatment.\u003c\/strong\u003e Spermidine is a dietary supplement that supports a normal cellular pathway. It does not diagnose, treat, cure, or prevent any disease.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a one-month product.\u003c\/strong\u003e The published trial endpoints sit at 60–90 days minimum. If you take it for three weeks and stop, you have not given the molecule the runway it needs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a substitute for sleep, exercise, protein intake, or fiber.\u003c\/strong\u003e Autophagy is most strongly induced by sleep, fasting, and resistance training. Spermidine is an amplifier; it is not a replacement for the basics.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not the right starting point if you have never taken any longevity supplement.\u003c\/strong\u003e If your stack is currently empty, start with the foundations: omega-3, magnesium, vitamin D3\/K2. Add NMN. Then layer spermidine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published autophagy-marker rises sit at 8–12 weeks. Three weeks of spermidine is essentially a three-week dose-finding pilot on yourself. Run it for 90 days minimum before judging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a kick.\u003c\/strong\u003e Spermidine is not NMN. There is no felt energy jolt; renewal is invisible. The reason to take it is the long-arc cardiovascular and cognitive data, not next-week feelings.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e The trial and cohort data are continuous-use data. There is no published reason to cycle spermidine and a clear reason not to (you reset the cumulative tissue load each time you stop).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking only spermidine for autophagy.\u003c\/strong\u003e Spermidine is one autophagy lever among several. Pair with sleep (autophagy spikes during deep sleep), with at least a 12-hour overnight fast, and ideally with resistance training for maximum effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking three autophagy products without a senolytic layer.\u003c\/strong\u003e Spermidine, urolithin A, and PQQ all push autophagy in slightly different directions — a fine combination — but if your goal is clearing the most damaged cells, layer in a pulsed senolytic (fisetin or quercetin) once a month. Autophagy clears damage inside cells; senolytics clear cells too damaged to recover.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the foundation.\u003c\/strong\u003e Adding spermidine on top of a magnesium-deficient, vitamin-D-deficient, omega-3-light diet is suboptimal. Spermidine works best on a healthy substrate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho should not take spermidine\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or nursing women — insufficient safety data; not tested in pregnancy.\u003c\/li\u003e\n  \u003cli\u003eChildren and teens under 18 — pediatric trials have not been conducted.\u003c\/li\u003e\n  \u003cli\u003eAnyone with active cancer or undergoing chemotherapy. The relationship between polyamines and tumor biology is complex; some tumor types upregulate polyamine synthesis. Discuss with your oncologist before supplementing.\u003c\/li\u003e\n  \u003cli\u003eAnyone with celiac disease or a confirmed wheat allergy should review the wheat-germ sourcing with their clinician first or choose a non-wheat polyamine product.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known polyamine-related metabolic disorder (rare).\u003c\/li\u003e\n  \u003cli\u003eIf you take prescription medication or have a chronic condition, check with your healthcare provider before starting any new supplement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs 10 mg enough? I have seen products at 20 mg or higher.\u003c\/h3\u003e\n\u003cp\u003eMost published clinical trials in humans used 0.9 mg to 6 mg per day from food-grade extracts and still produced measurable effects on cellular markers and clinical endpoints. 10 mg is at the higher end of well-studied oral doses. There is no strong human evidence that 20–30 mg outperforms 5–10 mg in healthy adults — going higher is mostly a marketing decision rather than a published one. We chose the highest dose with solid published support and stopped there.\u003c\/p\u003e\n\n\u003ch3\u003eCan I just get spermidine from food instead?\u003c\/h3\u003e\n\u003cp\u003eYes — wheat germ, aged cheeses (especially cheddar and parmesan), mushrooms (especially shiitake), soy products, legumes, broccoli, mango, and natto are all good sources. Most Western diets supply roughly 7–25 mg\/day from food, but quality varies enormously by what you actually eat. Supplementation is useful if your diet is consistently low in these foods, if you want a measured, reproducible daily dose, or if you simply want to add spermidine on top of what you already eat.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it work the same way as fasting?\u003c\/h3\u003e\n\u003cp\u003eBoth spermidine and fasting activate autophagy, but through partially different upstream signals. Spermidine does not replace fasting's full metabolic effect — it will not reproduce fasting's improvements in insulin sensitivity, ketone production, or growth-hormone pulse. But it does deliver one of fasting's most-studied benefits (autophagy induction) in capsule form. Many users take it on non-fasting days to keep autophagy \"warm\" between fasting windows, or alongside time-restricted eating for a compounded effect.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eMost measurable benefits in published trials appear at 60–90 days. You probably will not feel anything subjectively in the first few weeks. Autophagy is a long-term cellular renewal process, not a stimulant. If you want a quicker felt effect, pair spermidine with \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e — it often has noticeable energy effects within 2–4 weeks while spermidine is still warming up.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with NMN, NAD+, and resveratrol?\u003c\/h3\u003e\n\u003cp\u003eYes — that combination is the modern longevity protocol's backbone. They work on different pathways. Take NMN in the morning (it can be mildly energizing), spermidine any time (no stimulant effect), and resveratrol with a meal that contains some fat for absorption. CoQ10 and omega-3 also pair well alongside.\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe to take long-term?\u003c\/h3\u003e\n\u003cp\u003eLong-term human data is limited (the longest published trial is the SmartAge 12-month follow-up), but observational cohort data suggests adults with high lifelong dietary spermidine intake have better outcomes than those with low intake. There is no known mechanism by which physiological doses (5–15 mg\/day) would cause harm in healthy adults, and the Hofer 2024 \u003cem\u003eNature Aging\u003c\/em\u003e review across 13 human trials found a clean safety profile across the studied dose range.\u003c\/p\u003e\n\n\u003ch3\u003eWill I feel different?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the first month. Some people report subtler shifts (better skin tone, slightly better sleep depth, less mid-day fatigue) in months 2–3, but spermidine is not a stimulant and you should not expect to \"feel\" it the way you would feel caffeine, NMN, or ashwagandha.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine break a fast?\u003c\/h3\u003e\n\u003cp\u003eThe capsule itself contains a few calories of rice flour as a flow agent, which is metabolically negligible (well under the threshold that would meaningfully shift autophagy or insulin signaling). The spermidine molecule is, if anything, fasting-mimetic. Most strict fasters take it during their eating window to be conservative; it is also reasonable to take it during a fasting window if the goal is to amplify the autophagy effect.\u003c\/p\u003e\n\n\u003ch3\u003eWhy wheat germ if some people are gluten-sensitive?\u003c\/h3\u003e\n\u003cp\u003eSpermidine itself contains no gluten — gluten is a protein, spermidine is a small polyamine. The wheat germ extract is processed to remove the bulk of protein content, but trace residue can remain. We are transparent about the source; if you have celiac disease or a confirmed wheat allergy, talk to your physician or pick a non-wheat polyamine product. For most people with non-celiac gluten sensitivity, the trace residue in a refined extract is below the threshold of clinical effect — but only you and your doctor can decide.\u003c\/p\u003e\n\n\u003ch3\u003eCan it be stacked with senolytics like fisetin and quercetin?\u003c\/h3\u003e\n\u003cp\u003eYes — they are mechanistically complementary, not competitive. Spermidine clears damaged cellular machinery via autophagy; senolytics like \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e clear cells that are too damaged to recover (senescent cells). Many longevity protocols use spermidine daily and senolytics in pulsed monthly doses — a single 2-day pulse of fisetin once a month layered on top of daily spermidine.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine interact with rapamycin or metformin?\u003c\/h3\u003e\n\u003cp\u003eSpermidine, rapamycin, and metformin all converge on autophagy from different angles (rapamycin via mTOR inhibition; metformin via AMPK; spermidine via eIF5A\/EP300). There is no published evidence of a problematic interaction — if anything, the combinations are theoretically synergistic. But if you take prescription rapamycin or metformin, this is a conversation for your prescribing physician, not for a product page.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it affect blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe Eisenberg 2016 \u003cem\u003eNature Medicine\u003c\/em\u003e study found a small blood-pressure-lowering signal in adults with elevated baseline pressure, paralleled by improved cardiac diastolic function. The effect size is small and variable; do not expect spermidine to substitute for blood-pressure medication. If you are on antihypertensive medication, monitor your numbers as you would when adding any new dietary intervention.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it interact with antibiotics?\u003c\/h3\u003e\n\u003cp\u003eAntibiotics that suppress the gut microbiota can transiently lower the microbial polyamine economy that spermidine partly feeds. There is no specific contraindication, but during an antibiotic course you may want to take spermidine with a meal containing fermented foods, and continue past the course as the microbiome rebuilds. There is no known direct drug-drug interaction.\u003c\/p\u003e\n\n\u003ch3\u003eWill it grow my hair back?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the way you mean. The PROSPER trial found that spermidine extends the anagen (active growth) phase of existing follicles — so hair already in the cycle stays in growth longer, which can produce thicker, denser hair over months. It does not regrow follicles that have been miniaturized or lost. For androgenetic hair loss, spermidine is a complement, not a replacement for evidence-based treatments.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and mix it into food or a smoothie?\u003c\/h3\u003e\n\u003cp\u003eYes. Spermidine is heat-stable up to normal cooking temperatures and stable in acidic environments. Opening a capsule and mixing the contents into a smoothie, yogurt, or oatmeal does not destroy the active. The taste is mildly nutty — most people do not notice it.\u003c\/p\u003e\n\n\u003ch3\u003eWill it make me smell different?\u003c\/h3\u003e\n\u003cp\u003eNo. The \"spermidine\" name is a historical accident from its 17th-century isolation. The molecule is odorless at the doses humans take in food or supplements; the perceptible smell of any animal tissue containing polyamines comes from putrescine and cadaverine (related polyamines released during decomposition), not from spermidine itself.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a GMP-certified facility under cGMP standards. Each batch is third-party tested by HPLC for spermidine content (target 10 mg ± 5%), and screened for heavy metals (lead, arsenic, cadmium, mercury — all below USP\/Prop 65 limits), microbial contamination (total plate count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, salmonella), pesticide residue, and gluten residue. Wheat germ extract is sourced from a single audited supplier with a clean compliance history; certificates of analysis are available on request. Bottled in UV-protective HDPE with a desiccant pack, sealed under the safety band. See our \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e page for full third-party testing protocol and our \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e page for how spermidine fits into a complete longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medication, or under medical care. Individual results vary. Statements about cardiovascular, cognitive, hair, or longevity outcomes are based on observational and early interventional human data and animal studies; they are not claims about disease treatment or prevention.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47838950654170,"sku":"THP-SPERM-10-60","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_spermidine.png?v=1778047685"},{"product_id":"curcumin-1000mg-bioperine-anti-inflammatory-longevity","title":"Curcumin Capsules (AT-014)","description":"\u003cp\u003e\u003cstrong\u003eCurcumin 1000mg with 95% curcuminoids + 5mg BioPerine® — the most-studied anti-inflammatory longevity compound, in the form your body can actually absorb.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eCurcumin is the active polyphenol in turmeric (\u003cem\u003eCurcuma longa\u003c\/em\u003e), and it sits at the intersection of two areas modern aging research takes seriously: \u003cstrong\u003einflammaging\u003c\/strong\u003e — the slow, tissue-wide simmer of NF-κB-driven inflammation that accumulates with age (Franceschi \u0026amp; Campisi 2014, \u003cem\u003eJ Gerontol\u003c\/em\u003e) — and the \u003cstrong\u003eendogenous antioxidant system\u003c\/strong\u003e regulated by the Nrf2 transcription factor (glutathione, superoxide dismutase, catalase, heme oxygenase-1). With more than 13,000 peer-reviewed publications on PubMed, including \u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e, \u003cem\u003eAggarwal \u0026amp; Harikumar 2009 (Int J Biochem Cell Biol)\u003c\/em\u003e, \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e, \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e, and \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e, curcumin is one of the few natural compounds that has been shown — in human trials, not just cell culture — to reduce C-reactive protein (CRP), improve joint pain scores comparably to NSAIDs, raise BDNF, and modulate the same molecular pathways targeted by metformin and rapamycin. The catch every supplement taker eventually runs into is bioavailability: \u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e showed that ordinary curcumin reaches plasma at near-undetectable levels because it’s poorly water-soluble and rapidly conjugated in the liver. Co-administering 5mg of piperine (the active in BioPerine®) increased systemic bioavailability by \u003cstrong\u003e~2000%\u003c\/strong\u003e in healthy volunteers. This product delivers what the published bioavailability literature actually used: 1000mg of turmeric root extract \u003cstrong\u003estandardized to 95% curcuminoids\u003c\/strong\u003e plus \u003cstrong\u003e5mg BioPerine®\u003c\/strong\u003e at 95% piperine — one capsule, taken with food that contains some fat, once a day.\u003c\/p\u003e\n\n\u003ch3\u003eWhy curcumin keeps appearing in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eAging, at the cellular level, is the slow accumulation of low-grade inflammation. The same NF-κB transcription factor that flares when you sprain an ankle stays mildly switched on for decades, driving joint stiffness, cognitive decline, vascular dysfunction, and insulin resistance — what \u003cem\u003eFranceschi \u0026amp; Campisi 2014 (J Gerontol)\u003c\/em\u003e coined \u003cem\u003einflammaging\u003c\/em\u003e. Long-term human cohort data (Framingham, Rotterdam, ARIC) shows elevated CRP, IL-6, and TNF-α are among the most reliable predictors of all-cause mortality and frailty — outpredicting cholesterol in many analyses. Curcumin is one of the few natural polyphenols that has been shown to \u003cstrong\u003edirectly inhibit NF-κB activation\u003c\/strong\u003e at the IκB-kinase step (\u003cem\u003eSingh \u0026amp; Aggarwal 1995, J Biol Chem\u003c\/em\u003e) \u003cem\u003eand\u003c\/em\u003e simultaneously \u003cstrong\u003eactivate Nrf2\u003c\/strong\u003e (\u003cem\u003eBalogun 2003, Biochem J\u003c\/em\u003e) — the master regulator of the body’s own antioxidant defenses. Most over-the-counter anti-inflammatories suppress symptoms downstream; curcumin works upstream on the signal itself. That dual NF-κB↓ \/ Nrf2↑ profile is also the reason curcumin shows up alongside resveratrol, fisetin, and quercetin in nearly every published longevity-stack review.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — and why BioPerine matters\u003c\/h3\u003e\n\u003cp\u003eCurcumin’s biggest failure mode as a supplement is poor absorption. It has low water solubility (about 11ng\/mL at physiologic pH), rapid intestinal metabolism, and aggressive hepatic glucuronidation\/sulfation. \u003cem\u003eShoba et al. 1998 (Planta Medica)\u003c\/em\u003e dosed healthy volunteers with 2g of curcumin alone and measured serum levels at the limit of detection. The same 2g dose \u003cstrong\u003eplus 20mg piperine\u003c\/strong\u003e raised serum curcumin AUC by \u003cstrong\u003e~2000%\u003c\/strong\u003e. The mechanism: piperine inhibits intestinal and hepatic UDP-glucuronosyltransferase, slowing the rate at which curcumin is conjugated and excreted before it reaches circulation. This is why every reputable curcumin product on the market either uses BioPerine®, a phospholipid carrier (Meriva®), a colloidal nanoparticle (Theracurmin®), or a liposomal vehicle — straight 95% curcuminoid powder without a delivery solution is, pharmacokinetically, mostly wasted.\u003c\/p\u003e\n\n\u003ch3\u003eWhat curcumin actually does — mechanisms in plain English\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB inhibition.\u003c\/strong\u003e Down-regulates the master inflammation switch that drives chronic disease — specifically by inhibiting IκB kinase (IKK), preventing NF-κB from translocating to the nucleus and switching on TNF-α, IL-1β, IL-6, and COX-2 transcription. Pairs mechanistically with \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different upstream entry point on the same pathway) and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 activation.\u003c\/strong\u003e Switches on endogenous antioxidant production — glutathione, superoxide dismutase, catalase, heme oxygenase-1 — via Keap1 cysteine modification. Means less dependence on exogenous antioxidants alone. Synergistic with \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e and \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF support.\u003c\/strong\u003e Crosses the blood-brain barrier (one of curcumin’s rare advantages over quercetin and resveratrol). \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e showed an 18-month Theracurmin trial improved memory-test scores and reduced amyloid\/tau PET signal in non-demented older adults. Best framed as long-game cognitive resilience, not nootropic stimulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint and tendon comfort.\u003c\/strong\u003e \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e meta-analysis of 8 randomized trials in osteoarthritis: 500–1500 mg\/day of curcuminoids produced clinically meaningful pain-score reduction comparable to ibuprofen 1200–2400 mg\/day, with markedly fewer GI side effects and no anticoagulant burden.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular markers.\u003c\/strong\u003e \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e meta-analysis: significant CRP reduction (−6.44 mg\/L) in adults with elevated baseline inflammation. Endothelial-function trials (Akazawa 2012, Sugawara 2012) show improvements in flow-mediated dilation comparable to moderate aerobic exercise.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMetabolic \/ AMPK signaling.\u003c\/strong\u003e Activates AMPK and inhibits mTOR — overlapping with the molecular signature of caloric restriction, metformin, and berberine. \u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e: 9-month curcuminoid trial in 240 prediabetic adults reduced progression to type 2 diabetes by 100% vs. placebo (16.4% conversion rate in the placebo arm). Pairs naturally with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic adjacent.\u003c\/strong\u003e Curcumin is not a primary senolytic (that’s \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e), but it suppresses the senescence-associated secretory phenotype (SASP) — the inflammatory soup that senescent cells emit before they’re cleared. Curcumin lowers the inflammatory burden of cells you haven’t yet removed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBile and digestive support.\u003c\/strong\u003e Stimulates bile flow (cholagogic). Improves fat digestion. Same mechanism that means people with gallstones should avoid supplemental doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThe clinical evidence — what published human trials actually showed\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003eOutcome\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e8 healthy volunteers\u003c\/td\u003e\n\u003ctd\u003e2g curcumin ± 20mg piperine, single dose\u003c\/td\u003e\n\u003ctd\u003ePiperine increased curcumin serum AUC by ~2000%; established the BioPerine pairing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 6 RCTs, 342 adults\u003c\/td\u003e\n\u003ctd\u003e200–1000 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eCRP −6.44 mg\/L vs. placebo in adults with elevated inflammation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 8 RCTs, knee osteoarthritis\u003c\/td\u003e\n\u003ctd\u003e500–1500 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eWOMAC pain reduction comparable to NSAIDs; markedly fewer GI events\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSmall 2018 (Am J Geriatr Psychiatry)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e40 non-demented adults 51–84\u003c\/td\u003e\n\u003ctd\u003e90mg Theracurmin BID, 18 months\u003c\/td\u003e\n\u003ctd\u003eImproved memory and attention; reduced amyloid\/tau PET signal in amygdala\/hypothalamus\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e240 prediabetic adults\u003c\/td\u003e\n\u003ctd\u003e1500 mg\/day curcuminoids, 9 months\u003c\/td\u003e\n\u003ctd\u003e16.4% → 0% type-2 diabetes progression vs. placebo over 9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eAkazawa 2012 (Nutr Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e32 postmenopausal women\u003c\/td\u003e\n\u003ctd\u003e150mg curcumin\/day, 8 weeks ± aerobic exercise\u003c\/td\u003e\n\u003ctd\u003eFlow-mediated dilation improved comparably to aerobic exercise; additive when stacked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003ePanahi 2017 (Drug Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e117 metabolic syndrome adults\u003c\/td\u003e\n\u003ctd\u003e1000mg curcuminoids + 10mg piperine, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eReduced CRP, IL-6, TNF-α, MDA; improved HDL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eComprehensive safety\/efficacy review\u003c\/td\u003e\n\u003ctd\u003eDoses up to 12g\/day in human trials\u003c\/td\u003e\n\u003ctd\u003eNo serious adverse events at supplemental doses; well-tolerated long-term\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e56 adults with major depression\u003c\/td\u003e\n\u003ctd\u003e500mg BID curcuminoids, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eIDS-SR score improvement vs. placebo, particularly in atypical-depression subgroup\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cem\u003eReferences below are listed in full citation form for verification. Curcumin is one of the most extensively studied natural compounds in modern medicine; the trials above are representative, not exhaustive.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eForm comparison — what the marketing labels actually mean\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eCurcuminoid %\u003c\/th\u003e\n\u003cth\u003eBioavailability multiple\u003c\/th\u003e\n\u003cth\u003eCost \/ dose\u003c\/th\u003e\n\u003cth\u003eBest use case\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRaw turmeric powder (kitchen spice)\u003c\/td\u003e\n\u003ctd\u003e~3%\u003c\/td\u003e\n\u003ctd\u003e1× baseline\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eCooking; not clinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e80% curcuminoid extract, no carrier\u003c\/td\u003e\n\u003ctd\u003e80%\u003c\/td\u003e\n\u003ctd\u003e~1×\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eOutdated; underabsorbed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e95% curcuminoids + BioPerine® (this product)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e~20×\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$$\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily anti-inflammatory base layer at sustainable cost\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMeriva® \/ phytosome curcumin\u003c\/td\u003e\n\u003ctd\u003e20% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~29× (Belcaro 2010)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eOA \/ GI-tolerance issues with piperine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTheracurmin® \/ colloidal nanoparticle\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003ctd\u003e~27× (Sasaki 2011)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eBrain-focused trials (Small 2018 used this form)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal curcumin\u003c\/td\u003e\n\u003ctd\u003evariable\u003c\/td\u003e\n\u003ctd\u003e~10–25×\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eNiche; comparable to phytosome at premium cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurcuWIN® \/ Longvida®\u003c\/td\u003e\n\u003ctd\u003e~20–46% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~46× \/ ~67×\u003c\/td\u003e\n\u003ctd\u003e$$$$\u003c\/td\u003e\n\u003ctd\u003eSpecialty — high cost for daily use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eFor most people running a permanent daily anti-inflammatory layer, \u003cstrong\u003e95% curcuminoids + BioPerine\u003c\/strong\u003e hits the sweet spot of clinically meaningful absorption at sustainable cost. Specialty formulations (Meriva, Theracurmin, Longvida) are worth the upcharge when you have a specific need: severe inflammation, gut-absorption issues, or a neuro-focused protocol with brain endpoints in mind.\u003c\/p\u003e\n\n\u003ch3\u003eWhere curcumin fits in a longevity stack\u003c\/h3\u003e\n\u003cp\u003eMost longevity protocols cover an NAD+ precursor (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e), a sirtuin activator (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e), and senolytics (\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e). What’s missing in 80% of stacks is the \u003cstrong\u003einflammation layer\u003c\/strong\u003e — and you can have perfect mitochondrial output, restored NAD+, and cleared senescent cells while still aging fast in a constant low-grade NF-κB simmer. Curcumin is the inflammation-layer cornerstone — same NF-κB endpoint as quercetin, different upstream mechanism, additive in published combination trials, and the only one in the catalog with the brain-penetration data.\u003c\/p\u003e\n\n\u003ch3\u003eStacking guide — mechanism-organized\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInflammation layer (the natural pair).\u003c\/strong\u003e Curcumin (NF-κB IKK inhibition) + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (NF-κB downstream + mast-cell stabilization) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution). Three different mechanisms converging on the same inflammaging pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 \/ antioxidant layer.\u003c\/strong\u003e Curcumin + \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (recycles Vit C\/E\/glutathione) + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (glutathione precursor) + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (direct GSH). Curcumin upregulates the system; NAC\/glycine\/ALA feed the substrates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular layer.\u003c\/strong\u003e Curcumin (CRP ↓) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e (triglycerides, endothelial function) + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (LDL, glucose) + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e (mitochondrial energy in cardiac tissue, especially if on a statin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF layer.\u003c\/strong\u003e Curcumin (BDNF, amyloid, tau) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 DHA\u003c\/a\u003e (synaptic membrane fluidity) + \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e (BBB-crossing antioxidant) + \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e (HPA-axis \/ cortisol).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer (SASP suppression).\u003c\/strong\u003e Curcumin lowers the inflammatory output of senescent cells you haven’t yet cleared, while \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e trigger their apoptosis. Curcumin runs daily; senolytics run pulsed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ metabolic layer.\u003c\/strong\u003e Curcumin (AMPK↑, mTOR↓) + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (AMPK↑ via lysosomal mechanism) + \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG\u003c\/a\u003e (metabolite, epigenetic clock) — three different upstream entry points to the AMPK\/mTOR axis that caloric restriction also targets.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \/ connective-tissue layer.\u003c\/strong\u003e Curcumin (NF-κB, prostaglandin signaling) + \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eCollagen peptides\u003c\/a\u003e (cartilage substrate) + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vit C\u003c\/a\u003e (extracellular matrix support).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer.\u003c\/strong\u003e Curcumin sits in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e tier alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e as a permanent daily, not a pulsed compound.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational tier:\u003c\/strong\u003e Curcumin is one of the seven daily essentials in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e protocol — the layer that should be in place before exotic compounds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-inflammatory cornerstone:\u003c\/strong\u003e The inflammation-layer counterpart to \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e — both NF-κB inhibitors, different upstream mechanisms, additive.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive resilience:\u003c\/strong\u003e Member of the \u003ca href=\"\/he\/collections\/brain-cognitive\"\u003eBrain \u0026amp; Cognitive\u003c\/a\u003e stack, alongside Omega-3 DHA and Astaxanthin, by virtue of its blood-brain-barrier penetration and BDNF data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular:\u003c\/strong\u003e Member of the \u003ca href=\"\/he\/collections\/cardiovascular\"\u003eCardiovascular\u003c\/a\u003e stack via CRP reduction and endothelial-function improvement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \u0026amp; connective tissue:\u003c\/strong\u003e Most-clinically-validated daily for joint comfort short of NSAIDs; pairs with collagen peptides and HA.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhy 1000mg specifically\u003c\/h3\u003e\n\u003cp\u003eThe dose-response curve for curcuminoids in published human trials is fairly well characterized. Below 200mg\/day, even with BioPerine, you’re unlikely to see CRP movement. Between 500 and 1000mg\/day plus piperine, you sit in the band that produced the CRP, joint-comfort, and metabolic outcomes in \u003cem\u003eSahebkar 2014\u003c\/em\u003e, \u003cem\u003eDaily 2016\u003c\/em\u003e, and \u003cem\u003ePanahi 2017\u003c\/em\u003e. Above 1500mg\/day the marginal benefit plateaus and GI tolerance issues climb. \u003cstrong\u003e1000mg of 95% curcuminoids = 950mg active curcuminoids per capsule\u003c\/strong\u003e — right at the modal trial dose, deliverable in a single capsule, with cost-per-day low enough to sustain as a daily for years.\u003c\/p\u003e\n\n\u003ch3\u003eWhat to expect — week by week\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2.\u003c\/strong\u003e Most people notice nothing subjectively. Plasma curcumin steady-state takes about a week to establish.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4.\u003c\/strong\u003e Joint stiffness on waking starts to ease. Post-exercise recovery feels modestly faster. Sleep quality may improve modestly via reduced inflammatory tone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8.\u003c\/strong\u003e Subjective joint-comfort improvements consolidate; for OA-spectrum users, this is when WOMAC-style pain scores typically drop in trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8–12.\u003c\/strong\u003e Objective markers move — CRP, IL-6, TNF-α if you’re tracking them. \u003cem\u003eSahebkar 2014\u003c\/em\u003e meta-analysis used 8–12 weeks as the typical window for measurable CRP reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–18.\u003c\/strong\u003e The cognitive-resilience and cardiovascular-marker territory, per \u003cem\u003eSmall 2018\u003c\/em\u003e (18 months for memory\/PET endpoints) and \u003cem\u003eAkazawa 2012\u003c\/em\u003e \/ \u003cem\u003eSugawara 2012\u003c\/em\u003e (8 weeks for endothelial function, sustained with continued use).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e Plasma curcumin is cleared within 24–72 hours; the anti-inflammatory benefit unwinds gradually over 4–8 weeks as NF-κB signaling returns to your previous baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDaily protocol\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule (1000mg curcuminoids + 5mg BioPerine) per day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e With a meal that contains some fat — eggs, avocado, olive oil, fish, full-fat yogurt. Curcumin is fat-soluble; the fat improves chylomicron uptake.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food:\u003c\/strong\u003e Yes, always. Reduces the small risk of GI upset and improves absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Continuous daily — curcumin is treated like fish oil and vitamin D in most longevity protocols, not pulse-dosed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different NF-κB mechanism), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin pathway), \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e (immune-modulation overlap).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 vegetable capsules, 60-day supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin without piperine, phospholipid, or nanoparticle carrier.\u003c\/strong\u003e Most of the dose is wasted — 1g of plain curcuminoids absorbs roughly the same as 50mg with BioPerine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin on an empty stomach.\u003c\/strong\u003e Curcumin is fat-soluble; without dietary fat the chylomicron uptake pathway barely engages, and GI tolerance is worse.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting same-day pain relief.\u003c\/strong\u003e Curcumin works on the underlying signal, not the prostaglandin endpoint. NSAIDs work in hours; curcumin works in weeks. Both work; they’re different timescales.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping after 2 weeks because “nothing happened.”\u003c\/strong\u003e The \u003cem\u003eSahebkar 2014\u003c\/em\u003e CRP-reduction window is 8–12 weeks; the \u003cem\u003eDaily 2016\u003c\/em\u003e joint-comfort window is 4–12 weeks. Curcumin rewards consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 80% curcuminoid extract because it’s cheaper.\u003c\/strong\u003e 15–20% less active per milligram. The savings disappear once you account for the dose you actually need.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairing with anticoagulants without checking.\u003c\/strong\u003e Curcumin has mild antiplatelet activity. If you’re on warfarin, apixaban, rivaroxaban, dabigatran, or daily aspirin, talk to your prescriber before adding it — not because curcumin is dangerous, but because the cumulative bleeding-time effect should be monitored.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContinuing through gallbladder symptoms.\u003c\/strong\u003e Curcumin stimulates bile flow. People with active gallstones or biliary obstruction can experience symptoms; stop and see a clinician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone running a longevity or healthspan protocol who wants to add the inflammation layer that most stacks miss.\u003c\/li\u003e\n  \u003cli\u003eAdults over 35 with CRP, IL-6, or TNF-α markers in the upper-normal range — the inflammaging audience.\u003c\/li\u003e\n  \u003cli\u003ePeople with morning joint stiffness, post-exercise inflammation, or osteoarthritis-spectrum symptoms looking for a daily anti-inflammatory that doesn’t carry NSAID GI risk.\u003c\/li\u003e\n  \u003cli\u003eAdults targeting cognitive resilience — particularly with family history of dementia or who want a daily compound with both BDNF and amyloid-clearance signal.\u003c\/li\u003e\n  \u003cli\u003eStatin-users (paired with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e) and prediabetic \/ metabolic-syndrome adults using curcumin as part of an AMPK \/ inflammation strategy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is not for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnancy or nursing — supplemental doses (above culinary turmeric) are not recommended.\u003c\/li\u003e\n  \u003cli\u003eActive gallstones or biliary tract obstruction — curcumin’s cholagogic effect can provoke symptoms.\u003c\/li\u003e\n  \u003cli\u003eAnyone scheduled for surgery within 2 weeks — stop ahead of elective procedures (mild antiplatelet activity).\u003c\/li\u003e\n  \u003cli\u003eAnyone on warfarin or other anticoagulants without prescriber input.\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (not the population the trials studied).\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known allergy to turmeric or piperine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety and interactions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelets.\u003c\/strong\u003e Mild additive antiplatelet effect. Talk to your prescriber if you take warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, or daily aspirin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications.\u003c\/strong\u003e Curcumin can mildly improve insulin sensitivity (Chuengsamarn 2012). If you’re on insulin or sulfonylureas, monitor glucose more closely in the first month.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron supplements.\u003c\/strong\u003e Curcumin can chelate iron at high doses. If you have iron-deficiency anemia or take iron, separate by 4+ hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 2 weeks before elective procedures.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGI tolerance.\u003c\/strong\u003e Some people experience mild GI upset on an empty stomach — always take with food. Heartburn is a rare reason to switch to a phospholipid form (Meriva).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-metabolism interactions.\u003c\/strong\u003e Piperine inhibits CYP3A4. If you take a narrow-therapeutic-index drug metabolized by CYP3A4 (some statins, some calcium-channel blockers, certain immunosuppressants), check with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term safety.\u003c\/strong\u003e Curcumin has been studied at supplemental doses (up to 8g\/day) for 6 months to 2+ years with no serious adverse signal. The 1000mg dose in this product sits well below any reported tolerance threshold.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhat’s in it — per capsule\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTurmeric root extract (\u003cem\u003eCurcuma longa\u003c\/em\u003e) — 1000mg, standardized to 95% curcuminoids = 950mg active curcuminoids\u003c\/strong\u003e (curcumin + demethoxycurcumin + bisdemethoxycurcumin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBioPerine® (black pepper extract, \u003cem\u003ePiper nigrum\u003c\/em\u003e) — 5mg, standardized to 95% piperine.\u003c\/strong\u003e The branded form used in published bioavailability trials.\u003c\/li\u003e\n  \u003cli\u003eHPMC vegetable capsule (vegan).\u003c\/li\u003e\n  \u003cli\u003eMicrocrystalline cellulose, vegetable magnesium stearate (flow agents at trace levels).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo\u003c\/strong\u003e titanium dioxide, no artificial colors, no GMOs, no soy, no gluten, no dairy.\u003c\/li\u003e\n  \u003cli\u003eUV-protective HDPE bottle, 60 capsules — 2-month supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSourcing, manufacturing, and quality\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eManufactured in a \u003cstrong\u003ecGMP-certified, ISO 9001-registered\u003c\/strong\u003e facility in the United States.\u003c\/li\u003e\n  \u003cli\u003eTurmeric root sourced from \u003cstrong\u003eIndia\u003c\/strong\u003e — the species’ geographic origin and the supply chain with the most established curcuminoid testing infrastructure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e of curcuminoid content (must read ≥95% to ship). Per-batch verification of piperine content in BioPerine.\u003c\/li\u003e\n  \u003cli\u003ePer-batch testing for: heavy metals (lead, cadmium, mercury, arsenic) per USP \u0026lt;2232\u0026gt;, pesticide residues per USP \u0026lt;561\u0026gt;, microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e) per USP \u0026lt;2021\/2022\u0026gt;, residual solvents per USP \u0026lt;467\u0026gt;, and stability at end-of-shelf-life.\u003c\/li\u003e\n  \u003cli\u003eBioPerine® is the trademarked black pepper extract from Sabinsa Corporation, the formulation used in the majority of published curcumin bioavailability studies, including Shoba 1998.\u003c\/li\u003e\n  \u003cli\u003eCOA (Certificate of Analysis) available on request — \u003ca href=\"\/he\/pages\/contact-business-information\"\u003econtact us\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFrequently asked\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWhy curcumin instead of just eating turmeric?\u003c\/strong\u003e Raw turmeric powder is roughly 3% curcuminoids by weight. To get a 950mg curcuminoid dose from food, you’d need to eat ~32 grams of turmeric powder per day — about 6 tablespoons — and even then, your body would absorb only a tiny fraction without piperine and fat. The extract concentrates the active compound; BioPerine multiplies what reaches your bloodstream.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does “95% curcuminoids” actually mean?\u003c\/strong\u003e “Curcuminoids” is the umbrella term for three related compounds — curcumin (~75% of the curcuminoid fraction), demethoxycurcumin (~15%), and bisdemethoxycurcumin (~10%) — all of which contribute to the activity. A 95% standardized extract means 95% of the extract by weight is active curcuminoids. Older or cheaper products are often standardized to 80% or unstandardized; per equivalent capsule, that’s 15–20% less active compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy BioPerine and not regular black pepper?\u003c\/strong\u003e BioPerine® is a patented black pepper extract standardized to 95% piperine. It’s the formulation used in the majority of the published curcumin bioavailability studies, including Shoba 1998. Sprinkling pepper on your food gives you maybe 0.1mg of piperine per gram of pepper — not enough to meaningfully shift absorption.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin + BioPerine vs. liposomal \/ phytosome \/ Theracurmin?\u003c\/strong\u003e Specialized formulations like Meriva (phosphatidylcholine), Theracurmin (colloidal nanoparticle), and liposomal curcumin have higher absorption per milligram than curcumin + BioPerine — typically 25–30× for phytosome\/colloidal vs. ~20× for BioPerine. They also cost roughly 3–5× as much per dose. For most people running a daily anti-inflammatory base layer, 1000mg curcuminoids + BioPerine delivers a clinically meaningful dose at a sustainable price. If you have specific reasons (severe inflammation, gut absorption issues, neuro-focused protocol), the premium formulations are worth considering.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Subjective markers (joint comfort, post-exercise recovery, mental clarity) — usually 2–6 weeks of consistent daily use. Objective markers (CRP, oxidative stress panels) — 8–12 weeks per the Sahebkar 2014 meta-analysis. Curcumin is a slow-build compound; the goal is the cumulative anti-inflammatory effect, not a same-day pain reliever.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take curcumin long-term?\u003c\/strong\u003e Yes. Curcumin has been studied in human trials for periods of 6 months to 2+ years at doses up to 8 grams\/day with no serious safety signal. The 1000mg daily dose in this product is well below any reported tolerance threshold. Most longevity protocols treat curcumin as a permanent daily, like fish oil or vitamin D — not a pulse-dosed compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. ibuprofen?\u003c\/strong\u003e Multiple randomized trials in osteoarthritis have shown comparable pain-score reduction at curcumin doses of 1000–1500mg\/day vs. typical NSAID doses (Daily 2016 meta-analysis), with markedly fewer GI side effects and no anticoagulant burden. Curcumin works on the underlying inflammation signal; NSAIDs work on prostaglandin synthesis. They’re not equivalent mechanisms, but the clinical outcome on pain scores is similar over 4–12 weeks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. Boswellia, ginger, or other anti-inflammatory botanicals?\u003c\/strong\u003e Different mechanisms. Boswellia inhibits 5-lipoxygenase (leukotriene pathway). Ginger inhibits COX\/LOX. Curcumin works upstream on NF-κB \/ Nrf2 transcription. Stacking is rational and well-tolerated. If you can run only one as a permanent daily, curcumin has the deepest published trial base.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I cycle off?\u003c\/strong\u003e Not required. There is no published evidence of curcumin tolerance build-up at supplemental doses. Most longevity protocols run curcumin continuously alongside fish oil and vitamin D as the permanent base of the anti-inflammatory layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy “with food that contains fat”?\u003c\/strong\u003e Curcumin is fat-soluble. Taking it with a fat source increases the fraction that solubilizes into chylomicrons and enters circulation via the lymphatic system — bypassing some of the first-pass hepatic metabolism. This is why curcumin labels recommend taking with a meal, not on an empty stomach.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy pair with Quercetin if it’s the same NF-κB target?\u003c\/strong\u003e Different upstream mechanisms. Curcumin inhibits IκB-kinase (preventing NF-κB activation). Quercetin acts as a flavonoid antioxidant and mast-cell stabilizer that intersects the same downstream pathway from a different angle. Combination trials show additive (not redundant) effects. They’re frequently stacked in published longevity protocols for this reason.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eYellow staining — is that normal?\u003c\/strong\u003e Yes. Curcumin is the natural yellow pigment in turmeric. If a capsule splits open, the powder will stain — this is purity, not a defect. The same pigment turns Indian curries yellow.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill curcumin interact with my medications?\u003c\/strong\u003e The interactions worth flagging to your prescriber are: anticoagulants and antiplatelets (mild additive bleeding-time effect), insulin and sulfonylureas (mild glucose-lowering — monitor in month 1), iron supplements (separate by 4+ hours), and CYP3A4-metabolized drugs (BioPerine inhibits CYP3A4 — relevant for some statins, calcium-channel blockers, and certain immunosuppressants). Curcumin itself is not a strong CYP inhibitor; the piperine in BioPerine is the relevant variable.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs there a CRP threshold below which curcumin doesn’t do anything?\u003c\/strong\u003e The CRP-reduction effect is most pronounced in adults with elevated baseline CRP (above ~3 mg\/L). In adults with already-low CRP (under 1 mg\/L), the absolute reduction is smaller, but the upstream NF-κB \/ Nrf2 effects still operate — you’re running the protocol for the next decade’s baseline, not the current week’s blood draw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin and depression — is there really an antidepressant signal?\u003c\/strong\u003e Modest but consistent. \u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e showed an effect on Inventory of Depressive Symptomatology scores at 500mg BID over 8 weeks in adults with major depression, particularly in the atypical-depression subgroup. The effect size is real but smaller than that of standard antidepressants — curcumin is best framed as adjunctive (in conversation with a clinician), not a primary treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is my curcumin dose not bottled with the iron and zinc and other extras some products use?\u003c\/strong\u003e Combination products complicate dose-response and dilute the curcumin per capsule. The published trials used curcumin + piperine alone or curcumin + piperine + a single carrier. We follow that.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the BioPerine vegan \/ GMO-free?\u003c\/strong\u003e BioPerine® from Sabinsa is non-GMO and vegan. The capsule shell is HPMC (cellulose), so the entire product is vegan.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between “turmeric extract” and “curcumin”?\u003c\/strong\u003e Turmeric extract is the broader plant-derived material; curcumin is the specific active polyphenol. A “turmeric extract standardized to 95% curcuminoids” is concentrated extract where 95% of the weight is the active curcuminoid fraction. A label that just says “turmeric” without a standardization percentage is almost certainly raw turmeric powder — the kitchen spice — and a clinical dose would require ~32 grams a day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy isn’t curcumin in the senolytics collection?\u003c\/strong\u003e Curcumin suppresses the senescence-associated secretory phenotype (SASP) but doesn’t reliably trigger apoptosis of senescent cells in human-relevant doses. The catalog reserves the “senolytic” tag for compounds with the apoptosis signal — \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e. Curcumin is “senolytic-adjacent” — complementary, not duplicative.\u003c\/p\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/inflammaging\"\u003eInflammaging — the slow inflammatory simmer behind chronic disease\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/foundational-7\"\u003eThe Foundational 7 daily nutrients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/classic-longevity-stack\"\u003eThe classic longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eAll protocols\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003eShoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. \u003cem\u003ePlanta Med\u003c\/em\u003e. 1998;64(4):353–356.\u003cbr\u003e\nSingh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin. \u003cem\u003eJ Biol Chem\u003c\/em\u003e. 1995;270(42):24995–25000.\u003cbr\u003e\nBalogun E, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. \u003cem\u003eBiochem J\u003c\/em\u003e. 2003;371(Pt 3):887–895.\u003cbr\u003e\nAggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent. \u003cem\u003eInt J Biochem Cell Biol\u003c\/em\u003e. 2009;41(1):40–59.\u003cbr\u003e\nAkazawa N, et al. Curcumin ingestion and exercise training improve vascular endothelial function. \u003cem\u003eNutr Res\u003c\/em\u003e. 2012;32(10):795–799.\u003cbr\u003e\nSugawara J, et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women. \u003cem\u003eAm J Hypertens\u003c\/em\u003e. 2012;25(6):651–656.\u003cbr\u003e\nChuengsamarn S, et al. Curcumin extract for prevention of type 2 diabetes. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2012;35(11):2121–2127.\u003cbr\u003e\nSahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? \u003cem\u003ePhytother Res\u003c\/em\u003e. 2014;28(5):633–642.\u003cbr\u003e\nLopresti AL, et al. Curcumin for the treatment of major depression. \u003cem\u003eJ Affect Disord\u003c\/em\u003e. 2014;167:368–375.\u003cbr\u003e\nFranceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e. 2014;69 Suppl 1:S4–S9.\u003cbr\u003e\nDaily JW, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a meta-analysis of randomized clinical trials. \u003cem\u003eJ Med Food\u003c\/em\u003e. 2016;19(8):717–729.\u003cbr\u003e\nHewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. \u003cem\u003eFoods\u003c\/em\u003e. 2017;6(10):92.\u003cbr\u003e\nPanahi Y, et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus. \u003cem\u003eDrug Res\u003c\/em\u003e. 2017;67(4):244–251.\u003cbr\u003e\nSmall GW, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults. \u003cem\u003eAm J Geriatr Psychiatry\u003c\/em\u003e. 2018;26(3):266–277.\u003cbr\u003e\nBelcaro G, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. \u003cem\u003eAltern Med Rev\u003c\/em\u003e. 2010;15(4):337–344.\u003cbr\u003e\nSasaki H, et al. Innovative preparation of curcumin for improved oral bioavailability. \u003cem\u003eBiol Pharm Bull\u003c\/em\u003e. 2011;34(5):660–665.\u003cbr\u003e\nAnand P, et al. Bioavailability of curcumin: problems and promises. \u003cem\u003eMol Pharm\u003c\/em\u003e. 2007;4(6):807–818.\u003cbr\u003e\nGupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. \u003cem\u003eAAPS J\u003c\/em\u003e. 2013;15(1):195–218.\u003c\/p\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003e\u003cem\u003eReferences listed in support of mechanism and dose rationale; not as endorsements of off-label medical use. Curcumin and BioPerine are dietary supplements, not pharmaceuticals.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just buy this on Amazon?\u003c\/h3\u003e\n\u003cp\u003eYou can. Three things are different here. \u003cstrong\u003e(1) Per-batch HPLC verification\u003c\/strong\u003e of the 95% curcuminoid claim and the 95% piperine claim, with COA available on request — on Amazon you have no idea whether the bottle on the shelf was tested. \u003cstrong\u003e(2) BioPerine® from Sabinsa\u003c\/strong\u003e, the trademarked black pepper extract used in the original Shoba 1998 bioavailability literature — not a no-name piperine commodity. \u003cstrong\u003e(3) The catalog architecture\u003c\/strong\u003e — curcumin is positioned, dosed, and stack-mapped against the rest of a longevity protocol you’re likely running, not sold as a one-off SKU.\u003c\/p\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e1 capsule once a day, with a meal that contains some fat. Most people take it at breakfast alongside \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e and \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e — they’re all fat-soluble and they share the same dosing rule.\u003c\/p\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eEmail us at support@truehealthprotocol.health or use the \u003ca href=\"\/he\/pages\/contact-business-information\"\u003econtact page\u003c\/a\u003e. We answer within one business day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, especially if you take prescription medication, are pregnant or nursing, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"60 Capsules","offer_id":47839341248730,"sku":"THP-CURCUMIN-1000-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_curcumin.png?v=1778047676"},{"product_id":"pqq-20mg-mitochondrial-biogenesis-activator","title":"PQQ 20mg | Mitochondrial Biogenesis Activator | Pyrroloquinoline Quinone for Cellular Energy \u0026 Brain","description":"\u003ch2\u003eThe mitochondrial biogenesis layer most longevity stacks miss\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e30-second answer:\u003c\/strong\u003e Pyrroloquinoline quinone (PQQ) is the most direct nutritional lever known for \u003cem\u003emitochondrial biogenesis\u003c\/em\u003e — the creation of new mitochondria inside existing cells. Other longevity ingredients support the mitochondria you already have (CoQ10), recycle the broken ones (Urolithin A), or supply the energy currency they run on (NMN, Resveratrol). PQQ is the only widely-studied compound that activates PGC-1α — the master transcription factor that turns on the genes for building new mitochondria — through the same upstream signaling network that exercise and caloric restriction work through. One 20mg capsule daily with a fat-containing meal. Most users notice cognitive effects in 4–8 weeks; the mitochondrial-density change is silent and biological, on the order of 3–6 months.\u003c\/p\u003e\n\n\u003ch2\u003eThe mitochondrial biogenesis problem (and why most stacks ignore it)\u003c\/h2\u003e\n\u003cp\u003eWalk through any serious longevity stack and the mitochondrial coverage will look something like this: NMN or NR to raise NAD\u003csup\u003e+\u003c\/sup\u003e, CoQ10 to support the electron-transport chain, sometimes Urolithin A to clear damaged mitochondria via mitophagy, sometimes Resveratrol or Spermidine to support sirtuins and autophagy. That covers fuel, machinery, cleanup, and renewal signaling. What it doesn't cover is \u003cstrong\u003epopulation\u003c\/strong\u003e — the actual number of working mitochondria inside each cell.\u003c\/p\u003e\n\u003cp\u003eAnd mitochondrial number is one of the most measurable things that declines with age. By the seventh decade of life, mitochondrial density in skeletal muscle is roughly half of what it was at twenty (Conley et al., \u003cem\u003eJournal of Physiology\u003c\/em\u003e, 2000). The same trend appears in cardiac muscle, neurons, hepatocytes, and oocytes. You can have perfectly maintained NAD\u003csup\u003e+\u003c\/sup\u003e levels and pristine CoQ10 status, but if your cells are running on a thinned-out mitochondrial population, they're producing less ATP per unit of tissue, generating more reactive oxygen species per unit of work, and failing earlier under load. This is why people in their seventies fatigue faster than people in their thirties even when their hemoglobin and resting metabolic rate look identical: it isn't fuel delivery, it's how many engines the cells have left.\u003c\/p\u003e\n\u003cp\u003ePQQ is the most direct nutritional lever for this layer. The molecule was discovered in the 1970s as a redox cofactor in bacterial dehydrogenases, but its biological relevance for mammals only became clear in the 1990s when PQQ-deficient diets were shown to cause growth failure, immunosuppression, infertility, and dramatic loss of mitochondrial content in mice — and crucially, that all of these effects could be reversed by restoring PQQ to the diet (Steinberg et al., \u003cem\u003eExperimental Biology and Medicine\u003c\/em\u003e, 1994; Killgore et al., \u003cem\u003eScience\u003c\/em\u003e, 1989). The mechanism turned out to involve PGC-1α (the master regulator of mitochondrial biogenesis), CREB, and a series of downstream genes for mitochondrial DNA replication and oxidative phosphorylation — the same longevity-relevant signaling network that resveratrol, NMN, and caloric restriction work through, but PQQ enters at a different node.\u003c\/p\u003e\n\u003cp\u003eThe first major human supplementation study (Harris et al., \u003cem\u003eThe Journal of Nutritional Biochemistry\u003c\/em\u003e, 2010) showed measurable increases in mitochondrial-related gene expression and reductions in plasma C-reactive protein in healthy adults after eight weeks of PQQ supplementation. A 2013 follow-up showed reductions in oxidative-damage markers (8-isoprostane, methylated lysines) and improvements in mitochondrial-related metabolites (Harris et al., 2013). Subsequent Japanese trials extended the cognitive results — Nakano et al. (2009, 2012) showed improvements in higher cognitive function in middle-aged and older adults, with the effect amplified when PQQ was combined with CoQ10.\u003c\/p\u003e\n\n\u003ch2\u003eHow PQQ actually works inside the cell\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. PGC-1α activation — mitochondrial biogenesis.\u003c\/strong\u003e PQQ phosphorylates and activates CREB (cAMP response element-binding protein), which in turn activates PGC-1α — the transcription co-activator that turns on the entire genetic program for building new mitochondria, including nuclear respiratory factors NRF1 and NRF2 and mitochondrial transcription factor A (TFAM). This is the same pathway exercise activates. Sometimes called \"exercise in a capsule\" — that's an oversimplification because exercise also drives capillary growth, fiber-type changes, and a hundred other adaptations PQQ does not — but at the molecular level of biogenesis signaling, the description is more accurate than not.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Direct redox cofactor activity — durable antioxidant inside the mitochondrial environment.\u003c\/strong\u003e PQQ itself is one of the most catalytically efficient redox cofactors known. It can cycle through approximately 20,000 redox conversions before being consumed, compared with roughly four for ascorbic acid. That makes it an unusually durable antioxidant, particularly inside the lipid-bilayer environment of the inner mitochondrial membrane where most water-soluble antioxidants can't reach effectively. This complements rather than overlaps with CoQ10, which is the inner-membrane antioxidant for the lipid phase but does not catalyze cycle reactions in the same way.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. NGF (nerve growth factor) upregulation — neuronal support.\u003c\/strong\u003e PQQ has been shown in cell-culture studies to stimulate NGF mRNA expression and protein release from astrocytes (Yamaguchi et al., \u003cem\u003eBioscience, Biotechnology, and Biochemistry\u003c\/em\u003e, 1993). NGF supports neuronal survival, axonal growth, and synaptic plasticity. This appears to be part of why the most consistent subjective report from PQQ users is improved mental clarity and reduced brain fog rather than the muscular energy effect more typical of CoQ10 — the brain has the highest mitochondrial density and the highest NGF dependence of any organ system.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Synergy with CoQ10.\u003c\/strong\u003e The Nakano et al. (2009) trial in \u003cem\u003eFunctional Foods in Health and Disease\u003c\/em\u003e tested PQQ alone (20mg\/day), CoQ10 alone (300mg\/day), and the combination in adults with cognitive complaints. Both compounds produced individual improvements; the combination produced the largest improvements in attention, working memory, and processing speed. The mechanistic explanation is direct: PQQ drives the creation of new mitochondria, CoQ10 functionally populates them as the obligate cofactor for Complex I, II, and III of the electron transport chain. Building more engines without filling them with the cofactor that makes them run is half a stack; supporting existing engines without making more is the other half. Together is the full picture.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e5. mtDNA protection and biogenesis maintenance.\u003c\/strong\u003e Beyond turning on biogenesis, PQQ has been shown to reduce oxidative damage to mitochondrial DNA itself (Stites et al., \u003cem\u003eJournal of Nutrition\u003c\/em\u003e, 2006; Bauerly et al., \u003cem\u003ePLOS ONE\u003c\/em\u003e, 2011). Mitochondrial DNA is more vulnerable than nuclear DNA because it lacks histones, has fewer repair pathways, and sits in the most oxidative environment in the cell. Protecting mtDNA preserves the genetic blueprint for the new mitochondria PQQ is signaling the cell to build — without that, biogenesis would just produce defective copies.\u003c\/p\u003e\n\n\u003ch2\u003eWhere PQQ fits in your stack — the four-layer mitochondrial protocol\u003c\/h2\u003e\n\u003cp\u003eMitochondrial health is best understood as four distinct layers, each with a different lever:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePopulation (how many you have):\u003c\/strong\u003e PQQ — biogenesis via PGC-1α \/ CREB \/ NRF1 \/ TFAM. Builds new mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunction (how well they run):\u003c\/strong\u003e CoQ10 \/ ubiquinol — Complex I, II, III electron-transport cofactor. Powers existing mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCleanup (removing broken ones):\u003c\/strong\u003e Urolithin A — mitophagy via PINK1 \/ Parkin. Recycles defective mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuel (the energy currency they run on):\u003c\/strong\u003e NMN, NR, Liposomal NAD+, Resveratrol — NAD\u003csup\u003e+\u003c\/sup\u003e production, sirtuin activation. Supplies the substrate the mitochondria spend.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost stacks cover one or two of these. The strongest mitochondrial protocols cover all four. PQQ is usually the missing piece because it's the newest of the major longevity ingredients to reach mainstream attention — the molecule was only formally recognized as a vitamin-like compound in 2003 (Kasahara \u0026amp; Kato, \u003cem\u003eNature\u003c\/em\u003e), and the first major human supplementation study didn't appear until 2010. It's also the only one of the four that operates at the gene-expression level rather than the biochemical-substrate level, which is why the time-to-effect is measured in weeks-to-months rather than days.\u003c\/p\u003e\n\u003cp\u003eOne implication of the four-layer model worth naming directly: the layers are not interchangeable. NMN does not cover what PQQ covers. Urolithin A does not cover what PQQ covers. Stacking three NAD\u003csup\u003e+\u003c\/sup\u003e precursors together does not address mitochondrial number. If your stack already includes NMN, CoQ10, and Urolithin A, PQQ is the highest-leverage single addition you can make, because it's the only one that increases the population of working mitochondria the other three are supporting.\u003c\/p\u003e\n\n\u003ch2\u003eWhy PQQ matters for fertility and reproductive health\u003c\/h2\u003e\n\u003cp\u003eOf all the cells in the human body, the oocyte (egg cell) contains by far the most mitochondria — roughly 100,000 of them, compared with about 1,000–2,000 in a typical somatic cell. That density is not accidental. The early embryo runs entirely on mitochondrial ATP from the mother's egg until implantation; the sperm contributes essentially nothing to the embryo's mitochondrial population (and what little it does contribute is actively destroyed by ubiquitin-mediated degradation in the early embryo).\u003c\/p\u003e\n\u003cp\u003eThe downstream implication is that mitochondrial quality and quantity in the oocyte is one of the strongest predictors of fertility outcomes, and the most consistent biological reason that egg quality declines with maternal age. The same logic applies to sperm motility, which is almost entirely mitochondrial-ATP-dependent — the sperm tail is essentially a mitochondrial engine wrapped in a cytoskeletal scaffold; sperm count and morphology speak to genetic health, but motility speaks to mitochondrial bioenergetics.\u003c\/p\u003e\n\u003cp\u003eThis is why CoQ10 (or its reduced form ubiquinol) has been a mainstream recommendation in reproductive endocrinology clinics for over a decade and is now standard adjunctive therapy in many IVF protocols. PQQ extends the same logic at the population level: rather than just supporting the function of existing mitochondria, it actively stimulates the creation of new ones in tissues with high turnover. That's the rationale for stacking PQQ with CoQ10 in a fertility-focused protocol — the same logic that drives the rest of the longevity stack, but with the reproductive system as the primary target tissue.\u003c\/p\u003e\n\u003cp\u003ePQQ has not yet been studied head-to-head as a fertility intervention with the same depth as CoQ10, so this section is a mechanistic argument rather than a clinical-evidence claim. If you are actively trying to conceive, undergoing IVF, or working with a reproductive endocrinologist, the addition of any new supplement to your protocol should be discussed with that specialist before you start. We are providing the mechanism. Your clinician knows your case.\u003c\/p\u003e\n\n\u003ch2\u003eBrain and cognitive support — the most consistent subjective effect\u003c\/h2\u003e\n\u003cp\u003eThe brain is roughly 2% of body weight but consumes around 20% of the body's resting energy — a per-gram metabolic rate higher than any other tissue. That makes it acutely sensitive to mitochondrial population and function. It is also one of the tissues in which PQQ's NGF-upregulating effect is most relevant: NGF supports the survival of cholinergic neurons in the basal forebrain, sympathetic neurons, and nociceptive sensory neurons, all of which are vulnerable to age-related dropout.\u003c\/p\u003e\n\u003cp\u003eThe Nakano et al. (2009 and 2012) trials measured cognitive performance using the Stroop test, attention-shift tasks, and short-term memory assessments in middle-aged and older adults. PQQ at 20mg\/day for 12 weeks produced measurable improvements in attention and processing-speed measures versus placebo. The PQQ + CoQ10 combination amplified the effect. A separate trial in adults with subjective cognitive complaints (Itoh et al., \u003cem\u003eJournal of Clinical Biochemistry and Nutrition\u003c\/em\u003e, 2016) showed reductions in self-reported fatigue and improvements in sleep quality and concentration.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of dramatic cognitive enhancement and PQQ is not a stimulant. The signal across these studies is consistent with the mechanism: gradual improvement in mitochondrial-density-dependent functions in tissues that are already working, with the largest effects in people whose baseline cognitive function is below their personal optimum (afternoon brain fog, sleep-disruption-driven fatigue, age-related processing-speed decline). If you are looking for an acute focus aid, you want caffeine, theanine, or a racetam — not PQQ. If you are looking to add the layer that compounds quietly over months and supports the brain's mitochondrial population for years, PQQ is the foundational tool.\u003c\/p\u003e\n\n\u003ch2\u003eCardiovascular and metabolic effects\u003c\/h2\u003e\n\u003cp\u003eThe heart is the second-most mitochondria-dense tissue in the body — cardiomyocytes are roughly 30–35% mitochondria by volume. That density is what allows the heart to contract approximately 100,000 times per day at oxidative-phosphorylation-driven efficiency. It is also why mitochondrial dysfunction shows up clinically as heart failure with preserved ejection fraction, exercise intolerance, and the fatigue patterns associated with chronic cardiovascular disease.\u003c\/p\u003e\n\u003cp\u003eThe Harris 2010 trial showed a measurable reduction in plasma C-reactive protein (CRP) — a systemic inflammation marker associated with cardiovascular risk — after eight weeks of PQQ supplementation. The 2013 Harris follow-up showed reduction in oxidative damage markers including 8-isoprostane (a marker of lipid peroxidation associated with atherosclerosis) and methylated lysines (a marker of mitochondrial protein damage). A 2015 Chinese trial (Zhu et al., \u003cem\u003eCardiovascular Drugs and Therapy\u003c\/em\u003e) studied PQQ in patients with ischemia-reperfusion injury and found cardioprotective effects mediated by activation of PGC-1α and reduction of oxidative damage in cardiac tissue.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of cardiovascular treatment. PQQ is not a substitute for any prescribed cardiac therapy, lipid-lowering protocol, or blood-pressure management. It is a long-horizon mitochondrial support tool whose cardiovascular relevance derives from the same general mechanism that drives its skeletal-muscle and brain effects: cardiomyocytes are mitochondria-dense, mitochondria respond to PGC-1α-mediated biogenesis signaling, PQQ activates that pathway, and the downstream effects on inflammation and oxidative stress are measurable.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in this bottle\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePyrroloquinoline quinone disodium salt (PQQ): 20mg\u003c\/strong\u003e — pharmaceutical-grade BioPQQ™-grade material. The disodium salt is the chemical form used in essentially all of the major published clinical trials and the only form with established human oral-bioavailability data. The exact dose used in the Harris 2010 mitochondrial-density study and the Nakano 2009 and 2012 cognitive studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBioPerine® black pepper extract: 5mg\u003c\/strong\u003e — standardized to 95% piperine. Piperine inhibits the gut and liver enzymes (UGT1A1, CYP3A4) that break down many fat-soluble cofactors, including the ones PQQ is most often stacked with: CoQ10, curcumin, vitamin D, astaxanthin. PQQ itself has reasonable oral bioavailability and does not strictly need piperine; the BioPerine here supports the stack PQQ is intended to operate inside.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule.\u003c\/strong\u003e No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients.\u003c\/li\u003e\n\u003cli\u003e60 capsules per bottle — two-month supply at the standard daily dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDaily protocol (recommended):\u003c\/strong\u003e 1 capsule (20mg) taken in the morning with a fat-containing meal. PQQ is a small molecule with reasonable water solubility, but absorption is improved when taken alongside dietary fat — the same general principle that applies to CoQ10, curcumin, vitamin D, vitamin K, and astaxanthin. Morning rather than evening because the cognitive-clarity and energy-related downstream effects are more useful during the active part of your day; PQQ is not sedating but the mitochondrial-density signaling is most aligned with daytime metabolic demand.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStacking notes:\u003c\/strong\u003e PQQ pairs naturally with CoQ10 — take both with the same fat-containing meal. It also stacks logically with NMN, Urolithin A, Resveratrol, Spermidine, Fisetin, Quercetin, TMG, Apigenin, and the rest of the True Health Protocol mitochondrial and longevity stack. Each works on a different layer (population, function, cleanup, fuel, signaling), so there is no redundancy and no published evidence of negative interaction within this combination set. PQQ is also compatible with most cardiovascular medications and standard multivitamins; the antioxidant and biogenesis effects do not interfere with statins, antihypertensives, or thyroid replacement at the doses studied.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTime to effect:\u003c\/strong\u003e Subjective cognitive effects (mental clarity, reduced afternoon fatigue, sharper attention) are typically reported between weeks 4 and 8. The underlying mitochondrial-density change is much slower — the Harris 2010 study used an 8-week protocol to show changes in mitochondrial-related gene expression and inflammation markers; full effects at the cellular density level likely require 3–6 months of continuous use. The compounds that work via gene expression (PQQ, NMN, Resveratrol, Spermidine) all share this profile: slower onset, longer-duration changes, and best results at consistent daily dosing rather than intermittent or pulsed protocols.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling vs. continuous use:\u003c\/strong\u003e Unlike senolytics (Fisetin, Quercetin) which have a published rationale for monthly pulsing, PQQ is most effective as a continuous daily protocol. The biogenesis signaling is sustained, not pulsatile, and the underlying tissue change accumulates with continued exposure. There is no published evidence that PQQ requires breaks, develops tolerance, or downregulates its own pathway over time.\u003c\/p\u003e\n\n\u003ch2\u003eWho should not take this\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding.\u003c\/strong\u003e PQQ has not been studied in human pregnancy. Animal studies in PQQ-deficient diets show severe reproductive and growth effects (which is part of why PQQ is sometimes considered vitamin-like), but supplementation safety above dietary background levels in human pregnancy has not been established. Do not use without medical supervision.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnder 18.\u003c\/strong\u003e PQQ has not been studied in children or adolescents. Pediatric mitochondrial dysfunction is its own clinical area and any supplementation should be managed by a specialist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on chemotherapy or other treatment that depends on mitochondrial dysfunction in target cells.\u003c\/strong\u003e Some cancer therapies work by exploiting mitochondrial vulnerability in malignant cells; supporting mitochondrial biogenesis and antioxidant capacity during such treatment may interfere with therapeutic intent. Discuss with your oncology team before adding any antioxidant or mitochondrial supplement during active cancer treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone scheduled for surgery within two weeks.\u003c\/strong\u003e The mild antioxidant activity of PQQ may theoretically affect surgical bleeding response or anesthesia metabolism. Stop two weeks before any planned procedure as a standard precaution and resume after your surgeon clears post-operative supplementation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity to quinone-class compounds.\u003c\/strong\u003e PQQ is a quinone — chemically related to ubiquinone (CoQ10) and the K-vitamins. Rare individual sensitivities have been reported, typically presenting as nausea or mild headache at higher doses. Start at one capsule and monitor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on warfarin or other anticoagulant therapy.\u003c\/strong\u003e No published evidence of direct interaction, but quinone-class compounds participate in vitamin-K-related coagulation chemistry. If you are on warfarin, your INR should be monitored when adding any new antioxidant or mitochondrial supplement; talk with your prescriber first.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nThey work on completely different layers of mitochondrial health, and the cleanest way to think about them is as the population-versus-function pair. CoQ10 sits inside the inner mitochondrial membrane and shuttles electrons through Complex I, II, and III of the electron transport chain — it is a functional cofactor for ATP production in \u003cem\u003eexisting\u003c\/em\u003e mitochondria. PQQ doesn't do that. PQQ acts upstream at the gene-expression level, signaling the cell to build \u003cem\u003emore\u003c\/em\u003e mitochondria via PGC-1α activation. They're complementary, not redundant. The Nakano 2009 trial directly compared the two and found that the combination outperformed either alone on cognitive endpoints — that result is the empirical case for stacking them. If you can only take one, your decision should follow your symptom profile: CoQ10 if your concern is energy \/ heart \/ statin support, PQQ if your concern is age-related cognitive decline \/ long-term mitochondrial density.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from Urolithin A?\u003c\/strong\u003e\u003cbr\u003e\nUrolithin A drives mitophagy — the controlled clearance of damaged mitochondria via the PINK1 \/ Parkin pathway. It removes broken units. PQQ drives biogenesis — the creation of new mitochondria via PGC-1α \/ CREB \/ NRF1. It builds new units. Together they form a renewal cycle: clear the broken ones (Urolithin A), build new ones (PQQ), keep the rest running (CoQ10), and supply the energy currency they all spend (NMN \/ NAD\u003csup\u003e+\u003c\/sup\u003e). This is the four-layer model and stacking all four is the most complete mitochondrial protocol we publish.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from NMN, NR, or other NAD\u003csup\u003e+\u003c\/sup\u003e precursors?\u003c\/strong\u003e\u003cbr\u003e\nNMN and NR raise NAD\u003csup\u003e+\u003c\/sup\u003e, the substrate that mitochondria spend during oxidative phosphorylation and that sirtuin enzymes consume during cellular signaling. NAD\u003csup\u003e+\u003c\/sup\u003e is the energy currency. PQQ doesn't increase NAD\u003csup\u003e+\u003c\/sup\u003e — it increases the number of mitochondria that \u003cem\u003espend\u003c\/em\u003e NAD\u003csup\u003e+\u003c\/sup\u003e. If NAD\u003csup\u003e+\u003c\/sup\u003e is the dollar bills, PQQ is the staff that earns and spends them. Both layers matter; neither replaces the other. The Liposomal NAD+ Ultimate, Pure NMN, NMN 1000mg, NR Hard Capsules, NAD+ Daily Boost, Liquid NAD+, NAD+ Pure Focus, and NAD+ 5-in-1 in this catalog all address the fuel layer; PQQ addresses the population layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I just get PQQ from food?\u003c\/strong\u003e\u003cbr\u003e\nTechnically yes — PQQ is present in trace amounts in fermented soybeans (natto), parsley, green tea, papaya, kiwi, and a few other plant foods. Practically no — the typical Western diet provides roughly 0.1–0.4mg per day, while the supplementation studies use 10–20mg per day. You'd need to eat several pounds of natto daily to reach the studied dose, which isn't a realistic protocol for most people, and the natto fermentation profile is not well tolerated by Western palates. The dose at which the published cognitive and biogenesis effects are seen is fifty to two hundred times the typical dietary intake. This is one of the cleaner \"supplementation makes sense\" cases in nutrition science.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is 20mg the right dose?\u003c\/strong\u003e\u003cbr\u003e\n20mg per day is the dose used in the most-cited human studies, including the Harris 2010 mitochondrial-density \/ inflammation study, the Nakano 2009 PQQ + CoQ10 cognitive study, and the Itoh 2016 fatigue\/sleep trial. Higher doses (40mg) have been used safely in some protocols but did not produce proportionally larger effects on the published endpoints; lower doses (10mg) underperformed. 20mg is the dose the published research converges on as the empirical sweet spot for healthy adults. If you have specific clinical reasons (mitochondrial myopathy, severe cognitive complaint, fertility protocol) to pursue a higher or lower dose, that decision should be made with a specialist.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything from PQQ on day one?\u003c\/strong\u003e\u003cbr\u003e\nProbably not. PQQ works by changing what genes your cells transcribe — that takes weeks. Most users report no immediate effect, then notice gradual improvements in mental clarity and afternoon energy somewhere between weeks 4 and 8. If you're looking for a same-day stimulant effect, PQQ is the wrong tool — caffeine, theanine, tyrosine, or the prescription nootropics will all be faster. PQQ is the long-horizon mitochondrial-density layer that compounds over months and supports the rest of your stack quietly. The clinical literature is consistent on this profile: gene-expression interventions take time and produce changes that are larger than they feel on any given day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I take PQQ with my fertility protocol?\u003c\/strong\u003e\u003cbr\u003e\nPQQ is increasingly included in fertility-focused supplement protocols specifically because of its mitochondrial-biogenesis mechanism — oocytes contain roughly 100,000 mitochondria and sperm motility is almost entirely mitochondrial-ATP-dependent. It is commonly stacked with CoQ10 (or its reduced form, ubiquinol) in this context. That said, fertility is a medical area where any supplement should be discussed with your reproductive endocrinologist or fertility specialist, particularly if you are undergoing IVF or any active medical treatment. We provide the mechanistic rationale; your clinician knows your case, your medications, and your timeline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Why does it need BioPerine?\u003c\/strong\u003e\u003cbr\u003e\nPQQ on its own has reasonable oral bioavailability — better than most flavonoids and roughly comparable to CoQ10 in lipid form. The BioPerine in this formula isn't strictly required for PQQ absorption itself; it's there to support the broader fat-soluble cofactor stack you're likely taking PQQ alongside (CoQ10, curcumin, vitamin D, vitamin K, astaxanthin) by inhibiting the gut and liver enzymes (UGT1A1, CYP3A4) that break those compounds down before they reach circulation. Same logic and same 5mg dose as the BioPerine in our Curcumin, Apigenin, Quercetin, and Fisetin formulas — the BioPerine works for the stack, not the single compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What does the science actually show about mitochondrial number and aging?\u003c\/strong\u003e\u003cbr\u003e\nThe single best summary is the Conley et al. 2000 \u003cem\u003eJournal of Physiology\u003c\/em\u003e paper, which used 31-phosphorus magnetic resonance spectroscopy in living human muscle to show that mitochondrial oxidative capacity in skeletal muscle declines roughly 50% between the third and seventh decades of life. Similar declines have been documented in cardiac muscle (Lesnefsky et al.), in brain tissue (Manczak et al.), and in oocytes (Wang et al.). The decline is real, measurable, and one of the more consistent biological signatures of aging. PQQ is one of the cleanest direct nutritional levers known for that specific endpoint. It does not stop the decline, but the supplementation studies show measurable shifts in the mitochondrial-related gene-expression and inflammation signatures that track with the decline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I stack PQQ with my existing CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nYes — that is the most-evidence-supported stacking pattern for PQQ, dating back to the Nakano 2009 trial. The two compounds work on adjacent layers: PQQ creates new mitochondria, CoQ10 functionally populates them as the obligate Complex I\/II\/III cofactor. Take both with the same fat-containing meal in the morning. Standard CoQ10 stacking dose is 100–400mg\/day; our CoQ10 product is 400mg per capsule, which is in the upper range of the standard published dose. There is no published evidence of any negative interaction between PQQ and CoQ10 at the doses used here.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What's the difference between BioPQQ™ and generic PQQ?\u003c\/strong\u003e\u003cbr\u003e\nBioPQQ™ is the brand name for fermentation-derived PQQ disodium salt produced by Mitsubishi Gas Chemical in Japan, which is the form used in essentially all of the published human clinical trials. Generic PQQ refers to chemically synthesized PQQ from any other source. The disodium-salt chemistry is identical between the two; the difference is the manufacturing process and the supply-chain quality assurance. We use pharmaceutical-grade BioPQQ™ disodium salt because that is the form with the published bioavailability and clinical-effect data; if you compared a research paper on \"PQQ supplementation\" to the bottle in your hand, this is the form you would want to match.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Are there any reported side effects?\u003c\/strong\u003e\u003cbr\u003e\nAt the 20mg\/day dose, published trials report essentially no significant adverse effects — the safety profile in healthy adults is very clean. At higher doses (60mg+) there are isolated reports of mild gastrointestinal discomfort, headache, or transient sleep changes. Standing recommendations: start at one capsule per day, take with food, and if you tolerate it after a week, that is your protocol. There is no need to escalate above 20mg unless directed by a specialist.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eBioPQQ™-grade pyrroloquinoline quinone disodium salt, manufactured in a GMP-certified facility, third-party tested for identity, purity, heavy metals (lead, arsenic, cadmium, mercury), residual solvents, and microbial contamination (total plate count, yeast and mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients. Vegan capsule (vegetable cellulose). Bottle is BPA-free. Made in the USA in a cGMP-certified facility.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use, especially if you are pregnant, nursing, taking medication, scheduled for surgery, undergoing cancer treatment, or have an ongoing medical condition. Individual results vary. The references to clinical trials in this description are provided for mechanistic context and are not claims of treatment efficacy for any specific disease. PQQ is a dietary supplement, not a medication, and does not substitute for any prescribed therapy.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839440765146,"sku":"THP-PQQ-20-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pqq.png?v=1778047682"},{"product_id":"omega-3-fish-oil-2000mg-epa-dha","title":"Deep-Sea Fish Oil (AT-009)","description":"\u003cp\u003e\u003cstrong\u003e2000 mg of wild-caught fish oil per softgel\u003c\/strong\u003e, standardized to deliver \u003cstrong\u003e720 mg EPA + 480 mg DHA\u003c\/strong\u003e in the clinically-studied 3:2 ratio. Triglyceride-form (rTG), molecularly distilled, third-party tested for heavy metals and PCBs, in a small enteric-coated softgel — no fishy reflux, no aftertaste. The single nutrient with more peer-reviewed cardiovascular and brain-longevity research behind it than anything else in this catalog.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy people take it:\u003c\/strong\u003e long-chain omega-3s (EPA + DHA) lower triglycerides 20–30% (Skulas-Ray 2019, AHA Science Advisory), reduce systemic inflammation (Calder 2017), and physically build the phospholipid membranes of every neuron, retinal cell, and cardiomyocyte you own.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat it’s NOT:\u003c\/strong\u003e not flaxseed oil. ALA-to-EPA conversion in humans is 1–10% (Burdge 2002), and ALA-to-DHA is closer to 0.5%. If your goal is a measurable Omega-3 Index, fish oil is the only practical route — or algal oil for vegans.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe form matters:\u003c\/strong\u003e triglyceride (TG \/ re-esterified TG) is absorbed roughly 70% better than ethyl-ester (EE) over 6 months (Dyerberg 2010, Neubronner 2011). Most pharmacy fish oil is EE because it’s cheaper to concentrate. Ours is rTG.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 2 softgels = 1,440 mg EPA + 960 mg DHA. The dose used in REDUCE-IT (Bhatt 2019, NEJM) was 4 g\/day icosapent ethyl, but every dose-response analysis (Skulas-Ray 2019, Mozaffarian 2011) shows clear cardiovascular signal starting at ≈1 g\/day combined EPA+DHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTimeline:\u003c\/strong\u003e Omega-3 Index moves measurably in 8–12 weeks. Triglycerides move in 4–6 weeks. Joint and mood signal in 8–16 weeks. Cardiovascular event reduction is a multi-year endpoint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhere it sits in this catalog:\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7 100mcg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e, this is one of the three foundational supplements that earn their place in essentially every healthspan protocol — the always-on layer underneath your \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy omega-3s sit at the foundational layer\u003c\/h2\u003e\n\u003cp\u003eMost longevity stacks chase mechanisms — sirtuins, mitophagy, NAD+ precursors, senolytics. Omega-3s are different: they are a \u003cem\u003estructural\u003c\/em\u003e intervention. Every cell membrane in your body is built from a phospholipid bilayer, and the fatty acids on the “sn-2” position of those phospholipids dictate how the membrane behaves — how fluid it is, how it folds, how its receptors signal, and what eicosanoids it releases when injured.\u003c\/p\u003e\n\u003cp\u003eEPA and DHA compete with arachidonic acid (the omega-6 you get from seed oils, conventional poultry, and processed food) for incorporation into those membranes. When dietary EPA\/DHA is low and arachidonic acid is high — the default modern Western pattern — cells generate predominantly pro-inflammatory eicosanoids: 2-series prostaglandins, 4-series leukotrienes, thromboxane A2. When EPA\/DHA replace arachidonic acid in the membrane, the same enzymes (COX, LOX) instead generate \u003cstrong\u003e3-series prostaglandins, 5-series leukotrienes, and the entire Specialized Pro-resolving Mediator (SPM) family\u003c\/strong\u003e — resolvin E1\/E2, resolvin D1-D6, protectin D1, maresin 1 — which actively terminate inflammation rather than amplify it (Serhan 2014, Nature; Calder 2017).\u003c\/p\u003e\n\u003cp\u003eThis is why omega-3 supplementation has measurable effects across 12+ unrelated organ systems: it’s not a drug acting on one receptor — it’s a building material that changes the \u003cem\u003eresolution\u003c\/em\u003e capacity of every membrane in the body.\u003c\/p\u003e\n\n\u003ch2\u003eThe Omega-3 Index — the only blood marker that matters here\u003c\/h2\u003e\n\u003cp\u003eThe \u003cstrong\u003eOmega-3 Index\u003c\/strong\u003e (Harris \u0026amp; von Schacky 2004, Prev Med) is the percentage of EPA + DHA in red blood cell membrane phospholipids. It’s the cleanest single biomarker for omega-3 status because RBC membranes turn over slowly (≈120 days) and reflect long-term incorporation rather than the previous meal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026lt; 4%\u003c\/strong\u003e — high cardiovascular risk zone. The U.S. average sits in this range. Sudden cardiac death risk roughly 10x vs \u0026gt;8% (Albert 2002, NEJM, n=22,071 male physicians).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e4–8%\u003c\/strong\u003e — intermediate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026gt; 8%\u003c\/strong\u003e — cardioprotective range. This is the level epidemiologically associated with the lowest all-cause mortality in the Framingham Offspring follow-up (Harris 2018, J Clin Lipidol, n=2,500, 11-year follow-up: each 1% Omega-3 Index increase associated with 13% lower all-cause mortality).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2 softgels\/day of this product (1.44 g EPA + 0.96 g DHA) typically moves the Omega-3 Index from the 3–5% Western baseline into the 8–10% range over 12–16 weeks (Flock 2013, J Lipid Res — dose-response curve). 3–4 softgels move it faster but plateau in the same range.\u003c\/p\u003e\n\n\u003ch2\u003eTriglyceride vs ethyl ester — why the form on the label is non-negotiable\u003c\/h2\u003e\n\u003cp\u003eNative fish oil is in \u003cstrong\u003etriglyceride (TG) form\u003c\/strong\u003e — three fatty acids attached to a glycerol backbone, just as they exist in fish flesh. To concentrate EPA and DHA above the ≈30% native ratio (most fish oil starts there), manufacturers add ethanol, releasing fatty acids as \u003cstrong\u003eethyl esters (EE)\u003c\/strong\u003e. EE allows molecular distillation up to \u0026gt;90% EPA+DHA but produces a synthetic form that the gut absorbs differently:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipase activity:\u003c\/strong\u003e pancreatic lipase hydrolyzes TG roughly 10–50x faster than EE (Yang 1990, Biochim Biophys Acta).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6-month bioavailability:\u003c\/strong\u003e rTG produces 70% higher RBC incorporation than EE at the same dose (Dyerberg 2010, Prostaglandins Leukot Essent Fatty Acids; Neubronner 2011 same-design replication).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReflux\/burping:\u003c\/strong\u003e EE generates ethanol on hydrolysis and tends to produce more “fish-oil reflux.”\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e rTG is more oxidation-resistant than free fatty acid (FFA) form, less so than EE.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRe-esterified TG (rTG) is EE that has been enzymatically converted back to TG form — you get the concentration of EE plus the absorption of native TG. Most premium fish oil is rTG. Ours is rTG. Most U.S. pharmacy and big-box brands are EE because the regulatory pathway and unit cost are cheaper. Read the label; if it doesn’t specifically say “triglyceride form” or “rTG,” assume EE.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical evidence — six domains, not just heart\u003c\/h2\u003e\n\n\u003ch3\u003e1. Cardiovascular\u003c\/h3\u003e\n\u003cp\u003eThe cardiovascular evidence is the largest and most contentious in nutrition science. The high-level synthesis:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGISSI-Prevenzione (Marchioli 1999, Lancet):\u003c\/strong\u003e 11,324 post-MI patients, 850 mg\/day EPA+DHA, 3.5 years — 20% all-cause mortality reduction, 45% sudden cardiac death reduction. The trial that put fish oil on every cardiology guideline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJELIS (Yokoyama 2007, Lancet):\u003c\/strong\u003e 18,645 Japanese hypercholesterolemics, 1.8 g\/day EPA-only on top of statins, 4.6 years — 19% major coronary event reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eREDUCE-IT (Bhatt 2019, NEJM):\u003c\/strong\u003e 8,179 high-risk patients with elevated triglycerides, 4 g\/day icosapent ethyl (high-purity EPA), 4.9 years — \u003cstrong\u003e25% reduction\u003c\/strong\u003e in composite cardiovascular events. The strongest modern signal, and the basis for the FDA approval of icosapent ethyl as an Rx drug.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVITAL (Manson 2019, NEJM):\u003c\/strong\u003e 25,871 healthy U.S. adults, 1 g\/day EPA+DHA, 5.3 years — no change in primary composite, but a 28% reduction in MI in the “low fish intake” subgroup, suggesting baseline status matters.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSTRENGTH (Nicholls 2020, JAMA):\u003c\/strong\u003e EPA+DHA carboxylic acid form failed to reduce CV events vs corn oil placebo. The negative trial that complicates the EPA-only narrative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTriglyceride lowering:\u003c\/strong\u003e meta-analyzed across 70+ RCTs, 2–4 g\/day EPA+DHA lowers TG 20–30% in normolipidemic and up to 45% in hypertriglyceridemic patients (Skulas-Ray 2019, AHA Science Advisory).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest read: the evidence for triglyceride-lowering and Omega-3 Index improvement is unambiguous; the evidence for hard cardiovascular outcomes is dose-, form-, and population-dependent. The dose used in REDUCE-IT (4 g\/day high-purity EPA) is what produced the strongest signal. Your 2-softgel dose here is the foundational maintenance dose, not the pharmacological-event-reduction dose.\u003c\/p\u003e\n\n\u003ch3\u003e2. Brain \u0026amp; cognition\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eDHA is ≈30% of all gray matter fatty acids\u003c\/strong\u003e (Bradbury 2011, Nutrients) and is concentrated in synaptic membranes. Adult brain DHA turnover is slow but real, and dietary supply matters because de novo synthesis from ALA is \u0026lt;0.5%.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMIDAS (Yurko-Mauro 2010, Alzheimers Dement):\u003c\/strong\u003e 485 healthy older adults, 900 mg DHA\/day, 24 weeks — episodic memory improved equivalent to roughly 3 years of cognitive aging reversal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSmith 2010, PLoS One:\u003c\/strong\u003e B-vitamin trial in MCI showed brain atrophy slowed only in subjects with high baseline omega-3 status — a treatment-effect-modifier signal that’s been replicated in the OmegAD and AlphaOmega trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePottala 2014, Neurology:\u003c\/strong\u003e Omega-3 Index correlated with total brain volume and hippocampal volume in 1,111 women in the WHIMS-MRI cohort.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBDNF \/ synaptic plasticity:\u003c\/strong\u003e DHA upregulates BDNF and supports LTP in hippocampal preparations (Wu 2008, Neuroscience). The mechanistic story behind the cognitive trial signal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e3. Mood \u0026amp; mental health\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eEPA — not DHA — carries the depression signal.\u003c\/strong\u003e Meta-analyses repeatedly show that EPA-predominant formulations (\u0026gt;60% EPA) reduce depressive symptoms while DHA-predominant ones do not (Sublette 2011, J Clin Psychiatry; Mocking 2016 meta-analysis, Transl Psychiatry, n=1,233 patients across 13 RCTs — effect size SMD −0.40 with EPA-predominant). Our 3:2 EPA:DHA ratio is on the EPA-predominant side.\u003c\/p\u003e\n\n\u003ch3\u003e4. Eye health\u003c\/h3\u003e\n\u003cp\u003eThe retina has the highest DHA concentration of any tissue in the body — outer-segment photoreceptor membranes are ≈50% DHA. The AREDS2 trial (NIH-funded, n=4,203, 5 years) tested DHA + EPA on AMD progression and found no significant primary effect, but multiple smaller trials show benefit on dry eye symptoms (Bhargava 2013), tear film stability, and Meibomian gland function.\u003c\/p\u003e\n\n\u003ch3\u003e5. Joints \u0026amp; inflammation\u003c\/h3\u003e\n\u003cp\u003eOmega-3s are the most-studied non-NSAID joint intervention.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaroon \u0026amp; Bost 2006, Surg Neurol:\u003c\/strong\u003e 1,200 mg EPA+DHA\/day, 250 patients with chronic neck\/back pain — 60% reduced or eliminated NSAIDs at 75 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGoldberg \u0026amp; Katz 2007 meta-analysis, Pain:\u003c\/strong\u003e 17 RCTs, omega-3s reduced morning stiffness, joint swelling, and NSAID consumption in inflammatory joint pain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMechanism:\u003c\/strong\u003e resolvins and protectins actively terminate the inflammatory phase rather than just blocking COX. This is why the effect builds over months rather than within hours like NSAIDs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e6. Metabolic \/ liver\u003c\/h3\u003e\n\u003cp\u003eOmega-3s lower hepatic triglyceride content via SREBP-1c suppression and PPAR-α activation. Multiple meta-analyses show 2–4 g\/day EPA+DHA reduces liver fat 20–40% in NAFLD (Parker 2012, J Hepatol meta-analysis of 9 RCTs, n=355). HDL typically rises slightly; LDL rises modestly in some patients (the so-called “LDL paradox”), driven by a shift toward larger, less atherogenic LDL particles.\u003c\/p\u003e\n\n\u003ch2\u003eEPA vs DHA — what each one actually does\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eFunction\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eEPA (20:5 ω-3)\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eDHA (22:6 ω-3)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eTriglyceride lowering\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSlightly stronger\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory (resolvin E1\/E2)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSecondary\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eResolvin D \/ Protectin \/ Maresin\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNo\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMood \/ depression signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Mocking 2016)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eWeak\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCognitive \/ memory signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eModest\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Yurko-Mauro 2010)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eRetinal \u0026amp; neural membrane structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMinor\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary structural fatty acid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePregnancy \/ infant brain development\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSupportive\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCritical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular event reduction (REDUCE-IT)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (high-dose)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLikely additive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe 3:2 EPA:DHA ratio in this product (720 mg : 480 mg) is the ratio used in the largest cardiovascular trials including GISSI-Prevenzione — a balanced foundational profile that captures both the EPA-driven inflammation\/triglyceride\/mood story and the DHA-driven neural\/retinal\/membrane story. If your goal is purely depression-targeting you’d want pure EPA; if it’s purely pregnancy\/infant brain you’d want pure DHA; if it’s general healthspan, balanced is correct.\u003c\/p\u003e\n\n\u003ch2\u003eWhat’s in each softgel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWild-caught fish oil concentrate:\u003c\/strong\u003e 2,000 mg, sourced from anchovy, sardine, and mackerel (low-trophic-level species — minimum bioaccumulation of mercury and PCBs).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEPA (eicosapentaenoic acid):\u003c\/strong\u003e 720 mg, in re-esterified triglyceride (rTG) form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDHA (docosahexaenoic acid):\u003c\/strong\u003e 480 mg, rTG form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOther omega-3s:\u003c\/strong\u003e ≈100 mg DPA (docosapentaenoic acid), the “forgotten” intermediate omega-3 with its own resolvin pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant package:\u003c\/strong\u003e mixed natural tocopherols (vitamin E) to prevent in-bottle oxidation. No synthetic BHT\/BHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnteric coating:\u003c\/strong\u003e the softgel is enteric-coated so it dissolves in the small intestine, not the stomach — the single most effective fix for the “fishy reflux” problem.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat’s NOT in it:\u003c\/strong\u003e no titanium dioxide, no artificial colors, no soybean oil filler (a common label trick in budget fish oil), no proprietary blends.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation\u003c\/h2\u003e\n\u003cp\u003eFish oil is a peroxidation-vulnerable product. The clinical-grade signals to look for:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMolecular distillation\u003c\/strong\u003e — multi-stage vacuum process that removes mercury, PCBs, dioxins, and PFAS to below the most stringent international standards (CRN, GOED Voluntary Monograph, IFOS 5-star).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeroxide value (PV) \u0026lt; 5 meq\/kg\u003c\/strong\u003e and \u003cstrong\u003ep-Anisidine value (p-AV) \u0026lt; 20\u003c\/strong\u003e — both measures of oxidation. Industry-grade rancidity is – at minimum — PV \u0026gt; 5 or p-AV \u0026gt; 20. Multiple supermarket brands fail this on independent testing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTOTOX (total oxidation) \u0026lt; 26\u003c\/strong\u003e — the combined freshness metric.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e Hg, Pb, As, Cd all under USP \u0026lt;232\u0026gt; limits, third-party verified per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMarine-traceable sourcing:\u003c\/strong\u003e small forage fish (anchovy, sardine, mackerel) — not large predators (tuna, swordfish, shark) where mercury and PCBs concentrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNitrogen-flushed fill\u003c\/strong\u003e and \u003cstrong\u003eUV-protected amber bottle\u003c\/strong\u003e — both reduce in-bottle oxidation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured, FDA-registered facility\u003c\/strong\u003e — per-batch certificate of analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 2 softgels daily with the largest meal of the day. Fat-meal absorption \u0026gt; light\/empty-stomach absorption (Lawson 1988, Biochem Biophys Res Commun — the original observation; Davidson 2012 NEJM letter on the same effect with prescription EPA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose protocol:\u003c\/strong\u003e 3–4 softgels daily for elevated triglycerides, active inflammatory pain, or aggressive Omega-3 Index targeting. Monitor with a finger-prick Omega-3 Index test at week 12 (DHL OmegaQuant or equivalent).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any consistent timing works; with-food matters more than morning vs evening. The 24-hour pharmacokinetic curve is flat at steady state.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you take a blood thinner\u003c\/strong\u003e (warfarin, apixaban, rivaroxaban, clopidogrel): omega-3 prolongs bleeding time modestly at high doses (\u0026gt;3 g\/day). The clinical evidence for actual bleeding events at maintenance doses is weak (Wachira 2014 meta-analysis, Mayo Clin Proc; ACC\/AHA 2019 guidelines explicitly do not recommend stopping fish oil pre-procedure for \u0026lt;3 g\/day). Talk to your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e some surgeons request a 7–14 day stop pre-op out of caution. Follow your surgical team’s protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e cool, dark, dry. Refrigeration extends shelf life beyond the printed expiration. If a softgel ever tastes overtly fishy or rancid, throw out the bottle — it’s oxidized.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the foundational layer\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003ePair\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe two highest-deficiency-prevalence interventions in the modern Western diet. Both fat-soluble — same meal, same softgel slot. The cardiovascular and bone evidence stacks rather than overlaps.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular triad complete: omega-3 lowers TG and inflammation, Vitamin D supports calcium handling, magnesium handles arterial smooth-muscle tone and NAMPT cofactor duty. Fang 2016 mortality meta + GISSI overlap.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe single best in-membrane antioxidant for protecting omega-3 phospholipids from peroxidation. Astaxanthin spans the lipid bilayer (one polar end, one nonpolar end) and physically shields PUFA double bonds. The classical “DHA + astaxanthin” pair.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular pair. CoQ10 is mitochondrial-membrane-resident; omega-3s rebuild the membrane it sits in. Lipid-soluble — co-dose with same fat meal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory pair via two non-overlapping mechanisms — omega-3s shift eicosanoid output from pro-inflammatory to pro-resolving; curcumin inhibits NF-κB \/ COX-2 directly. Strongest joint-pain evidence in combination.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/glutathione-500mg-reduced-gsh-enteric-coated\"\u003eGlutathione 500mg (enteric)\u003c\/a\u003e \u0026amp; \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLipid peroxidation defense. PUFAs are the fuel for membrane peroxidation; glutathione (and the NAC GlyNAC pair) is the primary regeneration system. Without GSH support, high-dose fish oil + low-antioxidant intake is suboptimal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNAD+ stack pairs with omega-3 mechanistically: NAD+ supports mitochondrial ATP throughput, omega-3 supplies the membrane phospholipids those mitochondria sit in. Without omega-3 substrate, mitochondrial membranes drift toward stiff, arachidonic-acid-rich profiles even with abundant NAD+.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eJoint pair. Collagen is the structural protein; omega-3 is the inflammation modulator. The two address different sides of the same pathology — cartilage matrix supply + synovial inflammation resolution.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eUniversal antioxidant pair. ALA recycles vitamin C, vitamin E, and glutathione — all three of which protect omega-3 PUFAs from peroxidation. The complete antioxidant umbrella for any high-PUFA intake.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/biotin-10000-mcg-maximum-strength\"\u003eBiotin 10,000mcg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSkin\/hair\/nails triad. DHA is structural in skin barrier ceramide synthesis; collagen and biotin are the matrix and growth-phase complements. The dermatology stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat to expect — realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e usually no felt change. Some people notice softer stools (mild lipid laxation) or a one-week period of mild fish-oil reflux that resolves once the enteric coating is acclimated. Triglycerides start to decline but you wouldn’t lab-detect it yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–6:\u003c\/strong\u003e measurable triglyceride drop (lab a fasting lipid panel at week 6 if you want a number). Some users notice less morning joint stiffness. Mood signal — if any — starts here in the EPA-responsive subgroup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e Omega-3 Index moves measurably (re-test at week 12 with a finger-prick kit). Joint, skin barrier, and dry-eye signals consolidate. Cognitive signal — if any — starts here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the membrane composition is now fully turned over. This is the steady-state phase — omega-3 is doing what it does for you, whatever that turns out to be in your particular biology.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the cardiovascular and cognitive endpoints in the long-term cohorts (Framingham Offspring, AlphaOmega, MIDAS open-label extension) are measured in years, not weeks. Maintenance is the strategy, not pulse-dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e not a stimulant, not a quick fix, not a weight-loss agent (modest at best), not a substitute for omega-6 reduction (vegetable oils still matter), not a substitute for blood pressure or lipid medication if your numbers are deep into clinical-treatment range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone whose dietary fish intake is \u0026lt;2 servings\/week of fatty fish — which is most adults outside coastal Asia and the Mediterranean.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e, sirtuin stack, or longevity protocol — omega-3 is the foundational substrate underneath those interventions.\u003c\/li\u003e\n  \u003cli\u003eAdults 40+ thinking about cardiovascular and cognitive trajectory.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women: omega-3 status correlates with hippocampal and total brain volume in WHIMS-MRI; the period of most-rapid bone and brain aging.\u003c\/li\u003e\n  \u003cli\u003eAthletes and high-training-load individuals managing chronic low-grade inflammation.\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides (\u0026gt;150 mg\/dL) for whom dietary change alone hasn’t moved the number.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a family history of premature cardiovascular disease — the highest-leverage intervention category in the entire VITAL\/REDUCE-IT\/JELIS literature.\u003c\/li\u003e\n  \u003cli\u003ePeople with chronic joint pain or low-grade inflammation looking to reduce NSAID load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFish allergy:\u003c\/strong\u003e this is a fish-derived product. A vegan algal-DHA product is the alternative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive anticoagulation\u003c\/strong\u003e at high doses: 1–2 g\/day combined EPA+DHA appears safe in the meta-analyzed evidence even on warfarin\/DOAC; doses \u0026gt;3 g\/day in this context warrant prescriber discussion.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (\u0026lt; 7–14 days):\u003c\/strong\u003e follow your surgical team’s instructions. Most current cardiology guidance does not require a stop, but practice varies by surgeon.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy:\u003c\/strong\u003e DHA is critical for fetal brain development — but pregnancy supplementation should be guided by your OB, ideally with a low-mercury algal DHA product or a doctor-supervised fish oil protocol. This product is not labeled for pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAtrial fibrillation history:\u003c\/strong\u003e very-high-dose icosapent ethyl in REDUCE-IT modestly increased AF events. Standard 1–2 g\/day combined EPA+DHA carries no comparable signal in maintenance trials, but if you have known AF, raise it with your cardiologist before going to 3–4 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic GI fat malabsorption\u003c\/strong\u003e (severe pancreatic insufficiency, advanced IBD with steatorrhea): rTG fish oil still requires lipase. Speak with your GI team about phospholipid-form omega-3 (krill, herring roe) which is partially absorbed without lipase.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs this triglyceride form (TG\/rTG) or ethyl ester (EE)?\u003c\/strong\u003e\u003cbr\u003e\nRe-esterified triglyceride (rTG). The form with the best long-term bioavailability data (Dyerberg 2010, Neubronner 2011) and the form most premium fish oil brands use. If you’ve compared labels and seen the EE\/TG distinction, this is on the rTG side.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the dose 1,200 mg EPA+DHA at 2 softgels rather than 4 g like REDUCE-IT?\u003c\/strong\u003e\u003cbr\u003e\nREDUCE-IT used 4 g\/day icosapent ethyl (high-purity EPA) in patients with elevated triglycerides on statins as a pharmacologic intervention. The 1,200 mg combined EPA+DHA dose (or 2,400 mg at 4 softgels) is the maintenance dose used in the foundational Omega-3 Index literature and in GISSI-Prevenzione. If your goal is post-MI cardioprotection or aggressive triglyceride lowering, 4 softgels\/day = 2,880 mg combined EPA+DHA is closer to the trial-equivalent dose. For general healthspan, 2 softgels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to flaxseed oil or chia?\u003c\/strong\u003e\u003cbr\u003e\nFlax\/chia provide ALA, the short-chain plant omega-3. ALA-to-EPA conversion in humans is 1–10%; ALA-to-DHA is 0.5% or less (Burdge 2002, Br J Nutr). If your goal is moving the Omega-3 Index, flax does it inefficiently. Algal oil (DHA-only or DHA+EPA) is the legitimate vegan alternative.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to krill oil?\u003c\/strong\u003e\u003cbr\u003e\nKrill provides phospholipid-form omega-3 plus astaxanthin, both at lower per-capsule EPA+DHA than fish oil. Phospholipid form has a small absorption advantage in some studies (Schuchardt 2011); the per-mg cost is higher; the krill stocks are managed but ecologically debated. For matched EPA+DHA delivery, fish oil is more cost-efficient. The classical “fish oil + standalone \u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e” pair gives you both in measured doses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this raise my LDL?\u003c\/strong\u003e\u003cbr\u003e\nIn some individuals, particularly with high baseline triglycerides, omega-3 raises LDL-C modestly. This is largely a particle-size shift (fewer small dense LDL, more large buoyant LDL) which is metabolically favorable, not a true atherogenic burden increase. ApoB and LDL-P are the better markers. Re-test ApoB at week 12 if this question matters to you.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about “burping fish”?\u003c\/strong\u003e\u003cbr\u003e\nThree causes: oxidized oil (the bottle is rancid — throw it out), gastric-dissolution softgels (no enteric coating), and large dose on empty stomach. Enteric coating on this product addresses #2; with-food dosing addresses #3; cool-dark storage addresses #1.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much mercury \/ heavy metal is in fish oil?\u003c\/strong\u003e\u003cbr\u003e\nIn a properly molecularly-distilled product, all heavy metals are below detection limits per USP \u0026lt;232\u0026gt;. Mercury bioaccumulates in fish flesh, not fish oil — the distillation process strips it almost entirely. Anchovy\/sardine\/mackerel are low-trophic-level forage fish that don’t accumulate much to begin with; molecular distillation removes the residual.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I take this with or without food?\u003c\/strong\u003e\u003cbr\u003e\nWith food — particularly with a meal containing some fat — absorption is meaningfully better than empty-stomach (Lawson 1988; Davidson 2012 NEJM letter). Same fat meal as your \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, your \u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, and your \u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e if you take them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my statin?\u003c\/strong\u003e\u003cbr\u003e\nYes. The cardiovascular evidence for omega-3 is largely on top of statin therapy (JELIS, REDUCE-IT). No pharmacokinetic interaction. Many cardiologists actively co-prescribe.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes fish oil thin the blood — should I stop before surgery?\u003c\/strong\u003e\u003cbr\u003e\nModest effect on bleeding time at high doses; weak evidence for actual bleeding events at maintenance doses. ACC\/AHA 2019 guidelines explicitly do not require pre-procedure cessation at standard doses. Your surgical team may have local policy — follow theirs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy DPA on the label?\u003c\/strong\u003e\u003cbr\u003e\nDocosapentaenoic acid (22:5 ω-3) is the “forgotten” intermediate omega-3 between EPA and DHA. It’s a precursor to its own resolvin family (Rv-DPA series) and has independent triglyceride and platelet effects (Byelashov 2015). It’s naturally present in marine oils (the ≈100 mg here is native, not added) and is generally not concentrated out of premium products.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow do I know if it’s working?\u003c\/strong\u003e\u003cbr\u003e\nThree options: (1) lab a fasting lipid panel at week 6 and look for triglyceride decline; (2) order a finger-prick Omega-3 Index test at week 12; (3) track subjective endpoints — morning joint stiffness, dry eye, mood, sleep — against a baseline diary. Option 2 is the only truly objective single-data-point readout because the Omega-3 Index reflects the membrane-level intervention you’re actually buying.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegan \/ vegetarian alternative?\u003c\/strong\u003e\u003cbr\u003e\nAlgal oil (Schizochytrium-derived DHA, sometimes with EPA) is the legitimate plant-based EPA\/DHA source. Same molecules, different organism, lower aftertaste. We don’t currently stock an algal product but it’s on the catalog roadmap.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this if I have an iodine sensitivity?\u003c\/strong\u003e\u003cbr\u003e\nFish oil contains negligible iodine — iodine concentrates in fish flesh and thyroid, not the oil fraction. Generally compatible with low-iodine diets.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between this and prescription fish oil (Vascepa, Lovaza)?\u003c\/strong\u003e\u003cbr\u003e\nVascepa is icosapent ethyl — pure EPA in ethyl ester form, FDA-approved as a drug. Lovaza is mixed EPA\/DHA in ethyl ester form, FDA-approved. Both are EE not rTG; both are dosed at 2–4 g\/day; both are insurance-billable for triglyceride lowering or for the REDUCE-IT indication. This is not a drug, and the FDA disclaimer below applies. The active fatty acid molecules are the same.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy enteric coating?\u003c\/strong\u003e\u003cbr\u003e\nA standard softgel dissolves in the stomach. If the contents oxidize there or the user is sensitive to fish-oil reflux, “fish burps” happen. An enteric-coated softgel passes intact through the stomach and dissolves in the duodenum, where the oil meets bile acids and lipase under physiological conditions. The reflux\/burp problem largely disappears.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eOmega-3 Fish Oil 2000mg is one of the four foundational always-on supplements in the catalog — alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate TRAACS\u003c\/a\u003e, and the \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e+\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-precursor\"\u003eGlycine\u003c\/a\u003e GlyNAC pair. These are the supplements that do not chase a specific pathway but instead supply the structural and cofactor inputs that every other intervention assumes. Without them, an aggressive NMN\/sirtuin\/senolytic stack is being deployed onto a substrate-deficient cellular environment.\u003c\/p\u003e\n\u003cp\u003eThe supplementary anti-inflammatory and joint pairings — \u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin + BioPerine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e — sit on top of the omega-3 substrate. The cardiovascular pairings (\u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-foundational-cardiovascular-mitochondrial\"\u003eTaurine\u003c\/a\u003e) similarly assume omega-3 as the membrane-quality baseline.\u003c\/p\u003e\n\u003cp\u003eThe NAD+ family (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-500mg-pure-nmn-30-day-supply\"\u003eNMN 500\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-1000mg-anti-aging-formula\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e) and the senolytic\/sirtuin family (\u003ca href=\"\/he\/products\/fisetin-500mg-mayo-ranked-senolytic-flavonoid\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-bioperine-cd38-inhibitor\"\u003eApigenin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-trans-resveratrol-sirt1-activator\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e) layer above this. None of those pathways function correctly with stiff arachidonic-acid-dominated membranes.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003eMarchioli R et al. \u003cem\u003eGISSI-Prevenzione\u003c\/em\u003e. Lancet 1999;354(9177):447-455. (Post-MI all-cause mortality reduction.)\u003c\/li\u003e\n  \u003cli\u003eYokoyama M et al. \u003cem\u003eJELIS\u003c\/em\u003e. Lancet 2007;369(9567):1090-1098. (EPA on statins, Japanese hyperlipidemic cohort.)\u003c\/li\u003e\n  \u003cli\u003eBhatt DL et al. \u003cem\u003eREDUCE-IT\u003c\/em\u003e. N Engl J Med 2019;380:11-22. (4 g\/day icosapent ethyl, 25% CV event reduction.)\u003c\/li\u003e\n  \u003cli\u003eManson JE et al. \u003cem\u003eVITAL\u003c\/em\u003e. N Engl J Med 2019;380:23-32. (1 g\/day EPA+DHA in healthy U.S. adults, subgroup signal in low-fish-intake stratum.)\u003c\/li\u003e\n  \u003cli\u003eNicholls SJ et al. \u003cem\u003eSTRENGTH\u003c\/em\u003e. JAMA 2020;324(22):2268-2280. (EPA+DHA carboxylic acid, negative primary trial — the complicating result.)\u003c\/li\u003e\n  \u003cli\u003eAlbert CM et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346(15):1113-1118.\u003c\/li\u003e\n  \u003cli\u003eSkulas-Ray AC et al. AHA Science Advisory: omega-3 fatty acids for the management of hypertriglyceridemia. Circulation 2019;140:e673-e691.\u003c\/li\u003e\n  \u003cli\u003eHarris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004;39(1):212-220.\u003c\/li\u003e\n  \u003cli\u003eHarris WS et al. Omega-3 blood levels and total and cause-specific mortality — the Framingham Offspring Cohort. J Clin Lipidol 2018;12(3):718-727.\u003c\/li\u003e\n  \u003cli\u003eDyerberg J et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids 2010;83(3):137-141. (rTG vs EE absorption.)\u003c\/li\u003e\n  \u003cli\u003eNeubronner J et al. Enhanced increase of Omega-3 Index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr 2011;65(2):247-254.\u003c\/li\u003e\n  \u003cli\u003eYurko-Mauro K et al. \u003cem\u003eMIDAS\u003c\/em\u003e: Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010;6(6):456-464.\u003c\/li\u003e\n  \u003cli\u003ePottala JV et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes — WHIMS-MRI study. Neurology 2014;82(5):435-442.\u003c\/li\u003e\n  \u003cli\u003eSmith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment. PLoS One 2010;5(9):e12244. (Omega-3 baseline as treatment-effect modifier.)\u003c\/li\u003e\n  \u003cli\u003eMocking RJT et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016;6:e756.\u003c\/li\u003e\n  \u003cli\u003eMaroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to non-steroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006;65(4):326-331.\u003c\/li\u003e\n  \u003cli\u003eCalder PC. Omega-3 fatty acids and inflammatory processes. Biochem Soc Trans 2017;45(5):1105-1115.\u003c\/li\u003e\n  \u003cli\u003eSerhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92-101.\u003c\/li\u003e\n  \u003cli\u003eBurdge GC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Br J Nutr 2002;88(4):411-420.\u003c\/li\u003e\n  \u003cli\u003eParker HM et al. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;56(4):944-951.\u003c\/li\u003e\n  \u003cli\u003eWachira JK et al. Fish oils, omega-3 fatty acids, and bleeding: a systematic review and meta-analysis. Mayo Clin Proc 2014.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eReading on this catalog’s blog\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/the-foundational-four-supplements-of-healthspan\"\u003eThe Foundational Four: omega-3, vitamin D, magnesium, and the GlyNAC pair\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/the-omega-3-index-and-why-it-matters\"\u003eThe Omega-3 Index — the only blood marker that actually measures fish oil status\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/triglyceride-vs-ethyl-ester-fish-oil\"\u003eTriglyceride vs ethyl ester: why the form on the label is non-negotiable\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/cardiovascular-supplement-stack\"\u003eThe cardiovascular pairing stack — omega-3, CoQ10, magnesium, taurine, vitamin K2\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/membrane-fluidity-and-aging\"\u003eMembrane fluidity and aging: why every NAD+ stack assumes omega-3 substrate\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Speak with a qualified healthcare professional before adding fish oil to your protocol if you take blood thinners, are scheduled for surgery, or have a known atrial fibrillation history. The information here is educational and reflects published research as of 2025.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839533596890,"sku":"THP-OMEGA3-2000-60","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_omega-3.png?v=1778047681"},{"product_id":"creatine-monohydrate-1000mg-strength-cognitive-longevity","title":"Creatine Monohydrate 1000mg | Micronized | Sarcopenia Prevention, Strength \u0026 Cognitive Longevity","description":"\u003cp\u003e\u003cstrong\u003eCreatine is the most-researched supplement in human history — over 1,000 published trials — and it has quietly become one of the most-researched supplements in \u003cem\u003elongevity\u003c\/em\u003e as well.\u003c\/strong\u003e Skeletal-muscle mass is a stronger predictor of all-cause mortality after 60 than LDL cholesterol or systolic blood pressure (Srikanthan 2014, \u003cem\u003eAm J Med\u003c\/em\u003e). Creatine plus resistance training is the single most-validated nutritional intervention for slowing the muscle loss (sarcopenia) that drives frailty, falls, fractures, and the loss of independence. The cognitive evidence is now equally serious: creatine raises brain phosphocreatine stores, with the strongest effects in stressed, sleep-deprived, vegetarian, or aging populations whose ATP demand exceeds local supply. Five grams a day. The dose has not changed in thirty years because nothing has beaten it.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000 mg micronized creatine monohydrate per capsule\u003c\/strong\u003e — 5 capsules = the 5 g\/day dose used in the overwhelming majority of the human research, including the 2017 ISSN position stand.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e≥99.9% pure, Creapure\u003csup\u003e®\u003c\/sup\u003e-grade equivalent\u003c\/strong\u003e — verified absent of creatinine, dicyandiamide, and dihydrotriazine, the three contaminants that show up in cheap creatine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSarcopenia-grade evidence.\u003c\/strong\u003e Devries \u0026amp; Phillips 2014 meta-analysis (357 elderly subjects): creatine + resistance training added ~1.4 kg of lean mass and meaningfully improved chest-press and leg-press strength versus training alone (Devries \u0026amp; Phillips, \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive-grade evidence.\u003c\/strong\u003e Rae 2003 (\u003cem\u003eProc Roy Soc B\u003c\/em\u003e): 5 g\/day for 6 weeks improved working memory and reasoning. McMorris 2007: creatine offset cognitive impairment from 24-hour sleep deprivation. Gordji-Nejad 2024 (\u003cem\u003eSci Rep\u003c\/em\u003e): a single high-dose creatine load measurably improved cognition during 21 hours of sleep restriction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBone-density evidence.\u003c\/strong\u003e Chilibeck 2015 (12-month RCT, 47 postmenopausal women): the creatine + training group preserved femoral-neck bone density while the placebo group lost it (\u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl-pool sparing.\u003c\/strong\u003e Endogenous creatine synthesis consumes ~40% of the body's daily SAMe (S-adenosyl-methionine) budget. Supplementing creatine spares that methyl pool — lowering homocysteine and freeing methyl groups for DNA methylation, neurotransmitter synthesis, and epigenetic maintenance (Stead 2006, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational, not exotic.\u003c\/strong\u003e Stacks with everything in this catalog — particularly the \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eNAD+\u003c\/a\u003e precursor stack, the \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e mitochondrial layer, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a sports supplement keeps appearing in longevity research\u003c\/h2\u003e\n\n\u003cp\u003eEvery cell in the body uses ATP as its energy currency, but ATP cannot be stored in meaningful quantities — a typical cell holds only seconds of free ATP at peak demand. The phosphocreatine system is the buffer in front of mitochondrial ATP production: creatine binds a high-energy phosphate group, and when local ATP runs low (a muscle contraction, a neuron firing rapidly, a stressed cell trying to keep up with demand), the enzyme creatine kinase transfers that phosphate to ADP and regenerates ATP \u003cem\u003einstantly\u003c\/em\u003e — orders of magnitude faster than mitochondria can synthesize it from scratch. The effect is largest in tissues that demand short bursts of high power: skeletal muscle, the brain, and the heart.\u003c\/p\u003e\n\n\u003cp\u003eThe longevity-relevant question is what happens when that buffer runs low. Skeletal-muscle phosphocreatine stores fall with age. Brain creatine stores fall under sleep deprivation, hypoxia, hypoxic stress, depression, and aging. Without an adequate phosphocreatine pool, cells under load fall back on slower energy pathways, accumulate lactate, and signal stress — the same metabolic patterns that show up in frail elderly tissue and in sleep-deprived brains. Restoring the buffer to youthful levels is what supplementation does. It is not a stimulant, it is not a mitochondrial up-regulator, it is not a precursor to anything else — it is an energy \u003cem\u003ereserve\u003c\/em\u003e placed exactly where ATP is consumed, in the cytoplasm next to the contractile and synaptic machinery that needs it.\u003c\/p\u003e\n\n\u003ch2\u003eThe sarcopenia argument (why this matters past 40)\u003c\/h2\u003e\n\n\u003cp\u003eRoughly 30% of skeletal-muscle mass is lost between ages 40 and 80 if nothing intervenes; the loss accelerates after 60 and again after 75. The endpoint is sarcopenia — clinical muscle wasting — and its consequences are not cosmetic. Skeletal-muscle index (lean mass divided by height squared) is one of the strongest single predictors of all-cause mortality in adults over 65, comparable to or exceeding the predictive power of LDL cholesterol or systolic blood pressure for that age group (Srikanthan 2014). Sarcopenia drives falls, fractures, hospitalization, loss of independence, metabolic dysfunction (muscle is the largest sink for postprandial glucose), and immune decline (skeletal muscle is the body's largest reservoir of glutamine, the immune system's preferred fuel).\u003c\/p\u003e\n\n\u003cp\u003eThe Devries \u0026amp; Phillips 2014 meta-analysis pooled 357 elderly subjects (mean age \u0026gt;57) across multiple resistance-training trials and found creatine plus training added ~1.4 kg of lean mass and improved chest-press and leg-press strength meaningfully versus training alone. Candow's 2014 and 2019 work confirms the effect is not training-day-only — daily 5 g works whether or not you trained that day, and creatine taken on training days only also works. The 2022 ISSN updated position stand reaffirms creatine as the most effective nutritional ergogenic for muscle mass and strength, with explicit elderly applications (Kreider 2017; Antonio 2021). Without resistance training, creatine helps less — the muscle has to be loaded for the buffer to matter. With training, the effect size roughly doubles versus training alone.\u003c\/p\u003e\n\n\u003ch2\u003eThe cognitive evidence (which has caught up to the muscle evidence)\u003c\/h2\u003e\n\n\u003cp\u003eThe brain runs on ATP at extraordinarily high turnover — neurons spike, glia clear neurotransmitter, ion gradients are restored, and the whole loop has to happen on a millisecond timescale. The brain has its own phosphocreatine system mirroring the one in muscle, and brain creatine concentrations can be measured by magnetic resonance spectroscopy (MRS). What that imaging shows: brain creatine falls with sleep deprivation, with chronic hypoxia, in major depression, and with age.\u003c\/p\u003e\n\n\u003cp\u003eThe trial set is now substantial. \u003cstrong\u003eRae 2003\u003c\/strong\u003e (\u003cem\u003eProc Roy Soc B\u003c\/em\u003e): 45 vegetarian subjects, 5 g\/day for 6 weeks, double-blind crossover — significant improvement on Raven's Progressive Matrices and backward digit span. \u003cstrong\u003eMcMorris 2007\u003c\/strong\u003e: 5 g\/day for 7 days, then 24-hour sleep deprivation — creatine subjects performed better than placebo on a battery of cognitive tasks. \u003cstrong\u003eBenton 2011\u003c\/strong\u003e: vegetarian women, 5 g\/day for 5 days — improved memory. \u003cstrong\u003eAvgerinos 2018\u003c\/strong\u003e systematic review of 6 trials: short-term memory and intelligence\/reasoning improved consistently in creatine-supplemented subjects. \u003cstrong\u003eGordji-Nejad 2024\u003c\/strong\u003e (\u003cem\u003eSci Rep\u003c\/em\u003e): single oral dose of 0.35 g\/kg creatine restored cognitive performance during 21 hours of sleep restriction — confirming a fast-acting central effect distinct from the slow muscle saturation timeline.\u003c\/p\u003e\n\n\u003cp\u003eThe pattern across trials: the cognitive benefit is largest in populations whose baseline brain creatine is lowest — vegetarians (lower meat-derived creatine intake), the sleep-deprived (creatine consumed faster than synthesized), the elderly (declining endogenous synthesis), and the depressed (depressive episodes are associated with low brain phosphocreatine on MRS imaging). For a healthy, well-rested, omnivorous 30-year-old, the cognitive effect is detectable but small. For everyone else, it is meaningful.\u003c\/p\u003e\n\n\u003ch2\u003eWhat the rest of the human research shows\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eBone density.\u003c\/strong\u003e Chilibeck 2015 (\u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e) followed 47 postmenopausal women through 12 months of resistance training; the creatine group preserved femoral-neck bone-mineral density while the placebo group lost it. The mechanism is mechanotransduction — creatine-supported muscle pulls harder on bone, and bone remodels to load (Wolff's law).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCardiovascular and metabolic.\u003c\/strong\u003e Smaller but consistent effects on insulin sensitivity (creatine improves muscle glucose uptake during training) and reductions in homocysteine via the methylation cycle that endogenous creatine synthesis would otherwise consume (Stead 2006). The methylation-sparing effect is mechanistically interesting: ~40% of the body's daily SAMe budget goes into making creatine de novo if you don't supplement, and chronically high methyl-group demand is a candidate driver of the elevated homocysteine seen in some aging adults.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImmune and recovery.\u003c\/strong\u003e Creatine supplementation reduces post-exercise muscle damage markers (creatine kinase, lactate dehydrogenase) and inflammatory cytokines after eccentric exercise (Cooke 2009). Older adults using creatine recover faster between resistance sessions, which is part of why long-term sarcopenia outcomes improve.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSafety.\u003c\/strong\u003e Creatine is one of the most-studied supplements in human history. Long-term trials at 5 g\/day in healthy adults — including trials specifically designed to detect kidney function changes — show no signal for kidney damage, liver damage, or any other organ effect (Gualano 2012; Kim 2011; Lugaresi 2013). The persistent rumor that creatine harms kidneys traces to a single 1998 case report in a person with pre-existing kidney disease and has been repeatedly disproved in subsequent controlled trials. Creatine raises serum \u003cem\u003ecreatinine\u003c\/em\u003e in routine lab work — but creatinine is the breakdown product of creatine itself, not a kidney-damage marker; the rise is expected and harmless.\u003c\/p\u003e\n\n\u003ch2\u003eWhere creatine fits in this catalog\u003c\/h2\u003e\n\n\u003cp\u003eThe longevity stack we sell already addresses NAD\u003csup\u003e+\u003c\/sup\u003e production (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e), mitochondrial function (\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e), antioxidant cover (\u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e), inflammation (\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e), sirtuin activation (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e), epigenetic age (\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e), autophagy (\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e), and foundational nutrients (\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e).\u003c\/p\u003e\n\n\u003cp\u003eWhat it didn't address until creatine sat in the catalog is \u003cem\u003etissue-level energy buffering\u003c\/em\u003e: the phosphocreatine pool that determines how cells respond to short-term high-demand events — a muscle contraction, a cognitive task under stress, a heart beat under load. NMN and the NAD\u003csup\u003e+\u003c\/sup\u003e precursors raise the production ceiling of mitochondrial ATP. CoQ10 and PQQ optimize how mitochondria run. Creatine is the immediate-availability layer in front of all of that — the energy reserve that lets cells respond to demand at the timescale demand actually arrives at, rather than waiting for mitochondrial throughput to ramp.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in the bottle\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCreatine Monohydrate, micronized — 1000 mg per capsule.\u003c\/strong\u003e Monohydrate is the form used in over 90% of the published research, including every one of the trials cited above. Micronization reduces particle size for faster dissolution, lower GI side effects, and slightly better solubility in cool water than standard creatine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5 capsules per serving = 5 g daily\u003c\/strong\u003e — the dose that has been the standard since the early 1990s and remains the recommendation in the 2017 ISSN position stand and the 2022 update. Loading phase (20 g\/day for 5–7 days) is optional and only accelerates the speed at which intramuscular creatine reaches saturation; the long-term outcome at 5 g\/day daily without loading is the same.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade Creapure\u003csup\u003e®\u003c\/sup\u003e-equivalent purity\u003c\/strong\u003e — verified ≥99.9% creatine monohydrate by HPLC, with documented absence of \u003cem\u003ecreatinine\u003c\/em\u003e (the inert breakdown product), \u003cem\u003edicyandiamide\u003c\/em\u003e, and \u003cem\u003edihydrotriazine\u003c\/em\u003e. The cheap creatine sold globally — particularly product sourced from non-regulated synthesis routes — is where those three impurities concentrate; ask any reputable supplement distributor and they will tell you the same.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e90 capsules per bottle\u003c\/strong\u003e — 18-day supply at the 5 g\/day saturation dose, or one month at the 3 g\/day minimum-effective long-term dose. Designed to be taken alongside a meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules, not powder, intentionally.\u003c\/strong\u003e Powder is more economical per gram, but capsules eliminate the slight compliance friction of mixing — the people who fail at creatine usually fail because the powder sat unmixed on the counter, not because the dose was wrong.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule.\u003c\/strong\u003e No magnesium stearate, no titanium dioxide, no artificial colorants, no SLS, no proprietary blends. The label discloses the entire formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufactured in cGMP-certified facilities\u003c\/strong\u003e with third-party batch testing for identity, potency, and purity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily standard dose (recommended for 95% of people):\u003c\/strong\u003e 5 capsules (5 g) once per day, with a meal. Timing relative to training matters less than total daily intake; pick whichever time you'll actually remember. Adherence is the lever, not chronobiology.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOptional loading protocol:\u003c\/strong\u003e 20 g\/day (split into 4 doses of 5 g across the day) for 5–7 days, then drop to 5 g\/day. Reaches intramuscular saturation in about a week instead of about a month. Eventual outcome is identical; loading is purely about speed-to-effect for athletes with a competition timeline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term maintenance dose (post-saturation):\u003c\/strong\u003e 3 g\/day (3 capsules) is the lowest dose with reliable evidence for maintaining elevated muscle creatine once the pool is full. Some people use this dose during deload weeks or periods when they're not training hard.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTraining-days-only pattern:\u003c\/strong\u003e Candow 2019 showed that taking 5 g only on training days (e.g., 3–5 days\/week) produces gains comparable to daily dosing in resistance-trained subjects. Reasonable for cost-conscious or pill-fatigued users; for sarcopenia or cognitive applications, daily is still preferred.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHydration:\u003c\/strong\u003e creatine pulls water into muscle cells (this is partly the mechanism — cell volumization is itself an anabolic signal). Drink to thirst. Expect ~1–2 lb of intracellular water gain in the first 2–4 weeks; this is not fat and is not bloating in the gastrointestinal sense.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with carbohydrate or protein\u003c\/strong\u003e for slightly better uptake — insulin signaling drives muscle creatine transport via the SLC6A8 transporter. Not required; the effect is small.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoffee is fine.\u003c\/strong\u003e The early \"caffeine blunts creatine\" claim came from a single 1996 trial that did not replicate; subsequent work shows no antagonism at normal coffee doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with in this catalog\u003c\/h2\u003e\n\n\u003cp\u003eCreatine is foundational rather than mechanism-specific, so it stacks cleanly with every supplement we sell. The strongest pairings:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN + NAD\u003csup\u003e+\u003c\/sup\u003e precursors.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD\u003csup\u003e+\u003c\/sup\u003e, which feeds mitochondrial ATP production. Creatine buffers the ATP that production yields. The two operate at different timescales — NAD\u003csup\u003e+\u003c\/sup\u003e raises the steady-state energy ceiling; phosphocreatine handles the transient spikes — and people running NMN protocols who add creatine often report a step-change in muscular endurance and recovery that NMN alone does not produce. Same logic for the \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 + PQQ + Urolithin A — the mitochondrial-quality stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e shuttles electrons in Complex III of the mitochondrial chain. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e drives biogenesis (more mitochondria via PGC-1α\/NRF1\/TFAM). \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e drives mitophagy (clearing the damaged ones via PINK1\/Parkin). Creatine works \u003cem\u003edownstream\u003c\/em\u003e of all three — in the cytoplasm, where ATP is actually consumed. Better mitochondria + a fuller phosphocreatine buffer is the cleanest mechanistic case for combining all four.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTMG (Trimethylglycine).\u003c\/strong\u003e Endogenous creatine synthesis burns ~40% of the body's daily methyl-group budget; supplementing creatine spares that pool, lowering homocysteine and freeing methyl groups for DNA methylation, neurotransmitter synthesis, and the work \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e already supports. The two pair particularly well in NMN protocols, where the methylation demand of NMN itself stacks on top.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMagnesium Glycinate.\u003c\/strong\u003e Creatine kinase — the enzyme that actually uses phosphocreatine to regenerate ATP — is magnesium-dependent. Without sufficient elemental magnesium, the phosphocreatine system runs slower regardless of how saturated the creatine pool is. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e is the chelated form with the cleanest absorption profile and no laxative effect at the 400 mg elemental dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlycine.\u003c\/strong\u003e Glycine is the rate-limiting amino acid for endogenous creatine synthesis (creatine = guanidinoacetate + methyl group, and guanidinoacetate is built from glycine + arginine via AGAT). \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e supports the synthesis pathway and additionally improves slow-wave sleep, which is when creatine pool replenishment is most efficient.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol \/ Pterostilbene \/ Apigenin (sirtuin layer).\u003c\/strong\u003e Sirtuins use the NAD\u003csup\u003e+\u003c\/sup\u003e creatine helps cells make use of. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e activates SIRT1; \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e is the higher-bioavailability stilbenoid; \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e protects the NAD\u003csup\u003e+\u003c\/sup\u003e pool from CD38 degradation. Creatine indirectly supports the entire sirtuin layer by sparing methyl groups that the methylation reactions of healthy aging depend on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin D3 + K2.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e independently improves muscle protein synthesis and bone density; combined with creatine + resistance training the bone-density signal in postmenopausal women (Chilibeck 2015) is meaningfully larger.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhey or plant protein (food, not in this catalog).\u003c\/strong\u003e Creatine plus adequate protein (≥1.6 g\/kg\/day) plus resistance training is the maximally-validated muscle-preservation protocol in adults over 60. Creatine without adequate protein still works; the reverse is also true; combined the effect is largest.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — realistic timeline\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1.\u003c\/strong\u003e If you load (20 g\/day): intramuscular saturation reached by day 5–7; mild GI sensitivity in some users (mitigated by splitting doses and taking with meals); ~1–2 lb of intracellular water weight. If you don't load: nothing perceptible yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Saturation reached without loading. Strength improves measurably in the gym — typically 5–15% on compound lifts versus the same training program without creatine. Recovery between hard sessions improves. Body weight up ~1–2 lb (water).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 2–3.\u003c\/strong\u003e Lean mass gains accumulate: roughly 1–1.5 kg above what training alone would have delivered, per the Devries \u0026amp; Phillips meta-analysis. Cognitive effects, when present, become apparent — particularly during sleep restriction or stressful weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6.\u003c\/strong\u003e Sarcopenia-relevant strength gains compound — measurable improvements in chest press, leg press, and grip strength. People over 60 begin to see meaningful functional changes (climbing stairs without breath, easier carrying, better balance).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 6–12+.\u003c\/strong\u003e Bone-density signal in postmenopausal women becomes measurable on DEXA. Long-term cognitive and mood signals stabilize. The lean-mass gain plateaus — additional creatine does not push past the saturation ceiling — but the gains are \u003cem\u003emaintained\u003c\/em\u003e as long as supplementation continues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect.\u003c\/strong\u003e Acute energy. Stimulant feel. Sleep changes. Mood changes within the first week. Creatine is a slow-onset structural intervention; if you feel something dramatic in the first 48 hours, it's a placebo or it's the water shift. The signal you're looking for is in your training log over weeks, not in subjective feel on day 3.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003eAnyone over 40 — sarcopenia begins quietly in the 40s and accelerates after 60. Earlier intervention is cheaper than later remediation.\u003c\/li\u003e\n  \u003cli\u003eAnyone over 60, especially with concerns about frailty, falls, or grip strength — creatine + resistance training is the highest-evidence intervention available.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women — the bone-density preservation signal (Chilibeck 2015) is one of the cleanest creatine outcomes in the literature.\u003c\/li\u003e\n  \u003cli\u003eVegetarians and vegans — baseline muscle and brain creatine are lower because dietary creatine comes almost entirely from animal flesh; the cognitive trial effect sizes are largest in this group.\u003c\/li\u003e\n  \u003cli\u003ePeople running an \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eNAD+\u003c\/a\u003e protocol who want the energy buffer downstream of the production capacity NMN delivers.\u003c\/li\u003e\n  \u003cli\u003eAthletes and lifters across all ages — the original use case; the strength and recovery effect remains the most-replicated finding in sports nutrition.\u003c\/li\u003e\n  \u003cli\u003ePeople with high cognitive demand and poor sleep hygiene — students, parents of newborns, shift workers, founders, anyone whose week regularly contains a sub-6-hour-sleep night.\u003c\/li\u003e\n  \u003cli\u003ePeople in or recovering from depression — small but consistent literature on creatine as adjunct for depressive symptoms (Lyoo 2012; Roitman 2007), particularly in women.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for (or who should ask a doctor first)\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-existing kidney disease.\u003c\/strong\u003e Creatine raises serum creatinine in routine kidney-function lab work — not because it harms kidneys, but because creatinine is the breakdown product of creatine itself. People with diagnosed CKD, on renal-replacement therapy, or with single-kidney status should clear creatine with their nephrologist before starting; healthy adults have repeatedly shown no kidney impact in long-term controlled trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiuretic use.\u003c\/strong\u003e Creatine pulls water intracellularly and can affect overall hydration status; coordinate with your prescribing physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBipolar disorder.\u003c\/strong\u003e A small case-report literature describes creatine triggering hypomanic or manic episodes in bipolar individuals (Roitman 2007 reported one such case during a depression trial); not contraindicated but warrants caution and ideally psychiatric monitoring in the first weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding.\u003c\/strong\u003e Safety not formally established despite long-standing use; conservative recommendation is to wait. Endogenous creatine demand is elevated during pregnancy and the maternal-fetal creatine system is an active research area, but supplementation has not been formally studied in this population.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnder 18.\u003c\/strong\u003e Despite widespread use among adolescent athletes, formal long-term safety in growing humans is not established; conservative recommendation is to wait until skeletal maturity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant feel.\u003c\/strong\u003e Creatine is not pre-workout. If you want acute energy, look elsewhere; this is the structural buffer, not the pharmacological kick.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy not just eat red meat?\u003c\/strong\u003e A pound of raw red meat contains roughly 2 g of creatine. To hit 5 g\/day from food alone you'd be eating ~2.5 lb of meat daily — a saturated-fat, methionine, and IGF-1-stimulating load that defeats the longevity goal. Creatine in meat also degrades with cooking; heat converts a portion of it to creatinine (biologically inert). For vegetarians and vegans the food gap is even more severe; vegetarian baseline muscle creatine is meaningfully lower than omnivore baseline, which is why cognitive trials show some of the largest effects in vegetarian populations.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I gain weight?\u003c\/strong\u003e Yes — typically 1–2 lb (0.5–1 kg) in the first 2–4 weeks, almost entirely intracellular water. Muscle cells become slightly fuller, which is itself part of the mechanism (cell volumization is an anabolic signal). The scale change is water, not fat. If you are training, the lean-mass gain that follows over months 2–6 is on top of this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about creatine HCL, magnesium chelate, ethyl ester, buffered, or \"nitrate\" forms?\u003c\/strong\u003e Each has been marketed as superior to monohydrate. None has produced a head-to-head trial showing meaningful clinical advantage. Monohydrate has the deepest evidence base, the lowest cost per gram, the highest documented purity standards, and the longest safety record. The other forms typically solve for marginal GI tolerance differences — which micronization addresses without abandoning the most-studied molecule. Save the money for more grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle off?\u003c\/strong\u003e No. Long-term continuous-use trials at 5 g\/day show no decline in benefit and no need for washout. Some people prefer training-days-only dosing (Candow 2019); that works too. There is no biological \"tolerance\" to creatine — the muscle is either saturated or it is not.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Strength and recovery effects typically appear in 2–4 weeks (faster with loading). Cognitive effects, when present, tend to show in 4–8 weeks. Sarcopenia and bone-density benefits are longer arcs — 6–12 months of training plus creatine before the bone-density effect is measurable on DEXA.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs timing important?\u003c\/strong\u003e Less than the supplement industry suggests. Daily total intake is what matters; pre- vs post-workout timing differences in trials are small and inconsistent. With a meal is a small absorption advantage via insulin-driven SLC6A8 transport; without a meal still works.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause hair loss?\u003c\/strong\u003e A single 2009 trial in rugby players showed an increase in serum DHT after a high-dose loading phase; the result has not replicated in subsequent studies, no trial has linked creatine supplementation to actual hair loss, and the meta-analytic literature finds no signal. If you are already on finasteride\/dutasteride for male-pattern baldness or are concerned about androgenic acceleration, the practical recommendation is unchanged: monohydrate at 5 g\/day is fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause kidney damage?\u003c\/strong\u003e No. Long-term controlled trials at 5 g\/day in healthy adults show no kidney impact. The persistent concern traces to a 1998 case report in a person with pre-existing kidney disease and has been disproved in subsequent prospective trials including Gualano 2012, Kim 2011, and Lugaresi 2013. The serum creatinine elevation that creatine produces in lab work is the breakdown product of creatine itself, not a kidney-damage signal.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause cramping or dehydration?\u003c\/strong\u003e The opposite. Creatine pulls water intracellularly (which means slightly more total body water, not less) and football and rugby trials in heat have actually shown \u003cem\u003efewer\u003c\/em\u003e cramps in creatine-supplemented athletes (Greenwood 2003). The 1990s-era concern came from anecdote, not from controlled work.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsules and put them in a smoothie?\u003c\/strong\u003e Yes. Micronized monohydrate dissolves better in cool water than coarse standard creatine; a few minutes of stirring or a brief shake is enough. Capsule shells are vegetable cellulose and pose no issue if discarded.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes coffee blunt creatine?\u003c\/strong\u003e No. The 1996 single-trial finding never replicated; subsequent work shows no antagonism at normal coffee doses (1–4 cups\/day). Take them together if convenient.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegetarian or vegan — bigger effect?\u003c\/strong\u003e Yes. Baseline intramuscular and intracerebral creatine are lower in plant-based eaters because dietary creatine is concentrated in animal flesh. The cognitive trial effect sizes (Rae 2003, Benton 2011) are among the largest in the literature precisely because the baseline was low. If you are vegetarian or vegan, creatine should arguably be your first supplement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs creatine an anabolic steroid?\u003c\/strong\u003e No. Creatine does not interact with the androgen receptor and does not affect endogenous testosterone production. It is an amino-acid-derived molecule that participates in cellular energy metabolism. The \"supplement\" categorization in the FDA framework is appropriate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy 1000 mg per capsule and not 2500 mg?\u003c\/strong\u003e Capsule swallowing limits — 1000 mg of micronized creatine fits a standard size-00 vegetable capsule reliably; pushing beyond that produces capsules that some users find difficult. Five 1000 mg capsules deliver the standard 5 g dose; users who prefer 3 g maintenance take three. Larger capsule sizes are achievable but increase swallowing-friction non-compliance — and adherence is the lever.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my medications?\u003c\/strong\u003e Likely not. Creatine has no significant CYP450 interactions and does not bind plasma proteins competitively. The known cautions are diuretics (hydration), lithium (mechanism unclear, theoretical), and renal-affecting drugs (NSAIDs in renal compromise). Always disclose all supplements to your prescriber.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does the bottle say 18-day supply at 5 g\/day?\u003c\/strong\u003e Because 90 capsules × 1000 mg = 90 g, divided by 5 g\/day = 18 days. The 90-capsule format is an entry-tier bottle suited to a first cycle, a saturation phase, or to running creatine on training days only (where a bottle lasts noticeably longer). For continuous daily 5 g\/day users, two bottles per month is the typical reorder cadence; a multi-bottle subscription is the lowest-friction option.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and purity\u003c\/h2\u003e\n\n\u003cp\u003eThe creatine market has well-documented purity issues. Cheap creatine sourced from non-regulated synthesis routes can contain creatinine (the breakdown product, biologically inert — present means less actual creatine per gram), dicyandiamide (a cyanamide-derived synthesis intermediate), or dihydrotriazine (a synthesis-route contaminant of regulatory concern). Independent surveys of unbranded global creatine have found varying levels of all three.\u003c\/p\u003e\n\n\u003cp\u003eOur creatine is verified ≥99.9% creatine monohydrate by HPLC, with documented absence of those three contaminants — Creapure\u003csup\u003e®\u003c\/sup\u003e-grade equivalent. Manufactured in cGMP-certified facilities with third-party verification on each batch (identity, potency, purity, and microbial safety). The certificate of analysis is available on request for any batch. The label discloses the entire formulation; there are no proprietary blends, no undeclared additives, no fillers beyond the vegetable cellulose capsule shell.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003eDevries MC, Phillips SM. Creatine supplementation during resistance training in older adults — a meta-analysis. \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e. 2014.\u003c\/li\u003e\n  \u003cli\u003eKreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2017.\u003c\/li\u003e\n  \u003cli\u003eAntonio J, et al. Common questions and misconceptions about creatine supplementation. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2021.\u003c\/li\u003e\n  \u003cli\u003eCandow DG, et al. Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. \u003cem\u003eJ Clin Med\u003c\/em\u003e. 2019.\u003c\/li\u003e\n  \u003cli\u003eChilibeck PD, et al. Creatine monohydrate and resistance training increase bone mineral content and density in older men. \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e. 2015.\u003c\/li\u003e\n  \u003cli\u003eRae C, et al. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. \u003cem\u003eProc Roy Soc B\u003c\/em\u003e. 2003.\u003c\/li\u003e\n  \u003cli\u003eMcMorris T, et al. Creatine supplementation and cognitive performance in elderly individuals. \u003cem\u003eAging Neuropsychol Cogn\u003c\/em\u003e. 2007.\u003c\/li\u003e\n  \u003cli\u003eAvgerinos KI, et al. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. \u003cem\u003eExp Gerontol\u003c\/em\u003e. 2018.\u003c\/li\u003e\n  \u003cli\u003eGordji-Nejad A, et al. Single dose creatine improves cognitive performance and induces changes in cerebral high-energy phosphates during sleep deprivation. \u003cem\u003eSci Rep\u003c\/em\u003e. 2024.\u003c\/li\u003e\n  \u003cli\u003eStead LM, et al. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2006.\u003c\/li\u003e\n  \u003cli\u003eSrikanthan P, Karlamangla AS. Muscle mass index as a predictor of longevity in older adults. \u003cem\u003eAm J Med\u003c\/em\u003e. 2014.\u003c\/li\u003e\n  \u003cli\u003eGualano B, et al. Effects of creatine supplementation on renal function: a randomized, double-blind, placebo-controlled clinical trial. \u003cem\u003eEur J Appl Physiol\u003c\/em\u003e. 2008\/2012.\u003c\/li\u003e\n  \u003cli\u003eLyoo IK, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. \u003cem\u003eAm J Psychiatry\u003c\/em\u003e. 2012.\u003c\/li\u003e\n  \u003cli\u003eRoitman S, et al. Creatine monohydrate in resistant depression: a preliminary study. \u003cem\u003eBipolar Disord\u003c\/em\u003e. 2007.\u003c\/li\u003e\n  \u003cli\u003eCooke MB, et al. Creatine supplementation enhances muscle force recovery after eccentrically-induced muscle damage in healthy individuals. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2009.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, particularly if you have kidney disease, are taking diuretics or lithium, are pregnant or breastfeeding, or are under 18. Creatine raises serum creatinine in routine lab work without indicating kidney harm — let your physician know you take creatine before any kidney-function test so that the result is interpreted correctly.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839621611738,"sku":"THP-CREATINE-1000-90","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_creatine.png?v=1778053143"},{"product_id":"ashwagandha-ksm-66-600mg","title":"Female Ashwagandha Capsules","description":"\u003cp\u003e\u003cstrong\u003eThe cortisol-and-sleep foundation underneath every longevity stack.\u003c\/strong\u003e KSM-66 ashwagandha — the standardized root extract used in the majority of published positive RCTs — at the 600mg\/day dose that produced the cortisol, sleep, strength, and cognition outcomes in the human-trial literature. One capsule daily. Sixty-day supply.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCortisol is the master accelerator of biological aging.\u003c\/strong\u003e Chronically elevated cortisol suppresses autophagy, accelerates telomere shortening, depletes the NAD+ pool (via CD38 upregulation), dysregulates insulin, shrinks the hippocampus, blunts immune surveillance, and degrades sleep architecture. The four levers most longevity supplements pull on — autophagy, NAD+, glucose, and sleep — are all the same levers chronic cortisol pulls in the opposite direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAshwagandha is the most-studied way to normalize the HPA axis.\u003c\/strong\u003e Multiple double-blind, placebo-controlled trials show 23-32% reductions in serum cortisol over 8 weeks (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23439798\/\" target=\"_blank\" rel=\"noopener\"\u003eChandrasekhar 2012\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31517876\/\" target=\"_blank\" rel=\"noopener\"\u003eLopresti 2019\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35873404\/\" target=\"_blank\" rel=\"noopener\"\u003eSalve 2019\u003c\/a\u003e), with parallel improvements on perceived-stress and anxiety scales.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePolysomnography-confirmed sleep changes.\u003c\/strong\u003e Langade et al. measured PSG-tracked sleep onset latency, total sleep time, sleep efficiency, and slow-wave sleep at 600mg KSM-66\/day for 8-10 weeks (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32574230\/\" target=\"_blank\" rel=\"noopener\"\u003eLangade 2020\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31728244\/\" target=\"_blank\" rel=\"noopener\"\u003eLangade 2019\u003c\/a\u003e). Latency dropped 28-43%; total sleep rose 13-25%; HAM-A anxiety dropped sharply. By instruments, not self-report.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKSM-66 is the chemistry that produced the trials.\u003c\/strong\u003e Full-spectrum, root-only (no leaves), standardized to ≥5% withanolides, green-chemistry milk-and-water extraction. It is the extract used in the cortisol, sleep, strength, cognition, and fertility studies that generated the modern ashwagandha file.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults whose stress curve is leaking into their sleep, recovery, and longevity stack — and who want the cortisol\/HPA layer of the stack done with the chemistry actually used in the trial data.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy cortisol normalization is a longevity intervention\u003c\/h2\u003e\n\n\u003cp\u003eCortisol is the hormone that lets you survive a real emergency. When it spikes acutely — physical injury, a tiger, an actual deadline — it does exactly what it should: mobilizes glucose, suppresses non-essential repair, sharpens attention, and steps on inflammation. The problem is not the spike. The problem is that the curve never comes back down.\u003c\/p\u003e\n\n\u003cp\u003eChronic cortisol — the kind produced by 21st-century work, sleep deprivation, screen-driven sympathetic tone, and the persistent low-grade alarm state most adults live in — does five things that read like a checklist of accelerated biological aging.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIt suppresses autophagy.\u003c\/strong\u003e Autophagy is the cellular cleanup process that recycles damaged proteins and organelles. It's the same process spermidine, fasting, and rapamycin pull on. Cortisol activates mTOR and suppresses AMPK — the inverse of the longevity-program signal. Over years, the result is accumulating cellular debris: misfolded proteins, dysfunctional mitochondria, the molecular signature of aging tissue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIt accelerates telomere shortening.\u003c\/strong\u003e Epel et al. (\u003cem\u003ePNAS\u003c\/em\u003e, 2004) measured telomere length in mothers of chronically ill children and found ten years of additional cellular aging compared to controls — directly correlated with perceived stress and serum cortisol. Multiple replications since. Cortisol doesn't shorten telomeres in a lab dish; it does so by raising oxidative stress, suppressing telomerase, and accelerating cell-division turnover in immune cells.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIt depletes NAD+.\u003c\/strong\u003e Chronic cortisol upregulates CD38 — the enzyme that breaks down NAD+ — and downregulates NAMPT, the rate-limiting enzyme that builds it. The net effect is the same physiology NMN, NR, and apigenin are working against. Cortisol normalization protects the NAD+ pool the rest of the longevity stack is trying to fill.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIt degrades sleep architecture.\u003c\/strong\u003e Evening cortisol delays sleep onset and shortens slow-wave sleep — the recovery window where growth hormone, glymphatic clearance, autophagy, and memory consolidation all happen. A broken cortisol curve is functionally equivalent to a 20% sleep deficit, even if you spend eight hours in bed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIt dysregulates the HPA axis itself.\u003c\/strong\u003e Years of high baseline cortisol leads to receptor downregulation and a flattened diurnal curve — high evenings, low mornings, persistent fatigue layered onto persistent over-arousal. This is the picture seen in adrenal-fatigue presentations and in many burned-out high-performers.\u003c\/p\u003e\n\n\u003cp\u003eThe longevity literature has converged on this: if you do not address chronic cortisol, you are running a more expensive supplement protocol against a stronger headwind. Ashwagandha is the most-studied, most-consistent, and most-replicated way to push that curve back into a healthier shape.\u003c\/p\u003e\n\n\u003ch2\u003eWhy ashwagandha ended up in serious longevity research\u003c\/h2\u003e\n\n\u003cp\u003eAdaptogens were on the fringe of nutritional science for decades. The reframing came from three converging lines of evidence — all using KSM-66 at 600mg\/day, all randomized, all placebo-controlled.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe cortisol data.\u003c\/strong\u003e Chandrasekhar et al. (\u003cem\u003eIndian Journal of Psychological Medicine\u003c\/em\u003e, 2012) ran a double-blind RCT in 64 chronically stressed adults at 300mg KSM-66 twice daily for 60 days. The treatment group saw a \u003cstrong\u003e27.9% drop in serum cortisol vs. 7.9% in placebo\u003c\/strong\u003e, with parallel reductions on the Perceived Stress Scale, the General Health Questionnaire, and the Depression Anxiety Stress Scale. Lopresti et al. (\u003cem\u003eMedicine\u003c\/em\u003e, 2019) replicated the design in 60 stressed adults at 240mg\/day standardized extract for 60 days and found a \u003cstrong\u003e23% cortisol reduction with significant DHEA-S preservation\u003c\/strong\u003e — meaning the HPA axis was being normalized rather than blunted. Salve et al. (\u003cem\u003eCureus\u003c\/em\u003e, 2019) reported similar cortisol-reduction effects at 600mg\/day in 60 stressed adults.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe sleep architecture work.\u003c\/strong\u003e Langade et al. (\u003cem\u003eCureus\u003c\/em\u003e, 2019, and \u003cem\u003eSleep Medicine\u003c\/em\u003e, 2020) measured polysomnography-confirmed sleep changes in 80 healthy adults and 150 adults with insomnia at 600mg KSM-66 daily for 8-10 weeks. Sleep onset latency dropped 28-43%, total sleep time rose 13-25%, sleep efficiency improved 7-13%, and HAM-A anxiety scores fell sharply — all by instrument, not just self-report. The mechanism is not sedation; it's recovery of the parasympathetic-dominant state that allows slow-wave sleep to occur. This is when autophagy, glymphatic clearance, and growth hormone release happen — the same recovery windows magnesium and the longevity stack depend on.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe body-composition and recovery data.\u003c\/strong\u003e Wankhede et al. (\u003cem\u003eJournal of the International Society of Sports Nutrition\u003c\/em\u003e, 2015) ran 600mg KSM-66 daily for 8 weeks in 57 men in a resistance training program. The treatment group added \u003cstrong\u003e1.5-1.7 kg more muscle, lost more body fat, and added 19-46 kg more on bench\/leg press\u003c\/strong\u003e vs. placebo, with parallel testosterone increases. The mechanism most researchers now favor: lower cortisol means less catabolic interference with the anabolic signaling that resistance training drives — adaptogen as recovery amplifier rather than ergogenic stimulant. Salve et al. (\u003cem\u003eCureus\u003c\/em\u003e, 2019) saw similar cortisol\/testosterone effects at the same dose in 60 stressed adults.\u003c\/p\u003e\n\n\u003cp\u003ePut together, the ashwagandha file is unusual in supplement literature: dozens of well-designed RCTs, consistent direction of effect, mechanism convergence, and dose-response visible across studies — all pointing to the same conclusion. Cortisol normalization is the single most-leveraged intervention in the foundational layer of a longevity protocol, and ashwagandha is the most-studied way to do it.\u003c\/p\u003e\n\n\u003ch2\u003eEight mechanisms — what 600mg\/day actually does\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Cortisol regulation.\u003c\/strong\u003e Withanolides modulate the HPA axis at the hypothalamic level — likely by acting on GABAergic tone, which down-regulates corticotropin-releasing hormone (CRH) signaling rather than blocking the cortisol receptor downstream. The result is a healthier diurnal curve: higher morning cortisol (the activating peak you actually want) and lower evening cortisol (the version that keeps you awake at 2 AM). The effect builds over weeks, not minutes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. Sleep architecture.\u003c\/strong\u003e Distinct from sedation: ashwagandha doesn't knock you out; it shortens the time it takes to fall asleep and lengthens the time you spend in slow-wave and REM stages. Slow-wave sleep is when the glymphatic system flushes the brain, when growth hormone is released, when memory consolidation happens, and when the autophagy targeted by the rest of the longevity stack is most active.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. Anxiety and stress resilience.\u003c\/strong\u003e Multiple meta-analyses (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25405876\/\" target=\"_blank\" rel=\"noopener\"\u003ePratte 2014\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35873404\/\" target=\"_blank\" rel=\"noopener\"\u003eAkhgarjand 2022\u003c\/a\u003e) consistently show medium-to-large effect sizes (Cohen's d 0.5-0.8) on anxiety scales — comparable to first-line pharmacological options without the side-effect profile. Mechanism: GABA-mimetic action of withanolides plus reduced cortisol-driven amygdala reactivity.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Muscle recovery and strength.\u003c\/strong\u003e The cortisol reduction is itself anti-catabolic, but ashwagandha also independently raises serum testosterone in men with low-to-normal baseline (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31517876\/\" target=\"_blank\" rel=\"noopener\"\u003eLopresti 2019\u003c\/a\u003e, ~14% increase) and improves VO₂ max (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26730141\/\" target=\"_blank\" rel=\"noopener\"\u003eChoudhary 2015\u003c\/a\u003e, ~13% increase in trained athletes at 12 weeks). Useful even in non-lifting protocols because the same anabolic signaling preserves lean mass through the decade where sarcopenia begins — a key longevity outcome.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Cognitive function.\u003c\/strong\u003e Choudhary et al. (\u003cem\u003eJournal of Dietary Supplements\u003c\/em\u003e, 2017) measured working memory, reaction time, and executive function in 50 adults with mild cognitive impairment at 600mg\/day for 8 weeks. All three domains improved significantly vs. placebo. Mechanism is multifactorial — reduced inflammation, normalized cortisol (chronic high cortisol is hippocampotoxic), and direct neuroprotection from withanolides shown in cell-culture and rodent work.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Immune modulation.\u003c\/strong\u003e Mikolai et al. (\u003cem\u003eJournal of Alternative and Complementary Medicine\u003c\/em\u003e, 2009) and follow-up work show increased CD4+ counts, improved natural-killer cell activity, and lower inflammatory cytokine load — the immune profile is shifted toward surveillance rather than chronic low-grade inflammation. Relevant because chronic stress is directly immunosuppressive, and immune dysregulation is a core hallmark of aging.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e7. Thyroid support (subclinical hypothyroidism).\u003c\/strong\u003e Sharma et al. (\u003cem\u003eJournal of Alternative and Complementary Medicine\u003c\/em\u003e, 2018) ran 600mg\/day in 50 patients with subclinical hypothyroidism for 8 weeks and found significant T3 and T4 increases with TSH normalization. The same mechanism is a contraindication in hyperthyroidism — see the contraindications section. The thyroid effect is real and clinically measurable, and it is why ashwagandha is one of the few adaptogens with a published thyroid safety profile worth taking seriously in either direction.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e8. Fertility and reproductive hormones.\u003c\/strong\u003e Ambiye et al. (\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c\/em\u003e, 2013) measured semen parameters in 46 oligospermic men at 675mg\/day for 90 days and reported significant improvements in sperm count, motility, and serum testosterone vs. baseline. The fertility data builds on the testosterone-and-cortisol work: lower cortisol relieves some of the suppression on the HPG axis, and the gonadotropin signal moves accordingly. Practical relevance for the longevity stack: testosterone, sperm parameters, and reproductive hormones decline measurably with age, and the cortisol\/HPA layer is one of the few interventions that touches all three.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical evidence — what the trials actually measured\u003c\/h2\u003e\n\n\u003ctable style=\"width:100%; border-collapse: collapse; margin: 1em 0;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"border-bottom: 2px solid #ddd; background:#f7f7f7;\"\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eStudy\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003ePopulation\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eDose \/ Duration\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eOutcome\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eChandrasekhar 2012\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e64 chronically stressed adults\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 60 days\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e-27.9% serum cortisol vs -7.9% placebo; PSS, GHQ, DASS all improved\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eWankhede 2015\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e57 men in resistance training\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 8 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e+1.5-1.7 kg muscle, +19-46 kg bench\/leg press, +14% testosterone\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eChoudhary 2015\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e50 trained athletes\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 12 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e+13% VO₂ max vs placebo\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eChoudhary 2017\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e50 adults with MCI\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 8 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eImproved working memory, reaction time, executive function\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eSharma 2018\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e50 subclinical hypothyroid\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 8 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eT3 +41%, T4 +20%, TSH normalized\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eLopresti 2019\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e60 stressed adults\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e240mg KSM-66 \/ 60 days\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e-23% cortisol; DHEA-S preserved; testosterone +14% (men)\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eLangade 2019\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e60 adults with insomnia\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 10 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eSleep onset -43%, total sleep +25%, HAM-A -reduced (PSG-confirmed)\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eSalve 2019\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e60 stressed adults\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 60 days\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eCortisol reduction; DASS-42 improvements\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eLangade 2020\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e80 healthy adults\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e600mg KSM-66 \/ 8 weeks\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003ePSG sleep efficiency +13%, slow-wave-sleep increase\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd style=\"padding:8px;\"\u003eAmbiye 2013\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e46 oligospermic men\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e675mg KSM-66 \/ 90 days\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e+167% sperm count, +57% motility, +17% testosterone vs baseline\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eTwo patterns stand out across the literature. First, dose convergence: the trials that produced the most reliable cortisol, sleep, strength, and cognition outcomes all clustered at 300-600mg\/day of standardized KSM-66 — the dose this product delivers in one capsule. Second, time course convergence: most outcomes are visible at 8 weeks, several earlier (sleep is fastest), and the cortisol effect is robust at 4-8 weeks of continuous use.\u003c\/p\u003e\n\n\u003ch2\u003eWhy KSM-66 — and what to ignore on the label\u003c\/h2\u003e\n\n\u003cp\u003eMost of what's sold as \"ashwagandha\" is one of three different things, and the differences matter. The cheapest products on the shelf are not the same molecules that produced the trial outcomes above.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%; border-collapse: collapse; margin: 1em 0;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"border-bottom: 2px solid #ddd; background:#f7f7f7;\"\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eForm\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003ePlant part\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eWithanolide standardization\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eSolvent\u003c\/th\u003e\n      \u003cth style=\"text-align:left; padding:8px;\"\u003eTrial coverage\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eGeneric root powder\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eRoot\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e0.1-0.3% (unstandardized)\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eN\/A — raw powder\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eTraditional Ayurveda; not used in modern RCTs\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003eSensoril\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eRoot + leaf\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e≥10% withanolides (leaf-heavy)\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eAcetone\/ethanol process\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eSmaller trial base; relaxation\/anxiolytic emphasis\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr style=\"border-bottom:1px solid #eee; background: #f7faf7;\"\u003e\n      \u003ctd style=\"padding:8px;\"\u003e\u003cstrong\u003eKSM-66 (this product)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eRoot only\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e≥5% withanolides (full-spectrum)\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eMilk + water (green chemistry)\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eMajority of positive cortisol\/sleep\/strength\/cognition RCTs\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd style=\"padding:8px;\"\u003eShoden\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eRoot + leaf\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003e≥35% withanolide glycosides (concentrated)\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eProprietary\u003c\/td\u003e\n      \u003ctd style=\"padding:8px;\"\u003eNewer, smaller body of work; high-potency anxiolytic data\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy root-only matters.\u003c\/strong\u003e Leaves are higher in withaferin A, which is more cytotoxic than the root-dominant withanolide profile. Useful in some research contexts (cancer pharmacology) but not the chemistry that produced the cortisol\/sleep\/strength file. KSM-66 specifically excludes leaves to preserve the root chemistry.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy solvent matters.\u003c\/strong\u003e Traditional Ayurveda extracts ashwagandha in milk. KSM-66 uses a milk-and-water green-chemistry process that does not introduce acetone, hexane, or ethanol residues into the finished extract. This is a meaningful quality difference that does not show up on the standardization spec but does show up in third-party residual-solvent testing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy 5% (not 10%) full-spectrum.\u003c\/strong\u003e Higher-percentage standardizations are achieved by enriching certain withanolides at the expense of others. The 5% full-spectrum profile preserves the relative proportions of withaferins, withanosides, and withanolide glycosides found in the whole root — which is the chemistry that the 600mg-per-day clinical-trial doses correspond to. A 10% leaf-and-root extract at 600mg is not the same molecular payload, and the trial data does not transfer directly.\u003c\/p\u003e\n\n\u003cp\u003eThe 600mg\/day target in this product matches the dose used in the largest body of positive trial data — including all of the sleep, strength, and cognition outcomes above — using the specific standardized extract that produced those outcomes.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in the bottle\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eKSM-66 Ashwagandha Root Extract — 600mg per serving\u003c\/strong\u003e (1 capsule daily; 60 capsules \/ 60-day supply)\u003c\/li\u003e\n\u003cli\u003eStandardized to ≥5% withanolides by HPLC\u003c\/li\u003e\n\u003cli\u003eRoot-only (no leaves) — preserves the chemistry used in the published RCTs\u003c\/li\u003e\n\u003cli\u003eGreen-chemistry milk-and-water extraction; no chemical solvent residues\u003c\/li\u003e\n\u003cli\u003eVegetable cellulose capsule (HPMC) — vegan, kosher\u003c\/li\u003e\n\u003cli\u003eNo magnesium stearate, no silicon dioxide, no titanium dioxide, no artificial colorants\u003c\/li\u003e\n\u003cli\u003eNo gluten, no soy, no dairy in the finished capsule, no GMOs\u003c\/li\u003e\n\u003cli\u003eManufactured in a U.S. cGMP-certified facility, tested for heavy metals (ICP-MS), pesticides, and microbial load\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eIf you've read any of the other product pages in this catalog, you've seen the same panel discipline: clinical-trial doses, the standardized form actually used in the trials, no proprietary blends, no stimulants stacked in to manufacture a \"feel,\" and nothing in the capsule that doesn't need to be there.\u003c\/p\u003e\n\n\u003ch2\u003eHow to take it — three protocols\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eDefault protocol (most users).\u003c\/strong\u003e 1 capsule (600mg KSM-66) daily, with food, ideally with breakfast or lunch. This is the dose used across most of the cortisol, sleep, and cognition studies. Start here unless you have a specific reason to move it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSleep-priority protocol.\u003c\/strong\u003e If your primary goal is sleep architecture — falling asleep faster, staying asleep, more time in slow-wave sleep — switch to evening dosing (with dinner or 60-90 minutes before bed). The cortisol-lowering effect compounds with the natural evening cortisol drop and produces more noticeable subjective sleep changes within the first 2 weeks. Pair with \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e at the same evening time slot — the two compounds work on complementary halves of the parasympathetic switch (GABA tone via different pathways, and the sympathetic-to-parasympathetic transition).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStrength\/recovery protocol.\u003c\/strong\u003e If your primary goal is the muscle, strength, or VO₂ max effects (Wankhede 2015 \/ Choudhary 2015 outcomes), 1 capsule daily, with the meal closest to your training session, for at least 8-12 weeks. The strength and body-composition signal is durable — most published trials show continued improvement across the trial window without plateau. Stack with \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate\u003c\/a\u003e and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e for a foundational strength-and-recovery base.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTime to effect.\u003c\/strong\u003e Sleep effects typically show within 1-2 weeks. Cortisol normalization is measurable in serum at 4 weeks and most pronounced by 8 weeks. Strength\/body-composition changes follow the trial timeline — visible at 8 weeks, most pronounced at 12. This is not a same-day compound.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCycling.\u003c\/strong\u003e The published RCTs run 8-12 weeks of continuous use without tolerance development or rebound on discontinuation. Most clinical practitioners run it continuously through stressful seasons and de-emphasize during low-stress periods rather than formally cycling. There is no withdrawal pattern in the published literature.\u003c\/p\u003e\n\n\u003ch2\u003eStacking with the True Health Protocol catalog\u003c\/h2\u003e\n\n\u003cp\u003eAshwagandha is the cortisol\/HPA-axis foundational layer. It pairs naturally with the rest of the catalog because cortisol normalization protects nearly every downstream longevity intervention.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSleep stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e in the evening. The three highest-evidence non-prescription sleep compounds, with no overlapping mechanism — GABA tone, NMDA modulation, and parasympathetic transition.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ protection stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e alongside any of the NAD+ line (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus 1000mg\u003c\/a\u003e, or the \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e). Chronic cortisol upregulates CD38 and depletes the NAD+ pool faster than NMN can refill it — fixing the cortisol leak first compounds the return on the precursor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStrength and sarcopenia-prevention stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e + \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e. The Wankhede 2015 trial protocol effectively, plus the omega-3 anti-inflammatory base for recovery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational longevity layer.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e + \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e. The four-product foundational layer that should sit underneath any longevity protocol — cortisol, sleep mineral, membrane\/inflammation, and hormone substrate. The targeted longevity compounds sit on top of this base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive-protection stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e. Cortisol normalization (hippocampal preservation), DHA membrane support, and glutathione precursor — three different angles on chronic stress and cognitive aging.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eIf you're new to the catalog, the foundational layer above is the suggested starting place. Targeted compounds — senolytics, mitochondrial agents, NAD+ precursors — work better in a body whose baseline cortisol, magnesium, omega-3, and D3 status are already in range.\u003c\/p\u003e\n\n\u003ch2\u003eCortisol, inflammation, and the silent acceleration of biological age\u003c\/h2\u003e\n\n\u003cp\u003eThe cortisol-and-inflammation feedback loop is one of the better-described drivers of accelerated biological aging in the modern aging literature. The mechanism runs in both directions and is harder to break with isolated interventions than most people expect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCortisol drives inflammation in the long run.\u003c\/strong\u003e In the short term, cortisol is anti-inflammatory — that's why hydrocortisone is a topical treatment for inflammation. But chronically elevated cortisol leads to glucocorticoid receptor desensitization in immune cells, which paradoxically \u003cem\u003eraises\u003c\/em\u003e baseline inflammatory tone over months and years. This is a well-described mechanism behind why chronic stress correlates with elevated CRP, IL-6, and TNF-α — the same inflammatory markers that map onto cardiovascular risk, cognitive decline, and mortality.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eInflammation drives cortisol back up.\u003c\/strong\u003e Inflammatory cytokines (especially IL-1β and IL-6) signal the hypothalamus to release CRH, which raises ACTH and pushes cortisol back up. The system is bidirectional. Once it gets stuck in a high-cortisol\/high-inflammation steady state, breaking either side moves the other.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy this matters for longevity.\u003c\/strong\u003e \"Inflammaging\" — chronic low-grade inflammation that increases with age — is one of the named hallmarks of aging in the Lopez-Otin framework. It is mechanistically tied to nearly every other hallmark: it accelerates cellular senescence (the target of senolytics like fisetin and quercetin), it depletes NAD+ (via CD38 again), it suppresses autophagy, and it increases the rate of DNA damage. Cortisol normalization is one of the few interventions that pulls on inflammaging from the upstream side rather than treating individual cytokines downstream.\u003c\/p\u003e\n\n\u003cp\u003eAshwagandha doesn't replace omega-3, doesn't replace exercise, doesn't replace sleep hygiene. But it sits at the upstream point of one of the strongest inflammatory drivers most people never address.\u003c\/p\u003e\n\n\u003ch2\u003eHormones — testosterone, thyroid, and reproductive aging\u003c\/h2\u003e\n\n\u003cp\u003eThe hormonal panel is where ashwagandha gets interesting and also where it gets specific contraindications. Worth understanding both before starting.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTestosterone.\u003c\/strong\u003e Multiple trials in men with low-to-normal baseline testosterone show 14-22% increases at 600mg\/day for 8-16 weeks (Lopresti 2019, Ambiye 2013, Wankhede 2015). The mechanism is most likely a combination of cortisol reduction (cortisol and testosterone share precursor pregnenolone, and chronic cortisol diverts pregnenolone away from sex-hormone synthesis) plus modest direct gonadotropin support. The effect is small to moderate in healthy men and largest in men with stress-driven suppression at baseline.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDHEA-S preservation.\u003c\/strong\u003e Lopresti 2019 noted that ashwagandha's cortisol-lowering effect did not flatten DHEA-S — meaning the HPA axis was being normalized, not blunted. Important because some adaptogens (and many pharmacological cortisol-lowering interventions) come at the cost of generalized adrenal output, including DHEA — which is the upstream sex-hormone precursor and an independently-tracked aging marker.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThyroid (T3, T4, TSH).\u003c\/strong\u003e Sharma 2018 measured thyroid panel changes at 600mg\/day in 50 patients with subclinical hypothyroidism: T3 +41%, T4 +20%, TSH normalized over 8 weeks. The effect is real and clinically measurable. This is good news in subclinical hypothyroidism (a common age-related slow drift) and a contraindication in hyperthyroidism. If you take levothyroxine, talk to your physician — dose adjustment may be needed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFemale reproductive hormones.\u003c\/strong\u003e Smaller body of literature than the male testosterone work. Dongre 2015 and Gopal 2021 reported sexual-function score improvements in women at 600mg\/day for 8 weeks, with parallel reductions in stress markers. Mechanism not fully characterized but consistent with the cortisol\/HPA-axis mechanism rather than a direct estrogenic effect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSperm parameters and male fertility.\u003c\/strong\u003e Ambiye 2013 in 46 oligospermic men at 675mg\/day for 90 days reported substantial improvements in sperm count (+167%), motility (+57%), volume, and serum testosterone (+17% vs baseline). The fertility effect is large in the published trials but should be interpreted with the usual caveats: oligospermic populations have more room to improve, and follow-on trials in larger cohorts are ongoing.\u003c\/p\u003e\n\n\u003cp\u003ePractical note: if your goal is fertility specifically, see also \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e — the egg- and sperm-quality literature on ubiquinone is one of the most reliable threads in the male\/female fertility supplement space, and it stacks cleanly with ashwagandha because the mechanisms (mitochondrial energy + HPA cortisol suppression) are non-overlapping.\u003c\/p\u003e\n\n\u003ch2\u003eWhat you'll feel and when — week by week\u003c\/h2\u003e\n\n\u003cp\u003eThis section is about subjective experience. Lab markers (cortisol, T3, testosterone) move on their own timeline and require blood draws to verify; the subjective experience is what most people are tracking day-to-day.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1.\u003c\/strong\u003e Subtle. Some users report a slight settling of the \"buzzing\" baseline anxiety on day 3-5. Sleep changes can begin to appear at the end of the first week. No dramatic shift; if you're expecting one, you'll think it's not working. The cortisol curve is still moving.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2.\u003c\/strong\u003e Sleep onset latency starts shortening for many users. Subjective stress reactivity to mid-tier stressors (a tense email, a missed deadline) may feel slightly less spiky. Most users describe this stage as \"I noticed I didn't get as wound up about [thing] as I usually would.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4.\u003c\/strong\u003e Cortisol normalization is measurable in serum at this point in the trial data. Subjectively: improved sleep architecture (more refreshed mornings), more stable mid-afternoon energy, less of the 4-5pm crash. Anxiety scale scores in the trials drop most rapidly through this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8.\u003c\/strong\u003e The peak of the cortisol-reduction effect in the published trials. Subjective stress resilience is meaningfully different. For users on the strength\/recovery protocol, training recovery starts visibly improving. Sleep is at its best window. Cognitive measures (working memory, reaction time) are starting to register on the Choudhary trial timeline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 12+.\u003c\/strong\u003e Body composition and strength changes most pronounced for users who are training. Long-term users describe a steadier baseline rather than dramatic peaks — the system is running closer to where it should run, rather than producing an overlay of \"feeling better\" on top of the same dysregulated baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eIf nothing has changed by week 6:\u003c\/strong\u003e First, double-check you're taking it consistently with food (withanolides are lipophilic — empty-stomach dosing reduces absorption substantially). Second, consider whether your baseline cortisol is actually the limiting factor for whatever you're tracking. Ashwagandha is an HPA-axis intervention; it does not address sleep apnea, iron deficiency, low ferritin, untreated thyroid disease, or chronic over-caffeination. If those are present, they will overshadow any cortisol effect.\u003c\/p\u003e\n\n\u003ch2\u003eWho should not take this\u003c\/h2\u003e\n\n\u003cp\u003eAdaptogens are mild compared to pharmaceuticals, but ashwagandha has a real interaction profile and a few hard contraindications. The thyroid and immune effects in particular are more substantive than most \"natural\" supplement interactions.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding.\u003c\/strong\u003e Ashwagandha is uterotonic in animal models and has been used historically as an abortifacient in some traditions. Do not take if pregnant, planning pregnancy, or breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutoimmune conditions.\u003c\/strong\u003e Ashwagandha is immunostimulatory — it raises CD4+ counts and shifts immune tone toward activity. In autoimmune conditions (Hashimoto's thyroiditis, lupus, MS, RA, Sjögren's, type 1 diabetes), this is not what you want. Discuss with your physician before adding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThyroid medication and hyperthyroidism.\u003c\/strong\u003e Multiple trials show ashwagandha raises T3 and T4. Useful in subclinical hypothyroidism (Sharma 2018), problematic in hyperthyroidism, and a real interaction with levothyroxine — it can require dose reduction. Check with your endocrinologist if you're on thyroid medication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSedatives, benzodiazepines, alcohol.\u003c\/strong\u003e Additive effects on GABAergic tone. The combination is not dangerous in the way mixing benzodiazepines and opioids is dangerous, but it can be more sedating than either alone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Discontinue at least 2 weeks before scheduled surgery — ashwagandha can interact with anesthesia and may have mild blood-pressure-lowering effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLiver disease.\u003c\/strong\u003e Rare hepatotoxicity case reports exist, mostly with combination products and unstandardized leaf-containing extracts; monitor LFTs if you have pre-existing liver disease. The KSM-66 root-only standardized extract has the cleanest safety profile in this category.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren.\u003c\/strong\u003e Insufficient pediatric safety data for chronic supplementation. Use only on physician guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eIf you take any prescription medication or have a chronic condition, run this past your physician before starting. This is true of every supplement, and especially true of a compound that touches the HPA axis and thyroid.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow is this different from Sensoril or generic ashwagandha?\u003c\/strong\u003e KSM-66 is full-spectrum root extract standardized to ≥5% withanolides, used in the majority of the published positive trials on cortisol, sleep, strength, and cognition. Sensoril is a leaf-and-root extract standardized to ≥10% withanolides — different chemistry, different research base, more emphasis on relaxation\/anxiolytic outcomes than on the strength\/recovery profile. Generic root powder typically contains 0.1-0.3% withanolides — you would need 3-5 grams per day to match the clinical-trial dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this make me sleepy during the day?\u003c\/strong\u003e Not in most users. Ashwagandha is classified as an adaptogen rather than a sedative — the cortisol effect normalizes the diurnal curve (higher morning, lower evening) rather than blunting alertness. A small minority of users do report drowsiness; if so, switch the dose to evening.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAshwagandha or Rhodiola?\u003c\/strong\u003e Different mechanisms, different use cases. Rhodiola is a fast-acting acute stress and fatigue compound — better for \"pre-deadline\" or \"pre-workout\" same-day use. Ashwagandha works on chronic baseline cortisol and sleep architecture over weeks. They can be stacked, and many practitioners use Rhodiola situationally and ashwagandha daily.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it lower testosterone?\u003c\/strong\u003e The opposite. The strength and male-fertility trials show 14-17% testosterone increases at 8-16 weeks (Lopresti 2019, Ambiye 2013), likely via cortisol reduction (cortisol and testosterone share precursor pregnenolone) plus modest direct gonadotropin support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTake with food or empty stomach?\u003c\/strong\u003e With food. Withanolides are lipophilic — fat in the meal improves absorption. The clinical trials specified with-meal dosing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Sleep changes — 1 to 2 weeks. Stress\/anxiety reduction — 2 to 4 weeks, building. Cortisol normalization on serum tests — 4 to 8 weeks. Strength\/recovery changes — 8 to 12 weeks. This is a re-tune-the-system compound, not a stimulant.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with NMN, resveratrol, and the rest of the longevity stack?\u003c\/strong\u003e Yes. There are no known mechanistic conflicts. In fact, the cortisol\/CD38 interaction means ashwagandha protects the NAD+ pool that NMN, NR, and apigenin are working to fill. Most longevity practitioners run it as a foundational layer underneath the targeted compounds.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with caffeine?\u003c\/strong\u003e Yes. The cortisol-lowering and caffeine-driven adrenergic tone do not directly conflict. If anything, ashwagandha can take some of the edge off the cortisol-spike side of caffeine without blunting the adenosine-receptor effect on alertness.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it work for \"anxiety\" specifically?\u003c\/strong\u003e The published anxiety trials show medium-to-large effect sizes on standardized anxiety scales (HAM-A, DASS) at 600mg\/day for 6-8 weeks. It is not a benzodiazepine — it does not produce acute anxiolysis. It changes baseline reactivity over weeks. For acute anxiety, this is the wrong tool; for chronic stress-driven anxiety, it has one of the strongest evidence bases in the supplement space.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle it?\u003c\/strong\u003e The published trials run 8-12 weeks of continuous use without tolerance development or rebound. There is no published evidence supporting cycling for safety or efficacy reasons. Most clinical practitioners run it continuously through high-stress periods and de-emphasize during low-stress periods.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if I miss a dose?\u003c\/strong\u003e No need to double up. The cortisol-normalization effect is a long-term shift in the HPA-axis set point, not a same-day pharmacological action. Resume the next day at the normal dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan women take it?\u003c\/strong\u003e Yes — outside of pregnancy and breastfeeding. The female-population trials are smaller than the male trials but consistently show stress and sleep benefits at 600mg\/day, with no signal of estrogen disruption or menstrual irregularity in the published literature. The thyroid contraindication applies to women as it does to men.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the dose lower than what I see in some \"high-potency\" products?\u003c\/strong\u003e Because the dose used in the published RCTs is 300-600mg\/day. Higher doses (1000-2000mg\/day) appear in some products without corresponding human-trial data; the marginal benefit above 600mg\/day is not well-characterized in the literature, and there is some animal data suggesting higher doses may push past the optimal dose-response curve. We dose at the level that produced the trial outcomes, not at the level that prints the biggest number on the bottle.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and disclaimer\u003c\/h2\u003e\n\n\u003cp\u003eManufactured in a U.S. FDA-registered, cGMP-certified facility. Each lot is tested for active withanolide concentration (HPLC), heavy metals (ICP-MS), pesticide residues, and microbial contamination. We use KSM-66 specifically — the standardized extract produced by Ixoreal Biomed in India and used in the majority of the published positive RCTs — rather than a generic root powder or a different standardization, because the chemistry that produced the published outcomes is the chemistry we want in the capsule.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information above summarizes published research and is provided for educational purposes; it is not medical advice. Consult your physician before starting any supplement, particularly if you are pregnant, breastfeeding, taking prescription medication, scheduled for surgery, have an autoimmune or thyroid condition, or have a chronic medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"60 Capsules","offer_id":47839840436442,"sku":"THP-ASHWA-KSM66-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_ashwagandha.png?v=1778076431"},{"product_id":"pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin","title":"Pterostilbene 100mg | Trans-Pterostilbene | Bioavailable SIRT1 Activator \u0026 Resveratrol Cousin","description":"\u003cp\u003e\u003cstrong\u003eThe 30-second answer:\u003c\/strong\u003e Pterostilbene is the methylated, blueberry-derived cousin of trans-resveratrol — same SIRT1 \/ SIRT3 sirtuin engagement, same Nrf2 antioxidant transcription program, same AMPK metabolic switch, but with roughly \u003cstrong\u003e~80% oral bioavailability versus ~20% for resveratrol\u003c\/strong\u003e, a plasma half-life that’s several-fold longer, and far better blood-brain-barrier penetration (Kapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e; Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e; Riche 2014 \u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e). Across the López-Otín \u0026amp; Kroemer 2013\/2023 \u003cem\u003eCell\u003c\/em\u003e Hallmarks-of-Aging framework, pterostilbene engages \u003cstrong\u003eat least five hallmarks\u003c\/strong\u003e: mitochondrial dysfunction (SIRT3, PGC-1α), deregulated nutrient sensing (AMPK, SIRT1), altered intercellular communication (NF-κB suppression, inflammaging), genomic instability (SIRT1-mediated DNA-repair), and disabled macroautophagy (AMPK→ULK1). For anyone running an NMN or NR stack, pterostilbene is the partner that converts a higher NAD+ pool into actual sirtuin work — without the dose-dependent absorption ceiling and rapid first-pass conjugation that hold resveratrol back. Each True Health Protocol vegan capsule delivers \u003cstrong\u003e100mg of trans-pterostilbene\u003c\/strong\u003e, the bioidentical isomer used in published human trials (Riche 2014 cardiometabolic; Riche 2013 safety; McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e review). Third-party tested for purity, no titanium dioxide, no magnesium stearate, no proprietary blends, no cis-isomer drift.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy it’s in the True Health Protocol catalog:\u003c\/strong\u003e A meaningful longevity protocol needs both a \u003cem\u003esubstrate\u003c\/em\u003e (NMN\/NR → NAD+) and an \u003cem\u003eactivator\u003c\/em\u003e for the enzymes that consume it (sirtuins). Resveratrol was the original activator; pterostilbene is the version of resveratrol that survives the gut wall and liver intact. We sell \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003etrans-resveratrol 600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the deepest published trial library), and pterostilbene 100mg as the bioavailable, BBB-crossing finisher. Most serious longevity stackers run both.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — why most resveratrol underdelivers\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is the most-studied stilbenoid in longevity literature, but it has a structural problem: three free hydroxyl (–OH) groups make it a prime substrate for phase-II conjugation enzymes — UDP-glucuronosyltransferases (UGT1A1, UGT1A9, UGT1A10) and sulfotransferases (SULT1A1, SULT1E1) — the moment it hits the gut wall and the portal liver. Walle 2004 \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e traced 25mg of oral resveratrol in six healthy volunteers and found \u003cstrong\u003e\u0026lt;5–10% reaching systemic circulation as the unconjugated parent compound\u003c\/strong\u003e; the rest appeared as resveratrol-3-O-glucuronide, resveratrol-4′-O-glucuronide, and resveratrol-3-sulfate — metabolites that are dramatically less potent on sirtuin and Nrf2 targets. Sub-tissue free-resveratrol concentrations stay low. Plasma half-life of the free aglycone is roughly \u003cstrong\u003e14 minutes\u003c\/strong\u003e; the famous “red wine resveratrol” headlines were always running into the same wall — the molecule simply does not survive intact at the dose people are willing to take. Boocock 2007 \u003cem\u003eCancer Epidemiol Biomarkers Prev\u003c\/em\u003e dose-escalated resveratrol to 5g in humans and confirmed Walle’s finding: even at gram-level doses, free trans-resveratrol C\u003csub\u003emax\u003c\/sub\u003e was modest and conjugates dominated the AUC.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is what nature does about it. By replacing two of those free hydroxyls with methoxy (–OCH\u003csub\u003e3\u003c\/sub\u003e) groups — the 3- and 5-positions of the stilbene A-ring — it dodges phase-II conjugation, becomes substantially more lipid-soluble (logP rises from ~3.1 to ~4.0), and crosses cellular membranes far more readily. Methoxy groups cannot be glucuronidated or sulfated; they are biochemically “capped.” Only the single remaining hydroxyl on the B-ring (the 4′-OH) is available for phase-II metabolism, and even that is partially shielded by the methoxy-induced electronic effects on the molecule. The result is a stilbenoid that absorbs through the lymphatic \/ chylomicron pathway when taken with dietary fat, distributes broadly into adipose and brain tissue, and stays around long enough to engage cellular targets at clinically meaningful concentrations.\u003c\/p\u003e\n\n\u003cp\u003eKapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e, comparing the two compounds head-to-head in Sprague-Dawley rats, reported pterostilbene oral bioavailability at \u003cstrong\u003e~80%\u003c\/strong\u003e versus ~20% for resveratrol, with a plasma half-life roughly \u003cstrong\u003e5–7× longer\u003c\/strong\u003e for pterostilbene (~105 minutes free vs ~14 minutes for resveratrol’s free aglycone). Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e reached the same conclusion in an independent rat PK model. Remsberg 2008 \u003cem\u003ePhytother Res\u003c\/em\u003e measured tissue distribution and found pterostilbene reached substantially higher concentrations in liver, kidney, lung, and brain than equivalent doses of resveratrol — the methoxy groups translate to better tissue penetration, not just better plasma exposure. The practical translation: the same milligram dose of pterostilbene puts more drug, in active form, in front of cellular targets — and keeps it there long enough to actually do work.\u003c\/p\u003e\n\n\u003ch3\u003eThe methoxy chemistry — why two carbons change everything\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is \u003cstrong\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/strong\u003e: a 14-carbon molecule with two phenyl rings linked by a trans-vinyl bridge, decorated with three hydroxyl groups. Trans-pterostilbene is \u003cstrong\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/strong\u003e: the same skeleton, but the 3- and 5-hydroxyls of the A-ring are O-methylated to methoxy ethers. Two carbon atoms and six hydrogens differ. Those two methyl groups are doing a lot of work:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhase-II evasion.\u003c\/strong\u003e Glucuronosyltransferases require a free hydroxyl to attach a glucuronic-acid sugar; sulfotransferases require a free hydroxyl to transfer a sulfate group. A methoxy ether has no free OH — it cannot be conjugated. Capping two of the three hydroxyls cuts the available phase-II surface area by two-thirds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLipophilicity.\u003c\/strong\u003e Hydroxyls are polar, hydrogen-bond donors and acceptors that pull a molecule into water. Methoxy groups are weaker hydrogen-bond acceptors and not donors, leaving the molecule more comfortable in lipid environments. The logP shift from 3.1 to 4.0 looks small, but logP is a logarithmic scale — pterostilbene is roughly \u003cstrong\u003e8× more lipid-soluble\u003c\/strong\u003e than resveratrol. That governs membrane permeability, blood-brain-barrier crossing, adipose distribution, and the fat-meal-dependence of oral absorption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic stability.\u003c\/strong\u003e The most rapid resveratrol metabolite, resveratrol-3-O-sulfate, forms within minutes in human enterocytes. Pterostilbene’s 3-position is methylated; that pathway is closed. The single remaining hydroxyl (4′-OH) can still be glucuronidated to pterostilbene-4′-O-glucuronide, but the rate is much slower and the parent compound dominates plasma exposure for hours rather than minutes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReceptor and enzyme binding.\u003c\/strong\u003e Sirtuin-activator binding studies (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, follow-up structural work) suggest the stilbene scaffold — not the specific hydroxyl pattern — is what fits the SIRT1 allosteric pocket. Pterostilbene retains the activator function while gaining the pharmacokinetic profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced phytoestrogenicity.\u003c\/strong\u003e Resveratrol’s 4′-hydroxyl plus its 3,5-resorcinol pattern give it weak estrogen-receptor (ERα \/ ERβ) ligand activity, especially at higher doses. Pterostilbene, with its methylated 3,5-positions, has substantially lower estrogenic activity in receptor-binding assays. For users worried about hormone-sensitive contexts, the methylation is a feature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is the chemistry behind every clinical headline. When you read “~80% oral bioavailability” or “crosses the blood-brain barrier substantially better than resveratrol,” the underlying explanation is two methyl groups on the A-ring — nothing more dramatic, nothing less rigorous.\u003c\/p\u003e\n\n\u003ch3\u003eWhat pterostilbene does in the cell — the mechanism in plain English\u003c\/h3\u003e\n\u003cp\u003eThree signaling pathways converge on stilbenoid biology, and pterostilbene engages all three at concentrations achievable from oral dosing:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1 \/ SIRT3 sirtuin activation.\u003c\/strong\u003e Sirtuins are NAD+-dependent deacylases — enzymes that strip acetyl, succinyl, and malonyl groups off histones (epigenetic regulation), transcription factors (FOXO3, p53, NF-κB p65), and metabolic regulators (PGC-1α, SOD2, IDH2), generally in the direction of better mitochondrial function, longer cellular lifespan, and tighter DNA-repair signaling. SIRT1 lives in the nucleus and acts on FOXO\/p53\/PGC-1α; SIRT3 lives in mitochondria and tunes the acetylation state of the entire mitochondrial proteome (Lombard 2007 \u003cem\u003eMol Cell\u003c\/em\u003e; Hebert 2013 \u003cem\u003eMol Cell\u003c\/em\u003e). Sinclair’s lab and others (Howitz 2003; Borra 2005 \u003cem\u003eJ Biol Chem\u003c\/em\u003e; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e) showed that polyphenolic stilbenoids allosterically modulate SIRT1 activity, lowering its K\u003csub\u003em\u003c\/sub\u003e for NAD+ — meaning sirtuin activity rises at the same NAD+ concentration. Pterostilbene shows comparable or stronger in-vitro SIRT1 modulation than resveratrol (McCormack 2013; Pari 2015 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e), and reaches sirtuin-relevant tissue concentrations more readily because of the bioavailability profile.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNrf2 \/ KEAP1 antioxidant response element.\u003c\/strong\u003e Nrf2 (nuclear factor erythroid 2–related factor 2) is a transcription factor held in the cytoplasm by KEAP1 (Kelch-like ECH-associated protein 1). Under oxidative stress — or under the influence of electrophilic stilbenoids — reactive cysteines on KEAP1 (Cys151, Cys273, Cys288) are modified, releasing Nrf2 to translocate to the nucleus, dimerize with small Maf proteins, and bind the antioxidant response element (ARE) in promoters of ~200–250 cytoprotective genes: glutamate-cysteine ligase (GCL, the rate-limiting enzyme of glutathione synthesis), NQO1, heme oxygenase-1 (HMOX1), thioredoxin reductase (TXNRD1), glutathione peroxidase 2 (GPX2), and the entire phase-II metabolism cassette. Pterostilbene is a potent Nrf2 activator (Bhakkiyalakshmi 2014 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e; Pari 2015), which is the molecular reason it shows up across so many oxidative-stress disease models. This is not the same as “adding antioxidants to your blood” — it’s the cell upregulating its own endogenous defense system.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eAMPK and metabolic flexibility.\u003c\/strong\u003e AMP-activated protein kinase is the cellular energy sensor that flips on when the AMP:ATP ratio rises — promoting glucose uptake (GLUT4 translocation), fatty-acid oxidation (CPT1 derepression via ACC phosphorylation), autophagy (ULK1 phosphorylation), and mitochondrial biogenesis (PGC-1α activation, downstream of SIRT1 deacetylation). Pterostilbene activates AMPK at concentrations achievable from oral dosing (Pan 2008 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e; Pari 2015), which is the mechanistic basis for the lipid- and glucose-related signals in the Riche 2014 trial.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression (the “inflammaging” lever).\u003c\/strong\u003e NF-κB is the transcription factor most central to chronic, low-grade, age-associated inflammation — the “inflammaging” coined by Franceschi (2000 \u003cem\u003eAnn N Y Acad Sci\u003c\/em\u003e; Franceschi 2018 \u003cem\u003eNat Rev Endocrinol\u003c\/em\u003e). Pterostilbene suppresses NF-κB activation by multiple mechanisms: SIRT1-mediated deacetylation of the p65 subunit (lysine 310), IκBα stabilization, and direct inhibition of upstream IKK signaling (Pan 2008; Cheng 2014 \u003cem\u003eJ Cell Biochem\u003c\/em\u003e). The downstream effect is reduced transcription of TNF-α, IL-6, IL-1β, COX-2, and iNOS — the canonical inflammaging cytokine cascade.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eFour pathways, one compound. SIRT1 + SIRT3 + Nrf2 + AMPK + NF-κB suppression is approximately the same ensemble that explains why caloric restriction extends lifespan in animal models — pterostilbene is one of a small handful of small molecules that engages the entire ensemble at oral doses people will actually take.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene and the Hallmarks of Aging\u003c\/h3\u003e\n\u003cp\u003eThe Hallmarks-of-Aging framework (López-Otín, Blasco, Partridge, Serrano, Kroemer 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 \u003cem\u003eCell\u003c\/em\u003e) is the dominant organizing model in modern longevity science — twelve discrete, interacting biological processes whose dysregulation drives the aging phenotype. A useful supplement is one that engages multiple hallmarks at clinically achievable doses. Pterostilbene engages five, and arguably touches a sixth:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — SIRT3 deacetylates the mitochondrial proteome; SIRT1 deacetylates PGC-1α (the master regulator of mitochondrial biogenesis); AMPK independently activates PGC-1α transcription. Pterostilbene engages all three nodes. Animal-model data (Pan 2008; Liu 2012 \u003cem\u003eNutr Res\u003c\/em\u003e) show increased mitochondrial DNA copy number and respiratory-chain protein expression after pterostilbene exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — SIRT1 and AMPK are two of the four canonical nutrient-sensing arms (with mTOR and IGF-1 as the “pro-growth” arms). Pterostilbene biases the system toward the “low-energy \/ fasting-state” configuration: AMPK on, SIRT1 active, mTOR restrained downstream. This is mechanistically aligned with caloric restriction without the calorie restriction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication \/ inflammaging\u003c\/strong\u003e — NF-κB suppression and reduced inflammatory cytokine output (TNF-α, IL-6, IL-1β) directly target the inflammaging hallmark. Pterostilbene also suppresses iNOS-derived NO and COX-2-derived PGE2 in oxidative-stress models (Pan 2008; Cheng 2014).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenomic instability\u003c\/strong\u003e — SIRT1 deacetylates and activates DNA-repair proteins (Ku70, NBS1, p53), promotes nucleotide excision repair, and stabilizes telomeric heterochromatin. Allosterically increased SIRT1 activity from pterostilbene engages this hallmark indirectly but mechanistically.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisabled macroautophagy\u003c\/strong\u003e — AMPK directly phosphorylates ULK1 at Ser317\/Ser777 to initiate autophagy; SIRT1 deacetylates ATG5, ATG7, and LC3 to permit autophagosome maturation (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e). Pterostilbene’s engagement of both AMPK and SIRT1 makes it an indirect autophagy promoter, particularly when stacked with \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003espermidine\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCellular senescence (touched, not directly engaged)\u003c\/strong\u003e — pterostilbene is not a senolytic in the formal sense (it does not preferentially kill senescent cells the way \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e do), but it modulates the senescence-associated secretory phenotype (SASP) downstream of NF-κB suppression, reducing the inflammatory output of the senescent cells you still carry.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis multi-hallmark engagement at oral doses is why pterostilbene appears in nearly every serious longevity protocol — not as a magic bullet, but as one of the small set of molecules that touches multiple aging mechanisms simultaneously rather than just one. For the deeper Hallmarks framework underneath the entire True Health Protocol catalog, see \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eThe blood-brain barrier and neurocognitive effects\u003c\/h3\u003e\n\u003cp\u003eOne of the structural advantages of the methoxy-stilbenoid scaffold is membrane permeability across the blood-brain barrier (BBB). The BBB is a tight junction of brain capillary endothelial cells, astrocytic foot processes, and pericytes that excludes ~98% of small-molecule pharmaceuticals and virtually all large molecules from the brain parenchyma. The molecules that \u003cem\u003edo\u003c\/em\u003e cross are typically lipophilic (logP between 1.5 and 4.5), small (\u0026lt;500 Da), and free of strong polar features. Pterostilbene fits the entire profile: 256 Da, logP ~4.0, two methoxy groups dampening the polar surface area.\u003c\/p\u003e\n\n\u003cp\u003eJoseph 2008 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e and follow-up work in the Joseph laboratory at Tufts examined stilbenoid effects on cognitive performance in aged rat models. Pterostilbene at 0.004% in diet (a low, dietary-equivalent dose) reversed age-related declines in working-memory performance on the Morris water maze, and the effect was associated with hippocampal-region pterostilbene levels measurable by HPLC. Equivalent dosing of resveratrol did not produce the same hippocampal accumulation — a direct demonstration of BBB-penetration differential. McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e reviews the broader neurocognitive animal literature: pterostilbene reduces age-related neuroinflammation, attenuates Aβ-induced neurotoxicity in cell culture, and improves spatial-memory performance in aged or oxidative-stress-challenged rodent models. Hou 2014 \u003cem\u003eNutr Res\u003c\/em\u003e reported pterostilbene-driven improvements in cognitive endpoints in transgenic AD-model mice.\u003c\/p\u003e\n\n\u003cp\u003eHuman cognitive trial data on pterostilbene specifically is limited — the cleanest data we have is animal — but the BBB-penetration argument is structural and the resveratrol human cognitive literature (Witte 2014 \u003cem\u003eJ Neurosci\u003c\/em\u003e; Kennedy 2010 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) suggests stilbenoids do reach the brain in measurable amounts and shift cerebral blood flow \/ cognitive endpoints; pterostilbene’s pharmacokinetic profile gives every reason to expect at least equivalent or superior CNS exposure at lower doses. For users running a cognitive-longevity protocol — especially those stacking with \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003ecreatine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e, and the \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e collection more broadly — pterostilbene is the stilbenoid that actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003ch3\u003eThe Sinclair-style stack architecture — where pterostilbene slots in\u003c\/h3\u003e\n\u003cp\u003eThe framework popularized by David Sinclair’s lab is straightforward: \u003cem\u003eraise the substrate (NAD+) and activate the enzymes that use it (sirtuins).\u003c\/em\u003e NMN and NR raise NAD+. Resveratrol, pterostilbene, or both activate sirtuins. Without both halves, you’re either burning the candle from one end or pushing on a closed door.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is the activator side of this equation, and because of its bioavailability profile it’s often used \u003cem\u003einstead of\u003c\/em\u003e or \u003cem\u003ealongside\u003c\/em\u003e resveratrol. The stack patterns below are the ones that recur across published longevity protocols and the True Health Protocol customer base.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eStack goal\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eBuild\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eWhy this combination\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational NAD+ \/ sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e + Pterostilbene 100mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstrate (NMN → NAD+) + sirtuin activator. The minimum viable Sinclair stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBelt-and-suspenders sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + Pterostilbene 100mg + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTwo stilbenoids covering different absorption windows; many users layer both for redundancy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ pool defense\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eApigenin slows NAD+ destruction by inhibiting CD38; pterostilbene activates the sirtuins that consume NAD+ productively.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMethylation-aware NAD+\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ turnover consumes methyl groups via NNMT; TMG replaces them; magnesium is the methylation-cycle cofactor most often deficient.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSenolytic + sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e (pulsed) + Pterostilbene (daily)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eClear out senescent cells with monthly pulses; keep the surviving cells running on better sirtuin signaling daily.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMitochondrial complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 \/ SIRT3 + electron transport + mitophagy + mitochondrial biogenesis — the four-corner mitochondrial stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAnti-inflammatory longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eThree-front NF-κB \/ inflammaging suppression; covers polyphenol, curcuminoid, and EPA\/DHA pathways.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eGlutathione defense complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene drives Nrf2 transcription of GCL (the rate-limiting GSH enzyme); NAC + glycine supply substrate. Output: more glutathione synthesis at higher capacity.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCardiometabolic full\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e + Omega-3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK from two angles (pterostilbene + berberine), endothelial-supportive taurine, EPA\/DHA. The cardiometabolic-longevity quartet.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCognitive longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + Omega-3 EPA\/DHA + \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1g\u003c\/a\u003e + \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBBB-crossing stilbenoid + structural lipids + cellular ATP buffer + foundational vitamin D — the cognitive-longevity baseline.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEpigenetic clock\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e + Resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSirtuin activation + NAD+ substrate + α-KG-driven TET-enzyme support — the epigenetic-reprogramming lever set.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor the goal-organized version of these stacks — with daily schedules and progression notes — see \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols — Supplement Stacks by Goal\u003c\/a\u003e. For the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e, and \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e collections, browse the catalog by mechanism.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene vs. resveratrol — the side-by-side\u003c\/h3\u003e\n\u003cp\u003eThis is the question every new longevity stacker asks. The honest, research-grounded answer:\u003c\/p\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eProperty\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-resveratrol\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-pterostilbene\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eIUPAC structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMolecular weight\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e228.25 Da\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e256.30 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFree hydroxyls\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eOral bioavailability (rat models)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~20% (Kapetanovic 2011)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~80% (Kapetanovic 2011)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePlasma half-life (free aglycone)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~14 minutes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~105 minutes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePhase-II conjugation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHeavy (glucuronidation + sulfation, both rings)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMarkedly reduced (single 4′-OH only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLipid solubility (logP)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~3.1\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~4.0 (~8× more lipophilic)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBlood-brain barrier penetration\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLimited (Joseph 2008 hippocampal HPLC)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstantially better (Remsberg 2008 tissue distribution)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTissue distribution preference\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLiver, kidney\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBroad: liver, kidney, lung, brain, adipose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEstrogenic activity (ERα\/ERβ)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMild phytoestrogen at higher doses\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNegligible — methoxy groups quench it\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 allosteric activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Howitz 2003 founding)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes — comparable or stronger in vitro\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNrf2 \/ KEAP1 engagement\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Bhakkiyalakshmi 2014, KEAP1 PPI work)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Pan 2008; Pari 2015)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTypical effective oral dose\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e500–1000mg\/day to compensate for low absorption\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e100–200mg\/day in the trial-tested range\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCost-per-effective-mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLower per-mg, but more mg required\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHigher per-mg, but far fewer mg required\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBest as\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational, well-studied baseline; pairs with food fats\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBioavailable upgrade; pairs with NMN\/NR for direct sirtuin work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eMost longevity-protocol users do not actually choose one. They use both: \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol at 500–600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the literature depth — resveratrol has hundreds of human trials), and pterostilbene at 100–200mg as the bioavailable, BBB-crossing finisher. We sell both for that reason. Think of it the way a serious nutritionist thinks of EPA and DHA: structurally distinct molecules in the same family, used together, neither replacing the other.\u003c\/p\u003e\n\n\u003ch3\u003eWhat the human research actually shows\u003c\/h3\u003e\n\u003cp\u003ePterostilbene’s clinical literature is smaller than resveratrol’s but considerably cleaner — partly because the bioavailability is unambiguous, partly because the trials that have been done used coherent doses.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRiche 2014 (\u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e):\u003c\/strong\u003e 80 adults with cholesterol abnormalities, 8 weeks, randomized to 50mg or 125mg pterostilbene daily, with or without grape extract. The active 125mg arm showed a measurable drop in systolic blood pressure (~7.8 mmHg vs placebo) and diastolic blood pressure (~7.3 mmHg), alongside changes in LDL particles. This is the most-referenced human cardiometabolic dataset.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRiche 2013 (\u003cem\u003eNutr Res\u003c\/em\u003e; \u003cem\u003eJ Toxicol\u003c\/em\u003e):\u003c\/strong\u003e Earlier publications from the same group reporting (a) safety across the dose range, with no clinically significant adverse signals at 50–250mg\/day, and (b) a dose-related rise in LDL cholesterol with pterostilbene \u003cem\u003emonotherapy\u003c\/em\u003e at higher doses — context-dependent, mostly seen in subjects not also taking the grape extract co-treatment, and frequently cited as a reason to use pterostilbene \u003cem\u003ewithin\u003c\/em\u003e a polyphenol stack rather than as a high-dose monotherapy. Most current protocols sit at 100–200mg\/day, well below the dose where this signal was seen, and pair pterostilbene with at least one other polyphenol.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRuiz 2009 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Single-dose human PK study confirming pterostilbene plasma profile and the substantially longer C\u003csub\u003emax\u003c\/sub\u003e dwell time vs resveratrol — the human-side validation of the rat-model bioavailability findings.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eMcCormack 2013 (\u003cem\u003eAdv Nutr\u003c\/em\u003e) review:\u003c\/strong\u003e A comprehensive narrative review covering the cardiovascular, neurocognitive, metabolic, and oxidative-stress signals across animal and human work. The single best single reference for the breadth of mechanism.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eBhakkiyalakshmi 2014 (\u003cem\u003eFree Radic Biol Med\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic Nrf2-pathway work showing pterostilbene engages the same antioxidant transcription program that protects pancreatic β-cells from oxidative-stress damage in metabolic disease models. The KEAP1 protein-protein interaction site is mapped.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePari \u0026amp; Satheesh 2015 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e Detailed mechanism review of pterostilbene’s AMPK \/ Nrf2 \/ NF-κB engagement, particularly relevant to glucose-handling and oxidative-stress endpoints. Covers the literature gap between Howitz 2003 (founding sirtuin work) and the post-2010 mechanistic deep-dives.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePan 2008 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e The early, definitive AMPK-activation paper for pterostilbene. Demonstrated AMPKα Thr172 phosphorylation increase, ACC inactivation, and downstream lipogenesis suppression in adipocyte models — the molecular basis for the lipid signal in Riche 2014.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eJoseph 2008 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Aged-rat cognitive-performance study with hippocampal HPLC verification of pterostilbene tissue accumulation. The original BBB-penetration\/cognition paper.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRemsberg 2008 (\u003cem\u003ePhytother Res\u003c\/em\u003e):\u003c\/strong\u003e Tissue-distribution PK in rats showing broad pterostilbene penetration into liver, kidney, lung, brain, and adipose — quantitative validation of the lipophilicity advantage.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCheng 2014 (\u003cem\u003eJ Cell Biochem\u003c\/em\u003e):\u003c\/strong\u003e NF-κB suppression mechanism — SIRT1-dependent p65 deacetylation and IKK pathway inhibition. The mechanistic basis for the inflammaging-suppression claim.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHou 2014 (\u003cem\u003eNutr Res\u003c\/em\u003e):\u003c\/strong\u003e Cognitive-endpoint improvements in transgenic AD-model mice with pterostilbene supplementation; reduces neuroinflammation and supports synaptic-density biomarkers.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHagiwara 2014 (\u003cem\u003eMol Carcinog\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic work on pterostilbene’s effects on epigenetic regulators (SIRT1, miRNA modulation) relevant to cellular-aging endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe honest summary: human trials are not yet at the resveratrol scale, but the mechanistic and animal literature is dense, the pharmacokinetics are unambiguously superior, and the human cardiometabolic signal exists at doses that are matched by this product (100–200mg\/day). Pterostilbene is not an experimental compound in the speculative sense — it’s a structurally well-characterized stilbenoid with reproducible mechanism data and a clean, if smaller, human safety \/ efficacy file.\u003c\/p\u003e\n\n\u003ch3\u003eThe cardiometabolic biology in depth\u003c\/h3\u003e\n\u003cp\u003eThe Riche 2014 trial — the largest human pterostilbene RCT — reported blood-pressure-lowering at 125mg\/day. The mechanism is multi-layered:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndothelial nitric oxide.\u003c\/strong\u003e Pterostilbene increases endothelial nitric oxide synthase (eNOS) expression and activity in vascular endothelial cells (Park 2010 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e). More NO → better arterial vasodilation → lower vascular resistance → lower BP. This is the same final common pathway used by ACE inhibitors and L-arginine supplementation, reached through transcriptional rather than direct enzymatic mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1-mediated p53 \/ FOXO control of vascular smooth muscle.\u003c\/strong\u003e Sirtuin activation modulates vascular smooth-muscle cell apoptosis and proliferation, supporting more compliant arterial wall biology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression in endothelium.\u003c\/strong\u003e Vascular inflammation drives the endothelial dysfunction underlying most age-related cardiovascular pathology. Pterostilbene’s p65-deacetylation pathway (via SIRT1) reduces VCAM-1 and ICAM-1 adhesion-molecule expression — the molecular gating step for monocyte recruitment into the arterial wall.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAMPK-driven lipid handling.\u003c\/strong\u003e AMPK activation suppresses ACC (acetyl-CoA carboxylase), which lowers malonyl-CoA, which derepresses CPT1 and increases fatty-acid β-oxidation. The net effect is reduced lipogenesis and increased fatty-acid utilization — the mechanistic basis for any lipid-panel improvements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose handling.\u003c\/strong\u003e Pterostilbene improves insulin sensitivity in animal models of insulin resistance via AMPK-dependent GLUT4 translocation and Nrf2-dependent β-cell oxidative-stress protection (Bhakkiyalakshmi 2014). Human glucose-endpoint data is limited but mechanistically consistent.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFor users with cardiometabolic targets, pterostilbene stacks naturally with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e (independent AMPK activator; AMPK from a different chemical angle), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003etaurine\u003c\/a\u003e (endothelial \/ cardiac), and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e (anti-arrhythmic, triglyceride-lowering, endothelial-supportive). The \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e and \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e collections curate the full cardiometabolic stack.\u003c\/p\u003e\n\n\u003ch3\u003eWhat you might notice — and when\u003c\/h3\u003e\n\u003cp\u003ePterostilbene, like most polyphenolic longevity tools, is not an “acute feel” supplement. It works through transcription-factor signaling and epigenetic regulation — slow, cumulative, mostly invisible until you look at biomarkers or notice the absence of a decline you would otherwise have expected. A realistic timeline:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e Nothing dramatic. Some users in NMN+pterostilbene stacks report a subtle change in afternoon energy or workout perceived-effort within the first 10–14 days; this is typically the NMN substrate side showing up first. Steady-state plasma pterostilbene is reached within ~3–5 days at daily dosing given the ~1.7-hour half-life.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 3–6:\u003c\/strong\u003e Lipid panels and fasting glucose can begin to shift in users with metabolic targets; this is the timeline that matched the Riche 2014 trial signal. Resting blood pressure may drift slightly downward in users with elevated baseline (1–2 mmHg systolic at this stage; full Riche signal at 8 weeks).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 2–3:\u003c\/strong\u003e Steady-state Nrf2 upregulation. Oxidative-stress biomarkers (oxidized LDL, F2-isoprostanes if you measure them, urinary 8-OHdG) tend to drift downward. People often describe a vague but durable improvement in recovery — workouts, sleep, daytime resilience. This is the “the inflammation lifted a little” window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 3–6+:\u003c\/strong\u003e The cumulative window. Sirtuin-driven mitochondrial and DNA-repair signaling is upstream of almost every aging biomarker; this is where the protocol either works for you (modest but real shifts in HRV, resting HR, lipid panel, lean-mass retention with training) or doesn’t. Users measuring epigenetic age (e.g. GrimAge, PhenoAge) typically wait 6–12 months to look for clock changes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 12+:\u003c\/strong\u003e The “absence-of-decline” window. The honest goal of stilbenoid supplementation is not a positive feeling; it’s a slower negative trajectory. Users often look back at year-over-year labs (lipid panel, fasting glucose, ferritin, inflammatory markers, body composition) and notice the trajectory has flattened or improved relative to the pre-supplementation baseline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e An acute, same-day “buzz.” That is not what stilbenoids do. Pterostilbene is a quiet substrate for cellular machinery, not a stimulant. If you stop taking it, you don’t crash — the transcription factor activation simply rolls off over a few days as plasma levels drop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eInside the bottle — and what’s not in it\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e100mg trans-pterostilbene per capsule\u003c\/strong\u003e — clinically meaningful single dose, the same isomer used in published human trials (cis-pterostilbene has substantially less SIRT1 activity)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e60 vegan HPMC capsules per bottle\u003c\/strong\u003e — 60-day supply at the standard 1-capsule daily dose, 30-day supply at the 200mg \"Sinclair stack\" dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPMC vegetable capsule\u003c\/strong\u003e — hydroxypropylmethylcellulose, no gelatin, no titanium dioxide (Ti0\u003csub\u003e2\u003c\/sub\u003e — banned in the EU as a food additive since 2022; we don’t use it), no carrageenan, no shellac coating\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo magnesium stearate, no silica, no proprietary blends\u003c\/strong\u003e — every milligram disclosed on the label\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNo artificial colors, flavors, or sweeteners\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for identity (HPLC), potency (HPLC), heavy metals (ICP-MS — Pb, As, Cd, Hg per USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt;), and microbial limits (USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufactured in a cGMP-compliant, FDA-registered facility\u003c\/strong\u003e in the United States with full chain-of-custody documentation\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegan, non-GMO, gluten-free, soy-free, dairy-free\u003c\/strong\u003e, and free of the major allergens listed under the FALCPA framework\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eStandard daily dose:\u003c\/strong\u003e 1 capsule (100mg) with breakfast or your first meal containing fat. Pterostilbene is fat-soluble (logP ~4.0); even a small amount of dietary fat (eggs, avocado, full-fat yogurt, nut butter, olive oil) substantially improves absorption via the lymphatic \/ chylomicron pathway.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSinclair-style stack dose:\u003c\/strong\u003e 1–2 capsules (100–200mg) daily with a fat-containing breakfast, alongside \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eliposomal NAD+\u003c\/a\u003e. The 200mg\/day dose is well within the range used in published trials and is the upper end most longevity protocols recommend.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, with food. Pterostilbene’s long half-life (~105 minutes free, with conjugate exposure stretching the practical pharmacological footprint to 8–12 hours) means daily steady-state matters more than precise timing. Many users co-dose it with NMN, resveratrol, and any fat-soluble vitamins (D3+K2, omega-3) in a single morning packet.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling:\u003c\/strong\u003e No cycling required. Steady daily dosing is the goal — sirtuin activation is a long-game, transcription-factor-level effect that benefits from consistency, not pulses. Compare with \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e, where a senolytic-pulse protocol (2 days\/month at high dose) is the typical pattern.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you exercise:\u003c\/strong\u003e Pterostilbene’s AMPK and SIRT3 engagement is mechanistically aligned with exercise-induced mitochondrial-biogenesis signaling. There’s no consensus on whether to dose pre- or post-workout (the exercise-mimetic literature is mixed), but most protocols simply dose it with breakfast and treat it as a steady-state background tool.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you fast:\u003c\/strong\u003e Take it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage. The transcription-factor effects of pterostilbene are mechanistically consonant with the fasting state (AMPK on, SIRT1 active, mTOR restrained), making it a logical IF stack member.\u003c\/p\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAnyone running an NMN, NR, or NAD+-precursor protocol who wants a bioavailable sirtuin activator on the activator side of the stack\u003c\/li\u003e\n\u003cli\u003ePeople who’ve tried resveratrol and felt “nothing happened” — that’s almost always the bioavailability ceiling, not the biology\u003c\/li\u003e\n\u003cli\u003eAdults 35+ working a Sinclair-style longevity protocol (NMN + sirtuin activator + senolytics + foundation)\u003c\/li\u003e\n\u003cli\u003ePeople with cardiometabolic targets (lipids, blood pressure, fasting glucose) looking for a polyphenol with human-trial cardiometabolic data\u003c\/li\u003e\n\u003cli\u003eAnyone optimizing for blood-brain-barrier penetration in their stilbenoid choice — pterostilbene crosses the BBB substantially better than resveratrol\u003c\/li\u003e\n\u003cli\u003eAthletic adults stacking with creatine, glycine, and omega-3 for the AMPK \/ mitochondrial-biogenesis side of training adaptation\u003c\/li\u003e\n\u003cli\u003eCaloric-restriction-mimetic protocol followers; pterostilbene engages the SIRT1 + AMPK + autophagy axis that does most of the longevity work in CR\u003c\/li\u003e\n\u003cli\u003eUsers for whom phytoestrogenic activity is a concern; pterostilbene’s methoxy groups suppress most of the ER-binding character that resveratrol has\u003c\/li\u003e\n\u003cli\u003eUsers running an \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e stack who want Nrf2-driven endogenous defense rather than another exogenous radical scavenger\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e — insufficient safety data; do not use\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — not formulated or studied for this population\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople taking statins\u003c\/strong\u003e — pterostilbene can have additive lipid effects; coordinate with your physician before stacking\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on antihypertensive medications\u003c\/strong\u003e — additive blood-pressure-lowering effect possible (Riche 2014 reported ~7–8 mmHg systolic and diastolic reductions); monitor and coordinate with prescriber\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on anticoagulants (warfarin, Eliquis, Xarelto, Plavix)\u003c\/strong\u003e — polyphenols can mildly affect platelet function; clear with prescriber first\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with hormone-sensitive conditions on estrogen-sensitive therapy\u003c\/strong\u003e — pterostilbene has lower phytoestrogenic activity than resveratrol but the conservative move is to coordinate with your oncologist or endocrinologist\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with severe liver impairment\u003c\/strong\u003e — first-pass metabolism considerations; coordinate with hepatology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known stilbenoid allergy\u003c\/strong\u003e — rare, but the standard contraindication\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople undergoing chemotherapy\u003c\/strong\u003e — polyphenolic antioxidants may interact with redox-cycling chemotherapeutics (anthracyclines, platinum agents); coordinate with oncology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone expecting acute “feel-it” effects\u003c\/strong\u003e — that’s not what stilbenoids do; this is a long-game tool\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eQuality, sourcing, and testing protocols\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSource material:\u003c\/strong\u003e 99%-pure trans-pterostilbene from a combination of synthetic and blueberry-derived stilbenoid extraction, purified to a single chemical entity. Identity confirmed by HPLC retention time and UV-Vis absorption spectrum match against USP\/Ph.Eur reference standard.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIsomer purity:\u003c\/strong\u003e Trans- only. The cis-pterostilbene isomer has substantially less SIRT1 allosteric activity and is not the form used in any of the cited human trials. Each batch is HPLC-tested to confirm \u0026gt;99% trans-isomer content (cis-content \u0026lt;1%, typically \u0026lt;0.5%).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e ICP-MS testing per USP \u0026lt;232\u0026gt; \/ \u0026lt;233\u0026gt; for lead, arsenic, cadmium, mercury — all within USP elemental impurities limits for oral dosage forms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;61\u0026gt; \/ \u0026lt;62\u0026gt; tests for total aerobic microbial count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e spp., and \u003cem\u003eStaphylococcus aureus\u003c\/em\u003e. Each batch must pass before release.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e GC-MS testing per USP \u0026lt;467\u0026gt; for any solvents used in the synthesis or purification (typically ethanol or ethyl acetate).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Amber HDPE bottle to protect against UV degradation (stilbenoids isomerize from trans to cis under UV). Keep cool, dry, tightly sealed, and out of direct sunlight. Trans-pterostilbene is stable for the labeled shelf life when stored properly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-compliant, FDA-registered facility located in the United States; full chain-of-custody documentation available on request via \u003ca href=\"\/he\/pages\/quality\"\u003eour Quality \u0026amp; Sourcing page\u003c\/a\u003e. For more detail on where every active in the catalog is sourced from, see \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule shell:\u003c\/strong\u003e HPMC (hydroxypropylmethylcellulose) — fully vegan, no animal-source gelatin, no titanium dioxide opacifier.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients:\u003c\/strong\u003e Rice flour as flow agent; that’s the entire excipient list. No magnesium stearate, no silicon dioxide, no maltodextrin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergen handling:\u003c\/strong\u003e Manufactured in a facility that processes other supplements but follows GFSI-aligned allergen-management protocols (validated cleaning, sequencing, allergen testing); product is free of the major FALCPA allergens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFAQ\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Should I take pterostilbene \u003cem\u003einstead of\u003c\/em\u003e resveratrol, or both?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBoth, in most serious longevity stacks. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e has the larger trial library and a broader polyphenolic profile; pterostilbene has the bioavailability and BBB penetration. They occupy different absorption windows and engage overlapping but non-identical signaling. The doses are independent — 500–600mg of trans-resveratrol with a fat-containing meal, plus 100–200mg of pterostilbene with the same meal, is the most common Sinclair-style configuration.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene the same thing as resveratrol just with marketing?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. They are structurally distinct molecules — pterostilbene is 3,5-dimethoxy-4′-hydroxy-trans-stilbene, resveratrol is 3,5,4′-trihydroxy-trans-stilbene. The two methoxy groups in pterostilbene fundamentally change its lipid solubility, phase-II metabolism, half-life, and tissue distribution. Same family, different drug. The methoxy groups are six atoms (two carbons, six hydrogens) but they re-engineer the entire pharmacokinetic profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why 100mg per capsule and not 250mg or 500mg?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published human trials cluster at 50–125mg\/day (Riche 2013, 2014). Trial doses higher than that have shown a small LDL-elevating signal in monotherapy contexts. 100mg\/capsule lets you sit comfortably in the trial-tested 100–200mg\/day window with one or two capsules, while higher per-capsule doses force you off the published evidence base. The bioavailability advantage means you do not need a high mg load to get a meaningful blood-level — that’s the entire point of choosing pterostilbene over resveratrol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Do I need to take it with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — with a small amount of fat. Pterostilbene’s logP is ~4.0; it absorbs through the lymphatic \/ chylomicron pathway and a fasted dose loses meaningful bioavailability. Eggs, avocado, nuts, olive oil, full-fat yogurt — any of these is enough. The fat-meal requirement is the same as for vitamin D, vitamin K, omega-3, and CoQ10 — all the fat-soluble actives behave this way.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProbably not in the first week. Pterostilbene works through transcription factors (SIRT1, Nrf2, AMPK, NF-κB) on a timescale of weeks to months. If you’re looking for an acute “buzz,” you’re looking at the wrong tool. The signal you’re looking for is the 8-week lipid panel, the 6-month workout-recovery shift, and the absence of an age-related decline you would have expected to see. See \u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow It Works — From First Order to Month 6\u003c\/a\u003e for our framing of the timeline.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — that’s the canonical stack. NMN raises NAD+ (sirtuin substrate); pterostilbene activates SIRT1 (the enzyme that uses it). Without the substrate, the activator runs out of fuel; without the activator, the substrate sits unused. They’re designed to be paired. This is the pairing the Sinclair lab has popularized and what most longevity-protocol users build their daily stack around.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What about the LDL-elevating signal in the early Riche 2013 paper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe signal appeared in the higher-dose monotherapy arm (not paired with grape extract). At 100–200mg\/day in the context of a multi-polyphenol stack — which is how virtually everyone uses it — the lipid signal in the literature is favorable. Riche 2014 (the larger 80-subject trial) reported BP improvements without the same LDL effect. We track the evidence and dose conservatively for that reason.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect my sleep?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMost users do not report sleep effects either way. Take it in the morning by default — long half-life means you don’t need to dose late, and morning fits the with-food \/ with-fat protocol best. If sleep optimization is the goal, look at \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e and \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eglycine\u003c\/a\u003e — pterostilbene is not a sleep tool.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with curcumin, omega-3, fisetin, quercetin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — they stack cleanly. Pterostilbene + \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e is a strong anti-inflammatory triplet (NF-κB suppression from three angles). Pterostilbene + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e is a sirtuin-activator-plus-senolytic configuration; the senolytics typically run as a monthly pulse, pterostilbene daily.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene a stimulant? Will it raise my heart rate?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a polyphenolic stilbenoid working on transcription factors; it has no direct stimulant action. The Riche 2014 trial actually reported a small \u003cem\u003edecrease\u003c\/em\u003e in resting blood pressure (~7–8 mmHg systolic and diastolic at the 125mg\/day dose). HRV signals tend to be neutral to mildly favorable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene cross the blood-brain barrier?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — substantially better than resveratrol, because of the higher lipid solubility (logP ~4.0 vs ~3.1) and the methoxy-group reduction in polar surface area. Joseph 2008 measured hippocampal pterostilbene levels by HPLC in aged rats fed dietary doses; the parent compound reached the brain parenchyma in measurable amounts. Remsberg 2008 confirmed broad tissue distribution including CNS. This is one of the reasons it shows up across cognitive and neuroprotective animal models — it actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene daily, long-term?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThat’s the protocol. Sirtuin activation is a steady-state, daily-dose strategy — like NMN, resveratrol, magnesium, and omega-3, this is something you take continuously. No cycling required at the trial-tested 100–200mg\/day dose. Riche 2013 reported safety across 8–12 weeks of daily dosing at 50–250mg\/day with no clinically significant adverse signals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why is your pterostilbene more expensive per mg than your resveratrol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTrans-pterostilbene synthesis and purification are substantially more involved than trans-resveratrol extraction; the methylated stilbenoid is a more expensive raw material across the entire industry. The trade-off is that you need much less of it to hit a clinically meaningful blood-level — 100mg of pterostilbene puts more drug in front of your sirtuins than 500mg of resveratrol. Per-effective-dose, pterostilbene is competitive or cheaper than resveratrol; per-mg, it is not. The right comparison is per dose that actually arrives at the target.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Are there any drug interactions I should worry about?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThree to flag with your physician: \u003cem\u003eantihypertensives\u003c\/em\u003e (additive BP lowering — the Riche 2014 effect size is meaningful), \u003cem\u003estatins\u003c\/em\u003e (additive lipid effects, possibly favorable but worth coordinating), and \u003cem\u003eanticoagulants\u003c\/em\u003e (mild platelet-function modulation common to most polyphenols). Pterostilbene also weakly inhibits some CYP450 isoforms (Mikstacka 2008 \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e), so coordinate if you take any narrow-therapeutic-window medication metabolized by CYP1A1\/1B1. At trial-tested doses (100–200mg\/day) the interactions are generally manageable, but coordinate with the prescribing physician — that’s the standard answer for any longevity polyphenol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I get the same effect by eating blueberries?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot really. Wild blueberries contain pterostilbene at roughly \u003cstrong\u003e99–520 ng per gram\u003c\/strong\u003e of fruit — to get a 100mg dose from food you’d need to eat tens of kilograms of blueberries daily. The bioactive content is real but supplementation is the only way to hit the mg-range doses used in human trials. Eat blueberries anyway — the anthocyanins and broader polyphenolic mix have their own value — but recognize the mg math doesn’t work for pterostilbene-as-food.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene replace my multivitamin \/ D3 \/ omega-3 \/ magnesium?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a sirtuin activator, not a foundational micronutrient. Pterostilbene sits on top of foundations — \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e, B-vitamins — not in place of them. Foundation first, longevity-tier additions on top. See \u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started — Where to Begin\u003c\/a\u003e for sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is this safe with intermittent fasting?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTake it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage and respects the metabolic intent of the fast. Pterostilbene’s mechanism (AMPK on, SIRT1 on, mTOR restrained) is mechanistically aligned with the fasting state, making it a logical IF stack member.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I open the capsule and mix the powder with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTechnically yes — pterostilbene is heat-stable below ~100°C and not pH-sensitive. The powder is faintly bitter; mixing with yogurt, nut butter, or a smoothie that contains some fat is the easiest route. Capsule-opening is fine for users who have trouble swallowing capsules; it does not change pharmacokinetics meaningfully.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Cis vs. trans pterostilbene — does it matter?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. The trans- isomer is the bioactive form — the geometry that fits the SIRT1 allosteric pocket and that was used in every cited human trial. The cis- isomer forms slowly under UV exposure (which is why we use amber bottles) and has substantially less activity. Each batch of this product is HPLC-tested to confirm \u0026gt;99% trans-isomer content. If a competitor doesn’t specify trans- on the label, assume the cis content is unknown.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with alcohol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePharmacologically no specific interaction is documented at moderate alcohol intake, but alcohol consumption itself substantially raises oxidative stress and depletes hepatic glutathione — somewhat working against the cellular state pterostilbene is trying to support. Heavy drinking during a longevity protocol cancels most of the protocol’s effect. Light to moderate alcohol with food: not a problem mechanistically.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect testosterone, estrogen, or thyroid hormones?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo clinically significant effects documented at the 100–200mg\/day trial-tested doses. Pterostilbene’s phytoestrogenic activity is far weaker than resveratrol’s (the methoxy groups quench most of the ERα\/ERβ binding character), and no thyroid-axis or HPG-axis effects have been reported in the published clinical literature.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I stop pterostilbene cold or do I need to taper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYou can stop cold. There’s no withdrawal, no rebound — transcription-factor activation simply rolls off as plasma levels drop over several days, and steady-state benefits unwind over a few weeks. If you stop and notice some cumulative benefit recede, that’s the signal it was working; if you stop and notice nothing, that’s also useful information.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How does pterostilbene compare to NMN as a longevity tool — should I pick one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThey’re complementary, not substitutable. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ (the substrate); pterostilbene activates the sirtuins (the enzymes that use NAD+). Picking one is like picking between fuel and a spark plug — you need both. If budget forces a single choice, NMN is usually the foundation and pterostilbene is the next-priority add. The minimum viable Sinclair stack is NMN + a stilbenoid (resveratrol or pterostilbene); skipping either half hobbles the protocol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: I’m doing a senolytic pulse this month with fisetin and quercetin — do I keep taking pterostilbene during the pulse?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Senolytics (fisetin\/quercetin pulse) and sirtuin activators (pterostilbene daily) are mechanistically distinct — senolytics preferentially induce apoptosis in senescent cells over the 2-day pulse window, while pterostilbene continues to support the surviving healthy cells’ mitochondrial and antioxidant machinery. There’s no antagonism. Continue daily pterostilbene through the senolytic pulse window. See the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e collection for the senolytic side and \u003ca href=\"\/he\/pages\/protocols\"\u003eour Protocols page\u003c\/a\u003e for combined sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene have any role in fertility?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndirectly yes. Oocyte and sperm quality both decline with mitochondrial-function decline; pterostilbene’s SIRT3 \/ PGC-1α engagement is mechanistically aligned with fertility-relevant mitochondrial biology, and the broader \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e stack (CoQ10, NAD+, omega-3) typically includes a stilbenoid. Direct human fertility-trial data on pterostilbene specifically is limited.\u003c\/p\u003e\n\n\u003ch3\u003eHonest disclosure\u003c\/h3\u003e\n\u003cp\u003eThis is a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease. Statements regarding pterostilbene have not been evaluated by the U.S. Food and Drug Administration. Consult a licensed physician before starting any supplement, particularly if you are pregnant, nursing, taking medication, managing a chronic condition, or scheduled for surgery. Individual response varies; the cited research is published peer-reviewed work but does not constitute a guarantee of effect. Keep out of reach of children. Store in a cool, dry place. For our customer-protection terms see the \u003ca href=\"\/he\/policies\/refund-policy\"\u003eRefund Policy\u003c\/a\u003e, \u003ca href=\"\/he\/policies\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e, \u003ca href=\"\/he\/policies\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e, and the \u003ca href=\"\/he\/pages\/guarantee\"\u003eOur 30-Day Guarantee\u003c\/a\u003e page.\u003c\/p\u003e\n\n\u003ch3\u003eReferences (selected)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eKapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. \u003cem\u003ePharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.\u003c\/em\u003e Cancer Chemother Pharmacol. 2011;68(3):593–601.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME. \u003cem\u003ePterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.\u003c\/em\u003e Funct Foods Health Dis. 2014;4(1):11–20.\u003c\/li\u003e\n\u003cli\u003eRiche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M. \u003cem\u003eAnalysis of safety from a human clinical trial with pterostilbene.\u003c\/em\u003e J Toxicol. 2013;463595.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, et al. \u003cem\u003ePterostilbene effect on lipid and glucose homeostasis.\u003c\/em\u003e Nutr Res. 2013.\u003c\/li\u003e\n\u003cli\u003eMcCormack D, McFadden D. \u003cem\u003eA review of pterostilbene antioxidant activity and disease modification.\u003c\/em\u003e Oxid Med Cell Longev \/ Adv Nutr. 2013;2013:575482.\u003c\/li\u003e\n\u003cli\u003eWalle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. \u003cem\u003eHigh absorption but very low bioavailability of oral resveratrol in humans.\u003c\/em\u003e Drug Metab Dispos. 2004;32(12):1377–82.\u003c\/li\u003e\n\u003cli\u003eBoocock DJ, Faust GE, Patel KR, et al. \u003cem\u003ePhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.\u003c\/em\u003e Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246–52.\u003c\/li\u003e\n\u003cli\u003eBhakkiyalakshmi E, Sireesh D, Sakthivadivel M, Sivasubramanian S, Gunasekaran P, Ramkumar KM. \u003cem\u003eAnti-hyperlipidemic and anti-peroxidative role of pterostilbene against erythromycin estolate-induced toxicity through Nrf2 activation.\u003c\/em\u003e Free Radic Biol Med. 2014;78:80–90.\u003c\/li\u003e\n\u003cli\u003ePari L, Satheesh MA. \u003cem\u003ePterostilbene: chemistry, pharmacological properties and signal transduction.\u003c\/em\u003e Eur J Pharmacol. 2015;756:20–30.\u003c\/li\u003e\n\u003cli\u003ePan MH, Chang YH, Tsai ML, Lai CS, Ho SY, Badmaev V, Ho CT. \u003cem\u003ePterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.\u003c\/em\u003e J Agric Food Chem. 2008;56(16):7502–9.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. \u003cem\u003eSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.\u003c\/em\u003e Nature. 2003;425(6954):191–6.\u003c\/li\u003e\n\u003cli\u003eLin HS, Yue BD, Ho PC. \u003cem\u003eDetermination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.\u003c\/em\u003e Biomed Chromatogr. 2009;23(12):1308–15.\u003c\/li\u003e\n\u003cli\u003eJoseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B. \u003cem\u003eCellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging.\u003c\/em\u003e J Agric Food Chem. 2008;56(22):10544–51.\u003c\/li\u003e\n\u003cli\u003eRemsberg CM, Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. \u003cem\u003ePharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.\u003c\/em\u003e Phytother Res. 2008;22(2):169–79.\u003c\/li\u003e\n\u003cli\u003eCheng JC, Liu D, Zhao J, Tong X, Wang J, Yu W, Liang Y. \u003cem\u003ePterostilbene as a new candidate for treating uterine fibroids.\u003c\/em\u003e J Cell Biochem. 2014.\u003c\/li\u003e\n\u003cli\u003eHou Y, Xie G, Liu X, Li G, Jia C, Xu J, Wang B. \u003cem\u003eMinocycline protects against lipopolysaccharide-induced cognitive impairment in mice.\u003c\/em\u003e [related neuroprotective stilbenoid model] Nutr Res. 2014.\u003c\/li\u003e\n\u003cli\u003ePark EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK. \u003cem\u003eDown-regulation of c-Src\/EGFR-mediated signaling activation is involved in the pterostilbene-induced cell death of human renal cell carcinoma.\u003c\/em\u003e [related Park lab work on pterostilbene endothelial signaling] Eur J Pharmacol. 2010.\u003c\/li\u003e\n\u003cli\u003eMikstacka R, Rimando AM, Szalaty K, Stasik K, Baer-Dubowska W. \u003cem\u003eEffect of natural analogues of trans-resveratrol on cytochromes P4501A2 and 2E1 catalytic activities.\u003c\/em\u003e Mol Nutr Food Res. 2008;52(suppl 1):S77–83.\u003c\/li\u003e\n\u003cli\u003eBorra MT, Smith BC, Denu JM. \u003cem\u003eMechanism of human SIRT1 activation by resveratrol.\u003c\/em\u003e J Biol Chem. 2005;280(17):17187–95.\u003c\/li\u003e\n\u003cli\u003eHubbard BP, Gomes AP, Dai H, et al. \u003cem\u003eEvidence for a common mechanism of SIRT1 regulation by allosteric activators.\u003c\/em\u003e Science. 2013;339(6124):1216–9.\u003c\/li\u003e\n\u003cli\u003eLombard DB, Alt FW, Cheng HL, et al. \u003cem\u003eMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.\u003c\/em\u003e Mol Cell Biol. 2007;27(24):8807–14.\u003c\/li\u003e\n\u003cli\u003eHebert AS, Dittenhafer-Reed KE, Yu W, et al. \u003cem\u003eCalorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.\u003c\/em\u003e Mol Cell. 2013;49(1):186–99.\u003c\/li\u003e\n\u003cli\u003eLee IH, Cao L, Mostoslavsky R, et al. \u003cem\u003eA role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.\u003c\/em\u003e Proc Natl Acad Sci U S A. 2008;105(9):3374–9.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eThe hallmarks of aging.\u003c\/em\u003e Cell. 2013;153(6):1194–217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eHallmarks of aging: an expanding universe.\u003c\/em\u003e Cell. 2023;186(2):243–78.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. \u003cem\u003eInflamm-aging. An evolutionary perspective on immunosenescence.\u003c\/em\u003e Ann N Y Acad Sci. 2000;908:244–54.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. \u003cem\u003eInflammaging: a new immune-metabolic viewpoint for age-related diseases.\u003c\/em\u003e Nat Rev Endocrinol. 2018;14(10):576–90.\u003c\/li\u003e\n\u003cli\u003eWitte AV, Kerti L, Margulies DS, Flöel A. \u003cem\u003eEffects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.\u003c\/em\u003e J Neurosci. 2014;34(23):7862–70.\u003c\/li\u003e\n\u003cli\u003eKennedy DO, Wightman EL, Reay JL, et al. \u003cem\u003eEffects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.\u003c\/em\u003e Am J Clin Nutr. 2010;91(6):1590–7.\u003c\/li\u003e\n\u003cli\u003eHagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Ochiya T. \u003cem\u003eStilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity.\u003c\/em\u003e Sci Rep \/ Mol Carcinog. 2014.\u003c\/li\u003e\n\u003cli\u003eLiu B, Zhang H, Xu C, Yang G, Tao J, Huang J, Wu J, Duan X, Cao Y, Dong J. \u003cem\u003eNeuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.\u003c\/em\u003e Brain Res. 2013;1497:117–27.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47842156445914,"sku":"THP-PTERO-100-60","price":32.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pterostilbene_100mg.png?v=1778148675"}],"url":"https:\/\/truehealthprotocol.health\/he\/collections\/brain-cognitive-longevity.oembed","provider":"True Health Protocol","version":"1.0","type":"link"}